










Instituto de Tecnologia Química e Biológica
Universidade Nova de Lisboa
S
tudies on resistance and response to vancom
ycin
in E
nterococcus faecalis: a last resort antibiotic
Enterococci are members of the gastrointestinal tract microbial con-
sortium of humans and other animals but the genus has proven adept 
at causing opportunistic infections in immunocompromised patients. 
Enterococci were the first clinically relevant etiological agents acquir-
ing vancomycin resistance. The appearance of vancomycin resist-
ance in enterococci and its successful spread within the genus and 
to bacteria from other genus directly implies less therapeutic options 
for critically ill patients infected with these opportunistic pathogens. 
Moreover, when antimicrobial therapy is prescribed to treat infection, 
both the bacteria which are the target of antibiotic treatment and the 
others are exposed to a range of subinhibitory concentrations in the 
host, during and after treatment with the therapeutic dose.
In the first part of this thesis we focused on molecular and microbio-
logical approaches to characterize the dissemination of vancomycin 
resistance determinants among enterococcal strains, contributing to 
draw a bigger picture of the scenario in Portugal. On the second part 
we carried out a more extensive study on the extent of the effects of 
vancomycin exposure and how metabolically E. faecalis cope with this 
exposure. This work contributes to the knowledge of the transcription 
events that E. faecalis undergoes under stress, and hopefully could be 
used in future to elucidate the biology of this bacterium. O
eiras | January 2011
Tânia R
ibeiro
Enterococci are members of the gastrointestinal tract microbial con-
sortium of humans and other animals but the genus has proven adept 
at causing opportunistic infections in immunocompromised patients. 
Enterococci were the first clinically relevant etiological agents acquir-
ing vancomycin resistance. The appearance of vancomycin resist-
ance in enterococci and its successful spread within the genus and 
to bacteria from other genus directly implies less therapeutic options 
for critically ill patients infected with these opportunistic pathogens. 
Moreover, when antimicrobial therapy is prescribed to treat infection, 
both the bacteria which are the target of antibiotic treatment and the 
others are exposed to a range of subinhibitory concentrations in the 
host, during and after treatment with the therapeutic dose. 
In the first part of this thesis we focused on molecular and microbio-
logical approaches to characterize the dissemination of vancomycin 
resistance determinants among enterococcal strains, contributing to 
draw a bigger picture of the scenario in Portugal. On the second part 
we carried out a more extensive study on the extent of the effects of 
vancomycin exposure and how metabolically E. faecsJis cope with this 
exposure. This work contributes to the knowledge of the transcription 
events that E. faecsJis undergoes under stress, and hopefully could be 
used in future to elucidate the biology of this bacterium. 
Studies on 
resistance and 




TAnia Catarino Ribeiro 
IIIBIIIuID de Tecnalagla Qurmlca • Blal6g1c11 




Studies on resistance and response 
to vancomycin in  
Enterococcus faecalis: 
a last resort antibiotic 
 
 
Tânia Catarino Ribeiro 
 
 
Dissertation presented to obtain a Ph.D. degree in Biochemistry by 
Instituto de Tecnologia Química e Biológica 





Instituto de Tecnologia Química e Biológica 
Universidade Nova de Lisboa 
Oeiras, January 2011 
 
ii 
Financial Support from Fundação para a Ciência e Tecnologia (FCT) – Ph.D: 










Cover conception and design by 
André Loureiro 













Professor Doutora Maria de Fátima Silva Lopes – Investigadora Auxiliar do 
Laboratório Associado de Oeiras, Instituto de Tecnologia Química e Biológica, 






Professor Doutor Michael S. Gilmore – Research Scientist of the 
Massachussetts Eye and Ear Infirmary, Sir William Osler Professor Department of 
Ophthalmology, Department of Microbiology and Molecular Genetics, Biological 
and Biomedical Sciences Program of the Harvard Medical School, Boston, USA 
(Principal Examiner).  
 
Professor Doutor Axel Hartke – Senior Scientist (PR1 of Molecular 
Microbiology), Leader of the group Stress and Virulence of Enterococci of Caen 
University, France (Principal Examiner). 
 
Professor Doutor Francisco Dionísio – Professor Auxiliar do Departamento de 







































“Fazer qualquer coisa completa, inteira, seja boa ou má - e, se nunca é 
inteiramente boa, muitas vezes não é inteiramente má -, sim, fazer uma coisa 
completa causa-me, talvez, mais inveja do que outro qualquer sentimento. É 
como um filho: é imperfeita como todo o ente humano, mas é nossa como os 
nossos filhos são.” 
 




“Do something complete, whole, good or bad – and, if is never entirely good, most 
of the times it is not entirely bad -, yes, make a complete thing causes me, 
perhaps, more envy than any other feeling. It's like a child: it is imperfect like any 
human being, but it is ours like our children are.” 
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Enterococci are part of the normal human and animal gut microbiota and 
hardly cause infections in healthy individuals. In the last 20 years enterococci 
have emerged as common causes of hospital-acquired infections. One of the 
major reasons why these microorganisms easily survive in the hospital 
environment is their intrinsic resistance to several commonly used antibiotics, and 
more importantly, their ability to acquire resistance to many currently used 
antibiotics, including glycopeptides. 
Development of resistance to the glycopeptide vancomycin in the 
Enterococcus genus presents a worldwide major problem. Infections with 
vancomycin resistant enterococci are not only difficult to treat but the organisms 
show a strong propensity to disseminate and spread from patient to patient in the 
hospital setting. Accurate knowledge of the real scenario of vancomycin 
resistance is essential to design national and global strategies and prevent 
community and nosocomial transmission of vancomycin resistant organisms. 
Vancomycin binds with high affinity to the D-Ala C-terminus of the 
peptidoglycan pentapeptide, thus blocking the addition of late precursors by 
transglycosylation to the nascent peptidoglycan chain and preventing subsequent 
cross-linking by transpeptidation. In enterococci, glycopeptide resistance is 
conferred by the presence of operons that encode enzymes for the synthesis of 
low-affinity peptidoglycan precursors to the glycopeptides. Eight types of 
glycopeptide resistance have been characterized on both phenotypic and a 
genotypic basis in enterococci. The classification of glycopeptide resistance is 
currently based on the primary sequence of the resistance ligases (vanA, vanB, 
vanC, vanD, vanE, vanG, vanL, vanM). The most frequently detected operons are 
vanA and vanB operons and both harbor genes with regulatory functions (VanRS, 
VanRBSB), resistance (VanHAXY, VanYBHBBXB) and accessory proteins (VanZ, 
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vanW). Their transcription is regulated by the VanRS and VanRBSB two-
component systems. 
In the first part of this thesis we screened phenotypically susceptible strains, 
from different origins in Portugal, for the presence of vancomycin resistance 
genes. vanA and vanB genes were both found in dairy food isolates and in clinical 
human and veterinary isolates. vanA gene was found to be more disseminated in 
the clinical setting and vanB gene was only detected in a restricted number of 
clinical isolates. However, none of the isolates carrying vanA and vanB genes had 
complete vancomycin resistance operons. This finding suggests that the studied 
strains were, at some point in time, in contact with vancomycin resistance 
determinants, and probably due to absence of selective pressure, allowed genetic 
events (deletions or insertions) ultimately leading to vanA and vanB operons 
incomplete or corrupted, respectively. However, the presence of some of the 
vancomycin resistance determinants in susceptible strains may suggest that 
those genes could play some other biological role in those strains as if they could 
confer any selective advantage in the presence of vancomycin.   
Furthermore, we characterized a set of human clinical enterococcal strains 
including three enterococcal vancomycin resistant Enterococcus faecium 
(VREfm) strains carrying the insertion sequence ISEf1 and two Enterococcus 
hirae strains responsible for nosocomial infection in two different patients. To our 
knowledge this is the first report of E. hirae strains as etiological agents of 
nosocomial infections in a portuguese hospital. We also point out to the 
vulnerability of VITEK system alone in providing a correct assessment of 
vancomycin resistant enterococci (VRE). 
Following findings from the first part of this work, namely the hypothesis that 
vanA and vanB incomplete operons still play some role in vancomycin resistance, 
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and recent evidences of involvement of two-component systems (other than 
VanRS) in response to vancomycin; in the second part of this thesis we aimed 
identifying complementary and/or alternative mechanisms that may be involved in 
response to vancomycin.  
During antimicrobial therapeutics the concentration of antibiotics in circulation 
and in the different tissues reach frequently doses that are lower than the 
therapeutic dose administered. Thus, we found important to study the 
transcriptional response of E. faecalis to different vancomycin doses, thus 
response to a subinhibitory and to a therapeutic dose of vancomycin was studied 
in E. faecalis. The subinhibitory dose strictly and specifically induced the 
vancomycin resistance genes. However, the therapeutic dose had a major effect 
on the overall expression profile, as 14% of the genes were differentially 
transcribed. These results demonstrate that E. faecalis responds globally to a 
therapeutic vancomycin dose, suggesting that survival/resistance to vancomycin 
may involve other genes and pathways.  
We observed that after vancomycin exposure one ORF presented the same 
level of transcription than the van genes. Our work led to the identification of a 
new gene belonging to the vanB operon of E. faecalis (vanV). We provide 
evidence of co-transcription of vanV together with vanYBWHBBXB and 
demonstrate that its expression is under the control of vanRBSB. However, vanV 
was not found to be required for vancomycin resistance and likely codes for an 
accessory protein. 
Taking together the transcriptomic results we obtained under vancomycin 
exposure and the available literature we suspect that other enterococcal two-
component systems might be involved in sensing and responding to vancomycin. 
We describe the involvement of CroRS and TCS06 in vancomycin resistance and 
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found that CroRS is needed for VanRS induction and for TCS06 induction by 
vancomycin.  
To investigate the possibility of vanB operon genes influencing the 
expression of other genes in E. faecalis, we used a genome-wide transcriptomic 
approach to evaluate the differential expression of E. faecalis genes in vanB and 
vanR independent mutants. In vanB mutant 205 and 309 of the V583 E. faecalis 
genes showed differential expression, depending on the growth phase sampled. 
For the vanR mutant 157 and 147 of the genes were differentially expressed. 
Moreover, both mutants showed a very high number of genes located on mobile 
genetic elements had their expression levels affected. These results suggest that 
the vanB system may play a wider role in the cell.  
In conclusion, the main findings presented in this thesis are that van-
resistance genes are spread among enterococcal strains from different origins. 
Although these strains may keep a susceptible background in the presence of 
vancomycin selective pressure, resistance may arise, suggesting that other 
alternative mechanisms exist and may develop, by which enterococci might 
survive in the presence of vancomycin. We also provide evidence that 
vancomycin resistance is not strictly a product of vanB operon fully expression 
and other two-component systems are involved and contribute to the high-level 
resistance to the antibiotic. Furthermore, vanB operon is likely to have a broader 
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Os Enterococcus fazem parte da microbiota normal do tracto gastrointestinal 
de humanos e animais e raramente causam infecções em indivíduos saudáveis. 
Nos últimos 20 anos os enterococos emergiram como uma das causa mais 
comuns de infecções adquiridas em ambiente hospitalar. Uma das principais 
razões pela qual estes microrganimos sobrevivem com sucesso em ambiente 
hospitalar deve-se à sua resistência intrínseca a vários antibióticos e, ainda mais 
relevante, à sua capacidade para adquirir resistência a muitos dos antibióticos 
frequentemente utilizados em terapêutica, incluindo os glicopéptidos. No género 
Enterococcus o desenvolvimento de resistência ao glicopéptido vancomicina 
constitui um sério problema a nível global. Infecções provocadas por enterococos 
resistentes à vancomicina são, não apenas difíceis de tratar, como estas 
bactérias também apresentam uma marcada propensão para se disseminarem 
de doente para doente em ambiente hospitalar.  
O conhecimento do cenário real do estado da disseminação da resistência à 
vancomicina é essencial para poderem ser planeadas e adoptadas estratégias 
globais de forma a prevenir a transmissão nosocomial de bactérias resistentes à 
vancomicina, bem como a sua transmissão na comunidade.  
A vancomicina liga-se com elevada afinidade ao D-Ala C-terminal do 
pentapéptido do peptidoglicano, bloqueando a adição de mais precursores à 
cadeia nascente do peptidoglicano e prevenindo o estabelecimento subsequente 
das ligações cruzadas por transpeptidação. Em enterococos a resistência a 
glicopéptidos é conferida pela presença de operões que codificam enzimas para 
a síntese de precursores do peptidoglicano com reduzida afinidade para estes 
antibióticos. Em enterococos, oito tipos de resistência a glicopéptidos já foram 
caracterizados aos níveis fenotípico e genotípico. A classificação dos tipos de 
resistência a glicopéptidos baseai-se na sequência primária das ligases 
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codificados nos diferentes operões (vanA, vanB, vanC, vanD, vanE, vanG, vanL, 
vanM). Os operões mais frequentemente detectados são os vanA e vanB que 
possuem genes com funções reguladoras (VanRS, VanRBSB), de resistência 
(VanHAXY, VanYBHBBXB) e proteínas acessórias (VanZ, vanW). A sua 
transcrição é regulada pelos sistemas de dois componentes VanRS e VanRBSB, 
respectivamente 
Na primeira parte desta tese pesquisámos a presença de genes de 
resistência à vancomicina em estirpes de enterococos fenotipicamente 
susceptíveis ao antibiótico, de diferentes origens. Os genes vanA e vanB foram 
detectados em isolados alimentares provenientes de alimentos lácteos, bem 
como em isolados clínicos humanos e veterinários. O gene vanA está mais 
disseminado no ambiente clínico e o gene vanB foi apenas detectado num 
número reduzido de isolados clínicos. No entanto, nenhum dos isolados que 
possuem os genes vanA e vanB apresentam operões completos de resistência à 
vancomicina. Estas observações sugerem que as estirpes estudadas estiveram, 
nalgum momento, em contacto com genes de resistência à vancomicina e, 
provavelmente devido à ausência de pressão selectiva, ocorreram eventos 
genéticos (delecções ou inserções) que, em última instância, levaram a operões 
vanA e vanB incompletos ou corrompidos, respectivamente. No entanto, a 
presença de alguns genes de resistência à vancomicina em estirpes susceptíveis 
pode sugerir que estes genes desempenham outros papéis biológicos nestas 
estirpes, como se constituíssem alguma vantagem selectiva em presença de 
vancomicina. Além disso, caracterizámos um conjunto de estirpes clínicas 
humanas, incluindo três estirpes de Enterococcus faecium vancomicina 
resistentes (VREfm) que têm a sequência de inserção ISEf1 e duas estirpes de 
Enterococcus hirae responsáveis por infecções nosocomais em dois doentes 
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diferentes. Esta é a primeira descrição de estirpes de E. hirae enquanto agentes 
etiológicos de infecção nosocomial em hospitais Portugueses. Também 
salientámos a vulnerabilidade do sistema VITEK, por si só, em identificar 
correctamente enterococos resistentes à vancomicina (VRE). 
Seguindo os resultados da primeira parte deste trabalho, nomeadamente a 
hipótese de que operões vanA e vanB incompletos continuam a ter um papel na 
célula, e as recentes evidências do envolvimento de outros sistemas de dois 
componentes (que não o VanRS) na resposta à vancomicina, a segunda parte 
desta tese teve por objectivo identificar mecanismos alternativos e/ou 
complementares que estejam envolvidos na resistência à vancomicina.  
Durante o processo terapêutico com um agente antimicrobiano a 
concentração do antibiótico em circulação em nos diferentes tecidos atinge 
frequentemente doses inferiores à dose terapêutica administrada  Por este 
motivo, considerámos importante estudar as respostas transcricionais de E. 
faecalis a diferentes doses de vancomicina. Assim, a resposta a uma dose sub-
inibitória e a uma dose terapêutica de vancomicina foi estudada em E. faecalis. A 
dose sub-inibitória induz estrita e especificamente os genes de resistência à 
vancomicina. No entanto, a dose terapêutica tem um efeito muito significativo no 
perfil geral de transcrição, com 14% dos genes a serem transcritos 
diferencialmente. Estes resultados demonstram que E. faecalis responde 
globalmente a uma dose terapêutica de vancomicina, sugerindo que a 
sobrevivência/resistência à vancomicina pode envolver outros genes e vias.  
Observámos que após exposição à vancomicina uma ORF apresentava o 
mesmo nível de transcrição que os genes van. O nosso trabalho permitiu 
identificar um novo gene pertencente ao operão vanB de E. faecalis (vanV). 
Fornecemos evidências da co-transcrição do vanV juntamente com 
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vanYBWHBBXB e demonstramos que a sua expressão está sob o controlo de 
vanRBSB. No entanto, o vanV não é necessário para a resistência à vancomicina 
e provavelmente codifica para uma proteína acessória.  
Considerando os resultados obtidos no estudo de transcriptómica sob 
exposição à vancomicina e a literatura disponível fomos levados a suspeitar do 
envolvimento de outros sistemas de dois componentes na detecção do sinal e 
resposta à vancomicina. Assim, analisámos e descrevemos o envolvimento de 
CroRS e TCS06 na resistência à vancomicina e percebemos que o CroRS é 
necessário para a indução do VanRS e para a indução do TCS06 pela 
vancomicina. 
Para investigar a possibilidade dos genes do operão vanB influenciarem a 
expressão de outros genes em E. faecalis, usámos uma abordagem 
transcriptómica para avaliar a expressão diferencial dos genes de E. faecalis em 
dois mutantes independentes, vanB e vanR. No mutante vanB, 205 e 309 genes 
de E. faecalis V583 mostraram-se diferencialmente expressos, dependendo da 
fase de crescimento. No mutante vanR, 157 e 147 genes foram diferencialmente 
expressos. Nos dois mutantes, um elevado número de genes localizados em 
elementos genéticos viram os seus níveis de expressão afectados. Estes 
resultados sugerem que o sistema vanB poderá ter um papel muito mais 
alargado na célula.  
As principais conclusões apresentadas nesta tese são, portanto, que os 
genes de resistência van estão disseminados entre estirpes de enterococos de 
diferentes origens. No entanto estas estirpes mantêm um background susceptível 
mas, em presença de pressão selectiva por vancomicina, a resistência pode 
surgir, sugerindo que existem mecanismos alternativos que se podem 
desenvolver e permitir aos enterococos sobreviver em presença de vancomicina. 
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Fornecemos ainda evidências de que a resistência à vancomicina não é 
estritamente produto de uma expressão plena do operão vanB e que outros 
sistemas de dois componentes estão envolvidos e contribuem para a elevada 
resistência ao antibiótico. É provável que o operão vanB tenha uma papel mais 
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The objectives proposed for this dissertation were all focused on vancomycin 
resistance determinants dissemination and vancomycin response in enterococci. 
In particular we intended to learn more about the current real amplitude of 
vancomycin determinants dissemination in different environments and what are 
the mechanisms that mediate vancomycin response in enterococci. 
The present Dissertation is divided in two main parts and into nine chapters. 
On the first part we present data related to the screening and detection of 
vancomycin resistance determinants in strains from different environmental 
sources. On the second part we focus in genes and pathways that might be 
involved in vancomycin resistance and response 
 Chapter 1 consists of a general introduction to contextualize the subject. A 
brief overview of vancomycin resistance in enterococci and its importance as a 
last resort antibiotic, to treat multidrug resistant infections caused by Gram-
positive bacteria, and as stress agent is made. The results of this Doctoral work 
are presented in the following chapters. Each chapter has its own Introduction, 
Results and Discussion of the respective work. 
In chapter 2 we describe the dissemination and prevalence of vancomycin 
resistance determinants (vanA and vanB) in a considerably large group of dairy 
isolates and human and veterinary clinical isolates and this way study the 
dissemination of these determinants in different ecological niches. The 
arrangement of the prototype resistance element Tn1546 is determined and high 
heterogeneity of this mobile element was observed. 
Chapter 3 consists on the characterization of enterococcal strains in a 
Portuguese Hospital. We report the detection of E. faecium strains belonging to 
CC17 and the presence of ISEf1 in Leiria Hospital. We also report the first two 
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cases of E. hirae as etiological agent of nosocomial infections in Portugal 
associated with wound infections. 
In chapter 4 we describe and discuss microarray data on how E. faecalis 
V583 responds to a therapeutic dose of vancomycin.  
In chapter 5 we demonstrate that vanB operon has one more gene on its 
constitution than previously acknowledged. 
Chapter 6 characterizes the involvement of two two-component systems in 
vancomycin sensing and potential induction of vancomycin resistance.  
Chapter 7 describes the behavior of vancomycin susceptible strains when 
exposed to serial passages in presence of antibiotic and discuss the possible 
mechanims behind the observed adaptation. 
Chapter 8 is centered on unraveling the role of vanB operon genes in 
enterococci in absence of vancomycin induction. We present and discuss 
transcriptomic results on vanB and vanR mutants.  
Chapter 9 is an integrated Discussion of the global results of the previous 
chapters and proposes the Future Perspectives regarding the vancomycin 
response mechanisms and alternative regulation pathways. There is an Appendix 
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AMP ampicillin 
APS antimicrobial peptide sensor 
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I. VANCOMYCIN 
HISTORICAL INTRODUCTION TO VANCOMYCIN DISCOVERY  
The use of substances with antibacterial activity has been documented 
throughout history. Over 50,000 years ago the Neanderthals used certain herbs 
and natural substances to kill bacteria in the wounds and stop their propagation. 
Human remains have been found with various herbs that are said to be used for 
therapeutic purposes by the prehistoric man. There is evidence in the Ebers 
papyrus (1550 BC) that the Egyptians have used beer yeast on wounds and 
numerous other ancient civilizations used molds in one form or another for cures 
and rituals. A chemical analysis of the bones of ancient Nubian mummies, shows 
that they were regularly consuming tetracycline, most likely in their beer since the 
grain used to make the fermented gruel contained the soil bacteria streptomyces, 
which produces tetracycline (Levy, 2002). The ancient Chinese also used molds 
to treat boils, carbuncles and other skin infections. 
Nevertheless, it is only in the end of the 19th century that the first scientific 
report of mold use with the specific aim of killing bacteria appeared. In 1897 
Ernest Duchesne reported that certain penicillium molds could indeed destroy 
Salmonella typhi and Escherichia coli in the test tube. He further showed that 
inoculating intraperitoneally a guinea pig with a solution containing Penicillium 
glaucum and E. coli, would protect the guinea pig against the lethal dose of E. 
coli. He had shown that certain molds could kill bacteria – he had discovered 
penicillin (reviewed in Duckett, 1999). 
However, it is generally accepted that the discovery of penicillin dates from 
1928 (reviewed in Podolsky, 1997) when the young bacteriologist Merlin Pryce 
noticed that one of the petri dishes floating in the sink and ready to be discarded 
was contaminated with a mold and, more important, that there was a clear ring of 
Chapter 1 
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lysed bacteria. Fleming, who was interested in the lysis phenomena, got intrigued 
by this observation and decided to pursue it further. After several experiments he 
showed that an active substance, produced by this mold, could kill bacteria such 
as staphylococci, streptococci, gonococci but not others such as those 
responsible for typhoid fever or cholera. Later he and his young assistant, Stuart 
Craddock, proved that injection of the mold filtrate could not only save rabbits and 
mice from lethal infections of staphylococci but it could also cure his assistant´s 
sinus and eye infections. 
Despite the successful experiments done by Fleming, the application of 
penicillin to treat infections would have remained only an academic curiosity, if it 
were not for the work of two other future Nobel Prize laureates. Fleming was 
discouraged, with no research funds to continue the experiments and with a very 
unstable compound of which only very small amounts could be purified. He was 
further disappointed by his own unpublished observation that staphylococci 
became resistant to penicillin very quickly (Podolsky, 1997). Fleming discretely 
described his preliminary findings and then turned his back on penicillin. Later 
Florey and Chain rescued penicillin and succeeded in purifying large amounts of 
the compound, generating enough interest so that when World War II started 
there was a bigger production of this antibiotic in order to decrease the fatalities in 
Europe and Asia. By this time penicillin had been used in fewer than 100 people 
in the United States of America. 
On Sunday morning, November 29, 1942, the Boston Herald front page 
announced the most devastating fire in the history of Boston, the Cocoanut Grove 
Nightclub disaster. There were more than 450 victims and the physicians were 
caring for the 200 survivors who resisted for the first 24 hours. The fire also 
occasioned a medical event now regarded as historically significant as the fire 
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itself – the trial of a new, unique drug available only through government sources. 
Limited amounts of penicillin were released to quell many of the infections 
contracted by survivors of the fire. Actually, the Cocoanut Grove victims became 
one of penicillin´s most important clinical trials and the success of skin grafting 
and treating the severely burned patients was largely attributed to the action of 
penicillin (Levy, 2002). Soon after, the use of antibiotics was widely spread and 
penicillin was considered as a miraculous drug. Penicillin discovery marked the 
beginning of the “antibiotic era”. 
The success of penicillin encouraged scientists to search for and discover 
new antibiotics that could treat other bacteria, including penicillin-resistant strains. 
As more antibiotics were discovered, from the late 1940s into the 1970s, the 
problem of resistance seemed little more than an annoyance. 
By the 1950s, it was apparent that penicillin was not going to remain effective 
against staphylococci. The pharmaceutical Eli Lilly and Company was soon 
operating a large-scale screening program aimed solely at the isolation of 
antibiotics with high level of specificity and activity against staphylococci. Soil 
samples were obtained from all parts of the world and were subjected to the 
screening procedures. An organic chemist at Lilly, Dr. E. C. Kornfeld, had a 
missionary friend in Borneo who sent him dirt from the deep interior of the jungle. 
In it, he found an organism that later was named Streptomyces orientalis. 
Fermentation broths of the organism were highly active and bactericidal against 
virtually all staphylococci tested. Studies in animals showed the level of toxicity to 
be relatively low. The active compound in S. orientalis fermentation was labeled 
compound 05865 (Levine, 2006). 
The difficulty with which staphylococci would become resistant to the 
compound 05865 was obviously a matter that required immediate appraisal. 
Chapter 1 
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Consequently, the earliest in vitro studies consisted on experiments on the 
induction of resistance to compound 05865 by daily serial passage. The results 
obtained lead to consider that the laboratory-induced level of staphylococcal 
resistance to compound 05865 was negligible (Levine, 2006). 
Since the impurities from the preparation and fermentation broth were linked 
to ototoxicity and nephrotoxicity and due to its brownish color, compound 05865 
earned the nickname "Mississippi mud". Soon, however, "Mississippi mud" was 
given the generic name vancomycin, derived from the word vanquish, and efforts 
were directed towards its purification (Levine, 2006).  
Although the early clinical trials of vancomycin were modest in scope and 
involved relatively few researchers, information concerning the efficacy of the 
antibiotic in difficult staphylococcal infections quickly spread. With the increased 
demand for vancomycin to be used in clinical studies and in emergency treatment 
of serious staphylococcal infection, supplies were often inadequate. On various 
occasions it was necessary for a representative of Eli Lilly and Company to locate 
some vancomycin in one hospital and deliver it to another where it was more 
urgently needed. The large volume of requests for vancomycin for emergency use 
was followed by numerous reports of satisfactory therapeutic responses. Because 
there was no other alternative in the treatment of serious infections caused by 
staphylococci resistant to the then available antibiotics, the U.S. Food and Drug 
Administration strongly urged Eli Lilly and Company to make vancomycin 
generally available as soon as possible. 
Early concerns regarding safety, which were based on results of studies in 
animals, may have been responsible for the limited use of vancomycin for 20 
years. It was reformulated and retested in animal models for toxicity in the 1970s. 
It was then found to have no otoxocity and little nephrotoxicity. In the late 1970s 
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vancomycin re-emerged as a key component in treating methicillin-resistant 
Staphylococcus aureus (MRSA). The clinical need for an agent to fight MRSA 
was apparent and vancomycin quickly became the drug of choice. 
 
VANCOMYCIN MODE OF ACTION 
The simultaneous worldwide emergence, first of methicillin-resistant S. 
aureus, and then, the penicillin-resistant Streptococcus pneumonia, together with 
the reported success on the treatment of pseudomembranous enterocolitis led to 
the clinical re-introduction of vancomycin (Levine, 2006). In the 1980s 
vancomycin was being widely used worldwide and its use increased specially in 
the United States. In contrast, the rise of vancomycin use has been less 
pronounced in Europe (Kirst et al., 1998).  
Vancomycin is the most relevant member of the glycopeptide class of 
antibiotics, which include also teicoplanin, telavancin and ramoplanin. The 
chemical structure shared by the glycopeptide antibiotic family has been 
determined by different methods as mass spectrometry, NMR and X-ray 
crystallography (Barna & Williams, 1984), elucidating its mode of action. 
Vancomycin, and other glycopeptide antibiotics, do not interact with the cell wall 
biosynthetic enzymes but form complexes with the carboxy-terminal D-alanine (D-
Ala) residues of peptidoglycan precursors thus preventing their incorporation into 
the cell wall, leading to cell wall synthesis inhibition (Reynolds, 1989).  
The synthesis of peptidoglycan involves several steps (Figure 1). In the 
cytoplasm, a racemase converts L-alanine to D-alanine (D-Ala), and then two 
molecules of D-Ala are joined by a ligase, creating the dipeptide D-Ala-D-Ala, 
which is then added to uracil diphosphate-N-acetylmuramyl-tripeptide to form 
uracil diphosphate-N-acetylmuramyl-pentapeptide. Uracil diphosphate-N-
Chapter 1 
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acetylmuramyl-pentapeptide is bound to the undecaprenol lipid carrier, which, 
after the addition of N-acetyl glucosamine (GlcNAc) from uracil diphosphate-
GlcNAc, allows translocation of the precursors to the outer surface of the 
cytoplasmic membrane. N-acetylmuramyl-pentapeptide is then incorporated into 
nascent peptidoglycan by transglycosylation and allows the formation of cross-
bridges by transpeptidation (Reynolds, 1989). 
Vancomycin binds with high affinity to the D-Ala-D-Ala C-terminus of the 
pentapeptide (Figure 1A), therefore blocking the addition of late precursors by 
transglycosylation to the nascent peptidoglycan chain and preventing subsequent 
cross-linking by transpeptidation (Reynolds, 1989). As a secondary and less 
relevant mechanism, glycopeptides inhibit the transglycosilation reaction of the 
peptidoglycan unit into the growing polymer, presumably by steric hindrance from 
the antibiotic-peptidoglycan precursor complex (Ge et al., 1999; Walsh, 1999). 
At present, glycopeptides are used for the treatment of infections caused by 
methicillin-resistant S. aureus (MRSA), coagulase-negative staphylococci (CoNS) 
or by ampicillin-resistant enterococci. Furthermore, these drugs are indicated in 
patients with serious β-lactam allergies (Levine, 2006). Glycopeptides are virtually 
not active against Gram-negative bacteria which are protected by an outer 
membrane. 
Resistance to vancomycin in a clinical enterococcal isolate was first reported 
in Europe in 1986 (Leclercq et al., 1988; Uttley et al., 1988) and in 1987 in the 
United States (Sahm et al., 1989). Enterococci were the first clinically relevant 
bacterial genus to acquire a resistance mechanism that specifically confers high-
















































Figure 1. Schematic representation of peptidoglycan biosynthesis in (A) vancomycin-
susceptible and (B) vancomycin resistant bacteria. Binding of vancomycin to the C-terminal D-Ala-
D-Ala of the late peptidoglycan precursors prevents the reactions catalyzed by transglycosylases, 
transpeptidases and D,D-carboxypeptidases. In vancomycin resistant strains there is still production of 
native peptidoglycan precursors ending in D-Ala-D-Ala resulting from the endogenous chromosomal 
pathway. Is on the native pathway that VanX and VanY act sequencing hydrolyzing the dipeptide D-
Ala-D-Ala. Ddl, D-Ala-D-Ala ligase; MurF, a synthetase protein; UDP, uracil diphosphate. Adapted 
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During the first several decades of use, staphylococci did not mount a 
resistance to vancomycin. It has only been within the last years that vancomycin-
intermediate Staphylococcus aureus (VISA) and vancomycin-resistant 




GENERAL DESCRIPTION OF THE GENUS  
In 1899, Thiercelin described Gram-positive coccoid-shaped bacteria from 
the human intestine and used the name “entérocoque” to emphasize their 
intestinal origin (Thiercelin, 1899). However, the term Streptococcus kept being 
more commonly used. In 1937, Sherman developed a scheme classifying the 
genus Streptococcus into four main groups: pyogenic, viridians, lactic and 
enterococci (Sherman, 1937). Enterococci and streptococci were proven to be 
different based on DNA hybridization experiments and subsequently the genus 
Enterococcus was introduced in 1984 (Schleifer & Kilpper-Balz, 1984). 
Enterococci are also separated from other Streptococcus species as they grow 
between 10 and 45ºC, in 6.5% NaCl and at pH 9.6, survive heating at 60ºC for 30 
min., hydrolyze esculine into esculitine (Devriese et al., 1991) and react with the 
Lancefield group D antisera (Murray, 1990). Enterococci produce L(+)-lactic acid 
homofermentatively from glucose.  
Although about 40 Enterococcus species are now recognized 
(http://www.dsmz.de/microorganisms/html/bacteria.genus/enterococcus.html), E. 
faecalis and E. faecium are the two most common species found in the human 
microbiota (Devriese et al., 1991). Enterococci are members of the 
gastrointestinal (GI) tract microbial consortium of humans and other animals 
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(Tannock, 2002). In humans enterococci also colonize the genito-urinary tract and 
the oral and vaginal cavities (Murray, 1990). They are also capable of surviving in 
many other environmental niches like soil, sand, water (usually as faecal 
pollutants), food products and in plants (Mundt, 1986).   
 
E. faecalis is currently the most intensively studied enterococcal specie due 
to its prominence in the nosocomial setting. Until recently the only publically 
sequenced genome available belonged to E. faecalis V583 (Paulsen et al., 2003), 
which was the first reported vancomycin resistant clinical isolate in the United 
States (Sahm & Olsen, 1990). In 2008 another E. faecalis strain, OG1RF, was 
sequenced but the genome was not made publically available (Bourgogne et al., 
2008). Very recently the genome of other 28 enterococcal strains (including E. 
faecalis, E. faecium, E. casseliflavus and E. gallinarum species) became available 
(Palmer et al., 2010).  
 
ENTEROCOCCI AS PATHOGENS 
The staphylococci and the streptococci were the most prevalent hospital 
pathogens in the 1960s and 1970s. Then, over a period of time, the distribution of 
organisms involved in nosocomial infections shifted from Gram-positive to Gram-
negative in the 1970s and 1980s and since then Gram-positive organism have re-
emerged as major hospital pathogens (Levy, 1998). In large part this trend may 
be attributed to the selection pressure created by antibiotics used in the hospital 
setting. Although enterococci have been recognized as an important cause of 
infectious endocarditis (IE) for more than a century (Singh et al., 2010), just in the 
last two decades they were recognized as one of the leading causes of 
nosocomial infections (Murray, 1990). The most prevalent infections caused by 
enterococci are urinary tract infections (UTI), bacteremia, abdominal wound 
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infections and endocarditis (Moellering, 1992; Murray, 1998). Most of these 
infections are caused by E. faecalis and only a small number are caused by E. 
faecium (Witte et al., 1999). However, in recent years a progressive increase of 
infections caused by E. faecium has been reported (Mundy et al., 2000; Treitman 
et al., 2005). With exception of E. faecalis and E. faecium, other enterococcal 
species are rarely associated to human pathogenesis and their clinical relevance 
is often neglected, although there are reports of infections caused E. durans 
(Stepanovic et al., 2004), E. hirae (Gilad et al., 1998; Poyart et al., 2002; Ribeiro 
et al., 2008), E. raffinosus (Wilke et al., 1997; Sandoe et al., 2001, Savini et al., 
2008, Mastroiani, 2009), E. gallinarum (Reid et al., 2001; Takayama et al., 2003), 
E. avium (Swaminathan & Ritter, 1999), E. casseliflavus (Reid et al., 2001; 
Pappas et al., 2004; Iaria et al., 2005), E. cecorum (Hsueh et al., 2000) and E. 
mundtii (Higashide et al., 2005). Enterococci are considered opportunistic 
pathogens considering that they are generally harmless for healthy people but 
able to cause serious infection in immunocompromised patients that are more 
susceptible to infections. 
Two main features contribute to enterococcal pathogenic aptitude: a wide 
range of virulence factors, and the accumulation of different antimicrobial 
resistance mechanisms. 
 
E. faecalis possess a plethora of virulence factors designed to help 
establishing infection and persist in the presence of the host immune response 
(Shankar et al., 1999). There are four main stages in the pathogenesis of 
enterococcal infections. The first is persistence in inanimate objects due to 
intrinsic properties of bacteria, namely resistance to desiccation, heat and other 
conditions that otherwise impair bacterial endurance outside of the host. This 
                                                                                                General Introduction 
 15 
persistence contributes largely to enterococci prevalence as a nosocomial 
pathogen by providing a means of survival until an opportunity for infection 
presents itself. Next, entry into the bloodstream or other non-native areas of the 
host is a critical step in the transformation of enterococci from commensals to 
damaging pathogens. This phase is usually facilitated by damage to host tissues 
and presence of bacterial factors such as bile acid hydrolases, adhesins like 
aggregation substance (AS) and enterococcal surface protein (Esp), and 
antibiotic resistance that give enterococci an edge in surviving these niches. Once 
inside the host, enterococci have been shown to utilize several classified 
virulence factors for adherence and colonization in the establishment of an 
infection site. In this step, adhesins play a vital role in attachment to host tissues, 
as well as in the formation of cell aggregates as biofilms. Also, factors that 
possess immune invasion qualities are vital to cell survival, such as cytolysin, AS, 
Esp, and lipoteicoic acid (LTA). The final stage is the clinical manifestation of 
infection resulting in damage of vital tissues. This results from the activity of 
proteins against host tissues and includes cytolysin, gelatinase and serine 
protease.  
 
Despite the accepted and demonstrated relevance of virulence factors in 
enterococci pathogenesis, those factors are present both in environmental and 
commensal strains. In fact it is still not clear yet what triggers the transition from 
commensal to pathogenic. It would be reasonable to admit that it would happen 
by induction of the molecules that are essential for the virulence. However, not all 
factors confer a selective advantage at the same infection stage or at the same 





Antibiotics interrupt vital cellular functions through different modes of action. It 
is usually achieved by attacking the cell-wall and cell membrane integrity, by 
interfering with DNA, RNA or protein synthesis (Figure 2). They can be either 
bactericidal or bacteriostatic depending on their mechanism of action. 
Bactericidals effectively kill the target bacteria and bacteriostatics halt cell growth 
and replication.  
From a clinical perspective, multidrug-resistant enterococci present a major 
problem. Infections caused by multidrug resistant enterococci are difficult to treat 
due to limited therapeutic options. The treatment of such infections varies widely 
from patient to patient, but it usually involves a combination of broad spectrum 
antibiotics. Drug regimens mainly utilize a cell-wall acting antibiotic coupled with 
an antibiotic that affects protein synthesis. It is conceivable that using broad 
spectrum antibiotics fails to specifically target the infectious strain and will likely 
remove beneficial commensal microorganisms. Furthermore, by exposing the 
entire bacterial community of the host to these antibiotics promotes the creation of 
an environment of extreme selective pressure with therapeutic and sub-
therapeutic levels of ongoing antimicrobial exposure (Mundy et al., 2000). 
Enterococci have been shown to possess a broad range of intrinsic antibiotic 
resistances (Moellering, 1990; Murray, 1990, Leclercq, 1997) and are able to 
acquire high-level drug resistance to certain antibiotics (Figure 2). The resistance 
may arise by point mutations in the drug binding site, like in quinolones (Onodera 
et al., 2002) and ampicillin, or by acquisition of resistance genes, as in the case of 
aminoglycosides, macrolides, chloramphenicol, tetracycline and glycopeptides, of 
which vancomycin resistance is the most relevant clinically (Moellering, 1990; 
Murray, 1990, Landman & Quale, 1997; Leclercq, 1997; Onodera et al., 2002). 
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Figure 2. Mechanism of action for common antimicrobials. Antimicrobials mainly target the cell 
wall and cytoplasmic membrane, or affect DNA structure or protein synthesis. Colistin, polymyxin and 
daptomycin target the cytoplasmic membrane, while bacitracin, β-lactams, glycopeptides and 
cephalosporins disrupt the cell wall. Folate synthesis, which is required for construction of DNA base 
pairs, is a process that includes the conversion of para-aminobenzoic acid (PABA) into dihydropholate 
(DHF) and then finally into trihydropholate (THF). Trimethoprim and sulfonamides block these 
conversions and effectively arrest DNA synthesis. Quinolones function by interrupting DNA replication, 
while rifampicin blocks RNA synthesis. A wide group of antibiotics act by affecting protein synthesis. 
Antimicrobial resistance in enterococci can be divided in two classes, intrinsic resistance and acquired 
resistance. Bacteria are intrinsically resistant to antimicrobial agents because they either lack the 
target site for that drug, or the drug is unable to transfer through the organism´s cell wall or membrane 




III. VANCOMYCIN RESISTANCE  
MECHANISMS OF VANCOMYCIN RESISTANCE IN ENTEROCOCCI 
Resistance to vancomycin is due to the synthesis of modified cell wall 
precursors (Figure 1B) that show decreased affinity to vancomycin or to 
vancomycin and teicoplanin. Vancomycin resistance is conferred by the presence 
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of operons that encode enzymes for synthesis of low-affinity precursors, in which 
the C-terminal D-Ala residue is replaced by D-lactate (D-Lac) or D-serine (D-Ser), 
thus modifying the vancomycin-binding target. The operons encode enzymes for 
elimination of the high-affinity precursors that are normally produced by the host, 
thus removing the vancomycin-binding target (Arthur et al., 1996b). The genetics 
of vancomycin resistance has been studied in detail over the past decade and 
various molecular mechanisms have been elucidated (Arthur et al., 1993; Baptista 
et al., 1996; Leclercq & Courvalin, 1997; Rao et al., 1998). 
Replacement of the D-Ala C-terminal residue by a D-Lac suppresses a 
hydrogen bond crucial for antibiotic binding and considerably lowers the affinity 
for glycopeptides whereas substitution by a D-Ser does not alter the hydrogen 
bonds but it is responsible for a conformational change which slightly reduces the 
affinity for vancomycin (Gholizadeh & Courvalin, 2000). The D-Ala by D-Lac 
substitution results in a more-than-1000-fold lowering of the affinity to vancomycin 
while D-Ala by D-Ser substitution results in a six fold-lower affinity to vancomycin 
(Billot-Klein et al., 1994).  
 
In enterococci, resistance to glycopeptides is phenotypically and 
genotypically heterogeneous. Eight types of vancomycin resistance have been 
characterized so far. They can be distinguished on the basis of the range of 
glycopeptides to which the strains are resistant, resistance level and 
transferability (Table 1). Although the 8 types of resistance involve related 
enzymatic functions, they can be distinguished by the organization of the 
corresponding genes and by the mode of regulation of gene expression. 
The vanA cluster was originally detected in the non-conjugative Tn1546 
transposon (Arthur et al., 1993). VanA-type resistance is mediated by genetic 
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elements, identical or closely related to Tn1546, that are generally carried by self-
transferable plasmids (Leclercq et al., 1988) and, occasionally, by the host 
chromosome as part of larger conjugative elements (Handwerger & Skoble, 
1995). 
Gene clusters related to vanB are generally carried by large elements (90-
250 kb) that are transferable by conjugation from chromosome to chromosome 
(Quintiliani & Courvalin, 1994). Generally as part of Tn5382 (27 kb in size) (Carias 
et al., 1998), Tn1549 (34 kb in size) (Garnier et al., 2000) and related elements. 
Plasmid-borne vanB clusters have also been detected in clinical isolates of 
enterococci (Rice et al., 1998). By contrast to vanA gene cluster, vanB gene 
cluster shows greater sequence divergence. Three alleles have been reported to 
date (vanB1, vanB2, vanB3), of which vanB2 appears to be the most widespread 
(Dahl et al., 1999).  
 
Table 1. Types of vancomycin resistance found in Enterococcus spp. 
MIC (µg/ml) Type† 
(ligase gene) 
Expression 
Terminus of peptidoglycan 
precursor 
Vancomycin Teicoplanin 
VanA (vanA) Inducible D-Ala-D-Lac 64-1000 16-512 
VanB (vanB) Inducible D-Ala-D-Lac 4-1000 0.5-1‡ 
VanC (vanC) 
Both inducible and 
constitutive 
D-Ala-D-Ser 2-32 0.5-1 
VanD (vanD) Constitutive D-Ala-D-Lac 64-128 4-64 
VanE (vanE) Inducible D-Ala-D-Ser 16 0.5 
VanG (vanG) Inducible D-Ala-D-Ser 8-16 0.5 
    VanL (vanL) Inducible D-Ala-D-Ser 8 0.5 
VanM (vanM) Inducible D-Ala-D-Lac >256 96 
†All glycopeptide resistance types are acquired, except for VanC which is an intrinsic property of E. 
gallinarum (Leclercq et al., 1992) and E. casseliflavus/E. flavescens (Navarro & Courvalin, 1994). E. 
casseliflavus and E. flavescens were recently considered to be the same species and E. flavescens 
was reclassified as a later synonym of E. casseliflavus (Naser et al., 2006). ‡ Typical vanB isolates are 
susceptible to teicoplanin but resistance to this antibiotic can develop both in vitro and in vivo 
(Gutmann et al., 1992; Hayden et al., 1993).  
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Transfer of VanG-type resistance is associated to movement, from 
chromosome to chromosome, of genetic elements of about 240 kb that also carry 
ermB-encoded erythromycin resistance (Depardieu et al., 2003). VanM transfer 
was achieved and is associated with its putative location on a plasmid (Levine, 
2006). The other van clusters, apart from vanA and vanB, will not be considered 
further here.   
VanA is the most frequently encountered type of vancomycin in enterococci 
and the first to be described (Brisson-Noel et al., 1990, Dutka-Malen et al., 1990). 
The prototype Tn1546 VanA-type resistance element, which was originally 
detected on a plasmid in an Enterococcus faecium clinical isolate, is an 11 kb 
transposon. It encodes 9 polypeptides that can be assigned to various functional 
groups: transposition (ORF1 and ORF2), regulation of resistance gene 
expression (VanR and VanS), synthesis of the D-Ala-D-Lac depsipeptide (VanH 
and VanA), and hydrolysis of peptidoglycan precursors (VanX and VanY). There 
is an additional peptide, VanZ, which function remains unknown (Figure 3). 
The VanH dehydrogenase reduces pyruvate to D-Lac (Arthur et al., 1992a), 
the VanA ligase synthesizes the depsipeptide D-Ala-D-Lac which replaces the 
dipeptide D-Ala-D-Ala in the pathway of synthesis of the late peptidoglycan 
precursors, and the VanX D,D-dipeptidase hydrolyses the dipeptide D-Ala-D-Ala 
resulting from the endogenous chromosomal pathway (Reynolds et al., 1994). 
VanY encodes a D,D-carboxypeptidase (Arthur et al., 1996b) and hydrolyses the 
pentapeptide synthesized from the dipeptide D-Ala-D-Ala which as escaped VanX 
hydrolysis. VanZ confers low-level resistance to teicoplanin by an unknown 
mechanism (Arthur et al., 1995). VanY and VanZ are not required for 
glycopeptide resistance.  
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The VanR and VanS proteins are part of a two-component regulatory system 





Figure 3. Genetic organization of vanA and vanB operons. Regulatory genes are represented in 
blue, essential genes for resistance are represented in red and accessory proteins in green. The 
genes required for transposition, ORF 1 (transposase) and ORF 2 (resolvase), are not represented. 
The genes are not scale represented. Adapted from (Courvalin, 2006). 
 
As in VanA-type strains, acquired VanB-type resistance is due to synthesis of 
peptidoglycan precursors ending in the depsipeptide D-Ala-D-Lac instead of the 
dipeptide D-Ala-D-Ala (Arthur et al., 1996a). The organization and functionality of 
the vanB cluster is similar to that of vanA but differs in its regulation because 
vancomycin, but not teicoplanin, is an inducer of the vanB cluster. The vanB 
operon contains genes encoding a dehydrogenase (vanHB), a ligase (vanB), and 
a dipeptidase (vanXB) (Figure 3), all of which have a high level of sequence 
identity (67-76% identity) with the corresponding deduced proteins for the vanA 
operon and the vanRBSB regulatory genes that encode a two-component system 
only distantly related to vanRS (34% and 24% identity) (Evers & Courvalin, 1996). 
Chapter 1 
 22 
The function of the additional VanW protein found only in the vanB cluster is 
unknown, and there is no gene related to vanZ.  
 
Some VanA and VanB strains require vancomycin for growth (Dever et al., 
1995; Green et al., 1995). This phenomenon is clinically important, since these 
strains require special growth conditions, their presence and prevalence will 
probably be underestimated since they are not detected on routine laboratory 
testing. These strains lack a functional ligase (Ddl) due to mutations in the ddl 
gene. Thus, they require the presence of vancomycin to grow because the vanA- 
or vanB-encoded D-Ala-D-Lac ligase is induced overcoming the defect in the 
synthesis of the regular peptidoglycan precursors (Van Bambeke et al., 1999). 
Dependent strains can revert to a non-dependent, highly resistant phenotype. It 
can occur as a result of a mutation in either vanS or vanSB sensor, which lead to 
constitutive production of D-Ala-D-Lac, or in the ddl gene, which restores 
synthesis of D-Ala-D-Ala (Cetinkaya et al., 2000).  
The widespread of vancomycin-resistant enterococci (VRE) and the report of 
dependence on vancomycin for growth highlights the need to discover new 
therapeutic targets to treat infection. 
 
VANCOMYCIN RESISTANCE IN PORTUGAL 
The highest rates of VRE associated with nosocomial infections in Europe 
were reported in some countries of southern Europe. In recent years, the levels of 
detected VRE are up to 45% in Portugal  (EARSS, 2008). As observed in other 
geographical regions, vanA E. faecium isolates are mainly responsible for the 
high rates of infections caused by VRE in Portugal (Novais et al., 2005b; EARSS, 
2008). 
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The first large VRE surveillance study in Portugal which included data from 
ten participating hospitals was performed in 1994 and revealed rates of 1% of 
VREfs and 9% of VREfm among isolates causing urinary tract and invasive 
infections (Melo-Cristino et al., 1996). A remarkable increase in VREfm was 
documented in subsequent years with rates rising from 20% in 1996 (for the same 
10 hospitals screened in 1994) to 47% in 2003 (Figure 4) (EARSS, 2008, Melo-
Cristino, 1998). In 2008 EARSS (European Resistance Surveillance System) 
reported a decrease in VREfm rates to 24% (Figure 4). Whether the observed 
decrease is a result of the implementation of specific successful infection control 
measures or not, is not known.  
 
Figure 4. Reported percentage of VREfm in Portugal. Based on results from the European 
Antimicrobial Resistance Surveillance System. Available from http://www.rivm.nl/earss/result/.  
 
According to EARSS, the number of Portuguese participating laboratories 
has increased, providing nowadays coverage of almost 90% of the total 
population. 
Although polyclonality was frequently observed among VREfm, intra- and 
inter-hospital dissemination of persisting E. faecium and E. faecalis clones and 
specific vanA transposon (Tn1546) types seemed to have contributed to the rapid 
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and extensive spread of VRE in Portuguese hospitals (Novais et al., 2004; Novais 
et al., 2005b, Novais et al., 2008, Mato et al., 2009). 
Aware of the potential risk that VRE constitute outside of the clinical 
environment an effort has also been done in recent years to characterize 
vancomycin-resistant enterococci from non-clinical sources. VRE have been 
detected and isolated from healthy human volunteers (Novais et al., 2008), 
poultry food samples (Novais et al., 2005a; Novais et al., 2008), pets and wild 
animals (Poeta et al., 2005; Poeta et al., 2007; Radhouani et al., 2010) and 
environmental sources (Novais et al., 2008). Despite the valuable contribution of 
these studies for the characterization of vancomycin resistance in enterococci 
from different sources and geographic regions, characterization of the 
dissemination of vancomycin resistance determinants is still poor, as the existing 
studies do not cover all country geographical areas and only look for VRE strains 
and not for the presence of van-genes in vancomycin-susceptible enterococci 
(VSE). 
 
VANCOMYCIN RESISTANCE IN OTHER BACTERIA 
Vancomycin resistance emerged in enterococci in the middle 1980s, and it 
took more than a decade until significant resistance to vancomycin was also 
discovered in staphylococci. In staphylococci, vancomycin reduced susceptibility 
is not related with the presence of vancomycin resistance genes, as in 
enterococci. Vancomycin-intermediate and –resistant coagulase negative 
staphylococci have been found in large numbers (Sieradzki et al., 1998; van den 
Braak et al., 1998). Vancomycin intermediate S. aureus (VISA) and glycopeptide-
intermediate S. aureus (GISA) were first reported in Japan in 1996 (Hiramatsu et 
al., 1997), almost immediately followed by two additional cases in the United 
States (CDC, 1997). The mechanisms by which S. aureus isolates become 
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intermediately resistant to vancomycin are poorly understood, but several 
common characteristics are shared by clinical and laboratory-derived strains. 
Those include slower growth rate, decreased lysostaphin susceptibility and 
reduced autolytic activity (Sieradzki & Tomasz, 1997; Boyle-Vavra et al., 2000, 
Pfeltz et al., 2000). These intermediary strains produce an excess amount of non-
cross-linked D-alanyl-D-alanine targets which sequester vancomycin molecules. 
A detailed description of the mechanism of heterogeneous resistance in 
Staphylococcus aureus can be found elsewhere (Liu & Chambers, 2003). 
Although the genetic basis behind this phenotype is not yet well defined, it is 
expected to involve chromosomal mutations (Wootton et al., 2004) and/or the 
disruption of the agr accessory gene regulator (Sakoulas et al., 2002), as well as 
mutations on the two-component regulatory systems vraSR and graSR (Cui et al., 
2009).  
The description of VISA/GISA strains was anticipated as a prelude for the 
emergence of vancomycin-resistant S. aureus and jeopardizes vancomycin 
clinical relevance. In fact, transfer of resistance genes from VRE to S. aureus was 
demonstrated in vitro several years ago (Noble et al., 1992), and a first clinical 
case of infection with vancomycin-resistant S. aureus strain carrying vanA, 
originated in a VRE isolate, was described in 2002 (CDC, 2002) from a diabetic 
foot ulcer. There are already 11 VRSA reported in the United States (Sievert et 
al., 2008; Tenover, 2008; Zhu et al., 2008). 
The description of S. aureus harbouring vancomycin resistance determinants 
transferred from enterococci is the irrefutable proof of the threat that VRE 
constitute (Tenover et al., 2008; Zhu et al., 2008). Now that VRSA are a reality is 
probably just a matter of time until vancomycin resistance determinants are found 
in other clinically relevant microorganisms. This possibility is of utmost concern 
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since nowadays vancomycin is the last resort antibiotic for the treatment of 
infections caused by multidrug resistant Gram-positive bacteria. 
 
Although vanA and vanB gene clusters have been detected in several 
enterococcal species, E. faecium and E. faecalis are the most prevalent and 
clinically important (Woodford, 1998). Enterococcal glycopeptide resistance 
genes have occasionally been reported in non-enterococcal species. Homologues 
of the vanA gene have been detected in vancomycin resistant clinical isolates of 
Oerskovia turbata, Arcanobacterium haemolyticum isolated from stools of two 
patients during an outbreak of glycopeptide-resistant enterococci (GRE) infection 
in England (Power et al., 1995) and from a Bacillus circulans isolate in a case of a 
catheter-related infection (Fontana et al., 1997). A transferable vanB gene 
homologue was found in Streptococcus bovis isolated from a stool swab collected 
on admission from a patient as surveillance for GRE (Poyart et al., 1997) and the 
occurrence of Streptococcus gallolyticus strains containing vanA and/or vanB in 
faecal samples from avoparcin-fed veal calves was also reported (Mevius et al., 
1998). Experimentally, vanA resistance has been transferred from enterococci to 
Streptococcus sanguis, Lactococcus lactis, Streptococcus pyogenes as well as 
Listeria monocytogenes (Leclercq et al., 1989; Power et al., 1995; Biavasco et al., 
1996, Poyart et al., 1997).  
Vancomycin resistant S. pneumoniae has not been isolated yet, however, 
clinical strains of vancomycin tolerant S. pneumonia have been reported (Novak 
et al., 1999, McCullers et al., 2000; Rodriguez et al., 2004). Antibiotic tolerance is 
particularly insidious because it cannot be detected using conventional in vitro 
tests – tolerant strains seem to be sensitive to antibiotics (Gilmore & Hoch, 1999) 
and tolerance is thought to be a precursor to resistance development.  
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REGULATION OF VANCOMYCIN RESISTANCE 
The transduction signal systems are involved on the perception of the 
different extracellular signals and on the internal communication. They allow a 
rapid response to environmental fluctuations and make a fundamental link 
between the external stimuli and a specific response by inducing bacteria to 
synthesize the molecules that are, at each situation, essential. The general two-
component signal transduction mechanism by which bacteria sense and respond 
to different environmental conditions has been illustrated on Figure 5.  
The TCSs use energy in form of ATP to induce the response to a stress 
condition. They are composed of a sensor histidine kinase (HK) protein, located in 
the membrane, and a cytoplasmic response regulator (RR) that will induce the 
cellular response. In response to a specific extracellular signal, the HK undergoes 
trans-autophosphorylation on a specific histidine residue on a reaction that is ATP 
dependent. The phosphate group is then transferred to an aspartate residue of 
the cognate response regulator within its receiver domain and typically activates 
an attached output domain (Figure 5a). 
Regulation of VanA and VanB vancomycin resistance clusters occurs by a 
similar mechanism. On Figure 6 the regulation of VanA cluster is represented. 
Expression of glycopeptide resistance is regulated by a VanS/VanR-type TCS 
composed of a membrane-bound histidine kinase and a cytoplasmic response 






Figure 5. Schematic overview of a two-component signal transduction systems (A) and 
phosphorelays (B). A) On the prototypical two-component system a histidine kinase 
autophosphorylates on a conserved histidine residue (H) with subsequent transfer of the phosphoryl 
group to a conserved aspartate residue (D) on a cognate response regulator. Input domain on 
histidine kinases vary widely and typically do not share substantial homology to one another. The 
catalytic and TPase (CA) domain of the histidine kinase is responsible for binding ATP and catalyzing 
autophosphorylation of a conserved histidine found within the dimerization and histidine 
phosphotransferase (DHp) domain. The DHp domain mediates homodimerization and serves as the 
phosphodonor for a cognate response regulator. Many histidine kinases are bifunctional and also 
dephosphorylate their cognate response regulator. Response regulators typically contain two domains, 
a receiver domain and an output domain. Receiver domains contain the phosphoacceptor aspartate 
residue (D) and several other highly conserved amino acids and catalize phosphotransfer from a 
histidine kinase. Output domains, which are activated by phosphorylation of the receiver domain, are 
varied, but are often involved in binding DNA; B) On phosphorelays a stimulus activates 
autophosphorylation of a hybrid histidine kinase. The sensor kinase first transfers the phosphoryl 
group to a response regulator possessing the domain with the conserved aspartate but no output 
domain. The response regulator subsequently transfers the phosphoryl group to a histidine-containing 
phosphotransfer protein, and it is the latter protein that serves as a phosphodonor to the terminal 
response regulator, which possesses an output domain mediating a cellular response. Adapted  from 
(Laub & Goulian, 2007). 
 
 




Figure 6. Regulation of VanA cluster. Phosphorylation of the VanR by the VanS sensor. The colored 
arrows represent coding sequences and indicate the direction of transcription, The regulatory and 
resistance genes are co-transcribed from promoters PR and PH, respectively. The organization and 
functionality of the vanB cluster is similar to vanA but differs in its regulation, because vancomycin, but 
not teicoplanin, is an inducer of the vanB cluster. However, the phosphorylation events are similar in 
both clusters. Adapted from (Courvalin, 2006). 
 
VanS-type sensors comprise a N-terminal glycopeptide sensor domain with 
two membrane-spanning segments and a C-terminal cytoplasmic kinase domain. 
After a signal associated with the presence of vancomycin in the culture medium, 
the cytoplasmic domain of VanS/VanSB catalyzes ATP-dependent 
autophosphorylation on a conserved histidine residue (H164) and transfers the 
phosphate group to a conserved aspartate residue (D53) of VanR/VanRB present 
in the effector domain (Arthur et al., 1992b; Haldimann et al., 1997). VanS/VanSB 
also stimulates dephosphorylation of VanR/VanRB in absence of vancomycin 
(Arthur et al., 1997). The phosphorylated form of VanR/VanRB activates co-
transcription of vanHAXY/vanYBWHBBXB genes by binding to the PH/PYB promoter 
(Arthur et al., 1992b), and of vanRS/vanRBSB genes by binding to the PR/PRB 





affinity to the PR/PH and PR/PYB promoter regions. The VanS/VanSB sensor 
therefore modulates the phosphorylation level of the VanR/VanRB regulator: it 
acts as a phosphatase under non-inducing conditions and as a kinase in the 
presence of glycopeptides, leading to phosphorylation of the response regulator 
and activation of the resistance genes (Arthur et al., 1997). Moreover, 
VanR/VanRB can catalyze its own phosphorylation in the absence of VanS/VanSB 
by using acetyl-phosphate as a substrate or by a histidine kinase protein 
chromosomally encoded (Holman et al., 1994). Although, in this case the 
expression of the vancomycin resistance genes becomes constitutive due to the 
constitutive activation of the PR/PRB and PH/PYB promoters by VanR/VanRB in the 
absence of VanS/VanSB.  
 
Despite general common features on the regulation mechanism there are 
differences in the regulation of gene expression. The two VanR-VanS and VanRB-
VanSB systems display only limited homology. Furthermore, the putative 
membrane-associated sensor domains of VanS and VanSB are unrelated (Evers 
& Courvalin, 1996). It is therefore possible that VanS and VanSB sense the 
presence of glycopeptides by different mechanisms, which could account for the 
difference in induction specificity. These differences may also explain the large 
range of vancomycin MICs observed for the VanB phenotype (Quintiliani et al., 
1993).  
The general aspects of vanA and vanB gene clusters regulation, including the 
phosphotransfer reactions and promoter activation, are well characterized. In 
contrast, there are some aspects that have not yet been fully elucidated. The 
mechanism by which VanS and VanSB detect the presence of vancomycin is still 
unknown and the available work on this matter provides contradictable results. In 
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fact, it has never been established if signal recognition involves a direct 
interaction between the sensors and a specific ligand such as glycopeptides or 
peptidoglycan precursors (Arthur & Quintiliani, 2001). It is not likely that the 
accumulation of cytoplasmic peptidoglycan precursors could be the signal that 
triggers induction (Baptista et al., 1996; Ma et al., 2008). The heterologous 
expression of enterococcal HKs in E. coli inner membranes was evaluated and it 
was attempted to identify the activating signal for some of these HKs. In the case 
of VanS, there was no detectable increase in activity levels upon addition of a 10-
fold molar excess of vancomycin, indicating that vancomycin is not an activating 
signal for this specific kinase under this condition (Ma et al., 2008). Conversely 
Koteva and co-workers, using a synthesized vancomycin photoaffinity probe, 
proved that vancomycin directly binds Streptomyces coelicolor VanS (VanSsc) 
(Koteva et al., 2010). More studies are needed before a general assumption 
regarding the VanS ligand can be made since VanS proteins from different 
bacteria share little homology, raising the possibility that there is not only a single 
and common ligand to all VanS proteins. 
Although vancomycin resistance mechanism is very well described in 
enterococci, there is the suspicion that enterococci might have other cellular 
mechanisms contributing to vancomycin resistance and/or vancomycin response. 
In a study by Hancock & Perego (2004), the authors systematically inactivated 17 
response regulators genes belonging to the TCSs described for E. faecalis V583. 
A phenotypic analysis of mutants revealed that a mutant, other than vanR, 







ENTEROCOCCAL TWO-COMPONENT SYSTEMS 
Bacteria have different mechanisms available for the regulation of stress 
response (sigma factors, small RNAs and two-component systems).  Alternative σ 
factors have been shown to be important for the survival of various organisms 
under extreme conditions and to be involved with virulence and pathogenicity 
(Kazmierczak et al., 2005). Findings obtained in the past few decades have 
identified a new class of gene expression regulators, the small non-coding RNAs 
(sRNAs). sRNA candidate genes have been identified in different bacteria 
(Gottesman, 2005; Pichon & Felden, 2005).  
One of the differences between Enterococcus species, B. subtilis and S. 
aureus, is the absence of a σB hortologue in enterococci. In E. faecalis the 
general stress response involves other regulation mechanisms, although there 
are six described σ factors in V583 genome namely, RpoD or σD (Frere et al., 
1996), σN implicated in the nitrogen limitation response (Dalet et al., 2000) and 
other four putative extracytoplamic function sigma factors (ECF) namely, σV 
(Benachour et al., 2005),  σX, σG and σH (Benachour, personal communication).   
However, in enterococci the best characterized stress response mechanisms 
are the two-component systems. 
The two-component systems were first reported in 1986 (Ninfa & Magasanik, 
1986; Nixon et al., 1986) and with the genomic advances it is known that the 
chromosome of most bacteria encodes several two-component systems. For 
instance, Synechocystis sp. has 80 TCS, E. coli has 62 proteins associated to 
TCS  (Mizuno, 1998) and 36 TCS are identified in B.subtilis. There are other 
bacteria with a reduced number, as is the case of Haemophilus influenza with 6 
TCS and Mycoplasma genitalium with no described TCS. 
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On E. faecalis V583 genome there are 17 TCS Ehk-Err (enterococcal 
histidine kinase and enterococcal response regulator) composed of a HK and a 
RR, and an orphan RR (i. e. an RR without a partner HK) (Paulsen et al., 2003). 
However, the content in TCSs varies among other E. faecalis strains, e. g. 
OG1RF has 15 TCS and JH2-2 has 14 TCS (Teng et al., 2002; Le Breton et al., 
2003; Mcbride et al., 2007; Bourgogne et al., 2008). By comparative genomic 
hybridizations it was proposed that 12 out of the 17 enterococcal TCSs known, as 
well as the orphaned response regulator, are part of E. faecalis core genome 
(McBride et al., 2007). The TCS that belong to E. faecalis core genome include 
Ehk-Err01, Ehk-Err02, Ehk-Err03, Ehk-Err04, Ehk-Err05, Ehk-Err06, Ehk-Err07, 
Ehk-Err09, Ehk-Err10, Ehk-Err13, Ehk-Err14, Ehk-Err17 and Err18 (McBride et 
al., 2007). The functions of most of enterococcal TCSs are largely unknown. 
These systems were grouped according to the classification of Fabret et al. 
(1999) (Table 2), based on the analysis of B. subtilis genome. This classification 
is based on the structure similarities and on the sequence of each of the TCS 
components. Therefore, the TCSs are clustered according to the structure of the 
ATP binding site and the motif containing the phosphorylable histidine residue on 
the HK, as well as the structure of the receptor domain containing the aspartate 
residue on the response regulator. Based on this classification 6 classes were 
defined (I, II, IIIA, IIIB, IV and V) (Fabret et al., 1999), each one corresponding to 
the classes defined by Mizuno et al. (1997) in E. coli (Others-B, NarL, OmpR, 
NtrB, Others-A and CheY, respectively) (Mizuno, 1997).  
E. faecalis TCSs have been studied in more detail in three strains, namely 
V583 (Hancock & Perego, 2004b), JH2-2 (Teng et al., 2002) and OG1RF (Le 
Breton et al., 2003). The results of these studies, however, do not allow a 
definition of the precise role of each TCS, as the role of each TCS is strain 
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dependent. However, taken together, these studies can emphasize the role of 
some two-component systems on virulence, biofilm formation, antibiotic 
resistance and stress response.  
The number of TCSs varies among the studied strains which can be, in part, 
explained by the fact that both TCS Err11-Ehk11 (VanRS) and Ehk12-Err12 are 
located on mobile elements or on a pathogenicity island (PAI). Err07-Ehk07 
(VicRS) is considered to be an essential TCS to the cellular viability since a viable 
mutant has not been obtained. Err07-Ehk07 could be an equivalent to the 
essential system YycFG from B.subtilis (Fabret & Hoch, 1998). 
Err05 mutant presents some growth deficiencies and abnormal cellular 
morphology in JH2-2. salB expression, encoding for a putative stress protein, is 
altered on the mutant (Le Breton et al., 2003). Err05-Ehk05 has been implicated 
in resistance to antimicrobial agents that target the cell wall, like β-lactams 
(Comenge et al., 2003), and was named CroR-CroS, standing for ceftriaxone 
resistance. An err05 mutant also presents reduced susceptibility to vancomycin 
(Hancock & Perego, 2004b), revealing a potential role of this TCS in response to 
cell-wall active antibiotics. 
As mentioned above, TCS Err11-Ehk11 (VanRBSB) is the most widely studied 
enterococcal TCS and it is responsible for vancomycin resistance expression and 
regulation (Arthur et al., 1992b; Arthur & Courvalin, 1993; Evers et al., 1996, 
Arthur & Quintiliani, 2001). The systems Ehk01-Err01 and Ehk03-Err03 are 
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Table 2. Classification of E. faecalis TCSs, according to Hancock and Perego (2002). The 
homologies with known proteins are indicated, with Bli : B. licheniformis, Bce : B. cereus, Bsu : B. 
subtilis, Efa : E. faecalis, Lmo : L. monocytogenes, Sag : S. agalactiae, Sau : S. aureus, Spy : 





Histidine kinase Response Regulator 
Locus  
Homologies 
(% identic residues /% conserved residues) 
Locus Family†  
Homologies 
(% identic residues /% conserved residues) 
Ehk01-Err01 
I 
EF2219  YesM (37/58) Spy EF2218 AraC  YesN (43/64) Spy 
Ehk02-Err02 EF3197  LytS (55/74) Sau EF3196 Lyt  LytR (39/64) Sau 
Ehk03-Err03 II EF2912  VraS (48/69) Sau EF2911 NarL  VraR (62/79) Sau 
Err04-Ehk04 
IIIA 
EF1704  PhoR (31/50) Bsu EF1703 
OmpR 
 PhoP (55/76) Bsu 
Err05-Ehk05 EF3290  VanS (38/61) Bce EF3289  VanR (57/77) Bce ; BacR (44/64) Bli 
Err06-Ehk06 EF1261  YclK (44/62) Bsu EF1260  YclJ (60/72) Bsu 
Err07-Ehk07 EF1194  VicK(100) Efa ; YycG (45/69) Bsu EF1193  VicR (100) Efa ; YycF (77/88) Bsu 
Err08-Ehk08 EF1863  VncS (77/89) Sag EF1864  VncR (95/98) Sag 
Err09-Ehk09 EF0927  YxdK (41/65) Bsu EF0926  YtsA (47/70) Bli ; YdxJ (42/66) Bsu 
Err10-Ehk10 EF1051  EtaS (100) Efa ; LisK (50/69) Lmo EF1050  EtaR (100) Efa ; LisR (75/85) Lmo 
Err11-Ehk11 EF2298  VanS (100) Efa EF2299  VanR (100) Efa 
Ehk12-Err12 EF0570  KdpD (41/63) Lmo EF0571  KdpE (49/71) Lmo 
Ehk13-Err13 EF0373  CovS (35/62) Spy EF0372  SrrA (37/62) Sau 
Err18   - EF3329  ? 
Ehk14-Err14 
IV 
EF1209  CitA (32/55) Bce ; DpiB (32/56) Spy EF1210 Other-A  DpiA (44/64) Spy ; CitT (32/52) Bce  
Err15-Ehk15 EF1820  FsrC (100) Efa EF1822 Agr  FsrA (100) Efa 
Err16-Ehk16 EF1335  ? EF1336 Agr  ? 
Err17-Ehk17 EF1632  ? EF1633   ? 
  *TCS are grouped according to Fabret et al. (1999) classification, based on B. subtilis ; †TCS were 
classified in families according to Mizuno et al. (1997) classification, based on E. coli. 
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Err10 mutant has an increased survival rate in a mouse model by peritoneal 
injection compared with the wild type OG1RF, suggesting that the system Err10-
Ehk10 (EtaRS) is involved in virulence. Ehk13-Err13 (EtbRS) might also be 
involved in virulence although the evidences are not so compelling (Teng et al., 
2002).  
It was demonstrated that TCS Err15-Ehk15 (FsrCA) is activated by quorum 
sensing mechanisms (Nakayama et al., 2001) and has a role in biofilm formation 
(Hancock & Perego, 2004a) and virulence (Qin et al., 2000; Mylonakis et al., 
2002; Sifri et al., 2002) through transcriptional regulation of gelE, encoding a 
metalloprotease, and sprE, encoding a serine protease (Qin et al., 2001). 
Although some of the TCSs are associated to stress response, antimicrobial 
resistance and virulence, all together contributing to the opportunist character of 
E. faecalis, little is known about the target genes of these systems.  
 
TWO-COMPONENT SYSTEMS AND CROSS-REGULATION 
Histidine kinases and response regulators each comprise paralog gene 
families and members of each family share significant homology at both the 
primary sequence level and at the structural level. The similarity of these signaling 
proteins raises the possibility of cross-talk between different two-component 
pathways (Chang & Stewart, 1998). Although the existence of such cross-talk has 
been widely suggested, it is unclear to what extent it occurs in vivo. Cross-talk is 
defined as the communication between two pathways that, if eliminated, would 
leave intact two distinct, functioning pathways. In general cross-talk between 
distinct pathways should be kept to a minimum, otherwise an organism would not 
be able to evoke the necessary response to a specific input stimulus. However, 
under certain conditions, it may be advantageous to an organism to allow or use 
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cross-talk as a means of either integrating multiple signals or of diversifying the 
response to a single input. When cross-talk benefits the organism it is called 




The available data on cross-talk in E. faecalis are limited. Studies of the 
PhoR-PhoB and the VanS-VanR two-component signalling systems have been 
particularly useful in highlighting the mechanisms used by cells to prevent cross-
talk (Figure 8) (Fisher et al., 1995; Fisher et al., 1996; Haldimann et al., 1996; 
Haldimann et al., 1997; Silva et al., 1998). The PhoR-PhoB two-component 
system is endogenous to E. coli and allows the organism to sense and respond to 
changes in phosphate availability. The enterococci VanS-VanR two-component 
system can be expressed in E. coli. Cross-talk from the kinase VanS to the 
response regulator PhoB can occur in E. coli but only in the absense of PhoR 
(Fisher et al., 1995; Silva et al., 1998). Similarly, the kinase PhoR can cross-talk 
to the response regulator VanR but only in the absence of VanS (Haldimann et 
al., 1997; Silva et al., 1998). 
Figure 7. Cross-talk schematic representation. 
Cross-talk is defined as the communication between 
pathways that, if eliminated, would leave intact two 
distinct pathways. Histidine kinase (HK), response 
regulator (RR), histidine residue (H), aspartate 
residue (D). Adapted from (Laub & Goulian, 2007).  
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In a study using flow cytometry, Baptista et al. (1999) examined the induction 
of van gene expression in single cells of an enterococcal VanB strain. In 
enterococcal VanB strains, null mutations in vanSB lead to a phenotype termed 
“heterogeneous”, in which, in the absence of antibiotic, only a minority of the 
bacteria expresses the van genes (Baptista et al., 1999). Furthermore, addition of 
the antibiotic leads to uniform induction of the whole population, rather than 
selection of the subpopulation initially expressing resistance under non-inducing 
conditions. They concluded that a heterologous kinase activates VanRB in the 
absence of VanSB. Interestingly, this putative kinase was stimulated by 




Figure 8. Cellular mechanims for preventing cross-talk. Studies of the PhoR-PhoB and VanS-
VanR two-component pathways in E. coli demonstrate two major mechanisms by which cells prevent 
unwanted cross-talk between different pathways. (a) In wild-type cells any inadvertent cross-
phosphorylation of VanR is eliminated by the phosphatase activity of VanS, thereby preventing the 
accumulation of VanR-P. (b) Eliminating VanS can thus lead to increased cross-talk, represented by 
thicker arrows, from PhoR-P (or acetyl phosphate). (c) Competition between response regulators for 
the phosphodonor PhoR-P also helps prevent cross-talk. PhoR-P has a higher affinity for PhoB 
relative to VanR, and so preferentially phosphorylates PhoB. Eliminating PhoB therefore leads to even 
more cross-phosphorylation of VanR. Adapted from (Laub & Goulian, 2007). 
 
                                                                                                General Introduction 
 39 
Presumably, in the wild-type enterococcal VanB strains, the phosphatase 
activity of VanSB keeps VanRB in the unphosphorylated state in the presence of 
teicoplanin and moenomycin, preventing the putative heterologous kinase from 
activating van gene expression. The putative heterologous kinase has not yet 
been identified but a possible candidate is CroS, since it is known to be induced 
by vancomycin, teicoplanin and moenomycin A (Comenge et al., 2003). 
 
BACTERIAL RESPONSE TO VANCOMYCIN AND OTHER CELL WALL-
ACTIVE ANTIBIOTICS  
The regulatory network of the cell wall response is well studied in B. subtilis 
and includes several overlapping regulons: in the presence of cell wall active 
antibiotics, the inducible defensive response is coordinated by, at least, two 
alternative extracytoplasmic sigma factors (σ), σW and σM and four two-
component systems BceRS, LiaRS, YvcPQ and YxdJK (Cao et al., 2002; 
Mascher et al., 2003; Mascher et al., 2004). It was proposed that σW is involved in 
defending the cell against antimicrobial agents and that σM modulates the surface 
properties and maintains the envelope integrity. It was also speculated that the σB 
general stress response is activated by cell wall antibiotics as a secondary 
response (Mascher et al., 2003). 
In S. aureus, the mechanisms of antibiotic induction are poorly characterized 
and the available knowledge is based on wide genomic studies that have 
identified the regulation of several genetic determinants or proteins. A first 
indication that antibiotic challenge in S. aureus is linked to a physiologically wide-
range response came from the identification of the auxiliary genes and from the 
implication of σB regulatory element in the cell wall antibiotics resistance 
mechanism (Wu et al., 1996; De Lencastre et al., 1999). In this context, a cell wall 
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stimulon was defined as being the specific cell response to inhibition of 
peptidoglycan biosynthesis (Jablonski & Mychajlonka, 1988). However, the 
regulatory pathways associated to such stimulon are still unknown. 
Proteomic studies where a S. aureus strain was challenged with cell wall 
targeting antibiotics revealed a characteristic protein pattern which was not 
induced by non-cell wall targeting antibiotics (Singh et al., 2001). Later, 
microarray studies were performed in different S. aureus genetic backgrounds. 
The unique effects of oxacillin, bacitracin and D-cycloserine were studied (Utaida 
et al., 2003). Vancomycin effect was determined and a specific set of genes 
belonging to the regulon of the VraSR two-component system (standing for 
Vancomycin-resistance associated sensor/regulator) was described (Kuroda et 
al., 2003). The vancomycin effect was later determined in other S. aureus strains 
(McAleese et al., 2006; McCallum et al., 2006). The transcriptional profiles of all 
these studies showed subsets of 15 genes, proposed to belong to a “cell wall 
stimulon”, and the majority of the diversity observed is likely due to strain genetic 
diversity (McCallum et al., 2006). Whether any of the core genes specifically 
contribute to S. aureus response to antibiotic stress is not known, but is generally 
speculated that they act as part of a concerted action that would be essential for 
the bacteria to express physiological resistance. 
 
In E. faecalis, the mechanisms of antibiotic induction and antibiotic stress 
response are almost completely unknown with just a limited number of studies, 
using microarray transcriptomic approach, to understand the overall response of 
E. faecalis to antibiotics (Aakra et al., 2005; Aakra et al., 2010). Abranches et al., 
(2009) provide evidence that (p)ppGpp pools modulate vancomycin tolerance 
(Abranches et al., 2009). However, and opposite to B. subtilis and S. aureus, 
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nothing is yet documented on antibiotic cell wall stress response. Considering that 
enterococci were the first clinically relevant etiological agents acquiring 
vancomycin resistance and that they constitute primary carriers and a potential 
dissemination source of vancomycin resistance genes to other clinically relevant 
bacterial species, it is of utmost importance to study the enterococcal response to 
vancomycin. Moreover, the suspicion about the potential involvement of other 
TCSs suggests that vancomycin response can be more intricated than previously 
suspected. 
 
In summary, the response to vancomycin, as the majority of the biological 
processes cannot, be well understood if we do not have a detailed knowledge of 
the general and specific stress response mechanisms. There are several factors 
contributing to different response mechanisms to vancomycin exposure in 
bacteria. Vancomycin response is a multifactorial mechanism and works through 
the concerted action of different stress response mechanisms. In enterococci is 
fundamental the establishment of the molecular role of the two-component 
systems that will for sure allow the definition of stress response regulons in 
general. A deep knowledge of these regulons, in particular the antibiotic response 
regulons, is crucial for the determination of new targets for the development of 
alternative antibiotic therapies.  
With the work presented in this thesis we intend to contribute to identify and 
define other molecular players involved in the vancomycin resistance mechanims. 
Moreover, we intend to contribute to the future definition of the vancomycin 
response regulon in E. faecalis, through the identification of putative genes and 
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ABSTRACT 
A total of 113 enterococcal isolates from dairy food products and from human 
and dog infections, isolated in Portugal, and 26 type and reference strains of the 
genus Enterococcus were screened for vancomycin resistance. MIC values, for 
both vancomycin and teicoplanin, were determined. The genetic relatedness of 
isolates carrying vanA and/or vanB was determined using Pulsed Field Gel 
Electrophoresis. For vanA carrying isolates, transposon Tn1546 was partially 
mapped using PCR. None of the 63 dairy isolates was resistant to vancomycin 
and only one (out of 50 clinical isolates) was resistant, with a MIC value of 256 
µg/ml. The type and reference strains used were susceptible to both vancomycin 
and teicoplanin. vanA was found in 35% of the dairy isolates and 40% of the 
clinical isolates. vanB was detected in 18% of the clinical isolates, both human 
and dog isolates, and only in 6% of the dairy isolates. PCR partial mapping of 
Tn1546 on vanA-containing strains revealed 23 different patterns among 42 
isolates. Some patterns were shared between dairy and clinical isolates. Mapping 
of vanB operon on vanB carrying strains also revealed that these strains carry an 
incomplete vanB resistance operon. 
Using Pulsed Field Gel Electrophoresis for vanA-carrying strains, six groups 
of isolates were found to be genetically undistinguishable and grouping was found 
to be geographically and location specific/related. No genetic relatedness was 
found between isolates from dairy, human and veterinary sources. An incomplete 
and/or unfunctional Tn1546 element explains the absence of resistant behaviour 
in the studied isolates, even when vanA gene is present. As well, an incomplete 
vanB operon explains the absence of a resistant phenotype. Moreover, the work 
reported shows that both clinical (human and animal) and dairy isolates have 
been in contact with vanA and vanB genotypes of resistance and suggest that 
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dissemination of vanA gene has been through transposable elements, like 
Tn1546, and not by clonal dissemination of a resistant strain. Therefore, a 
national strategy should be implemented to survey both vancomycin resistance 





















Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes 
 61 
INTRODUCTION 
Enterococci constitute part of the natural gut microflora in mammals 
(Devriese et al., 1992). They are also found in a variety of food products, namely 
milk and cheese produced in the south of Europe (Flahaut et al., 1997; Barros, 
1998; Lopes et al., 1999). In some of these cheeses enterococci play a key role in 
the maturation and final organoleptic characteristics of the food product and 
constitute the main microbial population in the final product (Franz et al., 1999). 
For many years enterococci have been considered harmless to man. However, in 
the last decades, they have become the second most frequently reported cause 
of surgical wound infections and nosocomial urinary tract infections and the third 
most frequently reported cause of bacteraemia (Klein et al., 1998). Moreover, 
treatment of these infections has become more and more difficult due to the 
increasing number of antibiotic resistant enterococci. 
The optimal therapy for endocarditis, one of the most serious enterococcal 
infections, involves a combination of a cell-wall active agent and an 
aminoglycoside, usually gentamicin (Malani et al., 2002). With the emergence of 
high-level gentamicin resistance the only antibiotic available for a successful 
treatment of enterococcal infections is vancomycin, a glycopeptide. However, 
over the past decade, there has been a rapid increase in vancomycin resistant 
enterococci (VRE). Colonization and infection by VRE have been reported in 
hospitalized patients and in the community, and has also been associated with 
environmental sources and meat products. Glycopeptide resistance in 
enterococci is generally acquired and is encoded in genetic mobile elements, like 
transposons. This is the case of VanA, VanB, VanD, VanE, VanG and VanM 
phenotypes (Xu et al., 2010). It can also be encoded in a non-transferable 
chromosomal determinant, as in VanC phenotype and most likely in VanL 
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(Tendolkar et al., 2003; Boyd et al., 2008). VanA and VanB are the most globally 
widespread and prevalent phenotypes. The prototype VanA element is Tn1546, a 
10.8-kb transposon (GenBank accession number M97297) that carries a cluster 
of nine genes (Arthur et al., 1993), encoding nine different proteins, which 
mediates high-level inducible resistance to both vancomycin and teicoplanin. The 
nine polypeptides can be divided in four functional groups: transposition (ORF 1 
and 2), regulation (VanR and VanS), resistance to glycopeptides (VanH, VanA 
and VanX) and synthesis of peptidoglycan (VanY and VanZ). The vanB cluster 
encodes inducible resistance to vancomycin, but not to teicoplanin and is 
disseminated by large transposons such as Tn1547 and Tn5382 (Tendolkar et al., 
2003). Tn1547 is homologous to Tn1546 and most of the vanB genes share a 
large percentage of homology to the vanA cluster genes. In Europe, vanA has 
been found in VRE isolated in the community, from sewage, animal faeces and 
raw meat, which suggests that these environments can act as reservoirs of these 
microorganisms (Simjee et al., 2002). In fact, the emergence of VRE has been 
related to the use of antimicrobial agents both in human and veterinary medicine 
and as growth promoters in animal feed. Although enterococci isolated from 
traditional portuguese cheeses have not been subjected to the selective pressure 
of the use of glycopeptides, it would be of the utmost importance to ascertain the 
dissemination of vancomycin resistance in this environment. Therefore, the aim of 
this study was to survey vancomycin resistance among a group of dairy and 
clinical isolates and to ascertain the possible relatedness of the VRE isolates. 
vanA and vanB genes were chosen since they are the most widely found among 
VRE. Type and reference strains of the genus Enterococcus were included in this 
study since they are the representatives of the genus. 
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MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS  
All strains were grown at 37°C without shaking, in Brain Heart Infusion 
medium (BHI) (Oxoid). A total of 139 enterococci (113 wild type strains plus 26 
control and reference) were used in this study. Sixty three strains were isolated 
from Portuguese dairy products (ewe’s cheese and milk) collected from four 
different Registered Designation of Origin (RDO) designated as A, B, C and D, as 
described by Lopes et al. (1999) (Lopes et al., 1999). Thirty-nine isolates were 
obtained from human infections in several Portuguese hospitals. Eleven dog-
infecting isolates were obtained from Lisbon Veterinary Faculty. The dairy isolates 
were identified by phenotypic and molecular methods as 28 Enterococcus 
faecalis, 6 E. faecium, 24 E. durans, 1 E. raffinosus, 6 E. hirae, 1 E. dispar and 34 
Enterococcus spp. (Alves et al., 2004). The same methods applied to the clinical 
isolates identified 31 as E. faecalis, 8 as E. faecium, 1 as E. solitarius, 1 as E. 
durans and 9 as Enterococcus spp.. Twenty-six type and reference strains of the 
genus Enterococcus were also studied and are described in Table 3. The more 
recently described species E. pallens, E. gilvus (Tyrrell et al., 2002), E. 
phoeniculicola (Law-Brown & Meyers, 2003), E. italicus (Fortina et al., 2004), E. 
hermanniensis (Koort et al., 2004), E. devriesei (Svec et al., 2005b), E. 
aquimarinus (Svec et al., 2005a), E. caninstestini (Naser et al., 2005), E. caccae 
(Carvalho Mda et al., 2006) and E. silesiacus, E. termitis (Svec et al., 2006) and 
E. thailandicus (Tanasupawat et al., 2008) were not included in this study. E. 
faecalis DSMZ 2570 (equivalent to ATCC 29212) was used as a control strain in 
the E-test, for MIC determination (Minimum Inhibitory Concentration). 
Vancomycin MIC values for this control strain coincided always with the expected 
ones. E. faecium BM 4147 and E. faecalis DSMZ 12956 were used as positive 
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control strains for vanA and vanB PCR reactions, respectively. 
 
MIC DETERMINATION 
Minimum inhibitory concentrations for vancomycin and teicoplanin were 
determined using the E-test (AB Biodisk), according to manufacturer’s 
instructions. Each plate was inoculated with a suspension of the microorganism 
equivalent to 2 in the McFarland turbidity standard. Vancomycin and teicoplanin 
were purchased from Sigma. E. faecalis DSMZ 2570 was used as a control strain. 
Strains were classified as resistant (MIC≥ 32 µg/ml), intermediate (MIC≥ 8 µg/ml 
and MIC≤ 16 µg/ml) and susceptible (MIC≤ 4 µg/ml). 
 
PREPARATION OF DNA 
Total DNA was extracted from cells according to the method of Pitcher et al. 
(1989). 
 
PCR AND SEQUENCING 
Except for the type and reference strains, all dairy and clinical isolates were 
searched for the presence of the genes vanA and vanB using PCR. Primers used 
were as presented in Table 1. For the isolates for which vanA was detected by 
PCR eight primer pairs (Table 1) were used to partially map the Tn1546 
transposon. The primers used to map the vanB operon on dairy vanB carrying 
strains are also listed on Table 1.  
PCR was performed with T-personal Combi thermocycler (Biometra). Each 
50 µl PCR reaction mixture contained 250 ng of DNA, 0.5 µM of each primer, 1.5 
mM MgCl2, 0.2 mM deoxynucleoside triphosphates (dATP, dCTP, dGTP and 
dTTP), 1X PCR buffer, 0.005% W1 and 2.5 U of Taq DNA polymerase. All 
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reagents were purchased from GibcoBRL, except the primers that were 
purchased from MWG-Biotech. 
Table 1. Sequence of primers used to amplify genes and intergenic regions (IR) from vanA 
(Tn1546) and the vanB operons. 
Gene / 
IR 
Sequence Amplicon size (bp) 
VanA OPERON MAPPING – STRUCTURAL GENES and INTERGENIC REGIONS1  
vanA 

































































1 Sequences published by  (Miele et al., 1995) except for vanX (Manson et al., 2003). 2 The primers 




The thermocycler was programmed with the following conditions: 5 min at 
95ºC; 30 s at 94ºC, 30 s at 47ºC (vanA-related primers) or 49ºC (vanB-related 
primers) and 30 s at 72ºC for 30 cycles; 10 min at 72ºC; and 4ºC until analysis. 
Visualisation of amplicons was done with ethidium bromide (Sigma) under UV 
irradiation, after electrophoresis on 2% agarose (w/v) (GibcoBRL) gels. Image 
analysis was performed with Kodak Digital ScienceTM. Amplification of the above 
mentioned genes was confirmed with sequencing of the PCR products, after their 
purification either with ConcertTM Rapid PCR Purification System or with 
ConcertTM Matrix Gel Extraction System, both purchased from GibcoBRL. 
Sequencing was performed by MWG. 
 
INVERSE PCR 
Inverse PCR was performed for four vanA+ strains for which the presence 
and sequence of vanA gene was confirmed by sequencing. Strains from different 
origins and PCR patterns were chosen: one dairy strain (pattern T), one human 
clinical strain (pattern C) and two veterinary clinical strains (patterns J and G). As 
a control for the PCR reaction and for PCR products gel analysis comparison the 
strain BM4147, which carries the complete Tn1546, was used (Ochman et al., 
1988). 
In order to optimize this procedure different conditions were tested. 
Restriction digests were performed using 5 µg of source DNA treated with 20 
units of three different restriction endonucleases (HindIII, EcoRI, NsiI) according 
to the supplier´s specifications. Digested DNA samples were checked on a 1% 
(w/v) agarose gel in 1×TAE buffer (40 mM Tris-acetate, 1 mM EDTA) to verify the 
efficacy of digestion. Digested DNA samples were purified by phenol-chlorophorm 
extraction followed by an ethanol precipitation. Circularization was performed 
under conditions that favor intramolecular ligation. 1 µg of the appropriated 
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restriction fragment was diluted to a concentration of 0.002 µg/µl. The ligation was 
initiated by the addition of T4 DNA ligase to a concentration of 1 unit/µl and the 
reaction was allowed to proceed at 16ºC overnight. The ligated sample was 
purified by a phenol-chlorophorm extraction followed by an ethanol precipitation. 
The circularized fragment were linearized using either AegI or EagI and the PCR 
reactions were performed using the primers InVanA_1 (5’-
GCAAGGTTTTTCGCACATTTTCC-3’) and InVanA_2 (5’-CGTATGTAACTGGTT 
CTTAGGG-3’) purchased from STAB Vida. The PCR reactions were performed 
using either 100 ng or 250 ng of digested DNA, 10 pmol of each primer, 0.2 mM 
of dNTPs, and 2.5 U of Expand long template High Fidelity Taq DNA polymerase 
(Roche Diagnostics). PCR reactions were performed according to the 
manufacturer´s indications. The DNA products were fractionated in a 0.8% (w/v) 
agarose gel and bands of interest were further purified and sequenced. All the 




PFGE was performed with dairy and clinical isolates carrying vanA gene or 
vanB gene. Genomic DNA agarose discs and DNA digestion with SmaI were 
performed according to the method of Chung et al. (2000) except for lysis 
solution, which contained only RNase A and lysozyme (Chung et al., 2000),. 
Agarose discs were electrophoresed on a 1% (w/v) Seakem GTG agarose gel in 
0.5× TBE buffer low EDTA (50 mM Tris, 50 mM boric acid, 0.2 mM EDTA, pH 8.0) 
in a CHEF apparatus (Clamped Homogeneous Electric Fields) (BioRad) at 8ºC at 
220V with pulse times of 5 s rising to 35 s during 18 hours. Gels were stained by 
immersion in ethidium bromide solution (1 µg/ml) for 30 minutes and 




In this work 113 enterococcal isolates from two different environments, dairy 
products and clinical settings (both human and pets), and identified as different 
species, and 26 type and reference strains of the genus Enterococcus, were 
firstly investigated on their resistance to vancomycin using the E-test for MIC 
determination. Teicoplanin MICs were also determined and the study was 
completed with a survey of the presence of vanA and vanB genes using PCR. 
vanA positive isolates were subjected to PFGE to ascertain their relatedness and 
other regions of the Tn1546 transposon were also searched in these isolates, 




According to results shown in Table 2, no resistant isolates were found 
among dairy isolates, although nearly 16% (10 isolates) had MIC values above 6 
µg/ml, and can be considered intermediate.  
 
Table 2. Distribution of dairy and clinical isolates, carrying vanA/B genes of resistance, and of 
type and reference strains, between different MIC values for vancomycin. 
M I C  ( µ g / m l)   
 S t ra in s a  
0 . 3 8  0 . 5  0 . 7 5  1  1 .5  2  3  4  6  8  1 2  2 5 6  
D a iry  v an A +  1  0  0  3  0  0  7  7  4  0  0  0  
 v an A -/v an B -  1  0  1  3  9  7  1 1  2  3  0  0  0  
 v an B +  

























 T o ta l  2  0  1  6  9  7  1 8  1 0  7  1  2  0  
C l in ic a l v an A +  0  0  0  0  0  3  3  6  4  0  0  0  
 v an A -/v an B -  0  0  0  0  2  3  1 1  5  3  0  0  0  
 v an B +  

























 T o ta l  0  0  0  0  2  8  1 4  1 2  9  2  1  1  
R e f e re n c e  
S t ra in s  
T o t a l  1  3  5  9  1  0  7  0  0  0  0  0  
  
a Total number of isolates/strains in each column are in bold; vanA+/-, presence/absence of vanA gene 
only; vanB+, presence of vanB gene only; vanA+B+, presence of both vanA and vanB genes; vanA-B-, 
absence of both vanA and vanB gene. 
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In contrast, among the clinical isolates, 72% behaved as susceptible, 22% 
were intermediate and 6% were found to be resistant. All type and reference 
strains behaved as vancomycin susceptible, as they showed MIC values below 4 
µg/ml, and 70% of these strains had MIC values below 1 µg/ml (Table 3).  
 





DSMZ 11492T E.asini 0.5 0.25 
DSMZ 20679T E. avium 0.75 0.75 
DSMZ 20680T E. casseliflavus 0.5 0.094 
DSMZ 20682T E. cecorum 3 0.75 
DSMZ 7374T E. columbae 0.5 0.5 
DSMZ 6630T E. dispar 3 0.5 
DSMZ 20633T E. durans 1 0.094 
DSMZ 20478T E. faecalis 0.75 0.75 
CECT 187 E. faecalis 3 0.25 
CECT 184 E. faecalis 3 0.25 
DSMZ 20477T E. faecium 1 0.75 
DSMZ 7370T E. flavescens 0.75 0.094 
DSMZ 20628T E. gallinarum 0.75 0.75 
LMG 19487 E. haemoperoxidus 1 0.38 
DSMZ 20160T E. hirae 1 0.75 
DSMZ 20681T E. malodoratus 1 0.38 
LMG 19486 E. moraviensis 1 0.25 
DSMZ 4838T E. mundtii 1 0.38 
ATCC 700913 E. porcinus 3 0.38 
DSMZ 5632T E.pseudoavium 0.38 0.032 
DSMZ 5633T E. raffinosus 3 0.38 
ATCC 700914 E. ratti 1 0.25 
DSMZ 20726T E. saccharolyticus 1 1 
DSMZ 5634T E. solitarius 1.5 0.38 
DSMZ 6905T E. sulfureus 0.75 0.38 
LMG 12287 E. villorum 3 0.38 
  
a DSMZ, Deutsch Sammlung von Mikroorganismen and Zellkulturen (Braunschweig, Germany); CECT, 
Colección Española de Cultivos Tipo (Valencia, Spain); LMG, Laboratorium voor Microbiologie (Gent, 
Belgium); ATCC, American Type Culture Collection (Rockville, USA). 
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Overall, reference strains had lower MIC values than those of the other 
isolates studied. The clinical isolates showed higher MIC values than dairy 
isolates, with 28% of the clinical isolates presenting MIC values between 6 and 
256 µg/ml, against only 16% of the dairy isolates with MIC values above 6 µg/ml. 
All MIC values for teicoplanin fell under the susceptible classification, for all the 
isolates and reference strains studied (results not shown). 
 
SEARCH FOR THE vanA AND vanB GENES 
vanA gene was found in 35% of the dairy isolates and in 40% of the clinical 
isolates. vanB gene was found in only 6.3% (4 isolates) of the dairy isolates and 
in 18% (seven human isolates and two dog isolates) of the clinical enterococci 
studied. In four of the vanB positive clinical enterococci (two from humans and 
two from dogs), vanA was also detected. Among the dairy isolates, vanA was 
detected in four different species (E. faecalis, E. faecium, E. durans and E. hirae), 
both in milk and cheese isolates. In clinical enterococci, vanA was detected in E. 
faecalis and E. faecium, and in E. solitarius. The four isolates that showed both 
vanA and vanB were identified as E. solitarius, E. faecium and two as 
Enterococcus spp. 
No correlation was evident between the presence of vanA gene and higher 
MIC values for vancomycin (Table 2) or teicoplanin. In fact, both dairy and clinical 
isolates that were positive for vanA had MIC values under 6 µg/ml. Only two 
clinical isolates had MIC values of 8 and 12 µg/ml and in both of them vanB gene 
was also detected. In fact, the presence of vanB gene seems to increase MIC 
values for vancomycin since nine, among thirteen isolates positive for vanB, had 
MIC values between 6 and 256 µg/ml. In the E. faecium isolate with a MIC value 
of 256 µg/ml, only vanB gene was detected. 
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MAPPING OF vanA AND vanB OPERONS  
Strains carrying vanA, both clinical and dairy, were surveyed for the presence 
of other elements of Tn1546, the prototype mobile element carrying the vanA 
operon. Eight primer pairs were used in this screen assay. Two of these primer 
pairs were directed to two intergenic regions, XY and YZ, and the other six pairs 
of primers were directed to more conserved regions of this transposon, namely 
genes vanR, vanS, vanH, vanX and vanY. Among 42 isolates, 23 different PCR 
patterns were found (Table 4). All the genes and intergenic regions were 
detected, at least in one isolate, and with the exact size as predicted from the 
Tn1546 sequence. The absence of vanX was the only common feature among all 
the 42 isolates. The only two isolates for which all (except vanX) the searched 
elements were detected (pattern B), come from the clinical environment, but from 
different hospitals and with collection dates 10 years apart. They were both 
identified as E. faecalis and their MIC values for vancomycin were 4 and 6 µg/ml. 
PCR pattern A, corresponding to absence of all the fragments, was found in four 
isolates, one from dairy origin (E. durans, with a MIC value for vancomycin of 4 
µg/ml) and three from clinical environment (two E. faecalis and one Enterococcus 
spp., with MIC values for vancomycin of 4 and 3 µg/ml), and none of these strains 
was highly susceptible. 
A higher variability in PCR patterns was found among dairy isolates. In fact, 
seven patterns (from B to H) were only found in clinical enterococci (13 isolates), 
and 12 different patterns (from L to X) were found in dairy isolates (16 
enterococci). Four patterns were common to both environments (A, I, J and K). 
The only common feature among these four patterns was the absence of the X 
and S fragment. The S fragment, corresponding to vanS gene, was only found in 
six isolates and is the second most absent after the vanX gene. Region H, 
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corresponding to vanH gene, was present in 43% of the isolates and the 
intergenic region XY in 16 isolates (38%). The intergenic region YZ was found in 
55% of the isolates and is, overall, the most conserved region of the transposon. 
Despite the variability of PCR patterns found in these 42 enterococcal 
isolates, results from Table 4 suggest a higher presence of fragments XY, Y and 
YZ in dairy isolates and of fragments R, S, SH and H in clinical isolates. In fact, 
among the total of fragments detected in dairy isolates, 60% were XY, Y and YZ, 
and in clinical isolates 62% included the R, S, SH and H fragments. No correlation 
was found between the different PCR patterns and MIC values for vancomycin. 
The six veterinary isolates carrying vanA gene had PCR patterns similar to both 
human and dairy isolates (Table 4). No association was found between species 
and PCR pattern. E. faecalis, which was the most common species in both 
samples, were found in 11 of the 23 PCR patterns and shared patterns with either 
E. faecium or E. durans. Among patterns where dairy isolates were assigned, M 
and U are the most similar, sharing four fragments S, XY, Y and YZ. Isolates 
assigned to these two patterns are both from cheeses from RDO A. With three 
fragments in common, namely fragment XY, Y and YZ, are patterns J, L, M and 
U. Isolates assigned to these patterns come from RDO A cheese (three isolates) 
and RDO B milk. Although distant geographically, enterococci from these two 
regions are phenotypically related. 
 
Among the nine patterns with only one or two fragments (patterns I and O to 
X), patterns I, O and V, that share vanR, were found only in cheese and milk 
isolates from RDO B. Fragment S was only detected in RDO A. Fragment SH was 
not detected in RDO C. However vanH was mainly detected in this RDO. These 
observations point to a possible geographic correlation with the genetic events 
that led to the observed differences in Tn1546. 
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Table 4.  Distribution of vanA carrying isolates in the different PCR patterns of the Tn1546 
element found in this work. Patterns are represented as + (presence of the amplicon with the 
expected size) and - (absence of an amplicon) signs for each of the seven regions searched: genes 
vanR, vanS, vanH, vanX and vanY and intergenic regions SH, XY and YZ. 
 
 
Region of Tn1546 Origin 
Pattern vanR vanS SH vanH vanX XY vanY YZ Dairy Clinical 
A - - - - - - - - 1 3 
B + + + + - + + + 0 2 
C + - + + - - - - 0 2 
D + + + + - - - - 0 1 
E + + - - - + - + 0 1 
F - - + + - - - + 0 2 a 
G - - + - - - - + 0 2 a 
H - - - - - - - + 0 3 b 
I + - - - - - - - 2 1 c 
J - - + + - + + + 1 1 c 
K + - - + - - - + 2 2 
L - - - - - + + + 2 0 
M + + - - - + + + 1 0 
N - - - + - + - + 2 0 
O + - - - - - - + 1 0 
P - - + - - + - - 1 0 
Q - - - - - + + - 1 0 
R - - - + - + - - 1 0 
S - - - - - - + - 1 0 
T - - - + - - - - 2 0 
U - + - - - + + + 1 0 
V + - - - - - + - 1 0 
X - - - - - + - - 2 0 
 
SUMd 16 6 12 18 0 16 11 23 22 20 
  
a one of the isolates is from a dog infection; b  two of the isolates come from dog infections; c it is an 
enterococci isolated from a dog infection; d sum of isolates from each column. 
 
Dairy strains carrying vanB were searched for the presence of other vanB 
operon genes. The objective of screening vanB strains was to confirm that, as for 
vanA strains, the lack of phenotypic expression was also related with the 
presence of an incomplete operon structure. 
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We observed that none of the four mapped strains presented a complete 
vanB operon (Table 5). The common features to all isolates are that vanRB and 
vanXB are present in all strains while vanHB is absent in all strains. 
 
Table 5. Mapping of the vanB operon on vanB+ dairy strains.  Patterns are represented as + 
(presence of the amplicon with the expected size) and - (absence of an amplicon) signs for each of the 
genes investigated. 
 
Strain vanRB vanSB vanYB vanW vanHB vanXB 
Dairy_vanB1 + - - + - + 
Dairy_vanB2 + + + + - + 
Dairy_vanB3 + + - - - + 
Dairy_vanB4 + + - - - + 
 
Finally in order to have more information on the vanA and vanB forms of the 
studied isolates, for genes which we did not succeed to amplify, we performed 
PCR using different combinations of the primers, i. e., when a gene was not PCR 
detected we used the forward primer of the upstream gene/IR paired with the 
reverse primer of the downstream gene/IR. For example, for strains exhibiting 
pattern C, we performed PCR using the forward primer for vanR and the reverse 
primer for vanSH IR. However, we did not obtain the expected PCR products.  
 
INVERSE PCR  
Since no strains harboring the complete transposon Tn1546 were detected, 
inverse PCR was performed in an attempt to characterize the upstream and 
downstream regions of vanA. Inverse PCR was chosen because it allows the 
amplification of the regions that flank the DNA segment of a known sequence, 
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both upstream and downstream. The method has general applicability in genetics 
and can be used to establish the insertion sites of mobile genetic elements, 
analyze the regions adjacent to a specific sequence, or to proceed along a stretch 
of uncharacterized DNA. 
Despite several attempts to obtain PCR fragments eligible for sequencing, we 
did not succeed in amplifying any fragment, including for the strain that was used 
as positive control. Different experimental conditions were tested: three restriction 
enzymes were tested to digest the chromosomal DNA; two single cut enzymes 
were used to cut inside the vanA gene sequence; and DNA amounts for the self-
ligation step and for the PCR reactions. Also different sets of primers were 
designed to perform the inverse PCR reactions.  
Inverse PCR is straightforward, but revealed itself as being very time 
consuming and with many optimization steps. It is our goal to characterize the 
different polymorphisms on the Tn1546-type element and on the vanB operon 
present in these strains, as well as locate the vanA and vanB genes on the 
chromosome and know the surrounding genes. In order to do so we are 
considering different approaches such as TAIL-PCR (Thermal Asymmetric 
Interlaced Polymerase Chain Reaction) previously used by Boyd and coworkers 
to characterize vanD, vanG and vanL operons (Boyd et al., 2006a; Boyd et al., 
2006b; Boyd et al., 2008). 
 
GENETIC RELATEDNESS OF ISOLATES 
Dairy and clinical isolates for which either vanA or vanB were detected by 
PCR were subjected to PFGE and genetic relatedness was determined using 
criteria defined by Tenover et al. (1995) (Tenover et al., 1995). No relatedness 
was found between dairy, human clinical and animal clinical enterococcal 
isolates. Among the 22 dairy isolates with vanA gene, only eight were found to be 
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related, in pairs (Table 6). These four pairs were from the three RDOs where 
vanA was detected (RDO A, B and C). Each pair of isolates came from the same 
cheese manufacturing place, from the same product (milk or cheese) and belongs 
to the same species, but MIC values were different and so were the Tn1546 
patterns.  
 
Table 6. Relevant characteristics of isolates that were grouped according to their genetic 
relatedness, as determined by their PFGE banding patterns. 
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Among the 20 clinical isolates carrying vanA, only two PFGE groups were 
found (Table 6). The three isolates in group 5 were isolated in the same Hospital, 
were identified as E. faecalis and presented the same MIC value for vancomycin. 
Two of them had the same PCR pattern C, and the other had pattern B. Group 6 
isolates both came from dog infections, in two consequent years. They both had 
the same MIC value for vancomycin and their PCR patterns, H and G, although 
different, are related. 

















As mentioned before, vancomycin is still at the moment an antibiotic that can 
be used to treat infections caused by multiresistant enterococci and by other 
gram-positive bacteria. It is important to have an accurate knowledge of the 
dissemination of the genes responsible for vancomycin resistance in other 
environments than the clinical setting, namely in food enterococci since these are 
microorganisms that contact both with human commensal microorganisms and 
with those in soil, water, different solid interfaces and animals.  
The present work has demonstrated that vanA gene is equally disseminated 
in dairy enterococci, as it is in clinical (human and pets) environments. However, 
its presence does not correspond to a resistant phenotype. In order to understand 
the reason for this discrepancy between the susceptible behaviour and the 
presence of vanA and/or vanB genes, some elements of the Tn1546 transposon 
and of the vanB operon were searched, in vanA and vanB carrying isolates, 
respectively. For vanA carrying isolates, among 42 isolates, 23 different PCR 
patterns were found, showing either a high variability and heterogeneity in this 
element, as also reported by other works (Woodford et al., 1998; Van den Braak, 
2001), or that we are in the presence of remnant forms of Tn1546. In fact, if this 
transposable element had been present in these isolates, it had to suffer some 
independent deletions or insertions that would prevent the primers used from 
annealing with DNA. This is a very likely possibility in the light of some reports on 
the instability of enterococci genomes. For example, the strain V586, vancomycin 
resistant and appearing to have identical pulsed field gel electrophoretic banding 
patterns to the vancomycin resistant V583 strain, has been shown to derive from 
this strain as a result of high-frequency spontaneous excisions by an yet unknown 
mechanism (Tendolkar et al., 2003). This genetic instability of the Tn1546 
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transposon is also evident even in genetically undistinguishable isolates. Several 
authors support the thesis that the heterogeneity of Tn1546 is mainly explained 
by the presence of different ISs, which serve as hot spots for the rearrangement 
of genetic fragments (Heaton & Handwerger, 1995; Borgen et al., 2002; Paulsen 
et al., 2003).  
 
The lack of complete and functional Tn1546 may therefore account for the 
lack of resistance found both in dairy and clinical enterococci studied. In the 
particular case of pattern B, the fact that no full resistance was observed can be 
ascribed to the absence of vanX, that code for a carboxypeptidase essential for 
the vancomycin resistance phenotype. Although presenting only vanA gene, 
strains with pattern A were not fully susceptible. This fact suggests that the 
absence of vanX cannot, per se, explain the absence of resistant phenotype in 
the strains carrying pattern B. If the presence of vanA alone can account for the 
absence of full susceptibility in strains with pattern A remains to be established. 
No genetic association was found between dairy and clinical (human or 
animal) isolates, despite the equal presence of vanA in both environments. This 
excludes the hypothesis of clonal dissemination of the VanA-type resistance. This 
is in accordance with previous reports stating that in Europe there is a high 
degree of heterogeneity among VRE isolates (Van den Braak, 2001). However, 
the fact that dairy and clinical isolates share some Tn1546 PCR patterns is 
indicative of a possible genetic trading and share of a resistance genetic pool 
between these two environments. Despite these differences in PCR patterns, 
reasonable explanations based on deletion/insertions events can be 
hypothesized. Pair nº1 presents patterns A, characterized by the absence of all 
the fragments searched for, and M, that present all the genes, except vanH and 
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the intergenic region SH. One molecular event, like a deletion and/or an insertion 
in the region upstream from vanH and downstream from vanS would have been 
sufficient to prevent one of the primers of either primer pair to anneal to DNA. Pair 
nº2 isolates present patterns T, with only vanH, and pattern I, with only vanR. 
Although apparently not related, both these patterns are probably the result of 
multiple insertion/deletion events. Pair nº3 isolates present patterns O and I, 
which are, as mentioned above, similar. Pair nº4 isolates present patterns X and 
R, which are also related. 
The scenario is slightly different with vanB genes, since they were found in 
only 6.3% of the dairy enterococcal isolates, suggesting that dairy strains have 
less contact with vanB resistant isolates. In fact, to our knowledge this is the first 
time vanB gene is described in dairy isolates. Other papers where vanA/vanB 
genes were screened in cheese isolates report the non-detection of vanB gene 
(Mannu et al., 2003; Canzek Majhenic et al., 2005; Jurkovic et al., 2006; Serio et 
al., 2007; Javed et al., 2010; Ozmen Togay et al., 2010). However, there are a 
few reports were vanB isolates are present in other food products and from 
environmental sources (Mammina et al., 2005; Messi et al., 2006; Caplin et al., 
2008; Roberts et al., 2009). This is, again, in agreement with other reports 
showing that vanA resistance is more disseminated in the environment than vanB 
resistance. On the other hand, vanB carrier isolates, both human and animal, 
were found not to be genetically related, demonstrating that dissemination of 
vanB resistance is not clonal. 
Like all vanA isolates possess an incomplete Tn1546 element, the vanB dairy 
strains mapped also present an incomplete operon, explaining the lack of 
resistance expression on these strains. Due to the reduced number of strains we 
can only speculate about hypothesis regarding phenotype versus operon 
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composition. The absence of vanYB and vanW is not supposed to affect the 
resistance phenotype. However, the fact that vanHB is absent in all four strains 
can explain by itself the lack of a resistant phenotype since vanHB is essential for 
the expression of resistance. Absence of vanHB likely allows some level of 
resistance as three of the isolates have MIC values falling on the intermediate 
category (one with 8 µg/ml and two with 12 µg/ml). The strain with lower MIC (4 
µg/ml), also lacks vanSB. This result is in agreement with the fact that vanSB is 
also an essential gene for resistance, since it encodes for the histidine kinase 
protein responsible for sensing the antibiotic and induce the regulatory gene and 
thus all the resistance operon. 
VRE are often identified as E. faecalis, E. faecium, E. gallinarum and E. 
casseliflavus. The present work reports detection of vanA gene in VSE also from 
other species, like E. durans and E. hirae and E. solitarius, not often associated 
with infectious processes in clinical settings, and therefore neglected. This again 
shows that species is not a barrier for trading antibiotic resistance genes among 
the genus Enterococcus.  
If some years ago, vancomycin resistance enterococci were not relevant in 
the clinical environment, nowadays Portugal, together with Greece, has the 
highest rates of VRE associated with nosocomial infections in Southern Europe 
with levels up to 47% in 2003, being the vanA E. faecium isolates the main 
responsible (Werner et al., 2008). However, a decrease in the rates of vanA E. 
faecium was observed. And in 2007 a decrease to 27% was reported by EARSS 
(European Antimicrobial Resistance Surveillance System), suggesting the 
successful implementation of infection control measures (Werner et al., 2008). 
In conclusion, this work demonstrated that, although vancomycin resistant 
enterococci are not relevant in the food environment in Portugal, resistance 
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genes, namely vanA and vanB, are disseminated both in clinical and dairy food 
environments, although vanB to a less extend than vanA. However, their 
presence does not imply a resistance phenotype, which is probably due to lack of 
complete and fully functional Tn1546 element and vanB operon. The 
heterogeneity of vanA-carrying element in the isolates studied, even in genetically 
undistinguishable isolates, is once again described. But, as opposite to the 
generally published works, it describes a genetically variable unfunctional 
Tn1546. This is probably due to the lack of selective pressure of the studied 
isolates. Both the antibiotic and the resistance genes are needed to produce a 
clinical resistance problem (Levy, 2002). The more controlled use of vancomycin 
in Portugal, and in Europe in general, as well as the implementation of control 
measures, has so far protected people from a burden of vancomycin resistance in 
hospitals. However, from what has been shown with our work, the resistance 
genes are, or have been, present in both dairy food and in clinical environments. 
Therefore, if vancomycin use increases in Portuguese hospitals, the resistance 
gene will become more prevalent and the resistance problem may thus rise. This 
work also shows that MIC determinations together with the search for vanA or 
vanB genes is not enough to categorize and predict the isolate behaviour to 
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ABSTRACT 
Portugal has been reported as one of the major contributors to nosocomial 
vancomycin resistant enterococci in Europe, although very few publications deal 
with the molecular characterization of these isolates by Portuguese laboratories. 
During one year our laboratory received 24 enterococcal isolates from a 
Portuguese Hospital, four of them reported as vancomycin resistant Enterococcus 
faecium (VREfm) and two identified as Enterococcus hirae by the Hospital (using 
VITEK 2 Advanced Expert System). 
This study was set up to investigate the genetic relatedness of the collected 
isolates and to characterize the vancomycin resistance genotype of VREfm. 
Resistance to fifteen different antibiotics was also screened, revealing E. faecium 
as the multiresistant species, also associated with ampicillin and penicillin 
resistance. PFGE showed the existence of a high number of clones among E. 
faecium isolates. 
Among the four VREfm reported by the Hospital only three had MIC values 
accordingly, although vanA gene was detected in the four isolates. The confirmed 
three VREfm, collected from different patients over a period of three months, were 
found to be genetically related, presenting the same PFGE type, and belonging to 
the global Hospital-adapted clonal lineage CC17. Accordingly, these VREfm 
strains were found to be ampicillin and ciprofloxacin resistant and carried the 
genetic information for high level gentamycin resistance. ISEf1 was detected in 
the VREfm strains in the vanX-vanY intergenic region, as reported previously by 
another Portuguese study. Hybridization studies revealed that vanA is located in 
plasmid DNA. 
The strain that was found to carry the entire vanA operon but had a 
susceptible MIC (2 µg/ml), was re-tested using VITEK system and presented 
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divergent vancomycin resistance results. We decided to investigate this strain 
further in order to understand the reasons for discrepancies between phenotype 
and genotype of vancomycin resistance and different results in the two VITEK 
assays. We found that the isolate was a mixture of two E. faecium strains, one 
susceptible and the other vancomycin resistant, the resistant one belonging to 
CC17. These results indicate that, in the particular case of polymicrobial infection 
with the same enterococcal species, VITEK alone may not provide a correct 
assessment of VRE. To overcome the possibility of VRE misdiagnosis we 
suggest that VITEK should be complemented with growth in the presence of 
selective media with vancomycin. 
Reports of nosocomial infections caused by E. hirae are rare. The two E. 
hirae strains were isolated from wound infections in different patients. They were 
both resistant to methicillin, kanamycin, netilmycin, clindamycin, lincomycin, 
colistin and polymyxin B, described as associated to the genus Enterococcus. 
The screening of virulence factors associated with enterococcal infectious ability 
revealed that both E. hirae strains carried the cyl, fsr and gelE-sprE operons, all 
ascribed a role in virulence in E. faecalis. Although not clones, the two strains 
were related, as revealed by PFGE analysis. Overall, our results demonstrate the 
potential of E. hirae strains both to cause hospital outbreaks and as virulence trait 
carriers. To our knowledge this is the first description of E. hirae associated with 
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INTRODUCTION 
Enterococci are part of the normal intestinal microbiota of humans and other 
animals. However, they are also prominent nosocomial opportunistic pathogens 
and rank among the top three most common pathogens in the nosocomial setting 
(Murray, 2000). Infections caused by enterococci include urinary tract infections, 
bloodstream infections, endocarditis, bacteremia, catheter-related and wound 
infections, and intra-abdominal and pelvic infections (Moellering, 1992; Murray, 
1998). Enterococcus faecalis and Enterococcus faecium are the most prevalent 
species cultured from humans. Although E. faecalis is alone responsible for 80%-
90% of the infections caused by enterococci, E. faecium has increased its 
contribution to nosocomial enterococcal infections in the last two decades (Wade, 
1997; Mundy et al., 2000; Treitman et al., 2005). Frequently the relevance of 
other enterococcal species is neglected because they are rarely associated with 
severe infections in humans. However, there are some reports of infections due to 
E. gallinarum, E. casseliflavus (Reid et al., 2001; Takayama et al., 2003; Iaria et 
al., 2005), E. raffinosus (Sandoe et al., 2001, Savini et al., 2008), E. durans 
(Stepanovic et al., 2004), E. avium (Swaminathan & Ritter, 1999), E. cecorum 
(Hsueh et al., 2000), E. mundtii (Higashide et al., 2005) and E. hirae (Gilad et al., 
1998, Poyart et al., 2002). The E. hirae species is widely known to cause 
infections in animals (Etheridge et al., 1988, Lapointe et al., 2000), but is rarely 
associated with human infections. In all studies published the isolation of E. hirae 
corresponds, in average, to 1% of all enterococcal isolates. Since this is such a 
rare species in clinical environment it is comprehensible that is infrequently 
associated with infections in humans.  
In the USA, VREfm is endemic in hospitals, despite lack of carriage among 
healthy individuals. In Europe, however, hospital outbreaks are rare, but VREfm 
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carriage among healthy individuals is common. Greater use of glycopeptides such 
as vancomycin in US hospitals, and use of avoparcin as an animal growth 
promoter in Europe are assumed to be the cause of these epidemiological 
differences (Goossens, 1998). However, the predominant role of antibiotic 
pressure in the epidemiology of VREfm was challenged and VREfm outbreak 
have been reported (Willems et al., 2001).  
One of the characteristics of enterococci is their intrinsic and easily acquired 
resistance towards many of the antibiotics used in the clinical practice. The 
acquisition of vancomycin resistance by enterococci strains poses serious 
problem in terms of treatment and infection control. Vancomycin resistant 
enterococci (VRE), particularly E. faecium strains, are frequently resistant towards 
all antibiotics, creating serious limitations in treatment options (Murray, 2000). 
Thus, VRE are a prominent clinical and public health concern, contributing greatly 
to healthcare-associated infections (Huang et al., 2007). Despite their ubiquity, 
the population structure of E. faecium comprises a diversity of sequence types 
that seem to have host-specificity. Particular host-specific human clonal lineages 
are considered high-risk CCs (HiRCCs) since they are recovered mostly from 
hospitalized patients (Leavis et al., 2006). The most worrisome of these HiRCCs 
is clonal complex 17 (CC17), which is a hospital-adapted genetic subtype of E. 
faecium associated with epidemics and clinical infections, which has spread 
globally (Willems et al., 2001; Homan et al., 2002; Leavis et al., 2003; Willems et 
al., 2005). CC17 is associated with the presence of the variant esp gene as part 
of a pathogenicity island (Leavis et al., 2004) and resistance to ampicillin. In 2003, 
another putative virulence gene, hyaluronidase (hylEfm) was described to be 
enriched among clinical E. faecium isolates (Rice et al., 2003). More recently, 
Hendrickx and co-workers identified five surface-exposed LPXTG cell wall-
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anchored proteins (CWAPs) specifically enriched in CC17 E. faecium, suggesting 
that the presence of these proteins may constitute another factor contributing to 
hospital adaptation (Hendrickx et al., 2007).  
Portuguese Hospitals report one of the major contributions to the volume of 
nosocomial VRE strains in Europe, with VREfm contributing to nearly 30%, 
according to EARSS (European Antimicrobial Resistance Surveillance System) 
(Werner et al., 2008). However, only a few reports exist of genetic studies of VRE 
in Portuguese Hospitals (Melo-Cristino, 1998; Novais et al., 2005; Freitas et al., 
2009).  
The endemic nature of VRE in many healthcare institutions requires that an 
accurate detection of these bacteria is achieved. In Hospitals, appropriate studies 
must be performed in the microbiology laboratories before a decision is made on 
the correct antimicrobial therapy. These studies include susceptibility testing. 
VITEK system is used and constitutes a fast and reliable system for identification 
of enterococcal species and detection of VRE. This system has been reported as 
highly sensitive and no false positive results have been described in detection of 
VRE (van Den Braak et al., 2001). It is common to find enterococci in 
polymicrobial infections with other genera. Although less frequently, it is also 
possible to isolate, from the same infection site, two different enterococcal strains 
from the same species.  
In this work we had three major aims. The first one was to contribute to the 
general knowledge on distribution of enterococcal strains in Portuguese 
Hospitals. Leiria Hospital was never target of such a study and we believe it is 
crucial to cover as many clinical settings as possible to know better the strains 
circulating in Portuguese hospitals. Considering this we investigated the genetic 
relatedness of 22 enterococcal strains (E. faecalis and E. faecium) and the 
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genetic nature of the vancomycin resistance in four VREfm strains. Secondly, we 
report a case of misdetection of VREfm due to a mixed culture with a VSEfm and 
want to call attention to such cases, which can pass undetected and can 
contribute to the unnoticed spread of VRE. We also report the isolation of two 
related E. hirae strains that caused hospital infection in two different patients. To 
our knowledge this is the first time E. hirae species is reported as an etiologic 
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MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS  
During one year (between 2004 and 2005) 24 enterococcal isolates were 
collected from Leiria Public District Hospital, Portugal, and sent to our Laboratory. 
Identification to the species level was carried out by the hospital, using Vitek 120 
(Biomerieux). Overall, we received ten E. faecalis strains and twelve E. faecium 
strains and two E. hirae strains, from different biological products (Table 1). Four 
of the E. faecium isolates were reported by the hospital (using Vitek system) as 
vancomycin resistant. 
Strains were grown at 37ºC without shaking, in BHI medium (Oxoid). In the 
particular case of strain 72362, when specified, the strain was grown in parallel in 
BHI-drug free and in BHI supplemented with 2 µg/ml of vancomycin (Sigma).   
 
ANTIBIOTIC SUSCEPTIBILITY DETERMINATION 
After arrival at our laboratory, all isolates were screened by the disk diffusion 
method for resistance towards fifteen antibiotics, namely rifampicin (RD), 
ampicilin, (AMP), penicillin B (P), imipenem (IPN), cefoperazone (CFP), 
vancomycin (VA), nitrofurantoin (F), bacitracin (B), streptomycin (S), gentamicin 
(CN), kanamycin (K), tetracycline (TE), clindamycin (DA), erythromycin (E) and 
ciprofloxacin (CIP) according to the Clinical and Laboratory Standards Institute 
(CLSI, former NCCLS) guidelines and used the recommended breakpoints to 
define resistance (Clinical and Laboratory Standards Institute, 2000), as 
described elsewhere (Lopes et al., 2005). The antibiotic susceptibility of the two 
E. hirae strains was tested for a broader group of antibiotics. Their susceptibility 
towards 30 antibiotics was tested as previously described by Lopes et al. (2005). 
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MIC values for both vancomycin and teicoplanin were determined for the four 
isolates that were considered vancomycin-resistant enterococci (VRE) by the 
hospital. E-test (AB Biodisk) was used according to manufacturer’s instructions. 
Each plate was inoculated with a suspension of cells equivalent to #2 in the 
McFarland turbidity standard. E. faecalis DSMZ 2570 was used as a control 
strain. Strains were classified as resistant (MIC≥ 32 µg/ml), intermediate (MIC≥ 8 
µg/ml and MIC≤ 16 µg/ml) and susceptible (MIC≤ 4 µg/ml) according to the CLSI 
document (Clinical and Laboratory Standards Institute, 2000). 
 
PFGE TYPING 
To analyze clonal relatedness among the isolates, total DNA agarose discs 
were prepared and DNA digestion with SmaI was performed as described in 
(Chung et al., 2000), except for lysis solution, which contained only RNase A and 
lysozyme. Agarose discs were electrophoresed on a 1% Seakem GTG agarose 
gel (FMC Bioproducts) in 0.5× TBE buffer low EDTA (50 mM Tris, 50 mM boric 
acid, 0.2 mM EDTA, pH 8.0) in a CHEF apparatus (Pharmacia) at 12ºC for 18 
hours at 220V with pulse times of 5 s rising to 35 s during the electrophoresis 
period. Gels were stained by immersion in ethidium bromide (1 µg/ml) for 30 
minutes and photographed with a UV light source. Genetic relatedness of the 
strains was determined according to Tenover criteria (Tenover et al., 1995). 
Fragment patterns were analyzed by the software package BioNumerics version 
1.5 (Applied Maths). Clustering was performed with the unweighted average 
linkage (UPGMA) with the Dice similarity coefficient. 
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PCR SCREENING OF vanA OPERON OF VREfm 
Vancomycin resistance genotype was investigated using PCR for detection of 
both vanA and vanB genes as described by Ribeiro et al. (2007). Total DNA was 
extracted from cells as described elsewhere (Lopes et al., 2003). Since only vanA 
was detected in the four strains, vanA operons, using Tn1546 transposon as the 
source sequence, were partially mapped. vanR, vanS, vanH, vanX, vanY and 
intergenic regions SH, XY and YZ were investigated using PCR as previously 
described (Ribeiro et al., 2007). Sequencing was performed by Baseclear.  
 
PCR SCREENING OF RESISTANCE AND VIRULENCE DETERMINANTS ON 
VREfm AND E. hirae STRAINS 
The four E. faecium isolates reported by the hospital as VRE were also 
screened for the presence of the bifunctional gene aac(6’)-aph(2’’), responsible 
for high-level gentamicin resistance, as described previously (Lopes et al., 2003). 
PCR for esp gene was carried out using specific primers for E. faecium esp 
gene, using the primers espefm_f (5’-TTGCTAATGCTAGTCCACGACC-3’) and 
espefm_r (5’-GCGTCAACACTTGCATTGCCGA-3’).  
The presence of virulence traits (namely Cyl operon, Fsr and GelE-SprE 
operons and ace, asa1, and efaA genes) in the E. hirae strains was screened by 
PCR using primers described on Table 2 and Immolase DNA polymerase 
(Bioline), according to the manufacturer´s instructions. 
  
MLST TYPING  
VREfm were genotyped by MLST (multilocus sequence typing) as described 
by Homan et al. (2002). Internal fragments of seven housekeeping genes were 
amplified by PCR with the set of primers described in (Homan et al., 2002). PCR 
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products were purified with a Qiagen kit and both strands were sequenced 
(Baseclear). MLST alleles and sequence types (ST) were identified using the 
available database (http://efaecium.mlst.net/).  
 
SOUTHERN DOT BLOT HYBRIDIZATION 
In order to investigate if the vanA operon was located in the chromosome or 
in a plasmid, vanA amplicon obtained by PCR, was used as a probe. Both total 
DNA and plasmid DNA was prepared as described previously (Lopes et al., 
2003), spotted onto a Hybond–N+ membrane (Amersham Biosciences) and fixed 
to the membrane by heating to 80ºC for 2 hours. The Southern blot hybridization 
was performed with the ACLTM Direct Nucleic Acid Labelling and Detection 
System (Amersham Biosciences), according to manufacturer’s instructions. 













Molecular characterization of uncommonly found enterococci in portuguese hospitals: 
VREfm from CC17 carrying ISEf1 and E. hirae causing infections 
 103 
RESULTS AND DISCUSSION 
ANTIMICROBIAL SUSCEPTIBILITY AND VIRULENCE TRAITS 
Among the strains received from the hospital, 27% were isolated from blood 
infections, 55% from pus, 5% from catheters and the remaining 14% from other 
infections (Table 1). From the six strains responsible for blood infections, five 
were identified as E. faecium. 
All isolates were screened for antibiotic resistance to fifteen antimicrobial 
agents. Results of this study are presented in Table 1. The E. faecium strains 
were resistant to a higher number of antibiotics as compared to E. faecalis 
isolates. In fact, nine out of ten E. faecium strains were resistant to eight to ten 
antibiotics; as opposed to seven, out of nine E. faecalis, which were resistant to 
six to eight antibiotics. 95% (18 out of 19) strains were bacitracin resistant, 
regardless of the species, and vancomycin resistance was only detected in three 
of the four E. faecium isolates reported as possible VRE by the Hospital. All 
isolates were resistant to kanamycin and resistance to erythromycin was detected 
in 79% of the assayed strains. Resistance to both ampicillin and penicillin was 
detected in 47% of the strains, but only in E. faecium isolates. 
The four strains reported as VRE by the Hospital (21428, 57182, 60921 and 
72362) were further analyzed and MIC values for both vancomycin and 
teicoplanin were determined. As shown in Table 3, three strains were confirmed 
to be VRE, as predicted by the disk diffusion assay, but strain 72362 behaved as 
susceptible to both antibiotics. Thus, VRE isolates represent 14% (3/22) of the 
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Table 1. Identification, source of isolation and antibiotic resistance of the enterococcal strains 





Source Antibiotic resistance profileb 
113373 E. faecalis 26-11-04 Sputum nd 
118103 E. faecalis 28-11-04 Pus  from wound RD, CFP, B, S, CN, K, E 
125944 E. faecium 20-12-04 Pus from wound nd 
128555 E. faecium 30-12-04 Blood nd 
2692 E. faecium 11-01-05 Blood RD, AMP, P, CFP, B, S, CN, K, TE, E 
5534 E. faecalis 18-01-05 Vaginal secretions B, CN, K, TE 
9308 E. faecalis 21-02-05 Pus from wound RD, B, S, CN, K, TE 
12499 E. faecalis 21-02-05 Pus from cicatriz scar B, S, CN, K, TE 
19015 E. faecium 22-02-05 Blood RD, AMP, P, CFP, B, CN, K, E 
19864 E. faecalis 22-02-05 Bronchoalveolar aspiration RD, B, S, CN, K, TE, E 
127417 E. faecalis 21-02-05 Pus from wound CFP, B, S, CN, K, TE 
44132 E. faecalis 28-04-05 Blood CFP, B, S, CN, K, TE, E 
44805 E. faecalis 29-04-05 Pus  from wound RD, B, S, CN, K, TE, E 
21011 E. faecium 07-03-05 Pus from peritoneal absess RD, AMP, P, CFP, B, S, CN, K, TE, E 
21428a E. faecium 07-03-05 Blood RD, AMP, P, CFP, IPN, VA, F, B, CN, K, TE, DA, E 
24285 E. faecium 07-03-05 Pus RD, AMP, P, CFP, B, S, CN, K, TE, E 
27461 E. faecalis 29-03-05 Pus from scab CFP, B, S, CN, K, TE, E 
29379 E. faecium 29-03-05 Catheter RD, AMP, P, CFP, B, S, CN, K, TE, E 
41058 E. faecium 19-04-05 Pus from wound RD, AMP, P, CFP, B, S, CN, K, TE, E 
57182a E. faecium 03-06-05 Pus from surgical wound RD, AMP, P, CFP, VA, B, K, E 
60921a E. faecium 16-06-05 Pus from surgical wound RD, AMP, P, CFP, VA, B, K, E 
72632a E. faecium 24-08-05 Blood RD, CFP, B, K, E 
SAVE H1 E. hirae  Wound Infection MET, K, NET, DA, LIN, COL, PB 
SAVE H2 E. hirae  Wound Infection MET, K, NET, DA, LIN, COL, PB 
 
a reported as VRE according to the Vitek method used in the Hospital; b results of the disk diffusion 
method obtained after receiving the strains from the Hospital; , rifampicin (RD), ampicilin, (AMP), 
penicillin B (P), imipenem (IPN), cefoperazone (CFP), vancomycin (VA), nitrofurantoin (F), bacitracin 
(B), streptomycin (S), gentamicin (CN), kanamycin (K), tetracycline (TE), clindamycin (DA), 
erythromycin (E), ciprofloxacin (CIP), methicillin (MET), netilmycin (NET), lincomycin (LIN), colistin 
(COL), polymyxin B (PB); nd, not determined. 
 
In fact, E. faecium strains were not only associated with vancomycin 
resistance, but were also multiresistant. This result is in accordance to increasing 
observed tendency that point to E. faecium as the most resistant enterococcal 
species, in particular to vancomycin (Wade, 1997). One of these isolates, strain 
21428 from blood, was the most resistant isolate among the 22 strains, showing 
resistance towards fourteen of the fifteen antibiotics tested. Resistance to both 
penicillin and ampicillin was associated with E. faecium, which is in agreement 
with another study from Italy (Stampone et al., 2005). The co-resistance of 
vancomycin and ampicillin/penicillin is widely described in E. faecium (Fontana et 
al., 1994; Rice, 2001; Rice et al., 2005). In several countries the endemicity of 
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ampicillin resistant E. faecium (Suppola et al., 1999; Harthug et al., 2002; Torell et 
al., 2003) is documented and events of acquisition of vancomycin resistance have 
been published (Suppola et al., 1999; Harthug et al., 2000). 
In a previous study, we did not detect any VRE neither among E. faecalis nor 
E. faecium isolates from human infections in Portuguese Hospitals in the Lisbon 
and Porto areas (Lopes et al., 2005). In that same study, E. faecalis was the 
prevalent species among 39 isolates. In the present study, among 22 isolates, E. 
faecalis and E. faecium were found to be equally responsible for nosocomial 
infections. Recent publications report also the presence of VREfm from 
Portuguese hospitals, although not from the same areas of Portugal (Novais et 
al., 2005; Mato et al., 2009). Considering what was said, the present work 
represents the first report of VRE strains from the area of Leiria, Portugal. The 
number of VRE detected in this study (14% among 22 isolates and 25% among 
E. faecium only) is considerably high, but fits into the percentages reported by the 
EARSS for Portugal during 2007 (Werner et al., 2008). 
Both E. hirae isolates were susceptible to most of the antibiotics tested. They 
presented resistance to 7 antibiotics (methicillin, kanamycin, netilmycin, 
clindamycin, lincomycin, colistin and polymyxin B) described as associated to the 
genus Enterococcus (Lopes et al., 2005). Although not carrying clinically relevant 
antibiotic resistance determinants, these strains had the genes coding for three of 
the most relevant virulence factors described in the genus Enterococcus, namely 
the cyl operon, coding for the citolysin, the gelE-spreE, coding for gelatinase and 
a serine protease, and fsr, reported as controlling both gelatinase and serine 
protease expression and, among others, biofilm development in E. faecalis 
(Bourgogne et al., 2006). The cyl operon was not complete, since cylR1 was not 
detected (Table 2). However, these results demonstrate that other species then 
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E. faecalis, namely E. hirae, are acquiring the same virulence genes which are 
most probably responsible for the E. hirae success as an infectious agent. Other 
studies reporting E. hirae as the etiologic agent responsible for causing severe 
infection did not characterize the strains regarding their virulence traits (Gilad et 
al., 1998; Poyart et al., 2002). However, these studies describe E. hirae strains 
able to cause aortic-valve endocarditis (Poyart et al., 2002), bacteremia and 
septicaemia (Gilad et al., 1998) which require that the strains are able to adhere, 
invade and infect the host cells in order to cause disease. As the two E. hirae 
isolates that we report in this study, these strains described as causing severe 
infections, most likely carry several virulence factors.   
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Table 2. Virulence determinants found in E. hirae strains and primers (f-forward; r-reverse) used 
in the PCR reactions to detect the described genes (+, detected; -, not detected). 
 
Gene Primer (5’→3´) 
Amplicon 
size (bp) 
SAVE H1 SAVE H2 
cylR1 GCTATTTTTCTTTTTCTACCTAA-f 
TATGAAGTCCTCTTGTTGAAA-r 
128 - - 
cylR2 GCTTTATTAGAAGTTAGCAGACAA-f 
TGGAGTATTCAGGTAGTAAGCAA-r 
105 + + 
cylLL AAATGGAAGCGATTCAAGGT-f 
CAGCCACAAGCAGCACTACT-r 
100 + + 
cylLS AACTTGTTGGTCCTTCTTTTGA-f 
CCTATGGTAAAACATGCTGGAG-r 
106 + + 
cylM TGGTGTAAGGGAACTGTAGGTG-f 
ATGGCACAGACAATCTTTATTTTTA-r 
117 + + 
cylB GGAGAATTAGTGTTTAGAGCG-f 
TATCCCTAAAAAAAGACTATCTATTA-r 
99 + + 
cylA TGCTCGTGAAATGATGATGAC-f 
CGCTTACTTCTGGAGTTG-r 
125 + + 
cylI TGATGATGATGAAATAAGCCA-f 
AACCCATTGTTTTTCTGCTAT-r 
103 + + 
fsrA GCATCCAGATTTGATTAGAGTC-f 
TGGTACTTCCGTTCCGTC-r 
112 + + 
fsrB AAGTCAGTGATGGTGTGGGAA-f 
ATTCTTTTTAGCTTTTTCAGTTTGTC-r 
98 + + 
fsrC TAATACCGCAAAGCAAGCAA-f 
AGCCAACAAACGAATCACAA-r 
103 + + 
gelE TCTTCACTTTTTGTAGCCGC-f 
TGCCTGAGAAATTGCCTC-r 
96 + + 
sprE ACAGGCTTTGTTGTTGGAA-f 
ATCACGACCTGGATAAAACC-r 
123 + + 
ace AATCAAAATGTGGAAATGCC-f 
CACTTGTTTCTGTTGCCTGTT-r 
109 + + 
asa1 AGCCAATGTGGTTCCTGTTC-f 
AGTTCTGTCGTATCCCCTGTC-r 
126 + + 
efaA ACCTGAACAAATGACCACGA-f 
TCTTTTGAGACCCGTTCCAT-r 
108 + + 
 
 
MOLECULAR TYPING OF THE E. faecium, E. faecalis AND E. hirae 
ISOLATES 
 Dendrograms based on the PFGE SmaI restriction pattern of E. faecium and 
E. faecalis isolates are presented in Figures 1A and 1B, respectively. In general, 
diversity among isolates was observed, although a higher heterogeneity was 
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present among E. faecalis isolates. However, some clones were detected. 
Analysis of E. faecium isolates by PFGE showed three groups of isolates that had 
identical or similar profiles, differing by six or fewer bands (Figure 1A). According 
to the dendrogram, the coefficient of similarity (CS) can be fixed to 0.92. 
 
Figure 1. Dendrograms of E. faecium (1A) and E. faecalis (1B) strains, based on PFGE SmaI 
restriction pattern analysis. 
 
Strains in Group 3 were collected in the Hospital over a span of four months 
from different biological sources, namely pus, blood and catheter (Table 1). 
Among these strains, one clone is distinguishable (Clone 3). Group 2 is itself a 
clone, Clone 2. Among strains in Group 1 there is also a clone, Clone 1. Within 
the E. faecium clones (Clone 1, strains 57182 and 60921; Clone 2, strains 21011 
and 24285; Clone 3, strains 41058 and 29379) the same antibiotic resistance 
pattern was observed (Table 1). 
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E. faecium Clone 1 (assigned to Group 1) corresponds to two VREfm 
isolates. These strains were both collected from pus from surgical wounds, but in 
different days and from different patients. This PFGE pattern is similar to the 
PFGE profile of the other VREfm, strain 21428 (Figure 1A), differing by six bands. 
The strain 21428 was isolated from blood three months before the other two 
VREfm strains and is resistant to more antibiotics. Its antibiotic resistance profile 
(Table 1) differs from the other two VREfm strains by resistance to imipenem, 
tetracycline, clindamycin and nitrofurantoin. 
Strain 72632, also reported by the Hospital as VRE, but confirmed as VSE by 
MIC determination in the lab (Table 2), had a PFGE profile differing from the 
Group 1 profile by more than seven bands. Strain 72632 was resistant to a lower 
number of antibiotics, and was susceptible to ampicillin and penicillin, differing 
from strains in Group 1. This strain was isolated from blood two months after 
Clone 1 isolates and five months after VREfm strain 21428, also isolated from 
blood (Table 1). 
Among E. faecalis isolates, two groups with CS higher than 0.92 were 
observed by PFGE analysis (Figure 1B) and nine PFGE types could be 
distinguished. Strains in Group A, although identical, differed in resistance to 
erythromycin (Table 1). 
Among E. faecium strains, six different PFGE types were observed and 
vancomycin resistance was associated with PFGE type I. Among E. faecalis 
strains, nine PFGE types were detected. These results show that E. faecium 
clinical isolates are more clonal, which is particularly true for the VREfm isolates.  
The fact that the only three VREfm isolates belong to the same PFGE type 
and considering that they were collected over three months from different patients 
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and different biological samples (pus and blood) shows that the same PFGE type 
remains in the hospital for days and is able to cause infection in different patients.  
 
The PFGE profiles of the two E. hirae strains (Figure 2) indicate that they are 
genetically related but not clones as they present distinct macrorestriction 
patterns, differing in less than 7 bands. The two strains were isolated from 
different patients with just one week apart and were both isolated from the same 
kind of biological product (pus). Therefore, the PFGE results suggest that the first 
isolated strain (SAVE H1) was able to persist in the hospital, suffer a few genetic 
events that originated the second strain (SAVE H2) which was again able to 
cause an infection in another patient. However, the distinct PFGE patterns clarify 
that they are two distinct strains. Consequently we can rule out the hypothesis that 
the isolates could belong to the patient’s own commensal flora in the case of the 
second strain. It is widely known that enterococcal infections are most frequently 
caused by patient’s endogenous flora, which might be the case of the first 
infection, although we are not able to prove it.   
 




The genetic relatedness of VREfm observed by PFGE genotyping was 
confirmed by MLST. All three VREfm belong to ST18 (atp 7, ddl 1, gdh 1, purk 1, 
gyd 5, pstS 1, adk 1), which is part of the Hospital-adapted clonal lineage, CC17 
(Willems et al., 2005). As described for strains that form CC17, strains 21428, 
57182 and 60921 were all ampicillin resistant (Table 1). Ciprofloxacin resistance 
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was also associated with the studied VREfm, which is consistent with data that co-
relates CC17 strain adaptation to the Hospital environment and ciprofloxacin 
resistance (Leavis et al., 2006). 
Other studies with strains from different Portuguese Hospitals have reported 
the presence of E. faecium belonging to CC17, although not all are VRE (Freitas 
et al., 2009; Mato et al., 2009).  
Strain 72362 had a different PFGE profile from the other VREfm strains, and 
the following MLST allele sequence: atpA 46, ddl 18, gdh 10, purK 23, gyd 1, pstS 
46, adk 11, representing anew ST356. This strain was susceptible to ampicillin, 
penicillin and ciprofloxacin. 
 
MOLECULAR ANALYSIS OF VANCOMYCIN RESISTANCE IN VREfm 
STRAINS 
 The genotype responsible for the vancomycin resistance in the strains 
reported by the hospital as VREfm was checked by PCR. Both vanA and vanB 
genes were searched. vanB gene was not detected but vanA was found in four 
strains (Table 3). A partial mapping of the VanA genetic element based on the 
sequence of the Tn1546 transposon revealed the presence of all the essential 
genes for expressing resistance, namely vanR, vanS, vanH, vanA and vanX 
(Table 3). vanY was detected in the three confirmed VREfm strains, but with a 
smaller size then the expected 486 bp (Figure 3). In the same strains the PCR 
product of the PCR amplification of the vanX-vanY intergenic region had a higher 
molecular weight (2 kb) then the expected 594 bp (Figure 3) and was due to the 
presence of the insertion sequence ISEf1. ISEf1 has also been found in vanX-
vanY intergenic region in VREfm from other Portuguese Hospitals, namely from 
the areas of Coimbra, Viseu and Porto (Novais et al., 2005; Novais et al., 2008). 
This IS element is one of three predominant types found in the E. faecalis V583 
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genome (Paulsen et al., 2003). It thus appears that ISEf1 element is common 




Gentamicin resistance was also evaluated in the strains reported as VRE by 
the hospital. The bifunctional gene aac(6’)-aph(2’’), responsible for HLGR, was 
detected in all of the four strains, but only strain 21428 was HLGR (Table 3) by 
phenotypic analysis. The fact that only 21428 behaved accordingly, suggests that 
the gene may not be functional in the other two true VREfm strains. Similar 
results have been described in a previous work, but with another gene conferring 
HLGR (Lopes et al., 2003). Further studies are needed to clarify this behavior. 
The appearance of an increasing number of HLGR enterococci in the clinical 
environment makes it difficult to treat severe cases of endocarditis because the 
synergism with cell-wall active agents (like ampicillin, penicillin G or vancomycin) 
no longer works. HLGR is also associated with CC17 E. faecium Hospital-
adapted lineage (Leavis et al., 2006). 
 
In contrast to E. faecalis, little is known about the virulence of E. faecium 
(Gilmore et al., 2002). The enterococcal surface protein gene, esp, is part of the 
Figure 3. Electrophoresis on agarose gel of the 
PCR products of amplification of IR vanY-vanZ 
(2), vanY (3), IR vanX-vanY (4), vanX (5), vanA 
(6), vanH (7), IR vanS-vanH (8), vanS (9) and 
vanR (10) of strain 21428. Lanes 1 and 11, 1Kb 
Plus ladder purchased from GibcoBRL. 
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E. faecalis PAI (Shankar et al., 2002), is a major putative pathogenicity marker in 
clinical isolates of E. faecium and E. faecalis, and a marker for epidemic strains of 
E. faecium (Willems et al., 2001). We detected the presence of the esp gene in 
the true VREfm strains (Table 3).  
 
Table 3. Characterization of the four E. faecium isolates reported as VRE by the Hospital. 
Respective results of the PCR screening of genes and intergenic regions (IR) of the vanA operon, 
antibiotic resistance and esp gene.   
















VA TE CN 
21428 
RD, AMP, P, CFP, IPN, VA, F, B, 
CN, K, TE, DA, E, CIP 
+ > 256 24 > 1024 + + + +b +c + 
57182 RD, AMP, P, CFP, VA, B, K, E, CIP + > 256 16 12 + + + +b +c + 
60921 RD, AMP, P, CFP, VA, B, K, E, CIP + > 256 16 12 + + + +b +c + 
72362 RD, CFP, B, K, E, F - 2 1.5 32 + + + + + + 
 
a, results of the disk diffusion method obtained right after receiving the strains from the Hospital, 
rifampicin (RD), ampicilin, (AMP), penicillin B (P), imipenem (IPN), cefoperazone (CFP), vancomycin 
(VA), nitrofurantoin (F), bacitracin (B), streptomycin (S), gentamicin (CN), kanamycin (K), tetracycline 
(TE), clindamycin (DA), erythromycin (E), ciprofloxacin (CIP), teicoplanin (TE), in bold are the antibiotic 
resistances that are strongly associated with CC17; b, the amplicon had 2 kb instead of the expected 
594 bp. Sequencing of this amplicon revealed the existence of the insertion sequence ISEfl; c, the 
amplicon had 230 bp instead of the expected 486 bp. 
 
Leavis et al. (2003) propose an evolutionary scheme for E. faecium 
genotypes and phenotypes from an ancestral E. faecium type. and argue that the 
hospital-adapted genogroup of E. faecium developed and spread unnoticed, thus 
creating a pool of strains with epidemic potential that only become recognized 
and relevant after becoming vancomycin resistant (Willems et al., 2001; Leavis et 
al., 2003). The scheme is based on the presence of ampicillin and vancomycin 
resistance, presence of the variant esp gene, and the type 1 allele for the purK 
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gene (Leavis et al., 2003). Considering the results obtained for the three VREfm 
strains (AmpR, VanR, esp+, purK 1+) these strains fulfill all the requirements to be 
part of this well adapted epidemic hospital genogroup. The stress-inducing 
conditions in hospitals, such as antimicrobial drug use, may favour the selection 
of this CC17 genogroup, with enhanced antibacterial resistance, virulence and 
ability to spread. 
Since 2002, nine sporadic cases have been reported in the United States 
(Perichon & Courvalin, 2009). Spread of multi-resistant E. faecium strains and 
their resistance genes will have serious implications for health care. In Portugal 
the transfer of vancomycin resistance determinants to MRSA was not yet reported 
however, our results indicate that is possible that this transfer events occurs, 
since CC17 clones are becoming more frequent.  
 
LOCALIZATION OF THE ELEMENT CARRYING vanA OPERON ON VREfm 
STRAINS 
Hybridization of plasmid DNA, using vanA amplicon as a probe, gave positive 
reactions in all four strains reported by the hospital as VRE (Figure 4). Thus, our 
findings point to the presence of vanA genotype in a plasmid, in all of the vanA-
carrying strains. The presence of vancomycin resistance in mobile elements 
makes transfer and dissemination of resistance more prone. 
 
 
Figure 4. Southern hybridization of 
plasmid DNA, fixed on a Hybond–N+ 
membrane, of strains 57182 (1), 60721 (2), 
72632 (3), V583 (5) and 21428 (6) with vanA 
PCR amplicon as probe. (4), vanA PCR 
amplicon.  
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INCONGRUENCE PHENOTYPE VERSUS GENOTYPE FOR E. faecium 72362 
STRAIN 
VITEK is a fast and reliable system used in hospitals for identification of 
enterococcal species and detection of VRE. This system has been reported as 
highly sensitive and no false positive results have been described in detection of 
VRE (van Den Braak et al., 2001). However, strain 72362 that arrived to our 
Laboratory described as VREfm, using VITEK system, was found to be 
vancomycin susceptible by MIC determination (MIC 2 µg/ml), although carrying 
the vanA gene. The MIC for this isolate was confirmed by E-test several times 
and never changed from susceptible. We thus decided to investigate further this 
isolate in order to understand the discrepancy between phenotype and genotype 
and the reason for the apparent misidentification with VITEK system. The entire 
vanA operon (from nucleotide 3983 to 10200) of isolate 72362 was sequenced 
(Baseclear) and no mutations were found in this operon when compared to the 
published Tn1546 sequence from BM4147 (Genbank Accession Nº M97297). We 
then decided to retest 72362 in a similar VITEK 2 system, and it came identified 
as E. faecium, but susceptible to both vancomycin and teicoplanin. Assuming the 
reliability of the VITEK system, and the fact that VITEK protocol requires picking 
of a few colonies, an explanation for our findings could lay on the presence of a 
mixed culture, namely of two E. faecium strains, one VRE and another VSE 
(vancomycin-susceptible enterococci). The opposite results obtained in the two 
VITEK assays could result from the choice of a colony: in the first time, at the 
Hospital and before arriving at our Laboratory, a VRE colony could have been 
selected; and in the second assay, a VSE colony could have been selected. 
We thus decided to grow the original 72362 isolate in parallel in the absence 
and in the presence of 2 µg/ml vancomycin and perform E-test for both cultures.  
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Results are shown in Figure 5. It is clear from analysis of Figure 5a and 5b in 
particular, because of the presence of several small colonies inside the halo 
(Figure 5b), that 72632 behaves as VRE if previously grown in the presence of 
the antibiotic in a concentration that eliminates, or prevents, the growth of the 
VSE strain (which has a MIC of 2 µg/ml). We then picked four colonies inside the 
halo (In colonies) and four outside the halo (Out colonies) and re-grew each of the 
eight colonies in parallel in the absence and in the presence of 2 µg/ml 
vancomycin. For the sake of easier understanding, we name the isolation outside 
the halo as Out colonies, although we are aware that we were not able to pick just 
one colony, because outside the halo cultures grow as a film. 
As shown in Figures 5c and 5d, all In colonies were resistant to vancomycin 
even if not grown in the presence of the antibiotic. Moreover, it seems that these 
four cultures were now homogeneous. The PFGE profile of these four In colonies 
(Figure 6) was the same for all, in the presence and absence of vancomycin, but 
different from the original 72362 profile. In1 colony was selected for typing with 
MLST and confirmed to belong to a different ST from the original 72362 culture. 
In1 belongs to the ST18 and thus to CC17, as 21428, 57182 and 60921 strains. 
In the case of the Out colonies our results suggest that after one passage, we are 
still in the presence of mixed cultures. In fact, when grown in the presence of 
vancomycin, the cultures behaved as resistant to the antibiotic (Figure 5e) but in 
the absence of vancomycin a halo of growth inhibition was detected. Analysis of 
the PFGE profile of these cultures (Figure 6) revealed that the profile selected by 
prior growth in vancomycin is the same of the In colonies, and different from the 
original 72362 culture, which in turn is the same of the Out colonies grown without 
vancomycin.  
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After growth in the absence of the antibiotic, the Out colonies showed two 
different behaviours: Out 1, 2 and 4 colonies presented colonies inside the 
inhibition halo (Figure 5g); and Out3 colony had no colonies inside the inhibition 
halo, exactly as 72362 isolate (Figure g). These results suggests that Out 1, 2 
and 4 isolates, were enriched in VRE when compared with original culture 72362, 
but Out 3 would be similar to 72362. It is likely that if these four Out colonies 
would have been passed again through vancomycin, VRE enrichment could be 
achieved and the culture would behave as the In colonies.  
 
 
Figure 5. E-test plates containing vancomycin strips on BHI agar: 5a, 72362 original culture 
grown in the absence of vancomycin; 5b, 72362 original culture grown in the presence of 2 µg/ml 
vancomycin (small arrows indicate the position of the eight selected isolated “colonies” In1 to In4 and 
Out1 to Out4); 5c, colony In1 grown in the absence of vancomycin (results for In2 to In4 were the 
same); 5d, colony In1 grown in the presence of 2µg/ml vancomycin (results for In2 to In4 were the 
same); 5e, colony Out1 grown in the presence of 2 µg/ml vancomycin (results for Out2, Out3 and Out4 
were the same); 5f, colony Out3 grown in the absence of vancomycin; 5g, Out1 grown in the absence 
of vancomycin (results for Out2 and Out 4 were the same). 
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Our results clearly demonstrate that 72362 is a mixed culture of two E. 
faecium strains, with different susceptibilities to vancomycin. In the absence of the 
antibiotic in the medium, the VRE strain grows poorly or becomes nearly absent, 
thus leading to a susceptible outcome in E-test. However, if DNA is extracted 
from this mixed culture, and because PCR needs only (in theory) one copy of the 
gene to allow detection, we could detect the entire vanA operon, belonging to the 
VRE strain. In the same way, when MLST was performed, and because both 
strains are E. faecium, the primers used to amplify the housekeeping genes 
would amplify in both strains. The fact that the VSE strain grew much better, and 
was thus in much higher amounts, would obviously lead to the amplification of 
genes from this VSE strain, and therefore the ST found was not ST18. 
 
In Hospitals the use of the VITEK system is very useful and reliable, 
although, as shown in this report, indolent pathogens such as VRE can pass 
undetected if in mixed cultures with faster growing strains. The use of PCR, in 
Figure 6. PFGE of SmaI digested total 
DNA from In and Out colonies: M, 
Lambda Ladder PFG marker (NEB); 
lanes 1 and 10, original strain 72362; 
lanes 2 to 9, Out colonies as depicted in 
Figure 5b;  lanes 11 to 18, In colonies as 
depicted from Figure 5b, grown in the 
presence (+ VA) or absence  (- VA) of 2 
µg/ml of vancomycin. 
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parallel with the use of the VITEK system, to detect similar situations as the one 
reported in this manuscript, is probably not viable. One option could be to screen 
enterococci recovered from blood cultures, or other significant biological products, 
with a vancomycin screening agar in parallel with the VITEK or other commercial 
system. Recently, in a broad study by Huang et al. (2007), assessment of VRE in 
United States Hospitals was proven to be improved by routine screening 
performed with media containing 6 µg/ml vancomycin (Huang et al., 2007). We 
strongly believe that this same measure could easily be implemented during 
infection control and allow a better knowledge about the strains causing infection, 
thus enabling both a correct selection of antimicrobial therapy and epidemiology. 
In summary, it is important that physicians are aware that similar cases can occur 
during treatment of patients. A better assessment of VRE can be achieved easily, 
as we propose, improving the success of the therapy outcome. This is particularly 
striking when CC17 strains can pass undetected, because of being indolent 
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ABSTRACT 
Enterococci are harmless in healthy individuals but constitute a serious threat 
to patients with compromised immune system or under prolonged antibiotic 
treatments. Vancomycin, a glycopeptide antibiotic, used to treat multiresistant 
enterococcal infections is now close to become obsolete due to increasing 
isolation of vancomycin-resistant enterococci. Vancomycin resistance genes have 
been identified in Enterococcus faecalis. However, mutants in regulators have 
been shown to be essential for high-level resistance to vancomycin, revealing that 
much is yet to know on E. faecalis response to this antibiotic. The vancomycin 
stress response was studied in E. faecalis V583, a vanB carrying clinical strain, 
using a therapeutic (10 µg/ml) and a subinhibitory vancomycin dose (0.3 µg/ml). 
The study was done at two different exposure times (t10 and t30) to resolve 
antibiotic stress effects occurring on two biologically relevant time scales. The 
subinhibitory dose strictly and specifically induced the vancomycin resistance 
genes. In contrast, exposure to the therapeutic dose affected drastically the 
transcriptional profile of the cells. About 14% of the V583 genes were found to be 
differentially transcribed and are enrolled mainly in regulatory/signal transduction 
functions, transport and binding and cell envelope synthesis/modification. The 
differential expression of genes involved in transport and binding and in cell 
envelope metabolism suggests that transport and maintenance of cell integrity are 
key factors in stress response to vancomycin. The two-component systems (TCS) 
vanRS, croRS and ehk06-err06 responded to antibiotic treatment. The 
upregulated TCSs may display an important role on the specific response of V583 
to vancomycin as well as in the regulation of multiple genes and metabolic 
pathways that have been altered under vancomycin exposure. The fact that the 
subinhibitory dose selectively induced the vanB operon genes suggests a dose 
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threshold from which other genes and metabolic pathways start to be differentially 
expressed under vancomycin exposure. 
In conclusion, microarray data demonstrated that E. faecalis responds 
globally to therapeutic vancomycin doses, suggesting that survival/resistance to 
this antibiotic may involve other cell elements than just the van resistance genes. 
It seems also clear that, in order to express vancomycin resistance the cells alter 
they metabolism focusing on making available the metabolites that are required 
for cell wall synthesis. This knowledge might help future research on alternative 
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INTRODUCTION 
Antibiotics are associated with treatment of many infectious diseases and 
their therapeutic action relies on the use of high concentrations. During treatment, 
a range of concentrations below the inhibition one occurs in different tissues of 
the treated host. Such range of low concentrations remains also present in the 
host for long periods of time after treatment has finished. Therefore, 
microorganisms, both the targets of the antibiotic treatment and the others, are 
exposed to a range of subinhibitory (SI) antibiotic concentrations in the host, 
during and after treatment with the therapeutic dose. Work performed in recent 
years has shown that SI antibiotic concentrations, i.e, those which do not affect 
growth of the organism, influence considerably and widely, gene transcription in 
microorganisms. SI concentrations of antibiotics modulate the expression of a 
vast number of cellular functions such as SOS pathways and DNA repair systems 
(Mesak et al., 2008; O'Sullivan et al., 2008; Lopez & Blazquez, 2009), cell wall 
stress response (Sass et al., 2008), virulence genes (Shen et al., 2008; Weir et 
al., 2008), quorum sensing mechanisms (Skindersoe et al., 2008), flagella (Horii 
et al., 2003) and biofilm formation (Hoffman et al., 2005). Transcriptomic 
approaches using SI antibiotic concentrations have been used mainly for the 
purpose of understanding the mode of action of the molecule and for the 
discovery of new bioactive compounds. However, we can get further information 
with these kind of studies, namely if we apply these assays for antibiotics which 
are on the way of becoming obsolete due to significant resistance among the 
target organisms. Knowing the effects of low concentrations of the soon-to-
become-obsolete antibiotics can provide relevant information for finding either 
new ways of dosing the chemical or new targets for the resistant microorganism.  
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One of the most relevant examples of soon-to-become obsolete antibiotics is 
vancomycin, a glycopeptide. Vancomycin inhibits cell wall synthesis by forming 
complexes with the peptidyl-D-alanyl–D-alanine (D-Ala–D-Ala) termini of 
peptidoglycan (PG) precursors at the cell surface (Reynolds et al., 1994). 
Vancomycin was first introduced into the clinical practice in the 50s and in 1986 
the first resistant enterococcal strain was isolated (Leclercq et al., 1988). Since 
then, vancomycin resistant enterococci (VRE), responsible for several diseases 
such as endocarditis, bacteremia, urinary tract infections and wound infections, 
have emerged as one of the major nosocomial agents in Hospitals. Their 
prevalence as nosocomial opportunistic pathogens correlates with the increasing 
use of glycopeptide antibiotics (Shepard & Gilmore, 2002). The control of 
glycopeptide resistant enterococci spread within and between hospitals and an 
effective therapeutic are the major challenges concerning enterococci. 
Enterococcus genus constitutes the major reservoir of vancomycin resistance 
genotypes, although acquired resistance to this antibiotic is mostly due to two 
types of gene clusters, designated vanA and vanB. Both confer resistance by the 
same mechanism and encode related enzymes (Reynolds et al., 1994). In both 
cases, resistance is due to synthesis of peptidoglycan precursors ending in the 
depsipeptide D-alanyl–D-lactate (D-Ala–D-Lac) that binds glycopeptides with 
reduced affinity (Evers et al., 1996). The vanB operon contains the vanYBWHBBXB 
resistance genes, being the last three essential for the resistance phenotype. 
vanHB encodes a dehydrogenase that reduces pyruvate to D-Lac, vanB encodes 
a ligase that synthetize the depsipeptide D-Ala-D-Lac and VanXB hydrolyses the 
D-Ala-D-Ala dipeptide synthetized by the Ddl ligase. Expression of the resistance 
genes is regulated by the vanRBSB two-component regulatory system, composed 
by a membrane-associated sensor kinase (VanSB) and a cytoplasmic response 
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regulator (VanRB) that acts as a transcriptional activator (Arthur et al., 1992; Evers 
& Courvalin, 1996). The regulatory and resistance genes are transcribed from 
distinct promoters that appear to be coordinately regulated (Arthur et al., 1997). 
E. faecalis has an extraordinary ability to survive to a wide range of 
environmental stresses. This ability makes them reliable indicators of faecal 
contaminations of food products and drinking water (Franz et al., 1999; Giraffa, 
2002). E. faecalis is a commensal microorganism of the intestinal tract of humans 
and animals, is harmless in healthy individuals but constitute a serious threat to 
patients with compromised immune system or under prolonged antibiotic 
treatments. 
Recent studies on susceptible bacteria, namely Staphylococcus aureus 
(Kuroda et al., 2003; McAleese et al., 2006; McCallum et al., 2006), Bacillus 
subtilis (Cao et al., 2002), Bacillus licheniformis (Wecke et al., 2006), 
Streptococcus pneumoniae (Haas et al., 2005) and Mycobacterium tuberculosis 
(Provvedi et al., 2009), have shown that SI vancomycin concentrations elicit a cell 
wall stress stimulon, which seems to be predominantly regulated by TCSs and 
extracytoplasmatic function σ factors (Jordan et al., 2008). 
Based on what is described for other genus we are led to believe that 
vancomycin may act directly on other genes, either via a vanRB-dependent 
pathway or indirectly and that the knowledge of the transcriptional changes 
induced by this antibiotic may help us to understand how vancomycin acts on E. 
faecalis cells. We thus designed a study aimed to understand the extent of the 
effects of SI vancomycin concentrations in E. faecalis. We used V583 strain, 
carrying the vanB operon, and strain V583EryS∆vanB, which is erythromycin 
susceptible. We investigated the response to the exposure to a therapeutic and a 
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subinhibitory dose of vancomycin using a genome-wide microarray based on the 
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MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS 
This study was performed with E. faecalis V583 (V583), V583EryS and 
V583EryS∆vanB. V583 and V583 EryS are isogenic strains and V583EryS has a 
deletion of the gene that confers erythromycin resistance (EFA0007, ermB) 
(V583EryS strain was provided by A. Benachour). 
The strains were grown overnight in Brain Heart Infusion (BHI) medium, at 
37°C. Cultures were then diluted 20 times and grown in BHI until an optical 
density of 0.4-0.45 at 600 nm was reached. Cultures were split in two and 
vancomycin (Sigma) was added to one of the cultures to a final concentration of 
10 µg/ml (therapeutic dose) in case of V583 or 0.3 µg/ml (subinhibitory dose) in  
the case of V583EryS and its isogenic deletion mutant ∆vanB. The two cultures 
(BHI and BHI plus vancomycin) were then further incubated, and 5 ml samples of 
each culture were collected after 10 (t10) and 30 minutes (t30) past vancomycin 
addition. Samples were immediately suspended in RNA Protect solution 
(QIAGEN) and centrifuged for 10 min at 4°C. Pellets were conserved at 4ºC until 
RNA extraction. Growth of strains with and without vancomycin was monitored by 
measuring the optical density of the cultures in BHI media at 600 nm. 
 
CONSTRUCTION OF vanB MUTANT BY HOMOLOGOUS RECOMBINATION 
A fragment containing the vanB gene was amplified by PCR using primers 5’-
ATCAGGCATGCGATATCGGCAGACAAC-3’ (forward) and 5’-GCAGGGAGCTC 
GGTACAGAGT AAAGTTCTG-3’ (reverse), digested with SphI and SalI, and 
cloned into vector pUCB30 (Benachour et al., 2007). The deletion was created by 
inverse PCR from the sequence cloned into pUCB30 using primers 5’-
CTTGCATAGCTTCCATACGCCG-3’ and 5’-CCAGCAGACATTCCGGTCGAG-3’, 
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which hybridize inside the vanB gene. The PCR product obtained was ligated and 
reamplified with primers 5’-CGCAACCATGGCC GCTGGCAATCAATGC-3’ and 
5’-TTTCTGTCGACAAGAG AGTAATTGGTCTG-3’, containing NcoI and SalI 
restriction sites, underlined respectively, and cloned into pMAD vector. The 
resulting plasmid was introduced into E. faecalis V583. Integrations by double-
crossover recombination within vanB gene were checked by PCR and 
sequencing. The vanB gene deletion mutant was created in the strain V583EryS 
due to clone selection convenience since pMAD carries erythromycin resistance 
gene. 
 
TOTAL RNA EXTRACTION 
Total RNA extraction was performed with RNeasy Mini columns (QIAGEN). 
DNA digestion was done on the columns by adding RNase-free DNase (QIAGEN) 
and incubating at room temperature for 30 min. 10 µg of each RNA sample was 
used for hybridization experiments. 
 
DNA MICROARRAY CONSTRUCTION 
The Affimetrix microarrays used were previously designed and described in 
McBride et al. (2007). Briefly, the microarray was designed to contain a total of 
3582 probes including 3182 predicted ORFs from the chromosome of strain 
V583; additional pathogenicity island genes of strain MMH594, known to be 
absent in V583; and E. faecalis plasmid and antibiotic resistance genes or 
clusters from other E. faecalis strains for which nucleotide sequences had been 
reported, namely the vanA operon, blaZ, bcr operon, vanG operon, vanE operon, 
tetM, pRE25 plasmid/cat, as well as the genes present on the V583 endogenous 
plasmids pTEF1, pTEF2 and pTEF3. Additionally microarrays included 111 
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Affymetrix designed eukaryotic and prokaryotic negative control probe sets 
(McBride et al., 2007). A full list of probe sets including genes represented and 
excluded from the microarray is available in the ArrayExpress public repository at 
http://www.ebi.ac.uk/ under accession number E-MEXP-1090. Details of the 
algorithm used in construction of custom Affymetrix GeneChips are available at 
the manufacturer’s website (www.affymetrix.com/technology/index.affx). 
 
DNA MICROARRAY REPLICATES AND DATA ANALYSIS 
For each condition three batches of RNA were obtained in three separate 
growth experiments to provide true biological replicates. Each set of independent 
RNA samples was used to perform the microarray hybridizations. cDNA 
synthesis, fluorescent labelling, oligonucleotides array hybridization and 
preliminary data analysis was performed by the company Genome Explorations 
(Memphis, Tennesse). 
Average relative fold changes were calculated from the average of the signal 
log ratio (SLR) from three separate experiments by using the following equations: 
for an SLR of ≥0, average relative fold change = 2SLR; for an SLR of <0, average 
relative fold change =-1×2(-1×SLR) (Ng et al., 2003). 
 
SEMI-QUANTITATIVE REVERSE TRANSCRIPTASE PCR (RT-PCR) 
To independently confirm the differential expression observed by DNA 
microarray experiments some genes were selected for analysis by semi-
quantitative RT-PCR. The genes selected and the primers used are listed on 
Table 1 and were synthesized and purchased from Eurofins (Ebersberg, 
Germany). 
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cDNA was synthesized from RNA samples isolated from cells grown in 
presence and absence of vancomycin (10 µg/ml) and after 10 and 30 minutes of 
antibiotic exposure. cDNA synthesis was performed using Transcriptor High 
Fidelity cDNA Synthesis Sample (Roche) according to the manufacturer’s 
instructions and using 4 µg of RNA as template.  
 
Table 1. List of genes and primers (5´→3´) used for semi-quantitative RT-PCR 
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RESULTS 
Vancomycin therapeutic dose choice (10 µg/ml) was based on what is 
described in the literature. Therapeutic peak levels of 20-40 µg/ml and trough 
serum levels of 5-10 µg/ml have been identified for vancomycin and are accepted 
worldwide (Rybak et al., 2009). The vancomycin subinhibitory concentration (0.3 
µg/ml) choice was based on growth curves performed in BHI media with a 
V583EryS isogenic mutant, V583 EryS∆vanB, which is intermediate to vancomycin 
with a MIC of >12 µg/ml determined by microdilution. A vancomycin dose of 0.3 
µg/ml corresponds to the highest dose that does not affect the growth of the 
intermediary strain. 
 
GROWTH OF E. faecalis STRAINS UNDER EXPOSURE TO VANCOMYCIN 
 Figure 1 shows the growth curves of the strains used in this study, in the 
absence and presence of vancomycin stress. It is clear that, at both times of 
collection of RNA (t10 and t30 post vancomycin addition), growth was not yet 
affected in none of the strains. In fact, exposure to 10 µg/ml of vancomycin 
reduced slightly V583 growth when compared with the untreated control. 
However, this reduction in growth was only perceptible after 30 minutes of 
antibiotic exposure. The same behaviour was seen for the ∆vanB mutant. 
Therefore, any observations drawn from the results presented are mainly 
consequences of the action of the antibiotic and less a result of the growth 
inhibition. A SI concentration corresponds, by definition, to 1-10% of the MIC (Yim 
et al., 2006). The therapeutic dose used in this work is thus SI for V583. 0.3 µg/ml 
is a true SI concentration for both V583EryS and ∆vanB. For the sake of easier 
writing, 10 µg/ml will be referred to as therapeutic dose (and used for V583) and 
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0.3 µg/ml will be called SI concentration (used for both V583EryS and its ∆vanB 
isogenic deletion mutant). 
 
Figure 1. a) growth curve of E. faecalis V583 in BHI without vancomycin (), with a therapeutic 
vancomycin dose (10 µg/ml) (□) and a subinhibitory vancomycin dose (0.3 µg/ml) (); b) growth curve 
of E. faecalis V583EryS (), V583EryS with 0.3 µg/ml of vancomycin (●), V583EryS∆vanB () and 
V583EryS∆vanB with 0.3 µg/ml of vancomycin (). 
 
CRITERIA FOR ANALYSIS OF MICROARRAY RESULTS 
We only present and discuss here genes that were differentially transcribed 
in all three independent replicate experiments, with fold change higher than 2.0 in, 
at least, one of the sampling times. For change p-values higher than 0.9975, 
probes were considered downregulated and for p-values lower than 0.0025, 
probes were considered upregulated. Since the typical cell division time of E. 
faecalis in BHI medium is 30 minutes, cells were collected at two time points after 
the addition of vancomycin, 10 and 30 minutes, to resolve antibiotic stress effects 
occurring on two biologically relevant time scales. 
 
EXPRESSION OF SPECIFIC VANCOMYCIN RESISTANCE GENES 
All genes from vancomycin resistance operon vanRBSBYBWHBBXB (EF2299 
to EF2293) were, as expected, upregulated in the presence of vancomycin, both 
at t10 and t30, with both vancomycin concentrations (Figure 2). vanYB, vanW, 
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vanHB, vanB and vanXB were the most strongly induced genes by 10 µg/ml of 
vancomycin. vanRBvanSB had a discrete increment on expression, of about 3-fold.  
 
 
Figure 2. vanB operon genes fold changes under exposure to therapeutic vancomycin dose (10 
µg/ml) and subinhibitory vancomycin dose (0.3 µg/ml). vanRB and vanSB were not included on the 
graphic due to the significant difference between fold change values for these genes and the other 
genes from the operon. 
 
Although the fold change values observed with the SI concentration of 
vancomycin are lower for vanYB, vanW, vanHB, vanB and vanXB genes, compared 
to the ones observed with the therapeutic dose, they are still high in strains 
V583EryS and ∆vanB. For the same two strains vanRBvanSB genes presented fold 
changes lower than the ones observed for the therapeutic dose. 
 
EXPOSURE TO A VANCOMYCIN SUBINHIBITORY DOSE  
With 0.3 µg/ml of vancomycin the only genes differentially expressed were 
the genes from the vanB operon, together with a single hypothetical protein 
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(EF2292), in both V583EryS and ∆vanB strains. For these strains, the fold change 
values for vanRB and vanSB are below the cut-off value of 2. We only consider 
them here because they are directly involved in vancomycin response. However, 
despite the low level of induction, it is enough to induce the rest of the van operon 
to similar levels in both strains. 
 
EXPOSURE TO A VANCOMCYIN THERAPEUTIC DOSE 
As opposed to the SI concentration of vancomycin, the therapeutic dose was 
able to produce an overall differential expression in genes assigned to various 
roles in the cell (Figure 3). 
 
Figure 3. Functional classification of E. faecalis V583 genes showing differentially expressed 
levels, represented according to their absolute fold change value (light grey 2.0<|fold change|<5.0, 
medium grey 5.1<|fold change|<10.0, dark grey |fold change|>10.1), in response to exposure to 10 
µg/ml vancomycin. Functional classification refers to TIGR annotation. Differentially expressed 
plasmid-encoded genes are also included; genes that have been assigned with more than one cellular 
role were counted twice. A) Amino acid biosynthesis, B) Biosynthesis of cofactors/prosthetic 
groups/carriers, C) Cell envelope, D) Cellular processes, E) Central intermediary metabolism, F) DNA 
metabolism, G) Mobile and extrachromosomal element functions, H) Energy metabolism, I) Fatty acid 
and phospholip metabolism, J) Hypothetical proteins, K) Protein fate, L) Protein synthesis, M) 
Purine/pyrimidine/nucleoside and nucleotides, N) Regulatory functions, O) Signal transduction, P) 
Transcription, Q) Transport and binding proteins, R) Unknown function proteins. 
 
In total, 441 different genes, corresponding to 14% of the V583 chromosomal 
genes, were differentially transcribed. At t10, 205 genes (6%) were differentially 
transcribed, of which 127 genes were significantly upregulated and 78 genes 
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were downregulated. At t30, 445 genes were differentially transcribed, 
corresponding to about 14% of V583 genes, which indicates a general increase in 
transcriptional activity by exposure to the therapeutic dose of vancomycin. 
Although the transcriptional profile is different at both time points there is a 
considerable overlap since 129 genes are common. Only one plasmid encoded 
gene was upregulated, EFA0067, encoding a PTS system protein. Figure 3 
represents all the functional categories of genes that were differentially expressed 
under the conditions tested. It is worth mentioning that 5% of the differentially 
expressed genes present fold change values higher than |3| and that 2% have 
fold change values higher than |5|. These results show that transcriptional events 
in E. faecalis V583 are significantly altered by vancomycin exposure, concerning 
the number of genes involved and the fold change values that these genes 
present. 
 
Some functional classes of genes show no relevant changes at the 
transcription level under vancomycin exposure, namely the categories of genes 
involved in fatty acid and phospholipid metabolism, mobile and extrachromosomal 
element functions, protein synthesis and transcription. Cell envelope, energy 
metabolism, cellular processes, transport and binding and regulatory and signal 
transduction are the most affected functional categories under vancomycin 
therapeutic dose. Among the most upregulated categories are genes encoding for 
hypothetical proteins and proteins with unknown function followed by genes 
involved in synthesis of cell envelope components and genes with regulatory 
functions (Figure 3). At t30 a considerable number of genes encoding for transport 
and binding proteins were also upregulated. Considering the downregulated 
genes, the categories with more genes involved are again those encoding for 
Chapter 4  
 146 
hypothetical and unknown function proteins, transport and binding proteins, 
followed by genes involved in signal transduction and cell envelope-related 
proteins.  
 
A list of all genes found to be differentially expressed under exposure to 10 
µg/ml of vancomycin, sorted by locus order, is presented in supplementary table 
S1. In this table we distinguish, by different grey tones, genes differentially 
expressed at t10 and t30 from genes only expressed at one of the assayed time 
points. It is reasonable to assume that the first category of genes is responding 
either to vancomycin or to the immediate changes introduced by the high 
upregulation of the vanB operon genes and are directly responding to the stress. 
Since it is maintained through the time of the experiment, these genes also 
maintain their differential expression. Genes only up- or downregulated at 10 
minutes post-stress induction are likely involved in the immediate response to the 
presence of vancomycin. As soon as the cell changes, other responses are 
turned on, namely those elicited by the expression of genes which are turned on 
or off only 30 minutes post-stress induction. 
 
Among the genes which expression is regulated at both time points we find 
some which encode for hypothetical proteins and unknown function (50 genes), 
the vanB operon genes and genes with assigned roles in cell envelope (17 genes, 
of which 4 code for PBPs), energy or central intermediary metabolism (13 genes), 
regulatory functions (14 genes, among which we found three two-component 
systems, namely TCS05, TCS06 and TCS15), transport and binding (10 genes) 
and also some involved in DNA metabolism (3 genes), amino-acid, nucleotide, 
cofactor, prosthetic groups and carrier biosynthesis (9 genes) and protein fate (6 
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genes). Eight genes were found to be upregulated at one time point and 
downregulated at the other and encode proteins putatively enrolled in cell 
envelope (2 genes), nucleotide metabolism (1 gene), hypothetical proteins (1 
gene) and signal transduction/transport and binding (4 genes).  
 
INDEPENDENT ANALYSIS OF GENE EXPRESSION BY RT-PCR 
Semi-quantitative RT-PCR was performed for 19 genes (Table 1) to confirm 
results obtained with the microarray experiments. The choice of the genes was 
made to include vancomycin resistance genes, genes from different functional 
categories and different levels of expression. The transcriptional profiles from 
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DISCUSSION 
E. faecalis V583 was the first vancomycin-resistant clinical isolate reported in 
the United States (Sahm et al., 1989) and until recently it was the only 
Enterococcus isolate which genome sequence has been completed. Recently the 
sequence of 28 more enterococcal genomes, 16 of which are E. faecalis, became 
available (Palmer et al., 2010). 
Scarce information is available concerning gene expression in enterococci. 
The few transcriptomic studies have dealt with responses of E. faecalis to 
erythromycin (Aakra et al., 2005), chloramphenicol (Aakra et al., 2010), SDS and 
bovine bile salts (Solheim et al., 2007), growth in blood (Vebo et al., 2009) and in 
urine (Vebo et al., 2010) and exposure to copper (Reyes-Jara et al., 2010). The 
harsh nature of this bacterium and its relevance as a nosocomial agent clearly 
evidences that E. faecalis possesses important mechanisms for dealing with both 
biotic and abiotic stresses. The establishment of transcriptional profiles of 
Enterococcus under stress conditions is fundamental to understand and define 
the complex pathways triggered under stress. This may be a useful tool to 
identify, for instance, new targets for the development of alternative strategies to 
prevent or irradicate enterococcal severe infections. 
 
As mentioned above, SI antibiotic concentrations are in fact the real 
concentrations that most bacteria face after and even during antibiotic treatment. 
Therefore it is extremely relevant to understand the extent of changes induced by 
SI antibiotic concentrations, especially in E. faecalis, a bacterium intrinsically 
resistant to most antibiotics used in therapy and tolerant to vancomycin. 
Vancomycin is a last resort antibiotic on the edge of becoming clinically obsolete 
for treatment of enterococcal and other clinically relevant Gram-positive bacteria. 
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Vancomycin induced stress is relevant also because it is a cell-wall active 
antibiotic and the cell-wall is in fact the great sensory organ of the bacterial cell. 
Somehow, understanding the cell envelope stress response (CESR) imposed by 
vancomycin may shed light into the process of how E. faecalis senses the outside 
environment. Some work as been done on CESR using transcriptomics and SI or 
sublethal antibiotic concentrations in other Gram-positive bacteria (Jordan et al., 
2008). However, comparisons are hard to draw from the published results. 
Therefore, we designed this study in order to allow three different comparisons: 
we compared the same strain but with different vancomycin susceptibilities 
(namely the ∆vanB mutant, which is VanS, and the VanR strain V583) and using 
different concentrations adjusted to the same concentration relative to the MIC 
(we used approximately 2.5% MIC, which corresponds to 0.3 µg/ml and 10 µg/ml, 
respectively). Additionally, we compared the same strain when challenged with 
different vancomycin concentrations (for the VanR strains, we used two sublethal 
concentrations, namely 0.3 µg/ml and 10 µg/ml), and we looked for both the initial 
and transient stress responses (after 10 minutes) and the long term stress 
response (after 30 minutes) using a therapeutic dose.  
 
GLOBAL ADAPTATION OF THE V583 TRANSCRIPTOME REVEALS 
CHANGES COMPRISING MOST FUNCTIONAL GENE CATEGORIES 
Vancomycin was able to induce the van genes at both concentrations and in 
both VanS and VanR strains. However the level of induction was related with the 
absolute vancomycin concentration, and not to the concentration relative to MIC, 
since both VanR and VanS strains responded similarly to 0.3 µg/ml of the 
antibiotic. Moreover, at this low vancomycin concentration, only the van genes 
were differentially transcribed, thus implying that this low dose does not impose 
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any stress response on the cell, nor shows any of the overall transcriptomic 
changes precluded from the hormesis hypothesis (Yim et al., 2006). If one 
assumes that the hormesis hypothesis is true, then we can say that what induced, 
in fact, the overall cell response seen in V583 with 10 µg/ml was not just 
vancomycin per se, but also the extensive changes it induces in the cell wall of a 
resistant strain, i. e. the large substitution of the D-Ala-D-Ala precursors by D-Ala-
D-Lac. This substitution is likely small when the VanR cells are challenged with 0.3 
µg/ml, thus not inducing any other response in the cell. Those changes may alter 
in turn the substrates of many enzymes and thus induce a series of chain 
reactions leading to a stress response by the cell. This stress response may be 
responsible for the growth arrest seen in V583 after the 30 min challenge with the 
vancomycin therapeutic dose. 
 
STRESS RESPONSE OF V583 CAUSED BY VANCOMYCIN EXPOSURE 
Recent efforts to unravel the mechanisms involved in antibiotic mediated cell 
killing or growth arrest have revealed two common mechanisms: oxidative stress 
response and SOS DNA stress response (Dwyer et al., 2009). When we 
challenged V583 with the vancomycin therapeutic dose, genes belonging to both 
stress mechanisms were found to be differentially regulated. We found katA 
(EF1597) gene to be upregulated under vancomycin exposure. This gene 
encodes a heme-containing catalase. The physiological role of catalase is to 
remove the hydrogen peroxide formed under oxic conditions, which is toxic to 
cells. The E. faecalis katA gene is expressed when the cells are grown under 
aerobic conditions (Shepard & Gilmore, 1999). Although the gut is mainly an 
anoxic environment, enterococci are frequently in oxic environments, such as live 
tissues during colonization. Under these conditions, enterococci may produce 
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large amounts of superoxide and hydrogen peroxide. It is also possible that E. 
faecalis respiratory chain, which is active in the presence of oxygen and heme, 
produces hydrogen peroxide. Production of hydrogen peroxide has been 
suggested to be an important factor in virulence and bacterial competition 
(Frankenberg et al., 2002). E. faecalis cells can also encounter oxidative stress 
mediated by exogenous superoxide and hydrogen peroxide produced by host 
defense cells, like neutrophils. Conceivably, both bacterial hydrogen peroxide 
production and the expression of catalase are virulence factors. Catalase 
production, as well as the ability to use externally supplied heme, has been 
implicated in virulence in several pathogenic microorganisms, e.g., 
Staphylococcus aureus (Clements & Foster, 1999), Helicobacter pylori (McGee & 
Mobley, 1999), and Candida albicans (Wysong et al., 1998). Possibly, heme 
acquisition and catalase production by E. faecalis can be similarly incriminated as 
virulence determinants (Frankenberg et al., 2002). Of the 17 genes predicted in 
V583 to play a role in oxidative stress response (Riboulet et al., 2007) only katA 
was found, in our study, to be upregulated in presence of vancomycin. In a recent 
study by Bizzini et al. (2009) concerning vancomycin tolerance, superoxide 
dismutase was found to be essential for E. faecalis tolerance to vancomycin 
(Bizzini et al., 2009). In this study JH2-2, which is a vancomycin susceptible 
strain, was challenged with a vancomycin concentration 20 times its MIC value. 
We thus cannot compare the two studies, since we used a resistant strain and a 
SI vancomycin concentration. However, our results suggest, at least, the 
induction of catalase, which means that peroxide mediated stress was induced by 
vancomycin under the tested conditions. 
Concerning the SOS DNA stress response, genes involved in these 
pathways were also upregulated in the presence of a vancomycin therapeutic 
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dose. All together, the induction of these genes suggests a strong mutagenic 
pressure induced by vancomycin. One of these genes, EF1587, codes for MutT, a 
Nudix family protein. MutT hydrolyses 8-oxo-dGTP to 8-oxo-dGMP, an event that 
can prevent the misincorporation of 8-oxoguanine opposite adenine in DNA. 8-
oxoguanine (8-oxoG), a damaged form of guanine (G) generated by reactive 
oxygen species, is known to have highly mutagenic potency because of its 
mispairing with adenine. Somehow, the induction of EF1587 suggests the 
involvement of oxygen reactive species in the intracellular cascade of events 
induced by vancomycin challenge.  
 
When cells are exposed to some environmental stress, there is a rapid 
increase in synthesis of a group of evolutionary conserved proteins known as 
heat-shock proteins (HSPs), or stress proteins, consisting mainly of chaperones 
and proteases that are involved in protein (re)folding and protein degradation 
(Laport et al., 2004). We observed two HSPs upregulated under vancomycin 
exposure, EF1646 (hsIU) and EF1647 (hsIV), which are related to adaptation to 
atypical conditions and to protein folding and stabilization, respectively. Clp-
HSP100 ATPases are a widespread family of ubiquitous proteins that occur in 
both prokaryotes and eukaryotes and play important roles in the folding of newly 
synthesized proteins and refolding of aggregated proteins. We found it 
upregulated under vancomycin exposure (EF2355). This family is considered a 
class of stress proteins and it has been shown to participate in the virulence of 
several pathogens (Chastanet et al., 2004). 
 
Several authors hypothesize that gidA (EF3311) could be an important 
regulatory molecule, controlling virulence-associated factors of enteric pathogens 
Transcriptomic profile of Enterococcus faecalis V583 in response to vancomycin reveals 
bacterial support for full expression of high-level vancomycin resistance 
 153 
(Kinscherf & Willis, 2002; Sha et al., 2004) and there is some evidence that gidA 
mutants are avirulent in mice (Sha et al., 2004). We found this gene to be 
downregulated by vancomycin at t30, with an expression 2.1-fold decreased. 
 
EXPOSURE TO VANCOMYCIN AFFECTS THE EXPRESSION OF 
REGULATORY GENES AND TCSs 
Regulatory genes constitute one of the most important groups of induced 
genes under vancomycin treatment, which indicates that the response to 
vancomycin is a highly regulated process and is triggered early in the stress 
response.   
Two-component systems are employed by bacteria to sense and respond to 
environmental stimuli and typically consist of a membrane-bound histidine protein 
kinase and a cytoplasmic effector termed response regulator (Stock et al., 2000). 
The available genome sequence for E. faecalis V583 allowed the identification of 
17 TCSs Ehk-Err (enterococcal histidine kinase – enterococcal response 
regulator) and an orphan RR (Hancock & Perego, 2002). Studies on enterococcal 
TCSs have been performed with E. faecalis JH2-2, OG1RF and V583 (Teng et 
al., 2002; Le Breton et al., 2003; Hancock & Perego, 2004). These studies have 
implicated some of the enterococcal TCSs in virulence, biofilm formation, 
antibiotic resistance and stress response (Hancock & Perego, 2002; Le Breton et 
al., 2003).  
 
The best characterized TCSs in Enterococcus are the VanRS and VanRBSB 
systems Err11-Ehk11), which regulate VanA and VanB glycopeptide resistance, 
respectively (Arthur et al., 1992). Until very recently this TCS have not been 
associated to response to other antibiotics or different stresses, suggesting that 
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they are highly specific to vancomycin response. However, the recent work of 
Aakra et al. (2010) states that vanRBSB is induced under exposure to 
chloramphenicol (Aakra et al., 2010). Also, the fact that a vanRS homolog was 
found in a vancomycin susceptible strain (OG1RF) (Bourgogne et al., 2006), 
suggests that VanRS systems might have a broader role than exclusively 
vancomycin resistance.  
 
The histidine kinase EF3290 (croS) and its cognate response regulator 
EF3289 (croR) were both upregulated at t10 and t30. This TCS designated as 
croRS (ceftriaxone resistance), is known as Err05-Ehk05 by Hancock and Perego 
(2004). A mutant in rr05 in V583 background showed increased susceptibility to 
vancomycin (Hancock & Perego, 2002) and we determined that the vancomycin 
MIC for the same mutant is 32 µg/ml, suggesting a role in vancomycin resistance 
and/or in response to vancomycin stress. A croR mutant also shows increased 
susceptibility to bacitracin and to second- and third-generation cephalosporins 
(Hancock & Perego, 2004). Considering the present data together with Hancock 
and Perego observations, it seems that croR is involved in resistance to a wide 
range of cell wall-active agents, indicating a role in regulating cell-wall synthesis 
or stress. Le Breton et al. reported that croR mutation in E. faecalis JH2-2 led to 
significant growth defects and cell morphology alterations (Le Breton et al., 2003). 
The observed defects were ascribed to a deregulation of sagA (renamed salB), as 
a similar phenotype was observed for a sagA mutant (Breton et al., 2002). 
However, other authors did not observed any growth defect when analysing a 
croR mutant, but in E. faecalis V583 strain (Comenge et al., 2003; Hancock & 
Perego, 2004). The role of croRS remains to be clarified and might be strain 
specific. We found salB (EF0394) downregulated at t30 under vancomycin 
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exposure. SalB expression has been described dependent on CroR, supporting 
the thesis of a direct involvement of the CroRS two-component system in the 
activation of salB under environmental stresses such as high osmolarity and 
temperature (Muller et al., 2006). The fact that we found salB with reduced 
expression (-2.5-fold change at t30) might indicate that either salB responds 
differentially under a different type of stress (e. g. antibiotic exposure) or that 
depending on the stress type salB might be under regulation of a negative 
regulator, instead of croR. SalB was also found to be downregulated during 
growth in blood (Vebo et al., 2009). We also found differentially expressed other 
genes previously described as being under croR regulation, such as EF0443 
(coding for a surface protein of unknown function), EF3245 (coding for a cell 
envelope associated acid phosphatase, unknown specificity enzyme), EF0746 
(coding for a putative penicillin binding protein) and EF2222 (coding for an ABC 
transporter) (Muller et al., 2006). Interestingly, these genes were described as 
negatively regulated by CroR, however under vancomycin exposure they are all 
induced, once again indicating that stress response is strongly dependent on the 
stress-type imposed to the cells or is strain-dependent. 
 
We detected the upregulation of other response regulator (rr06) at both t10 
and t30 but its cognate histidine kinase was only detected at t30. The TCS Err06-
Ehk06 is homologous to the B. subtilis YclJ-YclK TCS, which is activated under 
oxygen limitation (Kobayashi et al., 2001; Hartig et al., 2004). In E. faecalis JH2-2 
this TCS has also been implied in the response to oxidative stress and in the 
expression of the catalase gene (kat) (Muller et al., 2008), which was found to be 
induced as previously mentioned on this discussion but only at t30, as observed 
for ehk06, confirming that katA expression is dependent on TCS06 in V583 and 
stress. Mutants in E. faecalis err06 were shown to be more susceptible than the 
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wild-type to heat and SDS (Hancock and Perego, 2004) and more sensitive in 
macrophages (Muller et al., 2008). The vancomycin induction of TCS06 may be 
related with the oxidative stress by H2O2 production in prolonged stress.  
The EF1820 (fsrC) which is the histidine kinase from TCS Err15-Ehk15 was 
downregulated in response to vancomycin treatment. The operon fsr/gelE/sprE 
regulated by this TCS is described as a virulence operon. fsr and gelE-sprE are 
more than virulence factors in E. faecalis. Recently, they have been assigned a 
role in autolysis activation and regulation by modulating the activity of cell wall 
murein hydrolases (Thomas et al., 2008). These enzymes are crucial for the 
correct growth of bacteria by allowing the cell-wall turnover. It is thus not 
surprising that a cell-wall active antibiotic, such as vancomycin, can substantiate 
changes in the expression of fsr and gelE-sprE operons.  
There are some data indicating that this operon is under the regulation of 
codY, which interacts with gelE/sprE promoter (Pascal Serror, personal 
communication). In this study codY was found to be upregulated, and as it is a 
negative regulator, genes under its regulation are repressed. Assuming that codY 
negatively regulated the fsr system, it does make sense that fsrC (and all the 
remaining detected genes of the operon) are downregulated.  
codY (EF1645) is described as a pleiotrophic regulator at it was first identified 
in B. subtilis (Slack et al., 1995; Serror & Sonenshein, 1996) as a repressor of 
several gene categories namely extracellular degradative enzymes, transport 
systems, catabolic pathways, genetic competence, antibiotic synthesis, flagellin, 
early esporulation functions and virulence. We found that codY is upregulated 
under vancomycin exposure (2.2-fold at t10/2.6-fold at t30). In our study, we 
actually detected downregulation of some genes from these categories, namely 
genes involved in virulence (fsr and cps operons, gelE, salB), degradative 
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enzymes (sprE),  many genes involved in transport (ABC transporters and PTS 
systems) (Figure 2). This study associates codY induction to vancomycin stress 
for the first time, suggesting that this regulator can also play roles in CESR. 
In B. subtilis codY is part of a 4-cistronic operon (codVWXY) (Slack et al., 
1995) as well as in S. aureus (xerC-clpQ-clpY-codY) (Frees et al., 2005). We 
believe that in E. faecalis V583 codY is also transcribed as part of an operon – 
EF1648-EF1647 (hsIV)-EF1646 (hsIU)-codY. All the putative codY operon genes 
are induced under vancomycin exposure at similar fold change rates. EF1647 
(hsIV) is homologous to B. subtilis codW and S. aureus clpQ and EF1646 (hsIU) 
is homologous to B. subtilis codX and S. aureus clpY. 
TCS03 and TCS08, homologous to vraRS of S. aureus and vncRS of S. 
pneumoniae, respectively, were not differentially regulated by vancomycin in E. 
faecalis V583. It is thus highly possible that those TCSs do not play the same 
roles in the three species. 
 
We have observed between 16 regulator genes (t10) to 26 regulator genes 
(t30) being differentially expressed under vancomycin exposure, which indicates a 
complex network of mechanisms involved in glycopeptide resistance/response. 
psr regulator (EF1569) is the PBP5 synthesis repressor of E. faecium, E. 
faecalis and E. hirae and was found upregulated in response to vancomycin 
exposure. It shares high sequence identity and similarity to S. aureus msrR and 
B. subtilis lytR and they all belong to the LytR-CpsA-Psr family of cell envelope-
related transcriptional regulators. msrR is strongly expressed in glycopeptide 
resistant strains of S. aureus and its expression is induced by cell wall related 
antibiotics including vancomycin and oxacillin (Rossi et al., 2003; Utaida et al., 
2003; Cui et al., 2005). We detected the upregulation of pbp4 (EF2476, 
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equivalent to pbp4 of E. faecium and E. hirae), pbp2a (EF0680) and EF0746, a 
putative penicillin-binding protein. Opposed to what is described for E. faecium 
and E. hirae (Ligozzi et al., 1993; Massidda et al., 1998), E. faecalis JH2-2 pbp4 
regulation seems to be psr-independent (Duez et al., 2001). There are evidences 
that E. hirae psr might be involved in the regulation of autolysis and of other cell 
surface-related properties or functions and not directly on the overproduction of 
PBP5 or on the levels of resistance to penicillin G (Massidda et al., 1996).  
 
Four out of the seven transcriptional regulators with LysR domains annotated 
on V583 genome were highly induced by vancomycin, namely EF1302 (6.4-fold at 
t10/10.1-fold at t30) and EF1303 (7.2-fold at t10/13.4-fold at t30) which are co-
transcribed, according to Biocyc database prediction, EF1815 (3.3-fold at t10/9.2-
fold at t30) and EF2703 (11.6-fold at t30), indicating a relevant role of LysR-type 
regulators on vancomycin stress response.  
 
EXPOSURE TO VANCOMYCIN ALTERS THE EXPRESSION LEVELS OF 
GENES INVOLVED IN CELL-WALL ASSEMBLY  
As far as the genes involved in cell envelope are concerned, we observed 
that dlt operon (dltABCDX, genes EF2746-2750) is upregulated under 
vancomycin exposure. This operon is responsible for D-alanylation of the teichoic 
acids (Peschel et al., 1999; Lai et al., 2007; Li et al., 2007a). The gene EF2749 is 
not annotated in the V583 genome, although it shares 40% identity with the 
homologous gene dltA of Staphylococcus epidermidis RP62A. In this species the 
dlt operon together with mprF gene (also known as fmtC), which is responsible 
for the incorporation of lysyl-phosphatidylglycerol in the cytoplasmic membrane, 
and a putative transporter system of unknown function that has homology to the 
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Staphylococcus aureus vraF and vraG genes, have been proven to control 
resistance to cationic antimicrobial peptides and were found to be under aps 
(antimicrobial peptide sensor) control in S. epidermidis (Li et al., 2007b). 
Li et al. (2007) also identified a similar peptide-sensing system in S. aureus 
though this system seems to have significant interspecies differences (Li et al., 
2007a). mprF has no similarity with genes of known function, but related genes 
were identified in the genomes of several pathogens including Mycobacterium 
tuberculosis, Pseudomonas aeruginosa, and E. faecalis (Peschel et al., 2001).  
In the genome of V583 there is a homologue to S. aureus vraF sharing 49% 
of identity (EF2752, not detected in this study), but there is no homologue to 
vraG. The aps system is homologous to the two component system vraRS 
previously described (Kuroda et al., 2000) and apparently important for 
vancomycin resistance.  
Peschel et al. (2000) showed that structural changes of teichoic acids in the 
cell envelope have a considerable influence on the susceptibility to vancomycin 
and other glycopeptides. S. aureus cells lacking D-alanine esters in teichoic acids 
exhibited at least three fold-increased sensitivity to glycopeptide antibiotics 
(Peschel et al., 2000). 
Since glycopeptide antibiotics bind to D-alanyl-D-alanine dipeptides, it is 
tempting to speculate that in order to resist to vancomycin exposure E. faecalis 
cells upregulate dlt operon likely as parallel resistance mechanism, probably 
common amongst enterococci. The teichoic acid D-alanine esters incorporated by 
dlt operon contain positively charged amino groups while the terminal D-alanine 
residues of murein peptides contain negatively charged carboxyl groups. This 
may constitute an alternative pathway for the cell wall biosynthesis to avoid the 
direct binding of vancomycin, a cationic antibiotic, to the D-alanine esters of 
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teichoic acids. dlt operon together with oatA gene (EF0783) contributes partially 
to lysozyme resistance in E. faecalis JH2-2, by altering the cell envelope net 
charge and in the case of oatA through the modification of different sites of the 
PG structure (Le Jeune et al., 2010). oatA gene is upregulated under vancomycin 
exposure in E. faecalis V583. 
Interestingly, also the capsule operon (cps operon, EF2485-EF2492) is 
downregulated both under vancomycin exposure and when cells are grown in 
blood (Vebo et al., 2009). We could assume that the capsule operon genes are 
downregulated in order to let available the substrates necessary for cell wall 
synthesis (Figure 4). 
Several other genes involved in cell wall synthesis and modification respond 
to vancomycin. GlmS activity has a critical role in the initiation of PG synthesis. In 
the Embden-Meyerhof pathway, this enzyme converts fructose 6-phosphate into 
glucosamine 6-phosphate, from which murein monomer precursor is synthesized. 
We observed that the glmS gene (EF2151) was downregulated under 
vancomycin exposure, suggesting that cell wall precursor synthesis is shifted 
towards the glycolysis pathway (Figure 4).  
It has also been found that just a few specific cell wall synthesis enzymes are 
upregulated, namely nagB (EF0466), nagA (EF3044), pbp2B (EF2857), pbp2a 
(EF0680), pbp4 (EF2476), EF0746 (penicillin binding protein, putative), murB 
(EF2733), murM (EF2658) and EF2585, a Mur ligase family protein. The MurB 
enzyme catalyzes the synthesis of UDP-N-acetylmuramic acid (UDP-MurNAc) 
from EP-UNAG (enolpyruvyl-UDP-N-acetylglucosamine). The absence of a 
homologue in eukaryotic cells makes murB an attractive target for small molecule 
inhibitors with the potential to have broad antibacterial activity (Yang et al., 2006). 
However, from the metabolic scheme presented on Figure 4, it seems that the cell 
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alters its metabolism in a way that favours the cell wall synthesis through the 
induction or repression of different metabolic pathways. 
Three proteins involved in cell division, belonging to the FtsW/RodA/SpoVE 
family (EF1300, EF1301, EF2502), were differentially induced under vancomycin 
exposure, as EF2502 is induced at both time points and the other two are only 
activated after 30 min of exposure to vancomycin. The enterococcal divisome is 
not well established but from what is known from Bacillus sp. and E. coli, FtsW 
family proteins are likely involved in the translocation of the lipid-linked precursor 
for PG synthesis from the inside to the outside of the membrane and delivery to 
its cognate PG-synthesizing complex. Also, these proteins are frequently close to 
the gene for a class B PBP (Errington et al., 2003) but its activity has to be 
concerted with at least one class A PBP. FtsK is a large protein with several 
distinct roles in the late stages of cell division since is required to complete final 
closure of the septum (Errington et al., 2003). EF2533 belongs to the 
FtsK/SpoIIIE family and is downregulated only after 30 min of exposure to 
vancomycin. As V583 growth slows down and enters stationary phase with 
vancomycin exposure, it is correct to speculate that this gene is repressed while 
cell division process is ongoing and it might be induced later when the division 
process gets on the later stages. Despite the lack of knowledge on the activity of 
enterococcal Fts proteins our results evidence that cell metabolism shifts towards 
the synthesis of peptidoglycan and thus to the cell wall synthesis and assembly. 
The cell shape determining complex MreBCD also belongs to this 
morphogenic network and is ubiquitous in rod-shaped bacteria. MreB is a 
bacterial actin that forms dynamic filaments located beneath the cell membrane. 
MreC and MreD are both membrane-associated proteins. MreC interacts with 
MreD as well as with several of the high-molecular-weight murein synthases 
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(PBPs). mreC is an essential gene in B. subtilis (Lee & Stewart, 2003). Cells 
lacking sufficient quantities of MreC undergo morphological changes, namely, 
swelling and twisting of the cells, which is followed by cell lysis. mreC and mreD 
may be involved in the regulation of cell-shape-related protease expression. In E. 
faecalis we found that genes mreC (EF3062) and mreD (EF3061) were induced 
by vancomycin, and mreB is absent in E. faecalis. As described in the literature, 
mreB orthologs are present, almost exclusively, in species with cylindrical or 
helical shaped cells, and are usually absent in species with round-shaped cells 
(Margolin, 2003).  
 
ADAPTATIVE METABOLIC SHIFT DURING VANCOMYCIN EXPOSURE 
Some operons involved in specific metabolic pathways were affected by 
vancomycin exposure, which is the case of pyrimidine metabolism, mevalonate 
and citrate pathways. Figure 4 resumes some of the more relevant transcriptional 
changes observed at the metabolic level. 
An overall downregulation of enzymes involved in pyrimidine metabolism was 
observed after 30 minutes. The pyrimidine biosynthetic genes (pyr genes) have 
been found to constitute a single operon in a number of different gram-positive 
organisms including Bacillus subtilis (Quinn et al., 1991), Bacillus caldolyticus 
(Ghim & Neuhard, 1994), Enterococcus faecalis (Li et al., 1995), and 
Lactobacillus plantarum (Elagoz et al., 1996). The operon pyrRPBCaAaB and the 
genes pyrDII, pyrD-2 were downregulated at t30. pyrD-2, pyrE and pyrF genes 
were upregulated at t10. We found other genes related to pyrimidine pathways 
scattered on the chromosome of E. faecalis, namely pyrG coding for a CTP 
synthase (EF1147) and pyn gene that codes for a pyrimidine-nucleoside 
phosphorylase (EF0173), both of them downregulated (Figure 4). The de novo 
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pyrimidine biosynthetic pathway includes five enzymes that results in the 
production of UMP. The five enzymes are aspartate transcarbamoylase 
(EF1719), dihydroorotase (EF1718), dihydroorotate dehydrogenase (EF1714), 
orotate phosphoribosyltransferase (EF1712) and orotidine 5′-monophosphate 
decarboxylase (EF1713). This pathway is tightly regulated as it directly influences 
DNA metabolism, and thus replication. It is possible that aspartate is being 
directed to L-alanine synthesis for cell-wall through upregulation of L-aspartate 
beta-decarboxylase (EF1037) and thus does not enter the pyrimidine de novo 
synthesis pathway. The increased flux to L-alanine can thus provide enough 
substrate for the upregulated enzymes encoded by EF2658 and EF2150, 
responsible for L-alanine addition to UDP-MurNAc-pentapeptide, thus allowing an 
increase of substrates for the upregulated transglycosylase and transpeptidase 
activities (EF0746, EF0680, EF2476 and EF2857), and thus increase 
peptidoglycan synthesis. 
  
Isopentenyl diphosphate (IPP) is the building block of all isoprenoids in all 
forms of life (Doun et al., 2005). Isoprenoids participate in processes as diverse 
as cell-wall biosynthesis (Reusch, 1984), photosynthetic light harvesting (Johnson 
& Schroeder, 1996), lipid membrane structure, intracellular signalling and electron 
transport (Hedl & Rodwell, 2004). Synthesis of IPP can occur either by the 
mevalonate pathway or by the glyceraldehyde-3-phosphate-pyruvate, or non-
mevalonate, pathway (Doun et al., 2005). However, mevalonate pathway is the 
exclusive route to IPP synthesis in Gram-positive cocci (Wilding et al., 2000). 
Inhibitors directed against the enzymes of this pathway might serve as antibiotics 
against these pathogens (Doun et al., 2005), and there are evidences that 
mevalonate pathway knockout mutants have an attenuated virulence (Wilding et 
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al., 2000). Some of the genes coding for enzymes of the mevalonate pathway 
were induced in this work, namely EF0902 encoding for a phosphomevalonate 
kinase, EF0903 (mvaD) that codes for a mevalonate diphosphate decarboxylase 
and EF0904 (mvk) coding for a mevalonate kinase (Figure 4). They are only 
induced at t10, suggesting that they might be involved in an immediate, but 
transient, response to vancomycin exposure. In a transcriptomic study of the 
response of S. aureus to cell-wall active antibiotics (oxacillin, bacitracin and D-
cycloserine), the mevalonate pathway genes were also found to be induced. 
EF0902 is induced by oxacillin exposure and EF0904 is induced by bacitracin 
(Utaida et al., 2003). 
We have detected the downregulation of several genes coding for proteins 
involved in the citrate pathway - citCDEFX genes (EF3319-EF3322). We also 
found some genes that code for enzymes involved in glucose metabolism, namely 
EF1503 (codes for a fructose-1,6-biphosphate, putative), EF2646 (codes for a 
glycerate kinase, putative) to be downregulated.  
 
As mentioned in this discussion, many genes involved in metabolism have 
altered expression by the presence of the therapeutic dose of vancomycin. Figure 
4 resumes some of those genes and intends to support, together with this 
discussion, the hypothesis that in order for V583 to express full high-level 
vancomycin resistance (HLVR), many metabolic genes are activated/deactivated 
in order to help the vanB operon activated genes. We also suggest that there are 
some key metabolites which concentrations must be tightly regulated in order to 
achieve HLVR. HLVR appears to rely on increased cell-wall synthesis and 
modification and we believe that the metabolic fluxes in the cells are reorganized 
in order to help the cell to perform this. We suggest that acetyl-CoA, a key 
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metabolite, does not enter the citrate pathway and is thus fluxed into UPP 
synthesis, used for cell-wall synthesis. Two other key metabolites are D-frutose-
6P and GlcN-6P. Frutose-1,6-bophosphatase (EF1503) is highly downregulated 
at both 10 and 30 minutes after vancomycin addition. Its downregulation will 
enable D-frutose-6P to enter the glycolysis pathway to provide the cell with 
enough pyruvate for D-lactate production, by VanH (EF2295), which will be used 
for cell-wall synthesis by VanB (EF2294). Another enzyme downregulated at both 
10 and 30 minutes is GlmS (EF2151). Decreased activity of this enzyme, together 
with upregulation of nagA (EF3044) and nagB (EF0466), will direct the flux of 
GlcN-6P into D-frutose-6P and this in turn will feed glycolysis for pyruvate 
production and cell-wall synthesis by the vanB operon enzymes. nagA, nagB and 
glmS genes have also been identified as key genes controlling cell-wall synthesis 
in S. aureus and D-frutose-6P and GlcN-6P as key metabolites (Komatsuzawa et 
al., 2004). Our results also show that, together with the suggested tight regulation 
of carbon flux for cell-wall synthesis, amino acids also appear relevant in this 
reorganization of the cell metabolism and some nitrogen containing metabolites 
seem to have key roles in this process, namely aspartate, alanine, glutamine and 
glutamate. L-aspartate is fluxed into L-Ala synthesis, by both upregulation of 
EF1037 and downregulation of EF1719 (pyrB). This will likely provide cell-wall 
synthesis with L-Ala for production of UDP-MurNAc-pentapeptide. Both glutamate 
and glutamine play key roles in cell-wall synthesis in S. aureus (Cui et al., 2000). 
Glutamate is used for cell-wall pentapeptide synthesis and glutamine serves as 
the NH4+ donor in the amidation reaction of the iso-D-glutamate in the stem 
pentapetide of the murein monomer precursor and for the reaction catalyzed by 
GlmS, which converts D-frutose-6P to GlcN-6P. This reaction is likely 
downregulated in the presence of vancomycin and glutamine synthase (EF2159), 
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which converts glutamate into glutamine, is downregulated. All together, this 
suggests that glutamine pool is either reduced under vancomycin exposure or is 
being directed to glutamate synthesis by EF2560, which in turn is used for cell-
wall synthesis. It is also possible that amidation of muropeptides is changed by 
vancomycin. 
 
VANCOMYCIN EXPOSURE AFFECTS TRANSPORTER GENES 
Transport and binding proteins is another category of genes with major 
differences in expression. Several genes encoding transport and binding proteins 
are highly induced, namely EF1053 (10.2-fold), EF1054 (16.8 fold) both encoding 
for an ABC transporter, EF1304 encoding for a magnesium-translocating P-type 
ATPase (15.7-fold) and EF1814 encoding a drug resistance transporter (15.3 
fold). Some of the transport genes were downregulated such as EF0082 (a major 
facilitator ABC transporter), EF0760 and EF2649 (amino acid transporters). 
Interestingly, with exception for EF2649, all these transporter genes are only 
induced or repressed at t30 revealing that their induction is not a first line 
response to vancomycin exposure. Many of the transporters differentially 
expressed in this study are ABC transporters, which belong to MDR (multidrug 
resistance) superfamily of transporters (Lubelski et al., 2007). ABC transporters 
are membrane proteins responsible for the uptake and secretion of a wide range 
of substrates, from ions and small molecules such as amino acids, sugars, 
xenobiotics and vitamins up to polymers such as peptides, proteins, and 
polysaccharides. Due to their wide substrate range, ABC transporters have been 
implicated in a range of cellular processes such as nutrition uptake, xenobiotic 
protection, extrusion of cellular waste products, bacterial immunity and virulence, 
osmotic stress, lipid transport, and export of macromolecules during biogenesis, 
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differentiation and pathogenesis (Lubelski et al., 2007). Bioinformatic analysis of 
E. faecalis genome revealed the presence of 34 putative MDR transporters, 23 of 
which belong to the ABC transporters family. Systematic gene inactivation 
studies in E. faecalis confirmed  the involvement of ABC-type MDR transporters 
in drug resistance (Lubelski et al., 2007). We found 17 ABC-type transporters 
differentially transcribed under vancomycin exposure, 7 of which were induced. 
The role of ABC transporters in vancomycin resistance is however poorly 
understood.  
 
Genes encoding hypothetical and unknown functions proteins are the most 
representative groups of differentially expressed genes. In total 180 of these 
genes were differentially expressed under vancomycin exposure, corresponding 
to about 41% of the total number of genes found in this study. This finding reveals 
the limitations of the current understanding of genes involved in major bacterial 
processes. Many of these genes are located next to genes with homology to 
proteins with known functions and that were also differentially expressed in this 
study.  
 
There is no significative overlap between E. faecalis transcriptional profile 
under vancomycin exposure and the other transcriptomic studies involving 
exposure to stress conditions (Aakra et al., 2005; Solheim et al., 2007; Vebo et 
al., 2009; Aakra et al., 2010; Vebo et al., 2010). However, gelE is the only gene 
that presents the same behaviour under vancomycin and erythromycin exposure 
and growth in blood, being downregulated in the three conditions. The only other 
genes that are common to these three stress conditions, although with different 
behaviour, are dltA, dltB, croR, croS, and EF3245 encoding for a cell envelope 
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associated acid phosphatase with unknown substrate. It is likely that these genes 
might have a role in general stress response. The only genes common to 
vancomycin, erythromycin, bile salts and SDS exposure are EF2049 and EF2050 
encoding for an ABC transporter. There are two gene clusters that are 
differentially expressed under vancomycin and chloramphenicol treatment and 
exposure to bile salts and SDS, EF1491-EF1500 (V-type ATPase) and EF1712-
EF1721 (Pyr). The V-type ATPase gene cluster is induced with vancomycin, 
chloramphenicol, SDS and bile salts pointing the importance of optimal redox 
conditions in the treated/stressed cell cultures, as discussed by Solheim et al. 
(2007). The pyr operon is downregulated under vancomycin exposure but 
induced under exposure to chloramphenicol and bovine bile. 
Recently a study using a proteomic approach to evaluate the effects of 
vancomycin exposure was published (Wang et al., 2010). Only six genes were 
common to both studies which is reasonable since the design of the two 
experiments differs greatly, including the growth phase at which the cultures are 
sampled, the vancomycin concentration and the exposure period of time to 
vancomycin. 
 
We have described here a profile of transcriptional events that occur in V583 
cells treated with a therapeutic and with a subinhibitory dose of vancomycin. The 
response to the subinhibitory dose was restricted to vanB operon genes both in 
V583 and on its isogenic mutant V583∆vanB. However, under exposure to a 
therapeutic dose the transcriptional profile of V583 presents major changes. In 
this latter case, the genes that responded to vancomycin presence are not, for 
sure, all directly related to the resistance mechanism, but should correspond to 
adaptation to environmental changes. Some of the genes may be in fact relevant 
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for vancomycin susceptible enterococci tolerance to low vancomycin 
concentrations. 
It is logical to assume that E. faecalis vancomycin resistance and/or stress 
tolerance is a multi-factorial phenomenon, particularly because V583 differentially 
expressed genes found to have several distinct biological functions. Some of the 
processes which are induced or repressed are responding to vancomycin and 
may be general amongst enterococcal isolates, others are induced in order to 
support the cell in its full expression of resistance by providing the cell with what it 
needs to keep the vanB operon with substrate, other may even be consequences 
of all the two other categories. This suggests that multiple genes and pathway 
adjustment may be needed to give rise to the diverse changes, which would then 
together give rise to vancomycin resistance and/or tolerance (Figure 4). 
Vancomycin-induced changes occurred mainly at the level of transcription of 
genes encoding cell envelope proteins, transporters and regulatory proteins, 
suggesting that E. faecalis respond to vancomycin regulating a panoply of 
mechanisms by increasing the transcription of several regulators. It became clear 
with this work that expression of vancomycin resistance expression is the final 
product of an orchestrated expression and fine-tuning regulation of many genes 
and major metabolic pathways. The establishment of a vancomycin stimulon 
would constitute a valuable tool for antibacterial drug development with the 
recognition of new cellular targets. 
In V583, a vancomycin resistant strain, vancomycin stress response has little 
in common with other stress responses, both in the same and other E. faecalis 
strains, as obtained either by transcriptomic or proteomic approaches. It has also 
little in common with S. aureus vancomycin resistance mechanisms, although 
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some features of enterococcal vancomycin resistance overlap with previous 
studies on CESR. 
We believe that the fact that we are challenging a vancomycin resistant strain 
with the inducer of the resistance mechanism can account for the differences 
mentioned. Moreover, we believe that some of the observed changes in 
expression are required for the full activity, and thus full expression of resistance 
phenotype (high-level vancomycin resistance), of the vanB operon. In Figure 4 we 
show some of the key genes involved in metabolic pathways which we propose 
are crucial for sustaining the expression of high vancomycin resistance in V583. 
Further work is required to test and establish the role of these metabolic steps 
which we propose are key in vancomycin resistance expression, but not directly 
regulated by vanRBSB system. Thus it is likely that many regulators and other 
genes shown to be induced or repressed by vancomycin are in fact helping the 
vanB operon to fully fulfil its role. 
This work constitutes a valuable contribution to the knowledge of the 
transcription events that E. faecalis undergoes under stress, and hopefully could 
be used in future to elucidate the biology of this bacterium. 
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Supplementary Table S1. Average relative fold change of genes with differential expression 
profiles under 10 µg/ml vancomycin exposure, sorted by functional category  
 
Fold change Locus 
(a) 
Gene Descriptions Role (a) 
t10 t30 
EF0019 - PTS system, IIB component 
Signal transduction/Transport 
and binding proteins 
-2.5 NDE 
EF0020 - 
PTS system, mannose-specific 
IIAB components 
Signal transduction/Transport 
and binding proteins 
-2.7 NDE 
EF0021 - 
PTS system, mannose-specific 
IIC component 
Signal transduction/Transport 
and binding proteins 
-3.0 NDE 
EF0022 - 
PTS system, mannose-specific 
IID component 
Signal transduction/Transport 
and binding proteins 
-2.7 NDE 
EF0025 - membrane protein, putative Cell envelope -2.4 NDE 
EF0026 - conserved hypothetical protein Hypothetical proteins 3.3 5.5 
EF0028 - PTS system, IIBC components 
Signal transduction/Transport 
and binding proteins 
NDE -2.7 
EF0029 - aminotransferase, class II Unknown function NDE -2.5 
EF0032 - membrane protein, putative Cell envelope NDE 2.6 
EF0038 proB glutamate 5-kinase Amino acid biosynthesis NDE 3.1 
EF0043 gltX cytolysin regulator R1 Protein synthesis NDE 2.7 
EF0053 dnaQ 
DNA polymerase III, epsilon 
subunit 
DNA metabolism NDE 2.4 
EF0054 - hypothetical protein Unknown function -2.3 3.5 
EF0062 - 5-nucleotidase family protein 
Purines, pyrimidines, 
nucleosides, and nucleotides 
-3.1 -2.8 
EF0071 - lipoprotein, putative Cell envelope NDE 3.7 
EF0082 - 
major facilitator family 
transporter 
Transport and binding proteins NDE -6.7 
EF0083 - hypothetical protein Unknown function NDE -4.8 




Transport and binding proteins -2.2 NDE 
EF0124 - hypothetical protein Unknown function NDE -2.2 
EF0156 - conserved hypothetical protein Hypothetical proteins NDE -2.1 
EF0157 - conserved domain protein Hypothetical proteins NDE -2.1 
EF0171 adD adenosine deaminase 
Purines, pyrimidines, 






nucleosides, and nucleotides 
NDE -2.5 
EF0176 - basic membrane protein family Cell envelope NDE -2.5 
EF0177 - basic membrane protein family Cell envelope NDE -2.1 
EF0178 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE -2.5 
EF0179 - ABC transporter, permease Transport and binding proteins NDE -2.8 
Transcriptomic profile of Enterococcus faecalis V583 in response to vancomycin reveals 




ABC transporter, permease 
protein 
Transport and binding proteins NDE -2.8 
EF0248 - hypothetical protein Unknown function -2.0 NDE 




DNA metabolism 2.0 NDE 
EF0266 - chaperonin, 33 kDa Protein fate 2.2 NDE 
EF0267 - 
zinc-binding TIM-barrel protein, 
nifR3 family, putative 
Unknown function 2.5 NDE 
EF0292 - PTS system, IIC component 
Signal transduction/Transport 
and binding proteins 
NDE -3.3 
EF0305 - conserved domain protein Hypothetical proteins NDE -2.1 





and extrachromosomal element 
functions 
NDE -2.2 
EF0318 - conserved hypothetical protein Hypothetical proteins NDE -2.1 
EF0326 - conserved hypothetical protein Hypothetical proteins NDE -2.1 
EF0327 - hypothetical protein Unknown function NDE -2.4 
EF0329 - conserved hypothetical protein Hypothetical proteins NDE -2.5 
EF0361 - chitinase, family 2 Cell envelope NDE -5.6 
EF0365 - conserved hypothetical protein Hypothetical proteins NDE 2.1 
EF0366 - conserved hypothetical protein Hypothetical proteins NDE 2.1 




Unknown function NDE -2.5 
EF0376 - hypothetical protein Unknown function NDE 2.2 
EF0394 salB secreted antigen, putative Protein fate NDE -2.5 
EF0397 - conserved hypothetical protein Hypothetical proteins -2.0 NDE 
EF0402 nhaC-1 Na+H+ antiporter Transport and binding proteins NDE -2.6 
EF0411 - 
PTS system, mannitol-specfic 
IIBC components 
Signal transduction/Transport 







Amino acid biosynthesis/Energy 
metabolism 
NDE -2.7 
EF0428 - conserved hypothetical protein Hypothetical proteins NDE -2.3 
EF0429 - 
TRAP dicarboxylate 
transporter, DctP subunit 
Transport and binding proteins NDE -2.8 
EF0432 - 
transcriptional regulator, AraC 
family 
Regulatory functions -2.7 NDE 
EF0439 - 
immunity protein PlnM, 
putative 
Cellular processes NDE 2.6 
EF0443 - LysM domain protein Unknown function 3.5 4.2 
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EF0455 - PTS system, IIC component 
Signal transduction/Transport 








EF0468 - LemA family protein Unknown function NDE 5.7 
EF0469 - conserved domain protein Hypothetical proteins NDE 6.0 
EF0516 - membrane protein, putative Cell envelope -2.4 NDE 
EF0539 - 
phosphosugar-binding 
transcriptional regulator, RpiR 
family 
Regulatory functions 3.1 4.0 
EF0542 - conserved hypothetical protein Hypothetical proteins NDE 2.2 
EF0543 - membrane protein, putative Cell envelope NDE 2.4 
EF0554 - PTS system, IIB component 
Signal transduction/Transport 
and binding proteins 
NDE 2.2 




Cell envelope 4.6 9.5 
EF0562 - hypothetical protein Unknown function -2.6 NDE 
EF0574 - hypothetical protein Unknown function NDE 2.0 
EF0662 - conserved hypothetical protein Hypothetical proteins NDE 2.9 
EF0664 - hypothetical protein Unknown function NDE -7.1 
EF0680 - penicillin-binding protein 2A Cell envelope 4.0 5.9 
EF0692 - 
phosphosugar-binding 
transcriptional regulator, RpiR 
family, putative 
Regulatory functions 2.4 4.5 
EF0708 - conserved hypothetical protein Hypothetical proteins 3.6 4.0 
EF0711 - conserved hypothetical protein Hypothetical proteins NDE -2.2 
EF0713 - conserved hypothetical protein Hypothetical proteins NDE -2.9 
EF0714 - hypothetical protein Unknown function NDE -3.1 
EF0720 - 
voltage-gated chloride channel 
family protein 
Transport and binding proteins NDE -2.4 
EF0723 - hypothetical protein Unknown function NDE -2.2 




Cell envelope 8.5 13.2 
EF0747 - conserved hypothetical protein Hypothetical proteins 3.2 4.6 
EF0760 - 
amino acid ABC transporter, 
ATP-binding protein 
Transport and binding proteins NDE -2.3 
EF0783 oatA acyltransferase, putative Unknown function 2.9 3.2 
EF0789 - 
ABC transporter, ATP-binding 
permease protein 
Transport and binding proteins NDE -2.7 
EF0790 - 
ABC transporter, ATP-binding 
permease protein 
Transport and binding proteins NDE -2.3 
EF0802 - hypothetical protein Unknown function 19.3 26.3 
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EF0803 - conserved hypothetical protein Hypothetical proteins NDE -2.1 
EF0815 - PTS system, IIAB components 
Signal transduction/Transport 
and binding proteins 
NDE -2.7 
EF0816 - PTS system, IIC component 
Signal transduction/Transport 
and binding proteins 
NDE -4.4 
EF0817 - PTS system, IID component 
Signal transduction/Transport 
and binding proteins 
NDE -3.0 
EF0819 - conserved hypothetical protein Hypothetical proteins 4.0 6.6 
EF0833 - conserved hypothetical protein Hypothetical proteins NDE -2.7 
EF0844 - hypothetical protein Unknown function -2.5 NDE 




Transport and binding proteins NDE -2.8 
EF0901 - 
isopentenyl diphosphate delta 
isomerase, putative 
Biosynthesis of cofactors, 
prosthetic groups, and carriers 
2.4 NDE 
EF0902 - phosphomevalonate kinase 
Biosynthesis of cofactors, 







Biosynthesis of cofactors, 




EF0904 mvk mevalonate kinase 
Biosynthesis of cofactors, 




EF0932 - hypothetical protein Unknown function 3.4 7.6 
EF0953 - hypothetical protein Unknown function NDE -2.1 
EF0972 - 
DNA repair exonuclease family 
protein 
DNA metabolism 7.6 11.7 
EF1006 - conserved hypothetical protein Hypothetical proteins 2.9 3.7 
EF1012 - PTS system, IIB component 
Signal transduction/Transport 
and binding proteins 
-5.9 5.2 
EF1013 - PTS system, IIC component 
Signal transduction/Transport 
and binding proteins 
NDE -5.6 
EF1017 - PTS system, IIB component 
Signal transduction/Transport 
and binding proteins 
-6.3 7.0 
EF1018 - PTS system, IIA component 
Signal transduction/Transport 
and binding proteins 
-6.4 5.9 
EF1019 - PTS system, IIC component 
Signal transduction/Transport 
and binding proteins 
-3.7 4.5 
EF1035 - lipoprotein, putative Cell envelope NDE 1.8 
EF1036 - nucleoside diphosphate kinase 
Purines, pyrimidines, 





Amino acid biosynthesis 2.8 3.8 
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Unknown function 2.4 3.2 
EF1041 - 
xanthineuracil permease family 
protein 
Transport and binding proteins NDE -2.1 
EF1053 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE 10.2 
EF1054 - 
ABC transporter, permease 
protein 
Transport and binding proteins NDE 16.8 
EF1067 - hypothetical protein Unknown function NDE 3.6 
EF1097 - hypothetical protein Unknown function -7.1 -12.5 
EF1098 - conserved hypothetical protein Hypothetical proteins -2.0 NDE 
EF1102 - 
conserved hypothetical protein 
TIGR01655 
Hypothetical proteins NDE 3.2 
EF1103 - 
amino acid permease family 
protein 
Transport and binding proteins NDE -2.6 
EF1128 sgaB 
phosphotransferase enzyme II, 
B compnent SgaB 




Energy metabolism NDE 3.0 
EF1130 - 
hexulose-6-phosphate 
isomerase SgbU, putative 




Energy metabolism NDE 2.7 













Unknown function NDE -2.1 
EF1147 pyrG CTP synthase 
Purines, pyrimidines, 
nucleosides, and nucleotides 
NDE -2.6 
EF1149 recU recombination protein U DNA metabolism NDE 2.1 
EF1156 - 
transcriptional regulator, GntR 
family 









Cell envelope NDE -2.3 
EF1174 - hypothetical protein Unknown function NDE -2.8 
EF1179 cscK Fructokinase Energy metabolism NDE 2.5 
EF1192 - aquaporin Z Transport and binding proteins -2.6 NDE 
EF1198 - conserved hypothetical protein Hypothetical proteins 4.2 6.7 
EF1199 - conserved hypothetical protein Hypothetical proteins 3.9 5.9 
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Energy metabolism NDE -3.1 
EF1212 - transcriptional regulator Regulatory functions 2.2 5.1 




Regulatory functions NDE 4.6 
EF1228 - hypothetical protein Unknown function NDE 2.1 
EF1229 - conserved hypothetical protein Hypothetical proteins NDE 2.1 
EF1231 - conserved hypothetical protein Hypothetical proteins 29.8 49.3 
EF1241 - hypothetical protein Unknown function NDE -2.0 
EF1247 - conserved hypothetical protein Hypothetical proteins NDE -2.1 
EF1248 - hypothetical protein Unknown function NDE -2.5 







EF1261 - sensor histidine kinase Signal transduction NDE 2.2 
EF1262 - hypothetical protein Unknown function 3.0 3.2 
EF1263 - hypothetical protein Unknown function 3.0 3.4 




Transport and binding proteins 4.5 6.4 
EF1300 - 
cell division protein, 
FtsW/RodA/SpovE family 
Cellular processes NDE 7.6 
EF1301 - 
cell division protein, 
FtsW/RodA/SpovE family 




Regulatory functions 6.4 10.1 
EF1303 - 
transcriptional regulator, LysR 
family 








Amino acid biosynthesis 2.6 3.8 
EF1322 - conserved hypothetical protein Hypothetical proteins -2.2 NDE 
EF1339 - conserved hypothetical protein Hypothetical proteins 2.3 2.4 
EF1340 - 






sugar ABC transporter, 
permease protein 
Transport and binding proteins NDE -3.5 
EF1347 - glycosyl hydrolase, family 13 Energy metabolism NDE -2.9 




Transport and binding proteins NDE 2.6 
EF1357 - 
transcriptional regulator, AraC 
family 
Regulatory functions NDE 2.4 















Biosynthesis of cofactors, 








Biosynthesis of cofactors, 






biosynthesis family protein, 
putative 
Biosynthesis of cofactors, 
prosthetic groups, and carriers 
NDE -2.6 
EF1403 - conserved hypothetical protein Hypothetical proteins NDE 2.1 
EF1412 - conserved domain protein Hypothetical proteins NDE 3.7 
EF1415 gdhA glutamate dehydrogenase Amino acid biosynthesis NDE 2.6 
EF1449 - conserved hypothetical protein Hypothetical proteins NDE 2.9 
EF1486 ply-2 Endolysin 




EF1492 - V-type ATPase, subunit F 
Energy metabolism/Transport 
and binding proteins 
NDE 3.4 
EF1493 - V-type ATPase, subunit I 
Energy metabolism/Transport 
and binding proteins 
NDE 3.0 
EF1494 - V-type ATPase, subunit K 
Energy metabolism/Transport 
and binding proteins 
NDE 2.9 
EF1495 - V-type ATPase, subunit E 
Energy metabolism/Transport 
and binding proteins 
NDE 2.5 
EF1496 - V-type ATPase, subunit C 
Energy metabolism/Transport 
and binding proteins 
NDE 2.3 
EF1501 - hypothetical protein Unknown function NDE 2.9 




Energy metabolism -4.8 -9.3 
EF1518 - conserved hypothetical protein Hypothetical proteins 5.1 8.3 




Protein fate 2.4 3.0 




Amino acid biosynthesis NDE -2.5 
EF1567 aroK shikimate kinase Amino acid biosynthesis NDE -2.9 
EF1568 - prephenate dehydratase Amino acid biosynthesis NDE -2.4 
EF1569 psr 
transcriptional regulator, PSR 
protein 
Regulatory functions 2.3 2.4 
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EF1571 - hypothetical protein Unknown function 2.4 4.1 
EF1572 - hypothetical protein Unknown function 2.6 3.6 
EF1582 - 
major facilitator family 
transporter 
Transport and binding proteins NDE -2.9 
EF1587 - MutT/nudix family protein DNA metabolism 5.4 8.1 
EF1589 - acetyltransferase, GNAT family Unknown function NDE 3.2 
EF1591 - 
transcriptional regulator, AraC 
family 
Regulatory functions NDE 3.6 
EF1597 katA Catalaseperoxidase Cellular processes NDE 2.1 
EF1599 - 
TPR domain transcriptional 
regulator, Cro/CI family 
Regulatory functions NDE 2.2 




Energy metabolism NDE 2.4 
EF1644 - lacX protein, putative Unknown function 2.5 2.8 
EF1645 codY transcriptional regulator CodY Regulatory functions 2.2 2.6 
EF1646 hslU 
heat shock protein HslVU, 
ATPase subunit HslU 
Cellular processes 2.4 3.1 
EF1647 hslV heat shock protein HslV Protein fate 2.5 3.2 
EF1648 xerC 
site-specific recombinase, 
phage integrase family 
DNA metabolism 2.4 3.2 
EF1665 - conserved hypothetical protein Hypothetical proteins NDE 2.9 
EF1668 - 





EF1669 - glyoxylase family protein Unknown function NDE -2.5 
EF1672 - permease protein, putative Transport and binding proteins NDE 2.1 
EF1673 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE 2.6 
EF1685 hlyIII hemolysin III Cellular processes NDE 4.6 











nucleosides, and nucleotides 
2.1 NDE 
EF1714 pyrD-2 dihydroorotate dehydrogenase 
Purines, pyrimidines, 




electron transfer subunit 
Purines, pyrimidines, 




synthase, large subunit 
Purines, pyrimidines, 




synthase, small subunit 
Purines, pyrimidines, 
nucleosides, and nucleotides 
NDE -4.3 
EF1718 pyrC Dihydroorotase 
Purines, pyrimidines, 






nucleosides, and nucleotides 
NDE -4.1 
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EF1720 - uracil permease Transport and binding proteins NDE -4.1 
EF1721 pyrR 






EF1727 ebsa ebsA protein Cellular processes NDE 3.6 
EF1751 - membrane protein, putative Cell envelope NDE 2.7 
EF1752 - conserved hypothetical protein Hypothetical proteins NDE 2.6 
EF1753 - conserved hypothetical protein Hypothetical proteins 2.8 4.7 
EF1793 ilvE 
branched-chain amino acid 
aminotransferase 
Amino acid biosynthesis NDE 2.2 
EF1812 - hypothetical protein Unknown function 3.1 8.2 
EF1813 - sulfatase domain protein Unknown function 4.1 14.1 
EF1814 - 
drug resistance transporter, 
EmrB/QacA family protein 




transcriptional regulator, LysR 
family, putative 
Regulatory functions 3.3 9.2 
EF1817 sprE serine proteinase, V8 family Protein fate -5.0 -9.6 




EF1820 fsrC histidine kinase, putative Signal transduction -2.7 -2.9 
EF1821 fsrB agrBfs protein Unknown function -2.3 -2.9 




Energy metabolism NDE 2.2 
EF1833 - hypothetical protein Unknown function NDE 4.3 
EF1841 - HD domain protein Unknown function 2.9 5.4 
EF1906 - conserved hypothetical protein Hypothetical proteins NDE 2.8 
EF1912 - ROK family protein Unknown function NDE 2.5 
EF1947 - hypothetical protein Unknown function NDE 2.4 
EF1988 - hypothetical protein Unknown function NDE 4.7 
EF2018 - conserved hypothetical protein Hypothetical proteins NDE 2.5 
EF2047 - 
amino acid permease family 
protein 
Transport and binding proteins NDE -2.1 
EF2049 - 
ABC transporter, permease 
protein, putative 
Transport and binding proteins NDE 3.2 
EF2050 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE 4.0 
EF2067 - 
conserved hypothetical protein 
TIGR00481 
Hypothetical proteins 2.9 3.3 
EF2068 - 
multidrug resistance protein, 
putative 
Cellular processes/Transport 
and binding proteins 
2.6 NDE 
EF2125 - hypothetical protein Unknown function NDE -2.1 
EF2126 - hypothetical protein Unknown function NDE -2.2 
EF2127 - hypothetical protein Unknown function NDE -2.1 
Transcriptomic profile of Enterococcus faecalis V583 in response to vancomycin reveals 
bacterial support for full expression of high-level vancomycin resistance 
 189 
EF2128 - conserved hypothetical protein Hypothetical proteins NDE -2.0 
EF2132 - recT protein, putative 




EF2133 - hypothetical protein Unknown function NDE -2.4 
EF2135 - hypothetical protein Unknown function NDE -2.9 
EF2148 - hypothetical protein Unknown function NDE 2.3 











EF2152 - cobalt transport family protein Transport and binding proteins NDE -2.7 
EF2153 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins -2.0 -2.8 
EF2154 - conserved hypothetical protein Hypothetical proteins -2.1 NDE 
EF2159 glnA glutamine synthetase, type I Amino acid biosynthesis -3.6 NDE 
EF2160 glnR regulatory protein GlnR Regulatory functions -2.8 NDE 
EF2196 - 
glycosyl transferase, group 2 
family protein 
Cell envelope NDE 2.1 
EF2197 epaB 
glycosyl transferase, group 2 
family protein 
Cell envelope NDE 2.3 
EF2205 - conserved hypothetical protein Hypothetical proteins NDE 3.3 
EF2213 - PTS system, IIBC components 
Signal transduction/Transport 
and binding proteins 
-3.3 3.3 
EF2214 - glyoxylase family protein Unknown function 3.5 6.9 








Transport and binding proteins NDE 2.9 
EF2222 - 
ABC transporter, permease 
protein 
Transport and binding proteins NDE 4.9 
EF2223 - 
ABC transporter, permease 
protein 
Transport and binding proteins NDE 6.7 
EF2236 - conserved hypothetical protein Hypothetical proteins NDE -2.9 
EF2237 - lipoprotein, putative Cell envelope NDE -5.8 
EF2247 - transcriptional regulator Regulatory functions NDE -2.1 
EF2292 - hypothetical protein Unknown function 131.5 176.9 
EF2293 vanX D-alanyl-D-alanine dipeptidase Protein fate 129.5 123.9 
EF2294 vanB D-alanine-D-lactate ligase Protein fate 188.0 132.9 
EF2295 vanH 


























EF2303 - conserved hypothetical protein Hypothetical proteins NDE -2.5 
EF2307 - conserved hypothetical protein Hypothetical proteins NDE -2.3 
EF2317 - hypothetical protein Unknown function NDE -3.0 
EF2342 - hypothetical protein Unknown function NDE 2.1 
EF2355 clpB 
ATP-dependent Clp protease, 
ATP-binding subunit ClpB 
Protein fate NDE 2.1 
EF2377 - 
amino acid permease family 
protein 




Amino acid biosynthesis NDE 2.6 
EF2427 - hypothetical protein Unknown function 3.0 6.5 
EF2428 - 
transcriptional regulator, PadR 
family 
Regulatory functions 2.7 6.3 
EF2429 guaC GMP reductase 
Purines, pyrimidines, 
nucleosides, and nucleotides 
2.7 6.4 












Unknown function NDE -2.2 
EF2440 - celC-related protein Unknown function -3.3 NDE 
EF2441 - conserved hypothetical protein Hypothetical proteins -3.9 NDE 
EF2442 - 
phosphate transporter family 
protein 




Biosynthesis of cofactors, 






Cellular processes NDE 5.1 
EF2470 - HD domain protein Unknown function 3.6 4.0 




Unknown function NDE 2.1 
EF2484 - conserved hypothetical protein Hypothetical proteins NDE -2.5 
EF2485 cpsK 
ABC transporter, permease 
protein 
Transport and binding proteins NDE -2.6 
EF2486 cpsJ 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE -2.4 
EF2487 cpsI UDP-galactopyranose mutase Cell envelope NDE -2.2 
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EF2488 cpsH lipoprotein, putative Cell envelope NDE -2.5 
EF2489 cpsG MurB family protein Cell envelope NDE -2.3 
EF2490 cpsF conserved hypothetical protein Hypothetical proteins NDE -2.5 
EF2491 cpsE 
glycosyl transferase, group 2 
family protein 
Cell envelope NDE -2.4 
EF2492 cpsD 
glycosyl transferase, group 2 
family protein 










Biosynthesis of cofactors, 
prosthetic groups, and carriers 
2.2 3.1 
EF2500 - GcvH family protein Unknown function 2.1 2.5 
EF2502 - 
cell division protein, 
FtsW/RodA/SpoVE family 
Cellular processes 2.5 2.2 
EF2514 - hypothetical protein Unknown function NDE -2.3 
EF2519 - conserved hypothetical protein Hypothetical proteins -2.4 -2.2 
EF2520 - conserved hypothetical protein Hypothetical proteins NDE -2.6 
EF2521 - conserved hypothetical protein Hypothetical proteins NDE -2.5 
EF2524 - sortase family protein Cell envelope/Protein fate NDE -2.5 
EF2532 - hypothetical protein Unknown function NDE -2.7 
EF2533 - FtsK/SpoIIIE family protein Cellular processes NDE -3.1 
EF2539 - hypothetical protein Unknown function -2.2 -3.9 
EF2567 selD selenide, water dikinase Protein synthesis NDE -2.6 
EF2582 - chlorohydrolase family protein Unknown function NDE -4.2 
EF2585 - mur ligase family protein Cell envelope 2.6 2.9 
EF2586 - cobyric acid synthase, putative 
Biosynthesis of cofactors, 





Transport and binding proteins -3.2 NDE 
EF2627 - 
teichoic acid glycosylation 
protein, putative 
Cell envelope 2.2 3.1 
EF2643 - conserved hypothetical protein Hypothetical proteins 2.1 3.4 
EF2646 - glycerate kinase, putative Energy metabolism -2.4 NDE 






Transport and binding proteins -2.3 NDE 
EF2650 - 
spermidineputrescine ABC 
transporter, permease protein 
Transport and binding proteins -2.2 NDE 







Unknown function 2.6 NDE 
EF2692 - conserved hypothetical protein Hypothetical proteins NDE 2.2 
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EF2697 - conserved domain protein Hypothetical proteins NDE 3.0 
EF2698 - 
tellurite resistance protein, 
putative 
Cellular processes NDE 2.8 
EF2702 - hypothetical protein Unknown function NDE 4.0 
EF2703 - transcriptional regulator Regulatory functions NDE 11.6 
EF2711 - 
transcriptional regulator, AraC 
family 
Regulatory functions NDE 4.3 
EF2713 - 
cell wall surface anchor family 
protein 
Cell envelope -2.2 2.0 
EF2721 sdhB-2 
L-serine dehydratase, iron-
sulfur-dependent, beta subunit 














Unknown function 3.2 4.6 
EF2746 dltD dltD protein Cell envelope NDE 2.5 
EF2747 dltC D-alanyl carrier protein Cell envelope NDE 2.7 




Cell envelope NDE 3.4 
EF2750 dltX conserved hypothetical protein Hypothetical proteins 2.7 6.0 
EF2771 - conserved hypothetical protein Hypothetical proteins NDE 2.9 
EF2784 - conserved hypothetical protein Hypothetical proteins NDE 2.1 
EF2796 - hypothetical protein Unknown function NDE 3.6 
EF2828 - 
transcriptional regulator, ArpU 
family 
Regulatory functions/Mobile 
and extrachromosomal element 
functions 
NDE 2.6 
EF2829 - hypothetical protein Unknown function NDE 2.7 
EF2830 - hypothetical protein Unknown function NDE 2.7 
EF2831 - hypothetical protein Unknown function NDE 2.9 
EF2832 - conserved domain protein Hypothetical proteins NDE 2.7 
EF2851 - conserved hypothetical protein Hypothetical proteins -2.8 NDE 




Unknown function NDE 2.9 
EF2862 - conserved hypothetical protein Hypothetical proteins 5.0 7.1 
EF2891 - 
glycosyl transferase, group 1 
family protein 
Cell envelope NDE 2.2 




Unknown function NDE 2.0 
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EF2922 - conserved hypothetical protein Hypothetical proteins NDE 2.7 
EF2929 - membrane protein, putative Cell envelope 2.4 2.6 
EF2930 - conserved hypothetical protein Hypothetical proteins 2.4 NDE 
EF2965 - conserved hypothetical protein Hypothetical proteins -2.3 NDE 
EF2985 - permease, putative Transport and binding proteins NDE 2.7 
EF2986 - 
ABC transporter, ATP-binding 
protein 
Transport and binding proteins NDE 2.9 
EF2987 - conserved hypothetical protein Hypothetical proteins NDE 3.3 
EF3004 - 
sulfate transporter family STAS 
domain protein 
Transport and binding proteins NDE -3.9 
EF3008 - conserved hypothetical protein Hypothetical proteins -2.2 NDE 
EF3023 - polysaccharide lyase, family 8 Cellular processes NDE -4.0 
EF3029 - PTS system, IID component 
Signal transduction/Transport 
and binding proteins 
NDE -3.4 
EF3030 - PTS system, IIC component 
Signal transduction/Transport 








EF3052 - hypothetical protein Unknown function NDE 2.4 




Regulatory functions 2.8 4.1 
EF3059 - 
transcriptional regulator, TetR 
family 
Regulatory functions 2.7 3.8 
EF3061 mreD 
rod shape-determining protein 
MreD 
Cell envelope 2.4 3.1 
EF3062 mreC 
rod shape-determining protein 
MreC 
Cell envelope 2.3 2.5 
EF3084 - 
iron compound ABC 
transporter, permease protein 
Transport and binding proteins NDE -2.1 





Unknown function NDE -8.7 
EF3149 - conserved domain protein Hypothetical proteins NDE 2.1 
EF3150 - peptidase, M16 family Protein fate NDE 2.4 
EF3151 - conserved hypothetical protein Hypothetical proteins 2.4 2.5 
EF3173 - hypothetical protein Unknown function -2.4 NDE 
EF3175 - rrf2 family protein Unknown function NDE 2.3 
EF3176 - membrane protein, putative Cell envelope NDE 2.9 
EF3189 - hypothetical protein Unknown function NDE 2.5 
EF3201 - OsmC/Ohr family protein Unknown function NDE -2.6 
EF3202 rpsN-3 ribosomal protein S14 Protein synthesis 2.8 NDE 
EF3222 - hypothetical protein Unknown function NDE 2.1 
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EF3232 - hypothetical protein Unknown function -2.7 NDE 
EF3234 - lipoprotein, putative Cell envelope NDE 2.6 
EF3235 - gluconate kinase, putative Energy metabolism NDE 3.4 
EF3239 - conserved hypothetical protein Hypothetical proteins 2.3 3.3 
EF3244 - hypothetical protein Unknown function 14.0 13.2 
EF3245 - 
cell-envelope associated acid 
phosphatase 
Unknown function 10.9 10.1 
EF3250 - hypothetical protein Unknown function NDE -2.5 










EF3290 - sensor histidine kinase Signal transduction 3.6 3.8 
EF3302 - hypothetical protein Unknown function NDE 3.4 




Unknown function NDE -2.1 
EF3312 trmE 





EF3313 - hypothetical protein Unknown function NDE -2.0 
EF3316 - malic enzyme family protein Unknown function -2.7 -3.2 





Energy metabolism/Protein fate -2.8 -4.3 
EF3319 citF citrate lyase, alpha subunit Energy metabolism -2.7 -4.1 
EF3320 citE citrate lyase, beta subunit Energy metabolism -3.1 -4.9 
EF3321 citD citrate lyase, gamma subunit Energy metabolism -3.3 -5.5 
EF3322 citC citrate lyase ligase Energy metabolism/Protein fate -3.0 -5.7 
EF3323 - conserved hypothetical protein Hypothetical proteins -3.2 -6.3 
EF3324 - 
sodium ion-translocating 
decarboxylase, beta subunit 





decarboxylase, biotin carboxyl 
carrier protein 
Transport and binding 
proteins/Energy metabolism 
-3.9 -11.8 
EF3326 - conserved hypothetical protein Hypothetical proteins -5.1 -12.7 
EF3327 - citrate transporter Transport and binding proteins NDE -15.1 
EFA0067 - 
PTS system, IIABC 
components 
Signal transduction/Transport 
and binding proteins 
NDE 2.3 
(a)gene numbers refer to TIGR locus tags and role refers to TIGR annotation; NDE, not significantly 
differentially expressed. In different grey tones are highlighted the genes differentially expressed at t10 
and t30 from genes only expressed at one of the assayed time points. 
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All the experimental work was carried out by T. Ribeiro with exception of vanV 
mutant construction and its MIC determination that was performed by S. Santos. 
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ABSTRACT 
We have previously found that EF2292, annotated as a hypothetical protein 
in the E. faecalis V583 genome, was highly induced under vancomycin exposure. 
In the present work, we provide evidence of its co-transcription with 
vanYBWHBBXB genes. We also demonstrate that its expression is under the 
control of vanRBSB and propose to name it as vanV. This gene was found not to 
be required for vancomycin resistance and can code for another accessory 
protein in the vanB operon. vanV was detected only in some E. faecalis carrying 
the vanB operon, suggesting that this operon can have different composition 
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INTRODUCTION 
Vancomycin was clinically used for the treatment of severe infections caused 
by gram-positive bacteria for over 30 years before resistance was described 
(Courvalin, 1990). The first vancomycin resistant strain was isolated in 1986 in 
France (Leclercq et al., 1988) and since then vancomycin resistance has 
emerged among enterococcal strains. Resistance emergence together with the 
previous knowledge that this resistance was, in some cases, transferable 
(Leclercq et al., 1989; Nicas et al., 1997), led researchers to define the resistance 
mechanism. In 1990 the vanA gene was identified and found to encode for an 
inducible resistance protein designated by vanA, with D-Ala-D-Lac activity (Dutka-
Malen et al., 1990). A D,D-carboxypeptidase (later designated as vanY) (al-Obeid 
et al., 1990), that was not required for resistance (Arthur et al., 1992a; Wright et 
al., 1992), was found to be also induced by vancomycin and was detectable on 
the enterococcal membrane fractions. Later on, sequencing of another open 
reading frame adjacent to vanA gene on plasmid pIP816 has identified another 
protein induced by vancomycin, VanH, encoding a dehydrogenase and found to 
be required for resistance (Arthur et al., 1991). 
In 1992, vanR was described (Handwerger et al., 1992) and it was proved 
that the two-component regulatory system vanR-vanS activates a promoter and 
induces co-transcription of vanH, vanA, and vanX (encoding a D,D-dipeptidase) 
resistance genes (Arthur et al., 1992b; Reynolds et al., 1994). An additional gene 
was found to be present in vanA operon, vanZ, confers low-level resistance to 
teicoplanin by a yet unknown mechanism (Arthur et al., 1995). 
The vanB phenotype was described shortly after (Arthur & Courvalin, 1993; 
Evers et al., 1993). vanB cluster organization and functionality is similar to vanA, 
differing only in the fact that vancomycin, but not teicoplanin, is an inducer of this 
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cluster. The vanB operon proteins essential for expression of resistance, VanHB, 
VanB and VanXB, have a high level of sequence identity (67-76% identity) with 
the corresponding proteins of the vanA operon. The VanRBSB proteins that 
encode the two-component system are only distantly related to VanRS (34% and 
24% identity) (Evers & Courvalin, 1996).  
In both VanA- and VanB-type, resistance is due to synthesis of peptidoglycan 
precursors ending in the depsipeptide D-Ala-D-Lac instead of the dipeptide D-Ala-
D-Ala (Arthur et al., 1996). Both clusters possess the so-called accessory 
proteins, since they do not contribute to vancomycin resistance, as is the case of 
VanY and VanZ on the vanA cluster and VanYB and VanW on the vanB cluster. 
Only in enterococci there are, so far, eight resistance genotypes that involve 
related enzymatic functions. However, the resistance to glycopeptides is 
phenotypically and genotypically heterogeneous and can be distinguished based 
on the range of glycopeptides to which the strains are resistant, the resistance 
level, transferability, the organization of the corresponding genes and the mode of 
regulation of gene expression. Major advances in the understanding of the 
biochemical mechanisms and genetics of vancomycin resistance in enterococci 
have been achieved. However, the origin of the resistance genes, how they 
assembled together and the role of accessory proteins remains unclear and is a 
controversial scientific matter. 
In a previous transcriptomic study E. faecalis V583, a vanB-carrying strain, 
was exposed to vancomycin and EF2292, located immediately upstream of the 
vanXB gene from the vanB operon and presented the same levels of induction as 
the vancomycin resistance genes (Chapter 4). This finding lead us to ask if 
EF2292 is part of the vanB operon and if it has any role in vancomycin resistance. 
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In the present study the co-transcription of EF2292 with the vanB operon 
genes in E. faecalis V583 was evaluated by RT-PCR and Northern blot 
hybridization. In order to examine the potential role of ef2292 gene in vancomycin 
resistance, the gene was deleted and the resultant ef2292 mutant strain was 
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MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS  
This study was performed with E. faecalis V583. The strain was grown 
overnight in Brain Heart Infusion (BHI) medium, at 37°C. Culture was then diluted 
20 times and grown in BHI until an optical density of 0.4-0.45 at 600 nm was 
reached. Culture was split in two and vancomycin (Sigma) was added to one of 
the cultures to a final concentration of 10 µg/ml. The two cultures (BHI and BHI 
with vancomycin) were then further incubated, and 5 ml samples of each culture 
were collected 30 minutes after vancomycin addition. Samples were immediately 
suspended in RNA Protect solution (Qiagen) and centrifuged for 10 min at 4°C. 
 
RNA EXTRACTION 
Total RNA extraction was performed with RNeasy Mini columns (Qiagen). 
DNA digestion was done using 1 U of RNase-free DNase I (Roche) and 
incubating reactions at 37ºC for 1 hour. When necessary the DNA digestion was 
done twice. The RNA was cleaned up from DNase I using the RNA clean-up kit 
(Qiagen). Prior to PCR reactions DNA contamination of the RNA samples was 
assessed by a standard (30 cycle) PCR reaction with primers targeting a 
chromosomal E. faecalis gene.  
 
REVERSE TRANSCRIPTASE PCR (RT-PCR) 
In order to perform reverse transcriptase PCR, cDNA synthesis was prepared 
using Transcriptor High Fidelity cDNA Synthesis Sample (Roche) according to the 
manufacturer’s instructions and using 1 µg of RNA as template. PCR reactions 
were performed using the reverse primer for ef2292 and the forward primer for 
Identification of a new gene in vanB operon of E. faecalis 
 205 
each one of the other vanB operon genes, namely, vanYB, vanW, vanHB, vanB 
and vanXB. Primers are listed on Table 1.  
 
ANALYSIS OF mRNA BY NORTHERN BLOT 
For the Northern blot experiments 20 µg of each RNA sample was used to 
analyze ef2292 mRNA on a 1.2% agarose MOPS/formaldehyde gel. RNA was 
transferred to Hybond-N+ membrane (Amersham Biosciences) by capillarity using 
20× SSC as a transfer buffer.  RNA was UV cross-linked to the membrane. 
Different oligoprobes complementary to ef2292 mRNA, ef2292-vanX intergenic 
region, vanX and vanB mRNAs were designed. Single-strand DNA probes were 
labeled in the presence of [γ-32P]ATP (Perkin Elmer). All probes were purified on 
G50 Microspin columns (GE Healthcare). Hybridizations were carried out at 42°C 
with the PerfectHyb Plus Hybridization Buffer (Sigma). When appropriate, 
stripping of the membranes was done following standard protocols and 
membranes were re-hybridized with a different radiolabeled probe. Following a 
washing step, signals were visualized on a Phosphorimager STORM 860 (GE 
Healthcare). 
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Table 1 – Primers designed for RT-PCR and mutant construction, and oligoprobes designed for 
Northern-blot hybridization. 
 
Primer or probe* Sequence (5’→3’) 
Primers 
RT-PCR 
    Forward vanYB TGAATCATCACAAACGGCATA 
    Forward vanW ATGAACAGAAAAAGATTGACACAGC 
    Forward vanHB ACTGGGGGATATGACTGTGG 
    Forward vanB GCA CAT GGA GCG TAA CAA TAT CG 




    ef2292 internal fragment An internal fragment was amplified using a forward primer 
TCTGCTTTATTATGCGGGCG and a reverse primer 
GAATCAGCAGAGCAAGAACG (expected size of 282 bp) 
    ef2292 deletion Upstream fragment was amplified using TTCGGGCTGTGAGGTCGG 
and CCTTCAACGAAAACCCGAATCAAAGCAGATTCCATCAGCGC 
(expected size 1131 bp), and the downstream fragment was amplified 
using GATTCGGGTTTTCGTTGAAGG and 
TTTGAAGCAGGCGAGTTACC (expected size 1163 bp) 
     ef2292 deletion 
confirmation  
The primes ACGGAAGAACTAAACGCTGC and 
CCGAATGTCCTGTTTCAAGC were used to screen the mutant clones 
and confirm the deleted clones (1651†/1363‡) 
  
Probes 
     EF2292 CGCCCGCATAATAAAGCAGATTCCATCAGCGC 
     IR_EF2292/vanX CTGATGAAATACTAAGTAATTTGTAGCCAACTTATAC 
     vanX GGTTTTCCCGTGAAGTTATCCCATGTAGCGTAC 
     vanB CATGTTCCTCCGAGCAACCGCCGAAGATAATTGCGAC 
 
†expected size for the vanV wild type sequence; ‡ expected size for the deleted vanV; IR, intergenic 
region; * all the primers and probes used were designed for this study, except the forward primer for 
vanB gene (Dutka-Malen et al., 1995). 
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MUTANT CONSTRUCTION 
The markerless deletion mutant was constructed by double cross-over 
essentially as described previously (Brinster et al., 2007). Briefly, 5’ and 3’ 
flanking regions of the target gene were amplified from chromosomal DNA of 
V583 by PCR. The two PCR fragments were fused by PCR using the external 
primers and the resulting PCR fragment was cloned into the T/A cloning vector 
pGEM-T (Promega). The inserted PCR fragment was excised was subsequently 
cloned in pG+host9 plasmid (Maguin et al., 1996), which was then electroporated 
E. faecalis V583. The ef2292 double-crossover mutant was selected as described 
by Brinster et al. (2007). Successful target mutations were identified by PCR 
screening and confirmed by Southern blot analysis. All primers used are listed on 
Table 1. 
 
MUTANT PHENOTYPE CHARACTERIZATION 
To characterize the mutant phenotype the MIC value for vancomycin was 
determined by E-test (AB Biodisk) according to manufacturer´s instructions. E. 
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RESULTS AND DISCUSSION 
In the transcriptomic study from chapter 4, where E. faecalis V583 was 
exposed to a therapeutic vancomycin dose (10 µg/ml), EF2292, annotated as a 
hypothetical protein, was highly induced, with induction levels similar to those for 
vanB operon genes (Chapter 4). The EF2292 ORF is located immediately 
upstream of vanXB gene. Moreover, data from chapter 4 show that, under 
exposure to a subinhibitory vancomycin dose (0.3 µg/ml) on a V583 derivative 
strain and on a V583∆vanB deletion mutant, the only induced genes are the vanB 
operon genes (with exception of vanB itself) and ef2292 (Chapter 4). Taking 
together, the consistency of the induction results under vancomycin exposure and 
the chromosomal location of ef2292, underline our suspicion that EF2292 could 
be part of the vanB operon structure. 
 
CO-TRANSCRIPTION ANALYSIS 
It is widely described in the literature that VanRBSB regulatory system controls 
transcription of the vanRBSB and vanYBWHBBXB operons from the PRB and PYB 
promoters, respectively (Evers & Courvalin, 1996; Silva et al., 1998). To analyze 
the co-transcription of ef2292 with vanYBWHBBXB, transcripts were extracted after 
exposure to vancomycin and analyzed by RT-PCR. PCR reactions were 
performed using the reverse primer for ef2292 and the forward primer for each 
one of the other vanB operon genes, namely vanYB, vanW, vanHB and vanXB. All 
the searched transcripts were detected as shown in Figure 1, evidencing that 
EF2292 is co-transcribed together with the other vanB operon genes.  
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Figure 1. Agarose gel of the RT-PCR products corresponding to vanB operon transcripts 
extracted after 30 minutes of vancomycin induction. The transcripts were obtained using the 
reverse primer for ef2292 and the forward primer of each one of the other vanB operon genes (lanes 
1-6), lane 7 corresponds to 1 kb ladder (Invitrogene).  
 
Therefore, it is likely that ef2292 transcription occurs from the same promoter 
PYB. The co-transcription was observed also in vancomycin uninduced cell 
cultures (data not shown) indicating that, although described as inducible, the 
vanB operon genes also have, in vancomycin absence, a residual constitutive 
transcription level.  
 
Northern blot hybridization was performed to confirm the co-transcription of 
ef2292 with the remaining vanB operon genes. Oligoprobes complementary to 
different possible mRNA transcripts were designed, namely for ef2292, for the 
intergenic region between vanXB and ef2292, for vanB and vanXB genes (Table 
1). All the probes used hybridized on the same regions of the gel, corresponding 
to three different bands/transcripts. The transcript sizes were the expected, 
substantiating the existence of a single vanYBWHBBXBef2292 transcript as can 
been seen in Figure 2. The transcript with an approximate size of 4.6 kb most 
likely corresponds to a mRNA comprising vanYBWHBBXBef2292 genes. Another 
band with 3.0 kb, matches the vanHBBXBef2292 transcript size. PYB is the only 
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promoter described upstream of the vanB genes, it is reasonable to assume that 
the transcript is processed between vanW and vanHB transcripts. Finally, the third 
transcript, with approximately 2.0 kb, matches the size of the vanBXBef2292 
transcript. For all the oligoprobes used, this last mentioned transcript was the 
most abundant, suggesting that processing occurs between vanHB and vanB. 
Smaller transcripts were not detected under the experiment conditions. Either 
smaller transcripts are not present or were not detected. For detection of smaller 
transcripts a polyacrylamide gel Northern blot would be more appropriate. 
Regardless of the RNA processing events suggested by these results, 
Northern blot hybridization confirms ef2292 transcription together with the other 
vanB operon genes, all transcribed from the same promoter PYB.  
 
 
We know, from microarray experiments (data not shown) that in a vanR 
mutant none of the known vanB operon genes is induced by vancomycin, 
including ef2292. Taking all results together and considering the accepted 
definition of operon as a series of genes transcribed in a single mRNA, often 
identified by the presence of promoters and terminators, we propose a new vanB 
Figure 2.  Northern blot analysis. mRNA from vanB operon 
genes was detected using probes for EF2292, intergenic region 
between EF2292 and vanX, vanB and vanX. The sizes of the 
transcripts were estimated based on the HypperLadderI 
(Bioline). 
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operon constitution for E. faecalis V583 as represented on Figure 3 and to name 
ef2292 as vanV.  
 
 
Figure 3 – Proposal for the composition of the vanB operon of E. faecalis V853 including the 
vanV gene. Using online available software no promoter regions were predicted upstream of vanV 
(http://molbiol-tools.ca/Promoters). Using the predicted terminators tool (www.jcvi.org), there is a 
terminator downstream of EF2298 (vanSB), consistent with what is described in literature, but no 
terminators are predicted downstream of EF2293 (vanXB) nor EF2292 (vanV).  
 
vanV DISSEMINATION 
In order to determine whether vanV gene is present in other enterococcal 
strains we did a blast search against the 28 recently sequenced enterococcal 
genomes (Palmer et al., 2010). Among the newly sequenced genomes there are 
9 vancomycin resistant enterococcal (VRE) strains: 4 vanA+, 1 vanB+ and 4 
vanC+, including 2 E. faecalis, 3 E. faecium, 3 E. casseliflavus and 1 E. 
gallinarum. Only one positive match, with 100% of sequence homology, in the E. 
faecalis Merz96 genome was detected. This is a blood isolate containing the 
vanB operon (McBride et al., 2007). In Merz96, vanV is also located immediately 
upstream of the vanXB gene, revealing thus the same vanB operon structure as E. 
faecalis V583. 
We also searched for vanV, by PCR, in E. faecalis and E. faecium isolates 
containing vanA or vanB operons. Only two strains amplified fragments with the 
expected size: E. faecalis V582 (isolated from animal calf faeces) and E. faecalis 
DSMZ 12956 (isolated from peritoneal fluid) both carrying vanB operon. 
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Despite the limited number of strains screened by PCR and available 
genomes, we can venture to say that vanV is exclusively present in E. faecalis 
strains containing the vanB operon, but is not ubiquous among these strains. 
 
vanV ORIGIN 
In an attempt to understand the origin of vanV we did a blast search against 
vancomycin intrinsically resistant species (namely Lactobacillus, Pediococcus and 
Leuconostoc), the producer strain Amycolatopsis orientalis and the vancomycin 
resistance biopesticide Paenobacillus spp.. All these species produce 
peptidoglycan precursors that terminate in lactate and possess ligase genes with 
homologies with either VanA (Marshall & Wright, 1998) or VanB ligases 
(Handwerger et al., 1994; Patel et al., 2000; Guardabassi et al., 2005). No 
sequences similar to vanV were found, thus vanV does not seem to have origin in 
other genera. 
V583 was isolated in 1988 and Merz96 in 2002, which rules out a linkage 
with time of isolation. It is true that we have not tested strains isolated prior to 
1988 but we searched strains isolated in between this temporal space and the 
frequency is not high. Therefore, the origin of vanV remains to be clarified. 
 
vanV ROLE ON VANCOMYCIN RESISTANCE 
To know if vanV has a role on vancomycin resistance a deletion mutant 
V583∆vanV was constructed and the MIC of the mutant and the isogenic wild 
type strain was determined. V583∆vanV showed the same MIC as the wt V583, 
indicating that a deletion of vanV confers no phenotype related to vancomycin 
resistance. vanV is thus not required for vancomycin resistance as is the case of 
vanYB and vanW from the same operon. vanV thus adds to the gaps in the 
Identification of a new gene in vanB operon of E. faecalis 
 213 
current understanding of structure, function and role of some of the described 
proteins in van operons. It is described that operons can comprise functionally 
unrelated genes and that even conserved operons often undergo rearrangements 
and acquire new genes, although the mechanisms remain unclear (Price et al., 
2006). Price et al. (2006) defend that there is more likely the appending of a new 
gene to the end of a pre-existing operon instead of prepending a gene to the 
beginning, so the majority of genes retain the origin promoter instead of acquiring 
a new one (Price et al., 2006), which might be the case for vanV.  
 
vanV PUTATIVE CELLULAR FUNCTION 
According to KEGG database, vanV (EF2292) is a hypothetical protein with 
no paralogs on V583 genome. It has orthologs that correspond to other 
hypothetical proteins or to AraC family regulator proteins, mostly from Clostridium 
species. Members of AraC transcriptional regulator family have been 
characterized from a wide variety of prokaryotes including both Gram-negative 
and Gram-positive bacteria. The characteristic feature of this family is a 
conserved sequence of 99 amino acid, usually on the protein C-terminal end, that 
serves as the DNA-binding domain. Within this domain two helix-turn-helix (HTH) 
motifs are responsible for binding to adjacent major grooves that constitute the 
DNA-binding site (Gallegos et al., 1997). In addition, most members contain a 
domain responsible for dimerization and interaction with a ligand effector 
molecule (Gallegos et al., 1997). These proteins, primarily transcriptional 
activators, have three main regulatory functions, which are carbon metabolism, 
stress response and virulence and/or pathogenesis (Martin et al., 1999; Wood et 
al., 1999). Some regulators are involved in the response to stress conditions, 
such as oxidative stress, tolerance to antibiotics, organic solvents, heavy metals 
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and even in the transition from exponential growth to the stationary phase [(for 
review  see (Gallegos et al., 1997)]. Moreover, it has recently been demonstrated 
that two AraC-type ORFs encoded on enterococcal pathogenicity islands regulate 
Esp and are involved in biofilm formation (Coburn et al., 2008).  
Considering that vanV gene belongs to the vanB operon, as well as the fact 
that AraC family members are known to regulate virulence factors, antibiotic 
tolerance and stress response in other pathogens, we cannot rule out the 
possibility of a role of vanV in the regulation of genetic determinants related to 
these functions. However, vanV has no common motifs with AraC family of 
bacterial regulators, namely no HTH motifs, which weaknesses this hypothesis. 
 
This work intends also to call attention to how much remains to be learned 
about these hypothetical and unknown function proteins. They definitely constitute 
a challenge and the characterization of such proteins will allow a better 
understanding of biological systems. 
Further work on vanV gene and protein is under way and will yield 
information regarding the role of this hypothetical protein.  
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ABSTRACT 
VanRS is the sole two-component system (TCS) involved in resistance to 
vancomycin. However, we tested several mutants in E. faecalis response 
regulators of TCSs and found that both croR and err06 V583 mutants were 
susceptible to vancomycin, in spite of the presence in V583 of an intact vanB 
operon. In order to understand the role of those TCSs in vancomycin 
response/resistance, we performed RT-PCR experiments, using croR and err06 
mutants in V583 and JH2-2, and measured the induction of those genes and 
vanB genes in response to vancomycin. Relevance of CroRS in VanA type of 
resistance was evaluated using JH2-2 and its croR deletion mutant 
complemented with pAT80. CroRS and TCS06 both responded to vancomycin, 
regardless of the presence of vancomycin resistance gene cluster. In the absence 
of croR gene, vanA+ JH2-2 was susceptible to vancomycin. CroRS was found to 
be needed for VanRS induction and for TCS06 induction by vancomycin. CroRS 
is likely sensing the vancomycin cell-wall perturbation and its induction probably 
triggers or provides the signals for vancomycin induction of both VanRS and 
TCS06. As TCS06 has been reported to respond to oxidative stress response and 
CroRS to cell-wall perturbations, the known link between cell-wall stress and 
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INTRODUCTION 
Two-component systems utilize the phosphotransfer cascade to alter specific 
gene expression profiles (West & Stock, 2001) and have been linked to tolerance 
and resistance to cell-wall active agents, namely resistance to β-lactams in 
Listeria monocytogenes (CesRK) (Kallipolitis et al., 2003), tolerance to 
vancomycin (VncSR) (Novak et al., 1999) and resistance to  β-lactams (CiaHR) in 
Streptococcus pneumoniae (Giammarinaro et al., 1999), and resistance to 
bacitracin in Bacillus subtilis (LiaSR, formerly YvqEC) (Mascher et al., 2003). 
Many aspects of bacterial physiology are under the control of TCSs (for review 
see Stock et al., 2000; Stortz & Hengge-Aronis, 2000; Hoch & Varughese, 2001). 
In Enterococcus faecalis, the primary form of vancomycin resistance is provided 
by expression of vancomycin-inducible gene cluster regulated by a TCS.  
The mechanism of high-level vancomycin resistance in enterococci is well 
understood and the more widely spread form of resistance is mediated by van 
genes which results in the generation of D-alanyl-D-lactate muropeptide stem 
termini in peptidoglycan precursor molecules, for which vancomycin has a binding 
affinity that is several orders of magnitude lower than that for the normal D-alanyl-
D-alanine termini. In vanB operons, expression of the vanYBWHBBXB resistance 
genes is controlled by vanRBSB genes, which encode a two-component regulatory 
system (Arthur et al., 1992). The regulator and resistance genes are transcribed 
from promoters PRB and PYB, respectively, which are coordinately regulated 
(Depardieu et al., 2003; Depardieu et al., 2005). In the presence of vancomycin, 
the membrane-bound VanSB sensor phosphorylates the cytoplasmic VanRB 
response regulator which then enhances the transcriptional activation of both the 
vanRBSB regulatory and vanYBWHBBXB resistance genes (Arthur et al., 1992). 
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Some E. faecalis TCSs have been shown to be involved in virulence (Teng et 
al., 2002), biofilm formation (Hancock & Perego, 2004a), intrinsic antibiotic 
resistance (Comenge et al., 2003; Hancock & Perego, 2004a), and/or stress 
responses (Teng et al., 2002; Comenge et al., 2003; Le Breton et al., 2003; 
Hancock & Perego, 2004b). E. faecalis V583, carrying the vanB operon, if 
impaired in the enterococcal response regulator err05, becomes susceptible to 
vancomycin (Hancock & Perego, 2004b). This finding suggests that E. faecalis 
has other sensing and responding pathways to vancomycin which, if knocked-
down, do not allow vanB genotype to fully express the respective high-level 
resistance phenotype, and that TCS05 is somehow involved in vancomycin 
resistance. The E. faecalis TCS05, also referred as CroRS (“ceftriaxone 
resistance”) or Err05-Ehk05 (Hancock & Perego, 2004b), was proposed to be part 
of the E. faecalis core genome (McBride et al., 2007). CroRS system is composed 
of the transmembranar CroS sensor histidine-kinase and the OmpR-family CroR 
response regulator. Its physiological role remains unclear although last decade 
studies have shown that CroRS is required for intrinsic β-lactam resistance 
(Comenge et al., 2003). CroR deletion resulted in a 4000-fold increase in 
susceptibility to ceftriaxone, a third-generation cephalosporin (Comenge et al., 
2003). A croR mutant was also significantly more sensitive to bacitracin, other 
second- and third-generation cephalosporins, such as cefuroxime and 
cefotaxime, vancomycin (Hancock & Perego, 2004b), fosfomycin, D-cycloserine, 
moenomycin and ramoplanin (Comenge et al., 2003), indicating a more general 
role of this TCS in enterococcal cell envelope stress response. Two target loci, 
encoding a secreted protein, SalB (previously referred to as SagA) (Le Breton et 
al., 2003), and a putative glutamine/glutamate ABC transporter GlnQHMP (Muller 
et al., 2006; Le Breton et al., 2007) have been recently identified as regulated by 
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CroRS. Recently, in two transcriptomic studies, CroRS was also shown to be 
induced by bovine bile and sodium dodecyl sulfate (Solheim et al., 2007) and by a 
therapeutic dose of vancomycin (Chapter 4). A croR mutation led to significant 
growth defects and alterations in cell morphology in E. faecalis JH2-2 strains (Le 
Breton et al., 2003) although no growth defect were observed in E. faecalis V583 
croR mutant (Hancock & Perego, 2004b). The signal recognized by CroS remains 
unknown, but evidence suggests that it could be related to cell wall perturbations 
(Comenge et al., 2003).  
 
We have recently used a microarray transcriptomic approach, based on E. 
faecalis V583 whole-genome, and exposed the vancomycin resistance E. faecalis 
V583 strain to a therapeutic dose of vancomycin (10 µg/ml) (Chapter 4). We 
found three TCSs induced under the conditions tested, namely VanRS (Err11-
Ehk11), which regulates the expression of the vanB operon, CroRS (Err05-
Ehk05), and Err06-Ehk06 (Chapter 4). Little is known about TCS06 (Err06-
Ehk06). Err06-Ehk06 is present in different E. faecalis strains (McBride et al., 
2007) and Err06 belongs to the OmpR-family. Ehk-Err06 has homology to the B. 
subtilis YclKJ system, which is known to be activated under oxygen limitation 
(Kobayashi et al., 2001; Hartig et al., 2004). In E. faecalis JH2-2 strain, TCS06 
has been implicated in response to oxidative stress and in expression of the 
catalase gene (kat) (Muller et al., 2008). Mutants in E. faecalis err06 were shown 
to be more susceptible than the wild-type to heat and SDS (Hancock & Perego, 
2004b) and more sensitive in macrophages (Muller et al., 2008). 
In summary, recent findings show that in the absence of an active CroR, 
high-level vancomycin resistance phenotype is not expressed in a vanB resistant 
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strain, such as V583, and that there are two TCS is V583 which respond to 
vancomycin, namely CroRS and TCS06.  
 
We thus decided to further analyze the role of CroR in vancomycin resistance 
by answering the question: why does the inactivation of croR turns a vancomycin 
resistant strain into a vancomycin susceptible strain? Could it be because the 
vancomycin resistance genes are less induced by vancomycin in the croR 
mutant? To address this question, we used a croR insertional mutant in V583 
(Hancock & Perego, 2004b) and compared the expression of vancomycin 
resistance genes in the wt V583 and in the croR mutant. In order to see if CroR 
has also a role in VanA carrying strains, we introduced pAT80 plasmid (Arthur et 
al., 1992) into wild-type E. faecalis JH2-2 and in its isogenic croR deletion mutant 
and looked for differences in MIC for vancomycin. We also investigated the ability 
of vancomycin to induce CroRS and TCS06 in a vancomycin susceptible strain, 
JH2-2. By doing this, we wanted to know if induction of CroRS and TCS06 was 
independent of the presence and expression/induction of VanRS and its regulated 
genes. TCS06 has not been associated to cell-wall stress. We questioned if 
TCS06 induction could be dependent on a cell-wall responsive two-component 
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MATERIALS AND METHODS 
BACTERIAL STRAINS  
Strains used in this study are listed in Table 1. Plasmid pAT80 (Arthur et al., 
1992) (Table 1) was introduced into E. faecalis JH2-2 and JH2-2∆croR cells by 
electrotransformation. Transformants were selected in media containing 50 µg/ml 
vancomycin (Sigma). 
 
Table 1 – Strains and plasmids used on this study 
Strains and 
Plasmids 
Relevant characteristics Reference 
Strain   
V583::tet Insertion mutant of V583 (clinical isolate, VaR) 
with p3TET inserted between ehk02 and the 
adjacent open reading frame encoding a putative 
lipoprotein 
(Hancock & Perego, 2004b) 
V583croR::tet err05 (croR) insertion mutant of V583, TetR (Hancock & Perego, 2004b) 
V583erro6::tet err06 insertion mutant of V583, TetR (Hancock & Perego, 2004b) 
JH2-2 FusR RifR, clinical isolate derived strain, plasmid 
free 
(Jacob & Hobbs, 1974) 
JH2-2∆croR croR deletion mutant of JH2-2 (Le Breton et al., 2003) 
JH2-2∆err06 err06 deletion mutant of JH2-2 (Le Breton et al., 2003) 
SAVE 9 JH2-2/pAT80 This study 
SAVE 11 JH2-2∆croR/pAT80 This study 
   
Plasmid   
pAT80 PRvanRSPHHAXcat (Arthur et al., 1992) 
 
RNA EXTRACTION  
Growth was done overnight in Brain Heart Infusion (BHI) medium (Oxoid), at 
37°C. Cultures were then diluted 20 times and grown in BHI until an optical 
density of 0.4-0.45, at 600 nm, was reached. Culture was split in two, and 
vancomycin (Sigma) was added to one of the cultures to a final concentration of 
0.1 µg/ml, 3 µg/ml and 10 µg/ml. The split cultures (BHI and BHI plus 
vancomycin) were then further incubated, and 5 ml samples of each culture were 
collected 30 minutes past vancomycin addition. Samples were immediately 
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suspended in RNA Protect solution (Qiagen) and centrifuged for 10 min at 4°C. 
Total RNA extraction was performed with RNeasy Mini columns (Qiagen). DNA 
digestion was done using 1 U of RNase-free DNase I (Roche) at 37ºC for 1 hour. 
RNA was cleaned up from DNase I using the RNA clean-up kit (Qiagen). Prior to 
PCR reactions DNA contamination of the RNA samples was assessed by a 
standard (30 cycle) PCR reaction with primers targeting a chromosomal E. 
faecalis gene.  
 
REVERSE TRANSCRIPTASE PCR (RT-PCR) 
In order to perform reverse transcriptase PCR, cDNA synthesis was 
performed using Transcriptor High Fidelity cDNA Synthesis Sample (Roche) 
according to the manufacturer’s instructions and using 1 µg of RNA as template. 
Semi-quantitative RT-PCR was done from serial cDNA dilutions, assuming that 
intensity of PCR product bands correlates to the amount of cDNA, and thus to the 
amount of template mRNA. 16S rRNA was used as a control. 
 
MIC DETERMINATION 
MIC values for vancomycin were determined by E-test (AB Biodisk) 
according to manufacturer´s instructions. E. faecalis DSMZ 2570 was used as a 
control strain.  
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RESULTS AND DISCUSSION 
The current knowledge points to vanRS as the only two-component system 
known to confer resistance to vancomycin, although croRS has been previously 
shown to be induced by vancomycin (Comenge et al., 2003). Moreover, previous 
microarray experiments (Chapter 4) revealed that, besides VanRS and CroRS, 
TCS06 was also induced when E. faecalis V583 was exposed to 10 µg/ml of 
vancomycin. We determined the vancomycin MIC values for V583croR::tet and 
V583err06::tet insertional mutants in E. faecalis V583 genetic background and we 
found that both mutants presented a significant decrease in MIC value for 
vancomycin compared to the resistant wild-type strain (Table 2). JH2-2 also 
presented a lower MIC for vancomycin if either croR or err06 were deleted. These 
findings suggest that both CroRS and TCS06 also play a role in vancomycin 
resistance and raise two questions: are croRS and err06-ehk06 responding 
directly to vancomycin, or indirectly by sensing changes induced by the vanB 
operon induction? Why are V583croR::tet and V583err06::tet mutants susceptible 
to vancomycin, even in the presence of a fully functional vanB operon? 
 
Table 2. MIC values for vancomycin of E. faecalis V583 and JH2-2 and their derivative mutants 
in croR and err06 genes.  
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BOTH CroRS AND TCS06 RESPOND TO VANCOMYCIN IN A 
CONCENTRATION DEPENDENT WAY 
CroRS and Err06-Ehk06 systems may be induced by vancomycin either 
directly or indirectly by other gene(s) which expression is directly affected by 
vancomycin. In order to test if croRS and err06 respond directly to vancomycin 
and are not responding to any changes induced by the presence of vanB genes, 
we evaluated the expression of these two TCSs in a susceptible strain, JH2-2. 
This strain has intact CroRS and TCS06 systems and carries no vancomycin 
resistance genes. Vancomycin doses used were 0.1 µg/ml, corresponding to 
nearly 3% of the MIC, 3 µg/ml which is the MIC value of JH2-2, and 10 µg/ml 
which is the therapeutic dose for which croRS and err06-ehk06 induction was 
previously observed (Chapter 4). In E. faecalis JH2-2 strain both croR and croS 
were induced when exposed to vancomycin and induction levels correlate with 
vancomycin concentration, increasing with the increase of the antibiotic 
concentration (Figure 1A). This observation demonstrates that croRS is induced 
by vancomycin directly and not by any cascade events following vanRS induction, 
as JH2-2 does not have vanRS. Similar behavior was observed for TCS06, which 
also sensed vancomycin directly (Figure 1B). 0.1 µg/ml of vancomycin was 
enough to induce both TCS systems in JH2-2, MIC value - 3 µg/ml.  Comenge et 
al. (2003) tested vancomycin concentration ranging from 0.01 to 5 µg/ml and have 
shown that the maximum induction was achieved with 2 µg/ml (Comenge et al. 
2003). Here we show that at least until the MIC value for JH2-2 (3 µg/ml) 
induction is constant and shows a significant increase if a therapeutic dose (10 
µg/ml) is used, in both TCSs tested. 
 
 











Figure 1. Semi-quantitative RT-PCR of JH2-2, A) croR and croS and B) err06 and ehk06 transcripts, 
after 30 min exposure to different vancomycin concentrations. 
 
 
CroRS IS NEEDED FOR INDUCTION OF vanB AND vanA CLUSTERS 
Expression levels of some vanB operon genes, namely vanRB, vanSB, vanB 
and vanXB, in V583::tet and V583croR::tet strains were compared in cells grown 
in BHI and in BHI supplemented with 10 µg/ml of vancomycin. The aim was to 
know if vancomycin susceptibility in V583croR::tet strain was due to a lower 
induction of vanB genes by vancomycin. In the absence of vancomycin, vanB 
operon genes showed similar levels of expression in both V583::tet and 
V583croR::tet strains (Figure 2). In the presence of 10 µg/ml of vancomycin, 
vanRS genes showed the same induction levels in V583croR::tet strain as found 
for the same strain in the absence of vancomycin. This finding suggests that 
CroRS is needed for induction of vanRS genes by vancomycin. VanB and vanX 
genes were induced by vancomycin in both strains, although reaching higher 
levels of expression in V583::tet strain. This fact is likely contributing to the low 
MIC value of V583croR::tet strain and supports the role and involvement of 
CroRS system in induction of vanB genes by vancomycin.  
 
A B
0 µg/ml 0 µg/ml
1:100   1:10     1
[Va]
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Figure 2. Semi-quantitative RT-PCR of vanRB, vanSB, vanB and vanXB genes in V583::tet and 
V583croR::tet strains after 30 minutes exposure to 10 µg/ml vancomycin. 
 
Although the semi-quantitative RT-PCR experiments were repeated twice 
and gave similar results, this technique does not allow a precise quantitative 
analysis of induction levels of vanB genes. Therefore, in order to confirm the role 
of CroRS in vanRS induction by vancomycin, we used another approach. JH2-2, 
which carries CroRS but not VanRS, and its croR mutant, were transformed with 
pAT80 plasmid (Arthur et al., 1992). pAT80 carries the vanRASAHAAXA genes and 
is able to confer vancomycin resistance in JH2-2 host (Arthur et al., 1992).  
 
SAVE 9 strain was resistant to vancomycin (MIC >256 µg/ml), as expected. 
However, SAVE 11, although carrying the same pAT80 of SAVE 9 strain, was 
susceptible to vancomycin (MIC was 4 µg/ml). This result obtained for vanA type 
of resistance confirms our findings with vanB type of resistant and reveals that 
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CroRS MEDIATES TCS06 RESPONSE TO VANCOMYCIN 
TCS06 has been implied in response to oxidative stress and in the 
expression of the catalase gene (kat) (Muller et al., 2008) in E. faecalis JH2-2. 
Mutants in err06 gene were shown to be more susceptible than the wild-type to 
heat and SDS (Hancock & Perego, 2004b) and more sensitive in macrophages 
(Muller et al., 2008). Our findings show that TCS06 responds to vancomycin and, 
although the mechanism remains unknown, it is evident that it plays a role in 
resistance to vancomycin. We have shown that CroRS is also involved in 
vancomycin resistance and that its presence is essential for high induction of 
vancomycin resistance genes in E. faecalis. Previous works have already 
attributed a role for CroRS in response to cell-wall perturbations. We thus asked if 
CroRS could be the linker between cell-wall perturbations and TCS06 induction, 
as this system had never been correlated with cell-wall stress. 
 
We decided to test the expression levels of err06 and ehk06 genes in JH2-
2∆croR strain, under exposure to vancomycin. JH2-2∆croR strain has no vanRS 
and no croR. Results are shown in Figure 3. Both err06 and ehk06 genes 
responded to vancomycin lowest concentration, 0.1 µg/ml. However, further 
induction was not observed for higher vancomycin concentrations, and was 
absent when therapeutic vancomycin dose was used. Comparing these results 
with the ones shown in Figure 1B, obtained with JH2-2, which harbors an active 
CroRS system, we are lead to conclude that the presence of an intact CroRS 
system is essential for vancomycin induction of the TCS06 system. It is likely that 
CroRS senses the cell-wall perturbations induced by vancomycin and in turn 
induces, directly or indirectly, TCS06 expression. The link between these two 
TCSs suggests a link between cell-wall and oxidative stresses, which has been 
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already established, and provides clues for further studies involving the cross-talk 




Figure 3. Semi-quantitative RT-PCR of err06 and ehk06 genes in JH2-2∆croR strain after 
30 minutes of exposure to vancomycin. 
 
There is a restrict understanding of the signals/ligands sensed by well-
characterized histidine kinases, reflecting a drawback in the understanding of this 
systems. For example, VanRS is the best studied enterococcal TCS however, the 
signal to which vanS responds and initiates the phosphorylation cascade is not 
yet clearly identified. It is likely that these three TCSs (VanRS, CroRS, Err06-
Ehk06) may be part of a regulatory network since they all present a common 
phenotype towards vancomycin resistance.  
It is still unknown which array of genes are controlled and which expression is 
dependent on each of these three TCSs. We previously determined the set of 
genes that are differentially transcribed under treatment with a therapeutic dose of 
vancomycin. It would be interesting to determine the stimulons of CroRS and 
TCS06 systems using vancomycin as a triggering signal and compare them in 
order to find the common features. This can be a case of overlapping stimulons 
when using vancomycin as the signal. Given the important functions that have 
been attributed to the already characterized enterococcal TCSs, it is likely that 
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some of the uncharacterized systems have interesting roles in antibiotic 
resistance.  
 TCSs responding to vancomycin are widely described in Gram-positive 
bacteria. However, as opposite to what is described for enterococci, for other 
Gram-positive bacteria vancomycin is not the only and exclusive signal and most 
bacteria have more than one TCS able to respond to vancomycin presence. For 
enterococci, VanRS is the only TCS described, so far, as responding to 
vancomycin and moreover no other signal has been described to trigger VanRS 
system. This study is the first where other enterococcal TCSs are reported as 
responding to vancomycin. 
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ABSTRACT 
In a previous study we have found that vancomycin susceptible enterococci 
carrying vanA and vanB genes were able to grow in the presence of vancomycin 
concentrations above their MIC value, if grown in increasing vancomycin 
concentrations. We now reproduced these experiments using strains with a 
known genetic background derived from Enterococcus faecalis V583. For control, 
we used also OG1-RF, JH2-2 and DSMZ 2570 which are all vancomycin 
susceptible strains and bear no genes related to vancomycin resistance. Serial 
transfer passages in two-fold increasing concentrations and in subinhibitory 
concentrations of vancomycin were performed. Only strains impaired in one gene 
relevant for vancomycin resistance or response were able to become high-level 
resistant, in both adaptation processes. Moreover, ten serial passages in drug-
free media were not able to revert the acquired resistance phenotype. PFGE of 
adapted resistant cultures showed that no chromosomal rearrangements 
occurred during adaptation. High throughput sequencing of the V583∆vanB 
mutant also revealed that the mechanism involved in adaptation does not rely on 
mutations. Whether this stable and reproducible phenotypic alteration is a 
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INTRODUCTION 
The propensity of different antibiotics to select for resistant bacteria in an 
initially susceptible population can be examined by repeated subculture of 
bacteria in subinhibitory concentrations. The subinhibitory antibiotic concentration 
is increased as the MIC increases. This procedure tests the ability of the 
organism to adapt to antibiotics in its environment, presumably in incremental 
steps, and ultimately become resistant to the maximum antibiotic levels 
achievable with standard dosing. 
The general mechanism by which bacteria develop resistance through serial 
passages in presence of antibiotics is acquisition or accumulation of point 
mutations. However, several studies suggest that the observed phenomena of 
reduced susceptibility may be due to different mechanisms, and may be strain 
and antibiotic dependent. In a recent study by Schmidt et al. (2010) the authors 
succeeded in generating an S. aureus strain with reduced susceptibility to 
ramoplanin (Schmidt et al., 2010). In this case the resistance mechanism was 
similar to that observed in VISA strains, with increased cell wall material and 
reduced autolytic enzyme activity. Like in VISA-type resistance, induction of 
resistance by serial passages in ramoplanin most likely arises from multiple 
mutations in many loci by a gradual adaptative process (Howden et al., 2008, 
Neoh et al., 2008, Cui et al., 2009). Resistance to linezolid is frequently 
associated with mutations on 23S rRNA. However, in S. epidermidis development 
of resistance mechanisms to linezolid is not clear but it seem to be related with a 
decrease in drug uptake, due to changes in bacterial membrane permeability or 
due to an overexpression of an efflux system (Sierra et al., 2009).  
To our knowledge, in enterococci there are no described mutations that lead 
to glycopeptide resistance, most likely because in enterococci the resistance 
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mechanism involves a complicated and highly regulated genetic system rather 
than a panoply of phenotypic and morphological alterations, as in the case of S. 
aureus for which a single mutation could translate itself into a more immediate 
phenotypic alteration regarding vancomycin resistance. In fact in S. aureus, 
mutations in several genetic loci other than TCSs, such as sigB (Singh et al., 
2003), trfAB (Renzoni et al., 2009), tcaA (Maki et al., 2004), are known to 
contribute to glycopeptide resistance. 
In recent years, several genetic alterations in two-component regulatory 
systems have been reported to be related to glycopeptide resistance phenotype, 
namely as point mutations in vraSR (Cui et al., 2009) and graSR (Neoh et al., 
2008), and a defective agr function (Sakoulas et al., 2002). However, these 
genetic changes have only been found in very limited number of clinical and 
laboratory isolates of S. aureus and never in enterococci. Furthermore, no 
mutations were found in vraSR among some pairs of vancomycin-susceptible and 
–resistant clinical isolates (Howden et al., 2008). Hence, there are likely to be as 
yet unidentified loci and pathways linked to the glycopeptide resistance 
phenotype. 
We have previously identified vancomycin susceptible enterococcal strains 
from different environments, carrying incomplete van operons (Ribeiro et al., 
2007). In an attempt to understand if the presence of incomplete van operons 
would confer any advantage under vancomycin selective pressure, we have 
subjected these environmental isolates to vancomycin selective pressure through 
serial passages in increasing vancomycin concentrations. In these experiments, 
strains bearing incomplete van operons were able to become resistant to 
vancomycin. 
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MATERIAL AND METHODS 
MICROORGANISMS AND GROWTH CONDITIONS 
For this study eleven enterococcal strains were selected (Table 1). Growth 
was done in Brain Heart Infusion (BHI) (Oxoid) and 15 µg/ml of tetracycline was 
added to the medium for growth of insertional mutants.   
 
MUTANT CONSTRUCTION 
The markerless vanS deletion mutant was constructed by double cross-over 
essentially as described previously (Brinster et al., 2007). Briefly, 5’ and 3’ 
flanking regions of the target gene were amplified from chromosomal DNA of 
V583EryS by PCR. The two PCR fragments were fused by PCR using the external 
primers and the resulting PCR fragment was cloned into the T/A cloning vector 
pGEM-T (Promega). The inserted PCR fragment was excised and subsequently 
cloned in pG+host9 plasmid (Maguin et al., 1996), which was then electroporated 
in E. faecalis V583EryS. The vanS double-crossover mutant was selected as 
described by Brinster et al. (2007). Successful target mutations were identified by 




 Minimum inhibitory concentrations for vancomycin were determined by E-test 
(AB Biodisk) according to manufacturer´s instructions. E. faecalis DSMZ 2570 





Table 1. E. faecalis strains and primers used in this study. 
Strains and 
Primers 
Relevant properties/Sequence (5’-3’) Reference 
Strain   
V583 Clinical isolate, VanR (Sahm et al., 1989) 
V583EryS Derivative from V583 by deletion of EFA0007 A. Benachour 
JH2-2 FusR RifR, plasmid free  (Jacob & Hobbs, 1974) 
OG1-RF(TX4002) FusR RifR, plasmid free  (Wirth et al., 1986) 
V583croR::tet err05 insertion mutant of V583, TetR (Hancock & Perego, 2004) 
V583vanR::tet Err11 insertion mutant of V583, TetR (Hancock & Perego, 2004) 
V583err06::tet err06 insertion mutant of V583, TetR (Hancock & Perego, 2004) 
SAVE 3 vanS deletion mutant of V583EryS This study 
SAVE 2 vanB deletion mutant of V583EryS Chapter 4 
JH2-2∆croR err05 deletion mutant of JH2-2 (Le Breton et al., 2003) 
JH2-2∆rr06 err06 deletion mutant of JH2-2 (Le Breton et al., 2003) 
DSMZ 2570 Type Strain (VanS) DSMZ culture collection 
DSMZ 12956 Type Strain (VanR) DSMZ culture collection 
   
Primers   
vanS1 CCTCGACAAGTAGAATTCGTATC This study 
vanS2 CTTTGAAACTACAGGGAAACTAC This study 
   
vanS3 CACCAGCAGCAAAAGGATTTC This study 
vanS4 CTGACACTTCTGCCGGAG This study 
   
vanS5 GTTATACCTGTCGGTCAAAATC This study 
vanS6 GCTGGAAAACACCTCAGATG This study 
 
SERIAL PASSAGES IN VANCOMCYIN 
Cells were grown overnight at 37ºC in drug-free BHI broth and then plated on 
BHI agar for overnight growth. Then, one colony was picked and inoculated in 
drug-free BHI broth. Passage through BHI containing doubling vancomycin 
concentrations was performed by daily inoculation with a 1:100 dilution from the 
previous overnight cultures at 37ºC. The lower vancomycin concentration was 
0.125 µg/ml and the highest was 256 µg/ml. MIC values were determined after 
the strains were passed through the vancomycin concentrations of 0.5 µg/ml, 2 
µg/ml, 8 µg/ml, 16 µg/ml, 32 µg/ml and 256 µg/ml. The last culture was also tested 
for stability of MIC value and cross resistance with other antibiotics by the 
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standard disk diffusion test. Stability of MIC values was tested after 10 
consecutive subcultures in vancomycin-free media. 
Serial passages in BHI media with a fixed subinhibitory concentration of 
vancomycin were also performed. Choice of the vancomycin concentration was 
based on the MIC value of each strain (Table 2): 4 µg/ml was used for SAVE 2 
and V583croR::tet, and 1 µg/ml was used for V583∆vanS (SAVE 3), 
V583vanR::tet, V583err06::tet, JH2-2, JH2-2∆croR, JH2-2∆err06 and OG1RF. 
Although V583croR::tet and OG1RF strains have the same MIC the subinhibitory 
dose chosen for these two strains was different since at 4 µg/ml OG1RF strain 
grew poorly, reaching lower ODs when compared to V583croR::tet. After 10 
passages in subinhibitory concentrations, the mutants were cultured on a second 
subinhibitory concentration. The second subinhibitory concentration was chosen 
according to the MIC value that each strain presented after the 10th passage on 
the first subinhibitory concentration, corresponding to approximately 1/3-1/4 of the 
MIC: 16 µg/ml was used for V583croR::tet, 4 µg/ml for JH2-2∆croR and 8 µg/ml 
was used for V583err06::tet and JH2-2∆err06. MIC determination along the serial 
passages on subinhibitory concentrations was performed at the 3rd, 6th and 10th 
passage. 
 
HIGH THROUGHPUT DNA SEQUENCING 
Adapted SAVE 2 strain was sequenced using High throughput DNA 
sequencing, performed with an Illumina Genome Analyzer II with the single-paired 
end procedure (Tufts University Core Facility, Boston). Mapping and analysing of 
the reads was performed using the CLC Genomics Workbench software (CLC 




CONFIRMATION OF MUTATIONS BY PCR AND SEQUENCING  
Mutations found in adapted SAVE 2 strain were checked by PCR in the wild 
type strain V583EryS and in SAVE 2 before passage for confirmation. The ddl 
gene (EF0843) was also amplified and sequenced for SAVE 2, SAVE 3 and 
V583vanR::tet strains. Primers used were as presented in Table 1. PCR reactions 
were performed in a T-personal Combi thermocycler (Biometra) with PCR 
mastermix (Finnenzymes) and for each 50 µl PCR reaction mixture 250 ng of 
DNA were used with an annealing temperature of 55ºC. Primer synthesis and 
sequencing service were performed by STABVida. 
 
PULSED-FIELD GEL ELECTROPHORESIS 
 Strains used in the induction assay at three different stages, namely before 
induction (BI), after induction (AI) with 256 µg/ml and after 10 daily passages in 
drug-free BHI (BHI), were typed by PFGE. Genomic DNA agarose discs and DNA 
digestion with SmaI were performed according to the method of Chung et al. 
(2000) except for lysis solution, which contained only RNase A and lysozyme 
(Chung et al., 2000). Agarose discs were electrophoresed on a 1% (w/v) Seakem 
GTG agarose gel (FMC Bioproducts) in 0.5× TBE buffer low EDTA (50 mM Tris, 
50 mM boric acid, 0.2 mM EDTA, pH 8.0) in a CHEF apparatus (Clamped 
Homogeneous Electric Fields) (BioRad) at 14ºC for 22 hours at 220V with pulse 
times of 5 s rising to 35 s during the electrophoresis period. Gels were stained by 
immersion in ethidium bromide (1 µg/ml) for 30 minutes and photographed with a 
UV light source. 
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ANTIMICROBIAL SUSCEPTIBILITY TEST 
Antimicrobial susceptibility was determined using disc diffusion method 
according to CLSI (former NCCLS) (Clinical and Laboratory Standards Institute, 
2000). Disk diffusion zone diameters were determined on Muller-Hinton Agar 
(Oxoid) and measured using a calliper. The antibiotics tested were selected in 
order to cover all the known chemical and functional groups of antibiotics: 
gentamycin 10 µg, chloramphenicol 30 µg, erythromycin 15 µg, nitrofurantoin 300 
µg, tygecycline 15 µg, polymyxin B 300 IU, tetracycline 30 µg, mupirocin 5 µg, 
fusidic acid 10 µg, spiramycin 100 µg, cefoperazone 30 µg, 
sulphamethoxazole/trimethoprim (SxT) 25 µg, ofloxacin 5 µg, kanamycin 30 µg, 
lincomycin 15 µg, oxitetracyclin 30 µg, synercyd (quinupristin/dalfopristin) 15 µg, 
ampicillin 10 µg, amoxicillin 25 µg, linezolid 30 µg, ciprofloxacin 5 µg, tobramycin 
10 µg, ceftriaxone 30 µg, penicillin G 10 IU, methicillin 5 µg, vancomycin 30 µg, 
bacitracin 10 µg, trimethoprim 1.25, enrofloxacin 5 µg, imipinem 10 µg, netilmycin 
30 µg, colistin 10 µg, piperacillin 100 µg, rifampicin 5 µg. E. faecalis DSMZ 2570 
was used as control, as recommended by CLSI (Clinical and Laboratory 















RESULTS AND DISCUSSION 
PASSAGES IN TWO-FOLD INCREASING VANCOMYCIN CONCENTRATIONS 
As shown in Table 2 all strains, except JH2-2, OG1RF and DSMZ 2570, were 
able to adapt and grow in high vancomycin concentrations until 256 µg/ml. The 
common features among the strains which were able to adapt is that they have at 
least one gene involved in response to vancomycin, deleted.  
 
Table 2 – Vancomycin MIC values of E. faecalis strains during the two-fold increased serial 
passages in vancomycin.  
Vancomycin concentration (µg/ml)a 
Strain 
0 0.5 2 8 16 32 256 
V583 256 nd nd nd nd nd nd 
SAVE 2 6 4 4 48 48 >256 >256 
SAVE 3 3 3 4 48 48 >256 >256 
V583vanR::tet  3 3 4 48 48 >256 >256 
V583err06::tet 1.5 12 12 64 128 >256 >256 
V583croR::tet 4 4 6 32 48 >256 >256 
JH2-2 3 4 4 ng ng ng ng 
JH2-2∆croR 1.5 4 6 32 128 >256 >256 
JH2-2∆err06 1.5 12 12 64 128 >256 >256 
OG1RF 4 4 4 ng ng ng ng 
DSMZ 2570 4 4 4 ng ng ng ng 
avalues in bold correspond to resistant MIC values; nd, not done; ng, no visible growth. 
 
 In the case of SAVE 2, SAVE 3 and V583vanR::tet, at least one gene from 
vanB operon, involved in resistance to vancomycin, was missing. In the case of 
V583err06::tet, V583croR::tet, JH2-2∆croR and JH2-2∆err06 at least one 
regulator, proven in chapter 6 to be involved in response to vancomycin, is 
absent. All strains turn to be phenotypically resistant after the passage with 8 
µg/ml, suggesting that the observed MIC increase is not gradual but occurs at a 
certain concentration (Table 2). This phenomenon is illustrated in Figure 1. 
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 err06 mutants, both in V583 and JH2-2, showed a significant increase in the 
MIC (from 1.5 to 12 µg/ml) right after passage through 0.5 µg/ml of vancomycin. 
Despite, the reproducibility of our results (4 independent experiments were 
performed), we cannot ascertain if this earlier increase, compared with the other 
strains tested, has any biological relevance or not. 
 In case of SAVE 2 mutant, one hypothesis for resistance development was 
that the ddl gene might have suffered a mutation that would alter its substrate 
specificity and started to incorporate D-Lac in the peptidoglycan precursors, as 
done by VanB ligase. However, the ddl gene was sequenced and presented no 
mutations. It is difficult to establish a hypothesis at this moment since, in our 
understanding, the fact that the phenotype is stable after 10 nonselective 
passages suggests a stable change in the chromosome, i. e., mutation or 
chromosome rearrangements. 
Adapted and resistant SAVE 2 strain was thus sequenced. The sequencing 
revealed 6 SNPs (single nucleotide polymorphism) that translate themselves into 
amino acid changes. As those results were obtained by comparison with the 
published V583 genome and, due to the high genomic variability of strains, we 
decided to check if the mutations were already present in the V583 strain used to 
construct the SAVE 2 mutant. PCR reactions targeting the mutations found were 
performed using V583 DNA and the amplified fragments were sequenced. 
However, all mutations were also present in the V583 strain used for mutant 
construction, ruling out the possibility that any of these SNPs was responsible for 






Figure 1. MIC determination by E-test along the passages in two-fold increased serial passages 
in vancomycin for V583 genetic background mutants. 
 
Mwangi et al. (2007), using a similar approach, sequenced several S. aureus 
strains isolated from a patient undergoing chemotherapy with vancomycin and 
other antibiotics (Mwangi et al., 2007). The authors observed that when 
comparing the genome of the last strain recovered from the patient with the first 
recovered strain, there were 35 point mutations on 31 different loci. From the 
identified mutations some have already been described as implicated on 
vancomycin reduced susceptibility in staphylococci, namely on vraR and on agr 
locus (Mwangi et al., 2007). The fact that we did not find mutations that explain 
the increase of MIC in the enterococcal strains tested, once again, points out the 
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differences between the enterococcal and staphylococcal vancomycin resistance 
mechanisms. 
 
In order to know if the adapted resistant strains were a product of 
chromosomal rearrangements of the original susceptible strains PFGE was done 
with DNA from strains, before induction (BI), after induction (AI) and after 
induction and after passages in drug-free media (BHI). It is not likely that we 
would observe a band pattern change if the phenotype alteration was caused by a 
single mutation, unless the single mutation was located in the restriction site of 
the enzyme used, which is not very probable. However, if the alteration was due 
to some rearrangement on the genome we would be able to see it. The band 
pattern remained unchanged after passages in increasing vancomycin 
concentrations and after the 10 nonselective passages. Exception was 
V583vanR:tet which, before the passages, lacked a high molecular weight band 
(Figure 2). The PFGE gels were repeated 5 times, and the restriction patterns 
were reproducible. All different mutants analyzed by macro-restriction presented 
the same PFGE profile. SAVE 2 and SAVE 3 are deletion mutants and 
V583vanR::tet and V583croR::tet are insertional mutants, meaning that none of 
the chromosomal changes enforced by the mutant construction procedure inserts 






Figure 2. PFGE profile of V583 mutants before induction (BI), after induction (AI) and after 10 
passages in nonselective media (BHI). 
 
 PFGE results showed the absence of chromosomal alteration as revealed by 
sequencing of the SAVE 2 strain. Therefore, mutations or chromosomal 
rearrangements seem unlikely to be the mechanism responsible for the stable 
phenotype observed after passage in increasing vancomycin concentrations.  
The possibility of a transcriptomic change leading to a metabolic adjustment 
to the presence of the antibiotic is likely. However, we would expect that a 
transcriptomic change lasts while the pressure element is kept and once removed 
the metabolism of the cells comes back to its original pace. Another possibility is 
a phenotypic mutation, which is by definition an alteration on the phenotype that is 
somehow stabilized and kept for several generations to benefit the cells, although 
not individually subjected to inheritance and natural selection. The phenotypic 
mutations may constitute a potential future advantage to the cells progeny by 
subsequently buffering genomic mutations (Goldsmith & Tawfik, 2009). 
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Phenotypic mutations are supposed to vanish after enough generations. The 
matter is how many generations are needed and how dependent is that on the 
type of phenotypic mutation and nature of agent that causes the phenotypic 
mutation. In our case, if the phenotypic mutation is actually protecting the cellular 
progeny from subsequent genetic mutations is very likely that after 10 passages 
in drug-free media the phenotype is not yet lost. 
 
 Considering the fact that all mutant strains can be induced to grow in high 
vancomycin doses, we wondered if the mechanism underlying the observed 
phenotype was the same in different strains. It is known that in the absence of 
VanS, VanR can still function. Unphosphorylated VanR is still active, although 
with decreased activity compared to its phosphorylated form. VanR can undergo 
autophosphorylation by using acetyl-phosphate as a substrate or can be 
phosphorylated by a non-partner kinase chromosomally encoded (Holman et al., 
1994). Considering that CroRS and Err06-Ehk06 might have a role in response to 
vancomycin, their kinases are strong candidates to perform this cross-
phosphorylation. 
 
After the serial passages the induced mutants were screened for its 
susceptibility to other antibiotics by disk diffusion method. No relevant changes on 
antibiotic susceptibility were observed. The only change observed was an 
increased susceptibility to erythromycin and spiramycin in vanB and vanS 
mutants. Erythromycin was used as a selective antibiotic in the construction of 
both mutants. We are attributing this fact to some alteration occurring during 




PASSAGES IN SUBINHIBITORY VANCOMYCIN CONCENTRATIONS 
In order to know if vancomycin was able to induce resistance if selection is 
made using a constant concentration, we passed the same strains using 
subinhibitory vancomycin concentrations. None of the vanB operon mutants 
increased its MIC value through this method. However, croR::tet, err06::tet, JH2-
2∆croR and JH2-2∆err06 were able to increase the MIC consistent with high level 
resistance, >256 µg/ml (Table 3).  
The passages in subinhibitory concentrations were first done with a lower 
dose, according to the MIC of the strains but as the MIC increased the 
subinhibitory dose of vancomycin was also increased, to 16 µg/ml in the case of 
the croR::tet, 4 µg/ml for the JH2-2∆croR mutant and to 8 µg/ml in the case of the 
err06 mutants. The vancomycin subinhibitory concentration chosen to perform a 
second step-induction was different for the different mutants since their MIC at the 
10th first step-induction passage was different. 
 






















































16 3 >256 - - - 
Presented only the results for which strains a MIC increase was observed; anext passage with 16 
µg/ml; bnext passage with 4 µg/ml; cnext passage with 8 µg/ml; -, not done. 
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Passages in subinhibitory concentrations of vancomycin were able to 
produce an increase in the MIC value of the culture. A further increment in the 
dose of exposure allowed, only for mutants in croR and err06, an increase in MIC 
consistent with high level resistance.  
Err05-Ehk05 and Err06 were found to be directly induced by vancomycin 
(Chapter 6). These two systems are common to all E. faecalis strains (McBride et 
al., 2007) and are likely relevant sensing systems in E. faecalis. The results 
obtained with induction with constant concentrations suggest that both regulators, 
croR and err06, play a role in this response which is independent of the presence 
of an intact VanRS system as demonstrated by the fact that in both V583 and 
JH2-2, croR and err06 mutants behaved similarly. 
It is possible that CroRS and Err06-Ehk06 are compensating for the absence 
of each other by increasing expression of the regulator still present and eventually 
acting as a regulator for the other TCS. This could be checked by both RT-PCR 
and by gel-shift assays for CroR binding to promoter of err06 and vice-versa with 
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ABSTRACT 
Vancomycin resistance has become common and prevalent among 
enterococci, mostly in the clinical setting but also in the environment, jeopardizing 
the successful treatment of infections caused by Gram-positive bacteria. Previous 
data shows that although expression of vancomycin resistance was not found 
among a group of enterococcal strains from different environments, vancomycin 
resistance determinants are widely spread (Chapter 2).  
To investigate the possibility of vanB operon influencing expression of 
additional genes, we used a transcriptional profiling approach to evaluate the 
genome wide alterations by an Affymetrix DNA microarray based on the E. 
faecalis strain V583 sequence. The transcriptional analysis was made comparing 
the E. faecalis strain V583 profile with its mutants on vanB (SAVE 2) and vanR 
genes (V583vanR::tet). Using a sensitivity threshold value of 3.0 and 2.0, 
respectively, the absence of vanB and vanR genes altered the transcription of a 
large number of genes. In the case of vanB, 309 genes on early-stationary phase 
and 205 on mid-exponential phase out of 3182 ORFs for vanB were differentially 
expressed. In the case of vanR, a total of 249 different genes were differentially 
transcribed (157 at mid-exponential phase and 137 at early-stationary phase) in 
the mutant as compared to the wild type. Among these, 25 are plasmid encoded, 
with 8 encoded on pTEF1 and 17 on pTEF2.  
In both mutants, a high number of genes belonging to mobile genetic 
elements were differentially transcribed. However, the affected mobile genetic 
regions and the transcription direction were different for each mutant, indicating 
that it is a specificity response to the particular alteration induced on the cell by 
each mutation in particular. Both mutations seem to alter the transcription and 
likely the stability of the prophage regions.  
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The functional categories of genes that have more determinants being 
affected by the inactivation of vanB gene are energy metabolism, signal 
transduction, transport and binding proteins and the hypothetical and unknown 
function proteins. Several PTS systems involved on sugar uptake are 
downregulated. Genes involved in cell wall biosynthesis and sugar metabolism 
through glycolysis are also downregulated together with genes involved in the 
chorismate pathway. Simultaneously, we observed up-regulation of genes related 
to NamMN uptake, methionine, purine and pyrimidine biosynthesis.   
In the absence of vanR many genes involved in cell envelope and energy 
metabolism, signal transduction and transport and binding proteins were 
downregulated, suggesting that these genes might be, directly or indirectly under 
vanR influence. 
The newly potential Van-regulated targets include other factors, besides 
vancomycin resistance genes, with proteins implicated in several metabolic 
pathways being affected by these two genes. Our results suggest that the vanB 
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INTRODUCTION  
Enterococcus faecalis is adapted to survive, persist and proliferate in a wide 
range of environments as different as the gastrointestinal tract, heart valves, 
water and soil (Mundt, 1986; Tannock, 2002).  
Several organisms have developed sophisticated signaling systems for 
eliciting a variety of adaptive responses to their environment. Adaptive response 
systems is a class present in prokaryotes, lower eukaryotes, and plants which 
consist of at least two signal transduction proteins and are therefore referred to as 
two-component regulatory systems. Genomic sequencing of various 
microorganisms has revealed the presence of many two-component regulatory 
systems in every species. In E. faecalis V583, 17 sensor kinases and 18 
response regulators were found (Paulsen et al., 2003). Of the enterococcal two-
component systems, only three have been characterized and assigned a role in 
the cell. CroRS is implicated in resistance to antimicrobial agents that target the 
cell wall, like β-lactams (Comenge et al., 2003). It is known that the FsrCA is 
known to be activated by a quorum-sensing mechanism (Nakayama et al., 2001) 
and has as role in biofilm formation and virulence (Hancock & Perego, 2004a) 
(Qin et al., 2000). VanRS is by far the most well-known enterococcal two-
component system and its role in the regulation of vancomycin resistance is well 
characterized (Arthur et al., 1992, Arthur & Courvalin, 1993, Evers & Courvalin, 
1996). However, the functions of the other systems remain unknown.  
Transcriptomic approaches are powerful tools for the identification of groups 
of genes with similar expression patterns and for the establishment of putative 
regulatory relations. Using microarray technology, recent reports have described 
extensive changes in gene expression profiles when E. faecalis was challenged 
with different stress conditions (Chapter 4) (Aakra et al., 2010, Aakra et al., 2005, 
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Solheim et al., 2007, Vebo et al., 2009, Reyes-Jara et al., 2010). A mutant on fsrB 
gene was studied also using a transcriptomic approach and the authors describe 
that fsrB influence a large number of genes belonging to different metabolic 
networks (Bourgogne et al., 2006). These data show that regulator genes from 
two-component systems might have other cellular roles besides the ones directly 
attributed to its function as part of a TCS.  
The sequencing of OG1RF strain revealed the presence of an ORF with 82% 
of similarity with vanRG. vanSG and vanY homologues were also found 
(Bourgogne et al., 2008). However, this OG1RF-unique two-component system 
does not seem to be a remnant form of a vancomycin resistance operon, but 
rather part of a still unknown regulatory pathway. Taking together, the fact that 
TCSs can regulate an extensive group of genes involved in different metabolic 
pathways and the description of a VanRS-like system, in an E. faecalis strain, that 
is not related to vancomycin resistance, gives strength to the belief that VanR 
might have a broader role on the cells, besides its well described role on 
vancomycin resistance. 
We used custom made DNA microarray chips to profile the effect of vanB 
and vanR mutations on gene expression in the vancomycin resistant strain E. 
faecalis V583. Our results show that the E. faecalis vanB and vanR genes affect 
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MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS 
This study was performed with E. faecalis V583::tet, V583vanR::tet (Hancock 
& Perego, 2004b), V583EryS and V583EryS∆vanB (SAVE 2 from chapter 4). 
V583EryS is derived from V583 by deletion of ermB gene (EFA0007) (A. 
Benachour) and V583::tet is the V583 strain with p3TET inserted between ehk02 
and the adjacent open reading frame encoding a putative lipoprotein (Hancock & 
Perego, 2004b). For the sake of simplification V583EryS and V583::tet will be 
referred from now on by V583. Strains were grown overnight in Brain Heart 
Infusion (BHI) medium (Oxoid), at 37°C. For microarray analysis, the overnight 
cultures were diluted 20 times and grown in BHI broth until an optical density of 
0.4-0.45 at 600 nm was reached. 
 
SAMPLING AND RNA EXTRACTION 
Samples of each culture (5 ml) were collected 10 minutes (mid-exponential) 
and 30 minutes (early stationary) after cultures reached the OD 0.4-0.45. The 
double volume of RNA Protect Bacteria Reagent (QIAGEN) was added to 
cultures. The mixture was incubated for 5 minutes at room temperature, cells 
were centrifuged for 10 min at 3500 rpm at 4°C and pellets were kept at 4ºC until 
RNA extraction. Total RNA extraction was performed with RNeasy Mini columns 
(QIAGEN). RNA quality and quantity was determined by agarose gel 
electrophoresis and by measuring the absorbance at 260 and 280 nm, 
respectively. Total RNA from all samples was treated with RNase-free DNase I 
and incubated at 37ºC for 1 hour. Samples were further purified using RNeasy 
MinElute Cleanup kit (Qiagen) and quantified using the NanoDrop 
Chapter 8 
 274 
Spectrophotometer (Nanodrop Technologies). 10 µg of each RNA sample was 
used for hybridization experiments. 
 
ENTEROCOCCAL DNA CHIP DESIGN 
The Affimetrix microarrays used were previously designed and described in 
McBride et al. (2007). Briefly, the microarray was designed to contain a total of 
3582 probes including 3182 predicted ORFs from the chromosome of strain 
V583, additional pathogenicity island genes of strain MMH594, known to be 
absent in V583, and E. faecalis plasmid and antibiotic resistance genes or 
clusters from other E. faecalis strains for which nucleotide sequences had been 
reported, namely the vanA operon, blaZ, bcr operon, vanG operon, vanE operon, 
tetM, pRE25 plasmid/cat, as well as genes present in V583 endogenous plasmids 
pTEF1, pTEF2, and pTEF3. Additionally, microarrays included 111 Affymetrix 
designed eukaryotic and prokaryotic negative control probe sets. A full list of 
probe sets including genes represented and excluded from the microarray is 
available in the ArrayExpress public repository at http://www.ebi.ac.uk/ under 
accession number E-MEXP-1090. Details of the algorithm used in construction of 
custom Affymetrix GeneChips are available at the manufacturer’s website 
(www.affymetrix.com/technology/index.affx). 
 
DNA MICROARRAY DATA ANALYSIS 
For each condition three batches of RNA were obtained in three separate 
growth experiments to provide true biological replicates. Each set of independent 
RNA samples was used to perform the microarray hybridizations. cDNA 
synthesis, fluorescent labelling, oligonucleotides array hybridization and 
preliminary data analysis was performed by the company Genome Explorations 
(Memphis, Tennesse). 
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Average relative fold changes were calculated from the average of the signal 
log ratio (SLR) from three separate experiments by using the following equations: 
for an SLR of ≥0, average relative fold change = 2SLR; for an SLR of <0, average 
relative fold change =-1×2(-1×SLR) (Ng et al., 2003). 
 
REVERSE TRANSCRIPTASE PCR (RT-PCR) 
To independently confirm the differential expression observed by DNA 
microarray experiments some genes were selected for analysis by semi-
quantitative RT-PCR. The selected genes and primers used are listed in Table 1 
and were synthesized and purchased from Eurofins (Ebersberg, Germany).   
Total RNA preparation was performed exactly as described for the microarray 
assay. Residual DNA was removed using RNase-free DNase I (Invitrogen). cDNA 
was synthesized using Transcriptor High Fidelity cDNA Synthesis Sample 
(Roche) according to the manufacturer’s instructions and using 4 µg of RNA as 
template.  
 
Table 1. Primers used in this study to perform RT-PCR  





















Vancomycin MIC values for V583, V583∆vanB and V583vanR::tet mutants 
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RESULTS AND DISCUSSION 
Using two mutants in genes essential for vancomycin resistance (vanB and 
vanRB) we searched for genes putatively connected with van operon genes, in an 
attempt to unravel any possible gene network involving vanB operon. This could 
give us clues on the role of vanB operon in the cell besides the known role in 
vancomycin resistance.  
The experimental design consisted in defining the transcriptomic profile of the 
two mutants at two different growth curve points, namely mid-exponential and 
early stationary. Cells were harvested at the mentioned sampling points, RNA 
was prepared and the number and nature of genes which underwent change in 
transcriptional pattern was evaluated using a custom made Affymetrix DNA 
microarray. 
To our knowledge, the impact of the inactivation of these two genes at a 
global cellular level was never described before. The two mutants showed 
changes in properties like the vancomycin susceptibility (Chapter 4) (Hancock & 
Perego, 2004b), as expected and previously described, and the OD value at the 
late stationary phase. The mutants presented a reduction on the OD value 
reached at the late stationary phase, with a decrease on the OD value reached of 
about 14-19%, when compared with their wild-type strains (Figure 1). 
 
 All the strains were sampled 10 and 30 minutes after they reached an 
optical density of 0.4-0.45. These two sampling points were chosen to collect 
cultures at two moments of the growth curve, mid-exponential and early-
stationary growth phases. However, as the wild-type strains grow more than the 
mutants the growth stages at which the wild-type strains were sampled do not 
correspond exactly to the growth stages of the mutants. Aware of the potential 
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biological differences that sampling at different stages might impose, we intend to 
be cautious during the analysis of the presented data.  
 
 
Figure 1. Phenotypic characterization of V583, SAVE 2 (V583∆vanB) and V583vanR::tet. Growth 
curves were monitored at OD600, a) V583EryS and SAVE 3; b) V583::tet and V583vanR::tet; (b) 
vancomycin MIC value was determined by E-test. 
 
Analyzing the overall microarray results we observed that, in general, the 
fold-change values were lower for vanR mutant than for vanB mutant. Based on 
the differences observed on the fold-change values for both mutants we decide to 
assume a cutoff of 2.0 for the genes which are affected on vanR mutant and of 
3.0 on the vanB mutant. If we had chosen for the analysis of the results obtained 
for the vanR mutant the same cutoff value (-3>|fold-change|>3) we used for the 
vanB mutant we would be reducing the number to about half. The goal was to find 
a good compromise between stringency of the criteria used and the relevance of 
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the information that a broader group of data can provide. Also, another study on 
the analysis of an fsrB mutant, also a two-component system regulator gene, 
adopted the same fold-change cutoff (Bourgogne et al., 2006). 
Most likely, the genes that are differentially transcribed at both sampling 
moments constitute the core genes altered by the inactivation of these genes. In 
turn, genes that are only detected at one of the growth phases samples, are likely 
to be growth phase dependent.  
 
vanB DELETION INDUCED CHANGES IN THE OVERALL 
TRANSCRIPTIONAL PROFILE IN V583 
With a threshold value set at 3.0, 205 genes were affected at mid-exponential 
phase (41 up-regulated and 164 downregulated) out of the total of 3182 described 
open reading frames (ORFs) for E. faecalis V583. At early stationary phase the 
transcription of 309 genes was affected (52 up-regulated and 257 downregulated) 
(Table S1). With a threshold set at 5.0 the number of genes affected at mid-
exponential and early stationary phases was reduced to 139 and 201 genes, 
respectively. These numbers reveal the high fold-change values observed, 
underlining the relevance of these results. Figure 2 illustrates the high fold-
change values observed for the many of the genes that were differentially 
transcribed on the vanB mutant. It is observed a considerable overlap between 
genes differentially transcribed at both growth phases, with 178 genes common to 




Figure 2. Representation of the fold change value for the genes differentially expressed in the 
absence of vanB gene. 
 
A selected group of 8 genetic determinants showing differential transcription 
on the SAVE 2 mutant was chosen to test the validity of the microarray data using 
RT-PCR. The RT-PCR and microarrays results correlate well. 
 
vanB DELETION INDUCES CHANGES IN THE EXPRESSION OF MOBILE 
GENETIC ELEMENTS (MGE) DETERMINANTS 
Analysis of the results with vanB mutant revealed a high number of genes 
belonging to mobile and extra-chromosomal elements, namely integrated 
plasmids, phages and unidentified mobile genetic regions. The numbers reached 
72% and 55% of the total number of genes differentially expressed in mid-
exponential phase and early-stationary phase, respectively (Figure 3). MGE 
constitute about ¼ of the V583 genome sequence (Paulsen et al., 2003) and 175 
(out of approximately 680 chromosomally MGE) were differentially transcribed in 
this study, corresponding to about 25% of all MGE genes. 
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Figure 3. Numbers and percentages of genes differentially expressed plotted according to its 
mobile nature a) at mid-exponential phase and b) at early stationary phase. 
 
The distribution and number of genes belonging to different mobile genetic 
regions described in V583 genome is presented in Figure 4. There is a clear 
tendency for genes located in MGE to be downregulated in vanB mutant (Figure 
4), except for PAI genes (EF0479-EF0628) which were mostly upregulated. 
However, and according to Paulsen et al. (2003) the genes comprised between 
EF0506-EF0485 correspond to an integrated plasmid located within the PAI and 
appears to be derived from pTEF1-like plasmid. Thus, from the 18 PAI genes 






Figure 4. Distribution of genes differentially expressed in the vanB mutant within the mobile 
regions according to (McBride et al., 2007). 
 
E. faecalis V583 PAI encodes virulence determinants, namely enterococcal 
surface protein (Esp), cytolysin, and aggregation substance. However, it contains 
many components of unknown function which are hypothesized to facilitate 
survival and/or transmission in the health care setting (Shankar et al., 2002; 
Paulsen et al., 2003). 
Genes belonging to region 4 (phage 02), region 6, region 7 (phage 04), 
region 10 (Tn/vanB) and region 12 (phage 06) were not affected by vanB 
absence. E. faecalis V583 carries seven chromosomally located prophages 
(phage 01 to phage07) (Paulsen et al., 2003). These putative prophages are most 
closely related to phages from other low-GC Gram-positive bacteria. The 
integrated phage regions encode multiple homologs of Streptococcus mitis PblA 
and PblB, which have been implicated in binding human platelets, an important 
interaction in pathogenesis of infective endocarditis (Bensing et al., 2001). Genes 
encoded within the MGE show a transcriptional tendency. Within the phage 
regions, for instance, 90% of the ORFs align with the direction of replication. 
Strong selective pressure for genes to be transcribed in the direction of replication 
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appears to be a common feature of the low-GC Gram-positive bacteria (Paulsen 
et al., 2003).  
Within the firmicute division of Gram-positive bacteria, temperate 
bacteriophages are key vectors for the horizontal transfer of virulence genes. In 
Staphylococcus aureus, bacteriophages encode and mobilize an impressive array 
of immune evasion genes (van Wamel et al., 2006; Tormo et al., 2008) and 
Panton-Valentine leukocidin (Prevost et al., 1995). Several bacteriophage-
encoded virulence determinants also contribute to pathogenesis in group A 
Streptococcus (Banks et al., 2003; Aziz et al., 2004; Aziz et al., 2005). 
Not much information is available about prophages and their role in 
enterococcal genomes. From the enterococcal genomes recently made available 
(Bourgogne et al., 2008; Palmer et al., 2010) it is possible to extract some 
information about the prevalence of prophages/prophage-like regions in 
Enterococcus. It seems that phage 02 is widely disseminated among 
Enterococcus spp. from different sources (clinical and environmental) and it was 
proposed to be part of E. faecalis core genome (McBride et al., 2007). Also, 
phage 04 and phage 06 are common among different strains. Phages 02, 04 and 
06, the most prevalent among enterococcal strains, are the ones which genes 
were not differentially expressed in our study. Most likely these phages are not 
functionally related to vanB gene or vanB operon. In another transcriptional study, 
where V583 was exposed to chloramphenicol, the authors also observed the 
differential transcription of genes located on MGE (8% of total MGE genes) 
(Aakra et al., 2010). Genes from phages 02 and 04 were also not affected, 
however the authors did observe genes from phage 06 differentially expressed 
but it is not clear how many. The authors mention the upregulation of genes from 
phages 01, 06 and 07 and downregulation of PAI genes, exactly opposite from 
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what we observe in this study. Taken together, this might indicate that MGE are 
sensitive either to chromosomal alterations, such has deletion of a gene and to 
cellular perturbations imposed to the cells, such as the exposure to an antibiotic.     
We can speculate that the most prevalent phages among different strains are 
more stable and not easily disturbed. However, at this point, and with the 
restricted number of transcriptomic studies it is not possible to establish a 
consistent hypothesis for the transcriptional destabilization pattern of prophage 
genes.   
The actual knowledge on the role and metabolism of enterococcal phages is 
scarce. However, we can speculate that the observed downregulation of many of 
the genes within the prophages, that suffer transcriptomic alterations, might be 
associated with a destabilization of the genome created by the absence of vanB 
gene. It is conceivable that a chromosome destabilization trigger the entrance of 
prophages in a lytic or lysogenic state.  
 
vanB DELETION INDUCED CHANGES IN THE EXPRESSION OF NON-MGE 
DETERMINANTS 
In the vanB mutant we did not detect differential transcription of the other 
vanB operon genes, meaning that the deletion of vanB gene itself does not affect 
the transcription of the other vancomycin resistance determinants.  
Regardless the presence of vanB ligase, which catalyzes the formation of the 
depsipeptide D-Ala-D-Lac that will be incorporated onto peptidoglycan, bacteria 
carries a chromosomally encoded ddl ligase gene that catalyzes the formation of 
D-Ala-D-Ala. This means that the normal peptidoglycan precursors are always 
being synthesized. However, if vanB is present, and because it is transcribed, it is 
likely that D-Ala-D-Lac is incorporated in the nascent peptidoglycan.   
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Many genes from different functional categories were differentially 
transcribed and the most affected by inactivation of vanB gene were energy 
metabolism, signal transduction, transport and binding proteins and hypothetical 
and unknown function proteins (Figure 6).  
 
 
Figure 5. Number of differentially transcribed genes (up- and downregulated) at mid-
exponential and early stationary phases, assembled according to their cellular role (based on 
http://cmr.jcvi.org). The genes with more than one cellular role were counted twice. 
 
Overall genes were mainly downregulated and there are always more genes 
differentially expressed at early stationary phase than at mid-exponential phase, 
with clear exception of genes involved in amino acid biosynthesis. At mid-
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exponential phase 8 out of 10 genes involved in amino acid biosynthesis were 
downregulated and at early-stationary phase only the same two genes are 
upregulated (EF0289 and EF0290). Figure 6 shows which genes are up- and 
downregulated and their role on the cellular metabolism. 
Transcriptional changes appear to be operon specific, since within the same 
operon the genes always follow the same tendency, either up- or downregulated 
(Table S1).  
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PTS (phosphoenolpyruvate phosphotransferase system transporter) sugar 
uptake and phosphorylation require the participation of a number of soluble and 
membrane-bound enzymes. These proteins catalyze the transfer of the 
phosphoryl moiety of the phosphoenolpyruvate to the sugar substrate. The overall 
reaction requires Mg2+, and the products formed are sugar phosphate and 
pyruvate (Dills et al., 1980). E. faecalis V583 genome contains 35 putative PTS 
systems, and pathways for exploitation of 15 different sugars have been predicted 
(Paulsen et al., 2003). Its genome also encodes several ABC transporters and 
other sugar uptake systems. PTS systems responsible for the uptake and 
phosphorylation of at least 5 different sugars were identified in our study and were 
all downregulated. In addition, at least two sugar ABC transporters (EF1344 and 
EF1345, which are not part of the same transcriptional unit according to biocyc 
software) were also downregulated. These results suggest that the uptake of 
sugars in particular is being shutdown in the vanB mutant (Figure 6). However, 
the uptake of nicotinamide mononucleotide (NamMN) is being induced. This 
uptake system is mediated by EF0739 which encodes a putative nicotinamide 
mononucleotide transporter PnuC. Although the biosynthesis de novo of NAD+ 
uses precursors such as tryptophan and aspartic acid, the salvage metabolic 
pathway uses nicotinamide (Nam) and other analogous molecules like nicotinic 
acid (NA) and nicotinamide riboside (NR) (Zhu et al., 1989). NAD+ is used in 
abundance by the cell since it is a cofactor of many redox reactions, such as 
posttranslational modifications.  
DNA ligases catalyze the formation of phosphodiester linkages between 5'-
phosphoryl and 3'-hydroxyl groups in double-stranded DNA. These enzymes are 
essential for DNA replication and repair of damaged DNA (Wilkinson et al., 2001). 
All bacteria encode at least one DNA ligase which uses NAD+ as a coenzyme and 
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as the energy source for the reaction (Little et al., 1967; Wilkinson et al., 2001). 
V583 genome encodes a NAD+-dependent DNA ligase (EF0722, ligA) which was 
not found to be differentially expressed in this study. The EF0739 nicotinamide 
transporter is upregulated at both points on the growth curve (3.06-fold change at 
mid-exponential and 5.41-fold change at early stationary), which might indicate 
the relevance of this transporter in response to absence of vanB gene.  
We found genes belonging to purine and pyrimidine biosynthesis to be 
upregulated, namely EF0470 (nrdF) and EF0471 (nrdE), which encode the two 
subunits of the ribonucleoside-diphosphate reductase, and EF2754 (nrdD) and 
EF2455 (nrdG), which encode two ribonucleoside-triphosphate reductases. 
Ribonucleoside reductases catalyze the formation of deoxyribonucleotides from 
ribonucleotides. Considering the induction of determinants related to the NamMN 
uptake, methionine, purine and pyrimidine biosynthesis our results suggest that 
the cell is committed in maintain DNA replication and DNA protection and repair 
systems working properly. We observe upregulation of two genes involved in the 
methionine biosynthesis (EF0289 and EF0290, encoding a cysteine synthase and 
a cystathionine beta-lyase, respectively). The fact that methionine is the universal 
N-terminal amino acid of proteins as well as the use of its derivative S-
adenosylmethionine (SAM) in a variety of methyltransferase reactions argue for 
the importance of methionine in the cellular metabolism.  
The genes involved in cell wall biosynthesis and sugars metabolism through 
glycolysis are downregulated, as well as the genes involved in the chorismate 
pathway. Further work is need to formulate a robust hypothesis regarding other 
cellular roles of vanB ligase on the cell can be established however, this data 
indicate that vanB is likely to play a role other than just vancomycin resistance.  
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In Saccharomyces cerevisiae NAD+ also has recently been implicated on the 
control of thiamine homeostasis (Li et al., 2010). The authors found that lowering 
the NAD+ concentration the intracellular thiamine concentration is elevated due to 
increased thiamine biosynthesis and transport (Li et al., 2010). Thiamine 
phosphate derivatives are involved in many cellular processes. The best 
characterized form is thiamine pyrophosphate (TPP), a coenzyme in the 
catabolism of sugars and amino acids. In general TPP functions as a cofactor for 
key enzymes such as enzymes such as pyruvate dehydrogenase, 2-oxoglutarate 
dehydrogenase, branched chained- 2-oxoacid dehydrogenase and transketolase 
(Pohl et al., 2004). Genes encoding thiamine biosynthesis enzymes in 
microorganisms are tightly regulated such that low environmental thiamine 
concentrations activate transcription and high concentrations are repressive. If 
there is sufficient thiamine present in the cell then the thiamine binds to the 
mRNA encoding genes required in the pathway preventing the translation of the 
enzymes. If there is no thiamine present then there is no inhibition, and the 
enzymes required for the biosynthesis are produced. We found the thiamine 
biosynthetic pathway upregulated with the four genes of the operon (EF2775-
EF2776-EF2777-EF2778/thiD-thiE-thiM-thiW) being induced both at mid-
exponential phase and early-stationary phase, with fold changes varying between 
5.88 and 6.50 on mid-exponential phase and 8.41 and 11.39 at early-stationary 
phase. There might be a metabolic correlation between the induction of the 
NamMN transporter and the thiamine biosynthetic pathway. However, if there is, 
seems to be different from the one described on S. cerevisiae (Li et al., 2010). 
  
Physiological processes, in virtually all organisms, require metal ions as 
cofactors, and cellular depletion of particular metals causes defects in numerous 
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biological functions. However, certain metal ions, such as cadmium, are harmful 
to organisms. We found a cadmium-translocating P-type ATPase being 
downregulated (EF1400). To our knowledge, there are no studies attributing a 
function for EF1400 and it is possible that this is not a cadmium-specific 
transporter but a transporter of a different(s) metallic cation(s). It is known that 
some bacteria are able to remove metal ions from the media in a detoxifying 
process (Momose & Iwahashi, 2001; Topcu & Bulat, 2010). In the conditions of 
our experiment cadmium is not present on the cells, so the activation of a 
detoxifying mechanism is in theory unnecessary and might represent an energetic 
burden to the cells. However, we may be witnessing not a direct effect of 
cadmium presence or any other metal that can be a substrate of this transporter, 
but an indirect effect by the fact that this extrusion mechanism being shut down 
likely to save energy for other cellular processes. At this point, these hypotheses 
are mere speculations.  
 
vanRB MUTATION INDUCED CHANGES IN THE OVERALL 
TRANSCRIPTIONAL PROFILE OF V583 
It is known that vanRB, together with its cognate histidine kinase vanSB, in 
presence of vancomycin regulate the vanB operon by binding to its own promoter 
PRB and to the downstream promoter PYB that regulates the expression of 
vanYBWHBBXB genes. 
In total, at both sampling time points, 249 different genes were found to be 
differentially expressed in the V583∆vanRB mutant when compared to V583, 
which corresponds to nearly 8% of the total number of ORFs in the V583 
genome. 83 genes were significantly regulated at both sampling points. These 
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determinants are the ones that are likely vanR-regulated, since is likely that they 
are independent of the growth phase. 
Inactivation of vanR gene had an overall effect in the cell since genes from 
several different cellular roles were affected. Table 2 lists the number of genes 
differentially expressed and organized by cellular role. The cellular role categories 
with more genes differentially transcribed are genes associated with functions on 
mobile and extrachromosomal elements, signal transduction, transport and 
binding and hypothetical/unknown function proteins. In addition, 25 genes located 
on V583 endogenous plasmids were differentially transcribed, 8 located on 
pTEF1 (EFA) and 17 located on pTEF2 (EFB). Moreover, all plasmid-located 
genes are downregulated and only detected at mid-exponential phase. No 
plasmid-located gene was found at early-stationary phase.  
 
A complete list of all the genes differentially expressed is presented on Table 
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Table 2 – Number of genes differentially expressed in the vanR mutant compared 
with V583 wild type, grouped according to cellular role 
 
Cellular role category 
Nr. differentially expressed genesa 
Mid-exp Early-stat 
Up Down Up Down 
Amino acid biosynthesis 0 1 0 0 
Biosynthesis of cofactors/prosthetic groups/carriers  0 1 0 0 
Cell envelope  0 7 4 1 
Cellular processes  3 3 4 0 
Central intermediary metabolism 1 1 0 0 
DNA metabolism  1 0 4 0 
Energy metabolism  0 5 1 0 
Mobile and extrachromosomal element functions 2 13 11 7 
Protein fate  0 0 1 0 
Purine/pyrimidine/nucleoside/nucleotide  0 1 0 0 
Regulatory functions  0 3 4 0 
Signal Transduction 0 13 0 3 
Transcription 0 1 0 0 
Transport and binding protein  0 14 4 2 
Hypothetical proteins  8 36 29 6 
Unknown function  20 42 57 9 
TOTAL 35 141 119 28 
 176 147 
 
 
     aGenes assigned to more than one cellular role were counted twice. 
 
vanRB MUTANT INDUCED CHANGES IN THE EXPRESSION OF MGE 
DETERMINANTS 
The origin and number of genes found to be differentially expressed are 
represented on Figure 7. In mid-exponential phase a total of 157 genes were 
detected and from these 89 are located on MGE and only 58 are located on the 
“native” chromosome. In early-stationary phase, 118 out of the 147 differentially 
expressed genes belong to the MGE described for V583 genome and only 19 




Figure 7. Numbers and percentages of the genes with differentially expression levels plotted 
according to its mobile nature; a) at mid-exponential phase and b) at early stationary phase. 
 
There is not a preferential pattern of up- or downregulation among the genes 
belonging to different MGE (Figure 8). Overall, there is upregulation of genes from 
region 1, region 8 (phage 05) and region 11 (phage 06) and downregulation of 
genes from region 2 (phage 01) and region 03 (PAI). Regions 6, 12 (phage 06) 
and 13 (phage 07) have no representatives amongst the genes differentially 
expressed. The remaining regions have low number of genes being differentially 
transcribed. Within the same MGE the behavior of the genes is very consistent 
with all the genes adopting the same tendency (up- or downregulated).  
However, depending on the growth phase at which the cultures were 
sampled there are major differences. For example, at mid-exponential phase 
determinants from region 5 (phage 03) were not found to be differentially 
expressed. On contrary, at early-stationary the genes from region 6, region 7 
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(phage 04), region 9 and region 12 (phage 06) were not affected by vanR 
inactivation.    
 
 
Figure 8. Distribution of the genes differentially expressed in the vanR mutant within the mobile 
regions according to McBride et al. (2007)(McBride et al., 2007). 
 
According to Paulsen et al. (2003), the PAI (region 3) (EF0479-EF0628) 
contains an integrated plasmid (between EF0506-EF0485) that is likely a 
derivative from pTEF1-like plasmid. Curiously, the genes from this putative PAI-
integrated plasmid are downregulated at mid-exponential phase but suffered no 
change at early-stationary phase. There is an operon (kdpF-kdpA-kdpB-kdpC) 
encoding a predicted ATP-driven transport of potassium that is upregulated 
(except kdpF which was not detected in this study) at early-stationary phase and 
presents no change at mid-exponential phase. Potassium (K+) is essential for life 
in both prokaryotic and eukaryotic cells. K+ plays a vital role in bacterial osmotic 
adaptation, pH regulation, gene expression and activation of cellular enzymes. 
Also, both as an extracellular signal and as an intracellular metabolic regulator, 
plays critical role in adaptation to stressful environments in bacteria [for a review 
see (Ballal et al., 2007)]. Under extreme K+ limitation or osmotic upshock, the high 
affinity Kdp-ATPase is expressed (Laimins et al., 1981). We observe enhanced 
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transcription of EF0567 (kdpA)-EF0568 (kdpB)-EF0569 (kdpC) at early-stationary 
phase, however we did not detect differential transcription of EF0566 (kdpF) nor 
the regulatory system Ehk12-Err12 (EF0570-kdpD and EF0571-kdpE). The 
function of this two-component system is not clarified in E. faecalis but has likely 
the same function as the E. coli and L. monocytogenes Kdp regulator systems. 
 
COMPARISON OF THE EFFECTS OF vanB AND vanR INACTIVATION ON 
EXPRESSION OF MGE 
Although we cannot compare results from the two mutants, it is striking that 
the only common genes belong to MGE. Also, as we established the threshold 
values for the analysis of the results it became clear that the transcriptomic 
results from the inactivation of the two vancomycin resistance determinants were 
clearly different. 
Under the conditions tested the inactivation of either vanB or vanR genes 
resulted in a major adjustment of the transcriptional profile of the cell. Particularly 
unanticipated was the number of genes belonging to MGE that were differentially 
transcribed in both experiments. In fact, there is a considerable overlap and 83 
genes are common to both experiments, of which 74 are located in MGE (Figure 
9). However, some differences regarding genes located in MGE were observed, 
namely concerning region 11 and phage 06.  
VanR inactivation lead to differential expression of 29 genes of phage 06, but 
vanB deletion had no effect on phage 06 genes. Aakra and co-workers (2010) 
also report the up-regulation of genes from phage 06 when V583 is exposed to 
chloramphenicol (Aakra et al., 2010). The same authors describe the 
downregulation of PAI genes (Aakra et al., 2010). The behavior of the PAI genes 
is another major difference that we observe between the inactivation of these two 
genes. While with vanB inactivation the PAI genes were upregulated, vanR 
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inactivation lead to downregulation of PAI genes. This might indicate that MGE 
response to different cellular perturbations is specific to each disturbing 
factor/gene.     
 
 
Figure 9. Diagram representing the overlapping of differentially expressed genes in the two 
experiments (inactivation of vanB genes and vanRB gene). The numbers correspond to the total 
number of different genes differentially expressed in each experiment independently of the growth 
phase that they were detected. At the interception of each 2 circles is indicated the number of common 
genes in both experiments.  
 
With so restricted knowledge of the prophage functions on the enterococcal 
genomes is not a goal to speculate about it here. However, our observations 
might be helpful in the future to unravel the role of these prophages and 
eventually indentify conditions that trigger their lytic and lysogenic cycles.  
 
vanRB MUTATION INDUCED CHANGES IN THE EXPRESSION OF NON-MGE  
Analyzing the group of genes not located on mobile genetic elements we can 
observe that the ones with higher fold-change values are hypothetical or unknown 




Figure 10. Representation of the non-MGE determinants found to be differentially expressed in 
vanR mutant. Determinants are represented according to their location on the V583 genome and in 
function of their fold-change value; a) mid-exponential phase; b) early stationary phase. EF2298 
(vanS) is not represented. 
 
At mid-exponential phase the ORF with higher fold-change is EF0029 which 
encodes an aminotransferase with unknown function, followed by EF0413 (mltD) 
encoding a mannitol-1-phosphate 5-dehydrogenase, EF1033 encoding a 6 
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aminohexanoate-cyclic-dimer hydrolase, EF1385  encode a putative 
molybdopterin-guanine dinucleotide biosynthesis protein A, EF1810 (gspA-1) 
encoding a general stress protein, EF2978 and EF3210 encoding PTS system 
components and EF3284 encoding a putative cystathionine gamma-synthase. 
EF0413 (mltD) is putatively transcribed from the same transcriptional unit than 
EF0411 (PTS system, mannitol-specific IIBC component) and EF0412 (mltF), 
involved on the transport and phosphorylation of carbohydrates. The 
determinants that suffered most significative transcriptional alterations encode for 
proteins that belong to different functional groups. 
The transcriptional alteration of genes located on the V583 plasmids is just 
detected at mid-exponential phase. The fold-change for these genes is 
considerably high and are all downregulated. The majority of the plasmid-
associated genes encode for hypothetical protein but among them there is 
downregulation of the aggregation substance (asa1), the surface protein (prgC) 
and a TraG family protein. Actually, asa1 has the highest fold-change value with a 
transcriptional change of 10.9-fold. Aggregation substances enhance cellular 
aggregation or clumping facilitating plasmid transfer. Besides facilitating plasmids 
exchange potentially carrying virulence and antibiotic resistance traits, 
aggregation substances may increase adherence to intestinal and renal epithelial 
cells and to cardiac vegetations [for review see (Jett et al., 1994)]. It thus is 
reasonable to speculate whether asa1 transcription is vanR dependent or not and 
if the vanR mutant is affected on its conjugation potential and has a reduced 
virulence. However, further work is needed to elucidate the role of vanR in E. 
faecalis virulence aptitude. 
pTEF1 and the pAD1 share extensive sequence similarity and the 
aggregation substance asa1 encoded by pTEF1 is identical to the one of pAD1 
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(Paulsen et al., 2003). On the other hand pTEF2 share some regions of similarity 
with the sex pheromone plasmid pCF10, including identical copies of the 
conjugation genes prgA-prgB-prgC. According to Paulsen et al. (2003), asa1 is a 
virulence genes predicted to be surface exposed and is an integrin since it 
contains a putative integrin-binding motif, while prgC is a signal peptide (Paulsen 
et al., 2003).  
Also, at early-stationary phase the genes with the most significant fold-
change values encode for hypothetical and unknown function proteins. The 
exceptions are EF1012 encoding a PTS system subunit, EF1811 (gspA-2) 
encoding a general stress protein and EF1828 encoding a glycerol uptake 
facilitator protein. 
Comparing the results obtained for the vanR mutant with the results obtained 
on Chapter 4 for V583+Va10 µg/ml it is observed some overlap, with 33 genes 
common to both studies (Figure 11). 
 
 
Figure 11. Comparison of the transcriptional tendency of the genes found to be common to 
vanR mutant and V583 exposed to 10 µg/ml of vancomycin (Chapter 4).  
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The 10 min and the 30 minutes of vancomycin exposure correspond to the 
mid-exponential phase and to the early-stationary phase, respectively. Within this 
group of 33 genes we risk speculate that there are some genes which are 
regulated by vanR. Further studies, like gel shift mobility assays in presence and 
absence of induction by vancomycin, would be useful to confirm if vanR binds to 
the promoters of these vanR-regulated candidate genes. The genes we risk to 
point out as potentially regulated by vanR are the ones that present an opposite 
transcriptional behavior in both experiments. For example, if a gene is induced by 
vancomycin, assuming that the induction is vanR-dependent, in absence of vanR 
is expected to be down-regulated. Also, the strongest candidates are the ones 
that are differentially expressed at both sampling times, since are more likely 
related to vancomycin exposure and vanR absence than growth-related. We 
consider potential candidates for being vanR-dependent: EF2298 (vanS), EF2524 
(sortase family protein), EF2533 (FtsK/SpoIIIE family protein, involved in cellular 
processes), and the hypothetical proteins (EF2514, EF2519, EF2520, EF2521 
and EF2539). Also the hypothetical and unknown function proteins (EF0156, 
EF0443, EF2125, EF2126, EF2127 and EF2128), the PTS system components 
(EF1012 and EF1017) and EF2132 (recT protein, involved in DNA 
metabolism/mobile and extrachromosomal functions) are candidates however, 
they just presented differential expression at one of the sampling points. 
In absence of vanR gene it is likely that other regulator genes are 
differentially expressed to overcome vanR absence. Also, regulators which 
transcription is vanR-dependent are potential candidates for members of 
secondary regulation pathways. The regulatory proteins that were affected by 
vanR inactivation throughout the different growth phases are listed in Table 3. In 
mid-exponential phase 4 genes coding for potential regulatory proteins showed 
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higher expression in the wild-type strain than in vanR mutant and were not 
detected on early-stationary phase.  
There are two genes that were induced by vanR and encode for a two-
component system, the Ehk02-Err02. The Ehk-Err02 two-component system 
shares similarity with the LytSR system in Staphylococcus aureus and the LytST 
system in B. subtilis. In S. aureus, LytSR system affects the rate of autolysis and 
penicillin tolerance (Brunskill & Bayles, 1996). LytSR was shown to regulate 
lrgAB, whose gene products modulate murein hydrolase activity and penicillin 
tolerance (Groicher et al., 2000). LytSR system was found to sense decreases in 
∆ψ (Patton et al., 2006; Sharma-Kuinkel et al., 2009) and consequently induce 
lrgAB promoter activity (Sharma-Kuinkel et al., 2009). lrgAB operon activity is 
directly correlated with cidABC operon which has been shown to be a regulator in 
the control of cell death and lysis (Groicher et al., 2000). Furthermore, the LytSR 
regulatory system was found to be necessary for normal biofilm development. 
Table 3. Regulatory proteins influenced by vanRB inactivation 
Fold-change 





EF1423 transcriptional regulator, Cro/CI family - 3.1 
EF1886 transcriptional regulator, Cro/CI family -2.7 - 
EF2141 transcriptional regulator, Cro/CI family - 2.2 
EF2528 transcriptional regulator, Cro/CI family - 3.1 
EF2543 transcriptional regulator, putative - 2.2 
EF2981 
sigma-54 dependent DNA-binding response 
regulator 
-3.2 - 
EF3196 (RR02) response regulator -2.4 - 
EF3197 (HK02) sensor histidine kinase -2.4 - 
RR, response regulator; HK, histidine kinase; Minus (-) indicates downregulation. 
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In B. subtilis, a comprehensive analysis of the two-component regulatory 
systems by use of DNA microarrays has revealed that LytST controls the 
expression of ysbAB (Kobayashi et al., 2001). The YsbB protein is highly related 
to the lrgB gene product. Downstream of the E. faecalis HK-RR02 system is an 
operon with genes that share strong similarity to those of the lrgAB and ysbAB 
operons (EF3194-EF3193), suggesting the possibility that this two-component 
system is the E. faecalis orthologue of the Lyt system of S. aureus and B. subtilis 
(Hancock & Perego, 2002). However, no change in autolysis rate in a err02 
mutant was observed (Hancock & Perego, 2002). 
Five regulator genes differentially expressed are located on MGE and four of 
them were induced on the vanR mutant, meaning that in presence of an intact 
vanR these genes are repressed. Whether the differential transcription of these 
regulator genes is directly related to vanR absence or indirectly related by some 
kind of chromosomal destabilization is yet to be established.  
It is widely agreed that in bacteria the primary control of metabolism occurs at 
the transcription level. The wide range of determinants responding to inactivation 
of vanB and vanRB is a striking demonstration of the multitude and complexity of 
the transcription links that connect a large number of diverse cellular functions to 
a single gene involved on an alternative cell wall synthesis mechanism.  
A comprehensive description of the alterations at the transcriptomic level 
induced by two independent van-genes mutations was the objective of this 
chapter. Aware that these data need confirmation, our goal at this point was to 
formulate hypothesis and raise some questions. The alterations in the E. faecalis 
transcriptome described in this study hopefully give a clue on how a single gene 
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Unlike S. aureus, enterococci are not primary pathogens. Rather, they are 
normal components of the human bowel flora and are not problematic for healthy 
people, except as occasional agents of urinary tract infections. However, the 
genus has proven adept at causing opportunistic infections in hospital patients. 
These are mostly caused by E. faecalis, though infections caused by E. faecium 
raise greatest clinical concern because of a greater multidrug resistance in this 
species (Murray, 1990). 
The species of most concern have not changed in the last two decades but 
they have become more resistant. This directly implies less therapeutic options 
for critically ill patients that are infected with these opportunistic pathogens. 
Vancomycin-resistant enterococci are widespread, but are a greater problem in 
the US than in Europe. Many of the strains that cause hospital outbreaks in 
different countries represent expansion of a single successful clonal lineage by 
direct spread or repeated selection in multiple places. In addition, the horizontal 
spread of glycopeptide resistance genes is superimposed on this background. 
The biggest concern is the transfer of vancomycin resistance from enterococci to 
MRSA. Sporadic cases have already been documented in the US (Sievert et al., 
2008; Tenover, 2008; Zhu et al., 2008) but it is of utmost concern if this 
vancomycin resistance transfer events become common and frequent and raising 
the possibility that VanR-MRSA might supplant the other established health care 
MRSA clones.  
 Enterococci harbouring the most common vancomycin resistance 
operons, vanA or vanB, are high-level resistant or present variable levels of 
resistance to vancomycin, respectively. Lack of detection and control can result in 
endemic occurrence of the organism. So, it is of great clinical, social and 
economical importance that enterococcal strains are very well characterized and 
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closely monitored in order to draw a clear picture of the vancomycin resistance 
scenario. Consequently, the microbiology laboratory must be part of the first line 
of defense against the spread of VRE. 
In Europe, opposite to what happens in the United States for enterococci and 
in Europe for MRSA, VRE colonization is not restricted to the hospital setting. It is 
fundamental to know the dimension of vancomycin resistance, dissemination of 
resistance determinants and an accurate detection of VRE is mandatory to 
prevent strain dissemination. The work described in the first part of this thesis was 
focused on molecular and microbiological approaches for the identification of 
vancomycin resistance determinants among enterococcal dairy food and clinical 
human and veterinary isolates. 
 
Detection of vancomycin resistance determinants in Portugal 
Several studies have described fundamental differences in the epidemiology 
of vancomycin resistance in the United States and Europe (Goossens, 1998; 
Martone, 1998; Schouten et al., 2000). In Europe the initial VRE scenario 
consisted of polyclonal enterococcal population with a high diversity of Tn1546 
types in the community and with scarce presence on the nosocomial setting 
(Jensen et al., 1998; Schouten et al., 2001; Garcia-Migura et al., 2007). This 
epidemiological pattern seems to have changed in the last few years. Five 
European countries have reported prevalence rates of VRE in hospitals above 
20%. Frequent reports of nosocomial VRE outbreaks in most countries and a 
variable presence of these bacteria in community settings have been described 
(Leavis et al., 2006a). In chapter 2, we describe the screening of vancomycin 
resistance determinants among strains from different biological origins (human 
clinical, veterinary clinical – dog pets, dairy products – cheese and milk). Portugal 
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is currently one of the European countries with the highest VRE prevalence rate 
of invasive isolates in the nosocomial setting, has a frequent recovery rate in 
animals, healthy humans, and the environment, as seen in previous surveillance 
studies ( Novais et al., 2005a; Novais et al., 2005b; Novais et al., 2005c; Poeta et 
al., 2005; Novais et al., 2006). In our study it was determined that, within the 
sample screened and, although only one E. faecium VRE strain from a clinical 
sample was detected, vanA and vanB genes were found in a significative number 
of strains. vanA was detected in 40% of the clinical isolates and in 35% of the 
dairy food isolates whereas vanB was detected in 18% of the clinical isolates and 
in only 6.3% of the dairy food isolates. The incongruence between phenotype and 
genotype was explained by the fact that none of the isolates screened carried a 
complete Tn1546-like element. PFGE analysis of the vanA-carrying strains 
suggests that, in general, the isolates are not genetically related and that the 
dissemination of vanA gene is more likely to have been through transposable 
elements, like Tn1546-like elements, rather than by clonal dissemination. 
However, in a study by Novais et al. (2008) the authors point out that both clonal 
dissemination and horizontal transfer of particular genetic elements seem to play 
a relevant role in the recent wide dissemination of VRE in Portugal (Novais et al., 
2008). Moreover, common PFGE profiles among vancomycin resistant E. faecalis 
isolates from human origin and from cheese were found (Bertrand et al., 2000).  
The isolates studied in this work were isolated in the late 80s. Although this 
fact may, on one hand, justify the low frequency of VRE detection since 
vancomycin resistance has increased more recently, on the other hand hints that 
even before vancomycin resistance became a serious clinical concern the 
vancomycin resistance determinants were already spread among strains from 
clinical origin and, even more disturbing, among dairy food isolates. Enterococci 
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are found in a variety of food products, including milk and cheese produced in the 
south of Europe as non-starter lactic acid bacteria (Flahaut et al., 1997; Barros, 
1998; Lopes et al., 1999). In many of these cheeses enterococci play a key role in 
the maturation and final organoleptic characteristics of the food product and 
constitute the main micropopulation in the final product (Franz et al., 1999). 
Moreover, in Portugal cheese is part of the daily diet in rural areas as well as 
fashionable food products in urban centers. There are no studies on screening of 
VRE on dairy food isolates in Portugal. The available data on food isolates are 
restricted to samples isolated from poultry carcasses (Novais et al., 2005a; 
Novais et al., 2008) where the percentage of detected VRE is very high (>40%). 
Although there are studies indicating that vancomycin resistance determinants 
are spread from animals to humans (Simonsen et al., 1998; Klare et al., 1999) 
there are no unequivocal data and no demonstrated correlation between ingestion 
of food products containing enterococci and enterococci responsible for infections 
in humans (Phillips et al., 2004). This is still a question in debate and it is crucial 
to know how vancomycin resistance determinants are spread in different food 
products. Also, we detected vancomycin resistance determinants in clinical 
isolates from pets and in a previous study these same isolates were found to be 
highly multiresistant to the same antibiotics of human clinical isolates (de Fatima 
Silva Lopes et al., 2005), a fact that is of some concern due to the intimacy of 
pets with humans. However, in our study no genetic relatedness was found 
between human clinical and veterinary clinical isolates or between dairy isolates 
and human clinical isolates.  
The spread of vancomycin resistance, therefore, may not be confined to the 
spread of resistant strains. Clearly, further work is required to investigate and 
characterize the mobile element carrying vancomycin genes in strains for which 
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only the detection of some of the vancomycin determinants from the Tn1546-like 
element was possible. Techniques such as primer walking or an optimized 
inverse PCR might be used. Further work will hopefully provide new knowledge to 
gain more detailed insight and to prevent spread of infections caused by 
vancomycin resistant enterococci.  
    
As previously mentioned, Portugal is one of the European countries with the 
highest rate of reported VRE in the nosocomial setting but only a very limited 
number of studies on the molecular characterization of VRE isolated from 
portuguese hospitals have been published, and only focusing on the two 
enterococcal species most commonly found in hospitals. In chapter 3 we 
performed the molecular characterization of four vancomycin resistant E. faecium 
isolated from a hospital in the center of Portugal (Leiria). Although the prevalence 
of VRE in this region of the country is unknown, we were informed that VRE 
detection by the hospital microbiology laboratory was uncommon. 
From the four VREfm strains identified by the hospital routine screening, at 
the arrival to our laboratory only three presented a MIC value compatible with the 
high-level vancomycin phenotype reported to us, although all strains were positive 
for vanA gene. The three confirmed VREfm strains were genetically related as 
proven by PFGE profile analysis, belong to ST18, ampicillin and ciprofloxacin 
resistant and carried esp gene, which makes us classify them as belonging to the 
global hospital-adapted clonal lineage CC17. ISEf1 insertion sequence was 
detected in the vanX-vanY intergenic region in these strains. ISEf1 insertion 
sequence (IS30 family), together with IS1216 (IS6 family), is one of the most 
frequently detected insertion sequences within Tn1546 (Novais et al., 2008). 
ISEf1 was first identified within Tn1546 among clinical Portuguese strains (Novais 
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et al., 2004), but these Tn1546 variants might be currently dispersed among 
European hospitals as they have recently been identified in enterococcal strains 
from a hospital outbreak in Germany (Werner et al., 2008). Transposon 
polymorphisms have been demonstrated for the first time by Handwerger et al. 
(1995) (Handwerger & Skoble, 1995). More recently, several more studies on the 
determination of genetic polymorphisms in Tn1546 have been published (Jensen 
et al., 1998; Woodford et al., 1998; Novais et al., 2008; Sung et al., 2008; Lopez 
et al., 2010). A common finding of these later studies was that although the 
coding potential for resistance remains generally unaffected, transposon 
polymorphisms could be detected quite easily. The presence of additional 
insertion elements in intergenic positions or deletions at the transposon termini is 
encountered frequently. The characterization of Tn1546 polymorphism allows 
tracking of transposon types, identification of source-specific transposons and, 
from this knowledge, several epidemiologic scenarios can be envisaged. 
Epidemic VRE can be identified and in the UK, for instance, there are examples 
of strains that seem to have travelled long distances (Morrison et al., 1995). 
Certain VRE are capable of highly efficient bacterial transfer from patient to 
patient in the hospital environment (Pegues et al., 1997), as was the case of 
Leiria Hospital VREfm strains. On the other hand, long-term colonization with a 
single type of VRE in a single individual has also been observed (Bonten et al., 
1998). In contrast, in certain hospital settings, highly promiscuous transposon 
types have been described. Instead of epidemic spread of a strain, a specific 
Tn1546 type is encountered in various VRE genomes. In conclusion, the spread 
of vancomycin resistance is facilitated by the epidemic capacity of both strains 
and transposons. In combination with the large number of environmental and 
animal reservoirs that have already been identified, at least in Europe, this means 
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that the clinical threat posed by VRE may not be easily overcome in the near 
future.  
The E. faecium ST17 lineage is predicted to be the founder of the designated 
complex-17 (Willems et al., 2005). ST17 evolved through genetic diversification, 
including mutations and recombination, and became the most successful hospital-
adapted subpopulation which has spread globally (USA, Europe, Asia, Australia, 
Africa and South America). CC17 seemed to be responsible for the worldwide 
emergence of nosocomial VRE, as most of the infection related and outbreak 
strains belong to this complex. CC17 isolates possess a wide group of features 
that makes them successful conquers of the nosocomial environment. In addition 
to being ampicillin resistant they are also characterized by high levels of 
quinolone resistance ( Torell et al., 2003; Coque et al., 2005; Leavis et al., 2006b) 
due to point mutations in gyrA and parC, in the quinolone resistance determining 
region (Leavis et al., 2006b). It is interesting that E. faecium isolates that 
harboured amino acid substitutions in the DNA mismatch repair proteins MutS 
and MutL belong to CC17 (Willems et al., 2003), which may suggest that CC17 
isolates are more prone to undergo mutations. In addition to resistant traits, the 
majority of CC17 isolates are characterized by the presence of a putative 
pathogenicity island of at least 14 kb (Leavis et al., 2004) carrying the esp gene  
(Willems et al., 2001; Coque et al., 2002; Leavis et al., 2003, Willems et al., 
2005). On the putative E. faecium PAI, the genetic region contained seven ORFs, 
representing putative genes implicated in virulence (nox and muramidase), 
regulation of transcription (a sigma-like factor and araC), antibiotic resistance (a 
multidrug resistance efflux pump) and potentially mobilization of the putative PAI 
(a hypothetical bacteriophage protein). This pathogenicity island is completely 
different from the esp-containing PAI previously disclosed in E. faecalis (van 
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Schaik et al., 2010). Furthermore, hyl, the putative virulence gene encoding a 
hyaluronidase (Rice et al., 2003), was enriched in CC17 isolates (Klare et al., 
2005; Oh et al., 2005). All these findings suggest that hospital-adaptation of CC17 
has been a multi-step process involving the sequential acquisition of adaptative 
mechanisms that provide CC17 with selective advantages, thus enabling the 
acquisition of even more adaptations. From our data on clinical VREfm, we 
learned that also in Portugal enterococcal infections in hospitalized patients are 
caused by E. faecium CC17 isolates. Since CC17, representing multidrug 
resistant isolates, already succeeded in acquiring resistance and virulence traits, 
development of resistance to recently introduced antibiotics seems inevitable. 
Furthermore, linkage of antibiotic resistance genes with post segregational killing 
systems, as demonstrated for vancomycin resistance genes (Sorum et al., 2006; 
Dahl et al., 2007, Moritz & Hergenrother, 2007, Sletvold et al., 2007,), predicts 
that reduction in antibiotic use may not result in reduced numbers of resistant 
enterococci. New strategies need to be developed to combat this multiresistant 
bacterium in hospitals. Identifying genes that might contribute to survival and 
spread in hospitals is mandatory. Unraveling how the bacterium can use CC17 
specific genes, most likely in concert with core genes, to colonize the human host 
and invade susceptible subjects is the necessary next step. The development of 
selective therapies directed at CC17, such as vaccines, phages or selective 
antibodies, seems a promising approach to combat the bacterium. 
 
Infections commonly caused by enterococci include urinary tract infections, 
endocarditis, bacteremia, catheter-related infections, wound infections, and intra-
abdominal and pelvic infections. Many infecting strains originate from the patient's 
intestinal flora. From here, they can spread and cause urinary tract infection, 
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intra-abdominal infection, and surgical wound infection. Enterococcal wound 
infections often manifest as part of a mixed infection (Giacometti et al., 2000). In 
chapter 3 we provide the first report of two cases of surgical wound infections due 
to E. hirae. The majority of enterococcal strains isolated from human specimens 
belong to the species E. faecalis and E. faecium. Other enterococcal species are 
rarely isolated. The E. hirae species is known to cause infection in a range of 
young farmed species and psittacine birds (Devriese et al., 1991; Devriese et al., 
1992), rats (Etheridge et al., 1988), kittens (Lapointe et al., 2000) but is very rare 
in humans. The first description of E. hirae infection in humans, by Gilad et al. 
(1998), reported a case of septicemia in a patient with end-stage renal disease 
undergoing hemodialysis (Gilad et al., 1998). More recently, Poyart et al. (2002) 
reported a case of patient with native valve endocarditis due to E. hirae (Poyart et 
al., 2002). In our study, as well as in the other two reported cases, the E. hirae 
strains responsible for the infections are still susceptible to the commonly used 
antibiotics for treatment of enterococcal infections. However, close monitoring of 
the spectrum of etiological agents in certain hospital setting is crucial for early 
detection of cases of uncommon strains causing infections that might have 
acquired antibiotic resistance determinants, thus jeopardizing the available 
therapeutics. 
 
In the second part of this Doctoral work we carried out a more extensive 
study on the effects of vancomycin exposure and how E. faecalis copes 
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Identification of new players and their roles in response to vancomycin 
In hospitals, 190 million doses of antibiotics are administered each day. 
Among non-hospitalized patients, more than 133 million courses of antibiotics are 
prescribed by doctors each year, and many of these prescriptions are 
unnecessary. 
Ideally, and by principle, the choice of a certain therapeutic protocol relies on 
the susceptibility of the etiological agent causing infection to the available 
antibiotics and on the pharmacokinetics of the drug of choice. The principle is in 
its essence correct but is vital to be aware that when one antibiotic (or a 
combination of antibiotics) is administered to a patient it will not only have an 
effect on the target microorganism but affects the whole patient microbiota. Also, 
during the course of treatment, at times, the antibiotic reaches concentrations in 
blood, serum and tissues that are below the therapeutic concentration.  
In chapter 4, we compared the expression levels of E. faecalis V583 under 
exposure to a subinhibitory vancomycin concentration using a whole genome-
based approach. This study was the first to evaluate the effect of vancomycin 
exposure to a subinhibitory dose on the expression profile of E. faecalis. Other 
studies report the effects of vancomycin exposure on other genus such as B. 
subtilis (Cao & Helmann, 2002; Wecke et al., 2006), S. aureus (Kuroda et al., 
2003; McAleese et al., 2006; McCallum et al., 2006), S. pneumoniae (Haas et al., 
2005) and M. tuberculosis (Provvedi et al., 2009). Apart from all the differences in 
the design of the experiments, it is unanimous that vancomycin exposure affects 
globally the transcriptomic profile of a strain and that exposure to subinhibitory 
concentrations potentiate the number of genes with altered transcription. This 
study brought new insights and contributed to the general knowledge on E. 
faecalis response to vancomycin. Our data is fundamental to help establishing a 
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vancomycin stimulon for E. faecalis which would constitute a valuable tool for 
antibacterial drug development with the recognition of new targets.  
However, from this study there are questions that remain unanswered and 
that would be interesting to further investigate. Establishing the connection 
between exposure to subinhibitory vancomycin concentrations and virulence, or 
persistence in the host, would provide additional support for prudent vancomycin 
use. Previous studies have suggested that antimicrobial agents can affect the 
expression of virulence genes in bacteria (Yim et al., 2006). Thus, it would be 
interesting to determine whether the increased transcription of putative virulence-
associated genes is related with an increased ability of vancomycin-treated 
enterococci to invade host cells.    
Another interesting outcome of this study was the identification of an ORF 
(EF2292) annotated as a putative hypothetical protein that presented the same 
levels of induction as the specific vancomycin resistance genes from the vanB 
operon. EF2292 is located on the E. faecalis V583 chromosome upstream of the 
vanXB gene. In chapter 5 we provide a new scheme for the composition of the 
vanB operon in E. faecalis which includes the EF2292 ORF, renamed in this work 
as vanV. We state that VanV does not contribute to E. faecalis V583 vancomycin 
resistant phenotype. It is most likely an accessory protein, such as VanW, but its 
contribution for the overall function of the operon, if there is one, as well as its role 
in the cell remain to be clarified.  
 
From the microarray data obtained in chapter 4 we got new information on 
regulatory genes putatively involved, directly or indirectly, in vancomycin 
response. Two TCSs were induced in the presence of vancomycin (TCS05 – 
CroRS, and TCS06) none never before unequivocally related to vancomycin 
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resistance. However, and since TCSs are, by definition, the prototypical stimulus-
response coupling mechanism we decided to further investigate the role of these 
two TCSs in response to vancomycin exposure. In chapter 6, we performed RT-
PCR experiments using croR and err06 mutants in V583 and JH2-2 genetic 
backgrounds and measured the induction of those genes and of vanB operon 
genes after exposure to vancomycin. We confirmed that both CroRS and Err06-
Ehk06 respond directly to vancomycin, regardless of the presence of vancomycin 
resistance gene cluster. We hypothesize that CroRS is likely sensing 
perturbations induced by vancomycin on the bacterial cell-wall and its induction 
probably triggers or provides the signals for vancomycin induction of both VanRS 
and TCS06. These results contribute for clarifying the cellular role of these two 
TCSs. However, and despite the involvement of CroRS in the response to other 
cell-wall active antibiotics has been described and TCS06 has been previously 
associated with response to oxidative stress, the mechanisms are not yet fully 
understood. Our work gives new insights on the functions of these two TCSs.  
 
In the 80s, when vancomycin was re-introduced in the clinical practice, it was 
not predictable that resistance would arise so promptly. Since vancomycin does 
not get inside the bacterial cell but targets cell-wall precursors, it was generally 
assumed that vancomycin-resistant organisms would be difficult to generate. 
However, shortly after vancomycin re-introduction the first vancomycin resistant 
Enterococcus was isolated (Leclercq et al., 1989). Although it is not fully 
understood how such a unique and complex resistance mechanism came 
together in enterococci, the fact is that, from the bacteria point of view, it is a very 
successful resistance mechanism. 
In chapter 7 we describe the development of vancomycin resistance 
phenotype when susceptible enterococci are submitted to serial passages in the 
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presence of the antibiotic. Several in vitro and in vivo studies in Staphylococcus 
spp. have documented the stepwise development of resistance either to 
vancomycin or teicoplanin (Kaatz et al., 1990; Biavasco et al., 1991; Shlaes et al., 
1993; Hiramatsu, 1998; Howe et al., 1999; Sieradzki et al., 1999; Kuroda et al., 
2000). In general, these studies indicate that the induction of resistance occurs 
but at a low frequency, bacteria reach a low-level of resistance. Moreover, the 
selection of resistance subpopulations is more successful for teicoplanin. Our 
study raises new questions regarding the development of vancomycin resistance 
by antibiotic induction, since the enterococcal strains we tested are fundamentally 
different from the staphylococci strains used on the above mentioned studies. 
Staphylococci do not possess a specific resistance mechanism for glycopeptides. 
We only observed development of resistance in strains which harbouring some 
vancomycin resistance mechanism, either van genes or the croRS and err06-
ehk06 (chapter 6), had one of the genes involved in the resistance mechanisms 
disrupted. Since we were not successful in inducing vancomycin resistance in 
enterococcal strains with no vancomycin resistance-related genes, it is likely that 
the induction of resistance in susceptible enterococci and staphylococci occurs by 
different mechanisms and involves different cellular tools. However, the induction 
of vancomycin resistance in strains harbouring van-resistance-related genes is 
very successful and the strains develop stable MICs compatible with high-level 
resistance. Considering the stability of the phenotype and the absence of 
detection of chromosomal mutations or rearrangements, the hypothesis of 
transcriptomic alterations or stabilization of phenotypic mutations become 
reinforced. Further work is needed to clarify the mechanisms beneath the 
induction of resistance in these strains 
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Despite the glycopeptide-specific differences, teicoplanin- and vancomycin-
resistant mutants resulting from in vivo or in vitro exposure of staphylococci to the 
antibiotics have some biochemical and morphological changes in common, in 
particular significant cell wall thickening, increased penicillin-binding protein 2 
production, and an increased binding capacity for glycopeptides by peptidoglycan 
(Shlaes et al., 1993; Hiramatsu, 1998; Sieradzki et al., 1999; Kuroda et al., 2000). 
In order to obtain further knowledge on the induction mechanism it would be 
interesting to perform microarray experiments and compare the transcriptomic 
profile of one of our adapted strains before and after passages in the presence of 
vancomycin. This would clarify what happens at the transcription level. From the 
transcriptional data we could possibly identify potential proteins that might be 
produced, repressed or stabilized in order to stabilize the resistant phenotype. 
Also, a longer experiment submitting the strains, after induction in presence of 
vancomycin, to more passages in non-selective medium would provide more 
information regarding the stability of the alteration. It would be of utmost 
importance to perform induction experiments using an in vivo model to 
understand if it occurs in the host and at what extent.  
 
The fact that vancomycin resistance genes are stable and kept on the 
chromosome of host bacteria (as described in chapter 2) even in the absence of 
selective pressure, might be an indication that genes belonging to vancomycin 
resistance operons might have a role on other cellular processes. In chapter 8 we 
performed microarrays using two mutants in genes essential for vancomycin 
resistance (vanB and vanR) and we searched for genes putatively connected to 
van operon genes, in an attempt to unravel any possible gene network involving 
vanB operon. We observed that a wide number of genes are affected by the 
Chapter 9 
 351 
absence of these genes, corroborating our theory of extra-vancomycin resistance 
functions for these genes.  
Many genes located on mobile genetic elements were affected by the 
absence of vanB and vanR genes. In the light of the current knowledge it is 
difficult to elaborate a unifying hypothesis for this observation. One may speculate 
that the inactivation of these genes cause a chromosome destabilization and that 
the mobile regions, namely the prophages, sense this destabilization and alter 
their expression in order to initiate a lysogenic phase, and keep integrated on the 
genome. PCR with specific primers for the sites of integration of the phages could 
be performed, providing information if the phage is integrated within the 
chromosome or if it was excised. This information would be very useful to unravel 
the role of phages on the stability of enterococcal genomes. The data presented 
in chapter 8 constitute valuable information to explain the role of prophage genes 
in the bacterial metabolism. However, we are still a long way from a complete 
understanding of how vanB and vanR genes influence the transcription of 
functional unrelated genes. Further work is needed to clarify whether the effects 
of vanB and vanR genes on the metabolic pathways and genes found in this 
study are direct or indirect. For instance, performing gel shift assays using VanR 
protein to test to which promoters the VanR protein binds to would give valued 
information on the genes directly regulated by this protein.  
 
The results from this Doctoral work have answered some questions but many 
new ones have been raised. The results obtained can be applied to better 
understand the stress response mechanism in E. faecalis. As such, we believe 
that the analysis of the global response to vancomycin exposure carried out in the 
course of this project may be extrapolated to other cell-wall active antibiotics and 
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contribute to the design of new anti-bacterial agents active and effective against 
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High-resolution structural information on optimally preserved bacterial cells can be obtained with cryo-
electron microscopy of vitreous sections. With the help of this technique, the existence of a periplasmic space
between the plasma membrane and the thick peptidoglycan layer of the gram-positive bacteria Bacillus subtilis
and Staphylococcus aureus was recently shown. This raises questions about the mode of polymerization of
peptidoglycan. In the present study, we report the structure of the cell envelope of three gram-positive bacteria
(B. subtilis, Streptococcus gordonii, and Enterococcus gallinarum). In the three cases, a previously undescribed
granular layer adjacent to the plasma membrane is found in the periplasmic space. In order to better
understand how nascent peptidoglycan is incorporated into the mature peptidoglycan, we investigated cellular
regions known to represent the sites of cell wall production. Each of these sites possesses a specific structure.
We propose a hypothetic model of peptidoglycan polymerization that accommodates these differences: pepti-
doglycan precursors could be exported from the cytoplasm to the periplasmic space, where they could diffuse
until they would interact with the interface between the granular layer and the thick peptidoglycan layer. They
could then polymerize with mature peptidoglycan. We report cytoplasmic structures at the E. gallinarum
septum that could be interpreted as cytoskeletal elements driving cell division (FtsZ ring). Although immu-
noelectron microscopy and fluorescence microscopy studies have demonstrated the septal and cytoplasmic
localization of FtsZ, direct visualization of in situ FtsZ filaments has not been obtained in any electron
microscopy study of fixed and dehydrated bacteria.
Gram-positive bacteria possess a cell envelope composed of
a plasma membrane and a thick network of peptidoglycan,
secondary acids, and proteins, which maintains cell shape and
provides resistance to osmotic pressure (39). Electron micros-
copy studies performed on fixed (either chemically or by freez-
ing) and dehydrated specimens favored the widely accepted
model of the cell envelope consisting of the peptidoglycan
network in direct contact with the plasma membrane (4). Nev-
ertheless, the existence of a periplasmic space separated from
the cytoplasm and the outer medium by a plasma membrane
and a thick cell wall has been suggested by previous bio-
chemical studies (3, 14, 25). Recent data obtained with
cryo-electron microscopy of vitreous sections (CEMOVIS),
a method that allows the observation of biological specimens in
the closest-to-native state, challenged the classical model (23,
24). CEMOVIS consists of cooling the specimen at high pres-
sure so rapidly that water cannot crystallize and instead be-
comes vitreous. Water stays liquid, but its viscosity dramati-
cally increases (10). It is then possible to make thin sections at
low temperatures and observe them using a cryo-electron mi-
croscope (1). Consequently, water does not need to be re-
moved from the sample, and molecular aggregation is sup-
pressed (11). Moreover, CEMOVIS is performed in the
absence of any stain so that contrast in the image is propor-
tional to density variations in the sample. Using this tech-
nique, Matias and Beveridge previously demonstrated that
Bacillus subtilis 168 and Staphylococcus aureus possess a
periplasmic space (termed the inner wall zone [IWZ]) lying
between the plasma membrane and the mature peptidogly-
can (termed the outer wall zone [OWZ]) in which molecules
should be able to freely diffuse (23, 24). Those authors
proposed that the low-density periplasmic space seen with
CEMOVIS corresponds to the electron-dense innermost
layer observed in stained sections of freeze-substituted
gram-positive bacteria (15). Accordingly, they suggested
that the periplasmic space is filled with a low-density mate-
rial that has a high affinity for heavy metal stains (23).
The general pathway of peptidoglycan synthesis is as follows:
(i) generation of nucleotide sugar-linked precursors UDP-N-
acetylmuramyl-pentapeptide and UDP-N-acetylglucosamine
in the cytoplasm, (ii) dimerization and translocation through
the plasma membrane, and (iii) cross-linking of the periplas-
mic precursors with mature peptidoglycan via transglycosyla-
tion and transpeptidation reactions. This last step is performed
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by a set of membrane-bound proteins, termed the penicillin-
binding proteins (PBPs) (37, 40). Several studies have shown
that translocated peptidoglycan precursors and PBPs are con-
fined to specific areas of the bacterial cell (8, 27, 31, 32, 36). In
particular, most gram-positive bacteria have them concen-
trated at the septum, indicating that polymerization of the
mature peptidoglycan happens at least partly in this area (37).
The septum is a cellular structure consisting of a ring of invag-
inating cell envelope. In the vast majority of bacterial species,
its development, eventually leading to cell division, is orches-
trated by FtsZ, a protein homologous to eukaryotic tubulin
(22, 44). FtsZ is expected to form a ring beneath the septal
plasma membrane, although such structures have never been
observed by any electron microscopy study (5, 45).
Because PBPs are bound to the plasma membrane, it is
generally considered that polymerization takes place at the
contact between the plasma membrane and the mature pepti-
doglycan. Evidence for the presence of a wide periplasmic
space (22.3 nm in B. subtilis and 15.8 nm in S. aureus) raises
questions about the spatial organization and the mechanism of
assembly of peptidoglycan. In their recent publication, Matias
and Beveridge reported that at least part of the septum of S.
aureus possesses a periplasmic space (24). The deeper part of
the septum where the plasma membrane is curved, which we
define as the constriction ring, was not investigated at high
resolution. Whether mature peptidoglycan is in contact with
the plasma membrane at this place thus remained an open
question, which we have investigated.
We report the structure of the cell envelope of three gram-
positive bacteria (B. subtilis, Enterococcus gallinarum, and
Streptococcus gordonii) revealed by CEMOVIS. In the three
cases, we observed a previously undescribed granular layer
(GL) adjacent to the plasma membrane in the periplasmic
space. The structure of peptidoglycan assembly sites in the
coccus species (E. gallinarum and S. gordonii) suggests a com-
mon mechanism of peptidoglycan cross-linking. We propose
that nascent peptidoglycan diffuses into the periplasmic space
and is cross-linked by components of the granular layer to form
mature peptidoglycan. Finally, CEMOVIS revealed cytoplas-
mic structures associated with the constriction ring, which
could be interpreted as being FtsZ complexes.
MATERIALS AND METHODS
Culture conditions. B. subtilis 168 and B. subtilis W23 were cultured in TS
medium [1.4% K2HPO4, 0.6% KH2PO4, 0.2% (NH4)2SO4, 0.1% Na3-citrate ·
2H2O, 0.02% MgSO4 · 7H2O, 5 M MnSO4, 0.5% glucose, 0.5% Na-glutamate,
and 0.001% yeast extract prepared in bidistilled water] (41) at 37°C with aera-
tion. Cells were harvested after the end of the exponential growth phase (optical
density at 600 nm [OD600] of about 2.0). S. gordonii Challis (33) and E. gallina-
rum DSMZ 20628 (DSMZ, Braunschweig, Germany) cells were cultured in brain
heart infusion (BHI) broth (Oxoid Ltd., Hampshire, United Kingdom) at 37°C
without aeration. S. gordonii cells were harvested in the middle of the exponential
growth phase (OD620 of about 0.5). E. gallinarum cells were harvested after the
end of the exponential growth phase (OD600 of about 1.6). In control experi-
ments, S. gordonii cells were grown in BHI broth supplemented with 10% glyc-
erol (10% glycerol–BHI) and harvested in the middle of the exponential growth
phase (OD620 of about 0.5).
Vitrification and cryosectioning. B. subtilis and S. gordonii cells were washed
twice in phosphate-buffered saline (PBS) supplemented with 20% dextran (20%
dextran–PBS) (average mass, 40 kDa; Sigma-Aldrich, Buchs, Switzerland). E.
gallinarum cells were washed twice in water supplemented with 20% dextran.
Cells were then introduced into copper tubes and high-pressure frozen with an
EM PACT high-pressure freezer (Leica, Vienna, Austria). The tubes were
trimmed at 140°C in an FCS Ultracut S cryomicrotome (Leica). Ultrathin
sections were produced with a 45° diamond cryo-knife (Diatome, Biel, Switzer-
land) at a nominal thickness of 50 nm and at a nominal cutting feed of 1 mm/s.
For control experiments, S. gordonii cells were washed twice in 10 mM HEPES
(pH 7.0) supplemented with 10% glycerol (10% glycerol–HEPES). After the last
centrifugation, the excess medium was absorbed with filter paper. The concen-
trated pellet was introduced into a sandwich aluminum carrier (sample cavity
depth, 200 m; Bal-Tec, Balzers, Liechtenstein). Empty space was filled with
1-hexadecene. Cells were then vitrified using an HPM 010 high-pressure freezer
(Bal-Tec). At 140°C, the cells were mounted onto a specimen holder covered
with cryoglue (mixture of ethanol-isopropanol [ratio, 1:3]) (34). Blocks were
trimmed, and ultrathin sections were produced at 160°C.
Cryo-electron microscopy. Sections were transferred onto carbon-covered
1,000-mesh copper grids (Agar Scientific, Essex, United Kingdom). Grids were
transferred to a Gatan cryoholder (Gatan, Warrendale, PA) kept at a tem-
perature below 170°C and inserted into a CM100 cryo-electron microscope
(Philips, Eindhoven, The Netherlands) equipped with an LaB6 cathode. The
accelerating voltage was either 80 or 100 kV. Specimens were irradiated with a
low electron dose. Electron diffraction was used to check whether water was
vitreous or crystalline. Crystalline sections were discarded. Images were recorded
with a TemCam-F224HD charge-coupled-device camera (Tietz Video and Im-
age Processing Systems, Munich, Germany) at magnifications ranging from
1,350 to 22,500. No image processing other than that described in the figure
legends was performed.
Dimension measurements. Pixel size and post magnification factor were cali-
brated by using a two-dimensional catalase crystal (Agar Scientific). Dimensions
were measured using images recorded at a magnification of 22,500. At this
magnification, the post magnification factor is 1.69 and the pixel size is 0.63 nm.
The horizontal resolution is therefore approximately 1.3 nm. During cryosec-
tioning, material was compressed along the cutting direction. We could not
precisely determine the average compression rate because the studied specimens
were not perfectly spherical. By analogy to our previous study, where we used
similar cutting conditions, we estimate the average compression rate to be 0.2 to
0.3 (46). Nevertheless, it has been shown that compression does not affect
dimensions measured perpendicularly to the cutting direction (11). Dimensions
were measured accordingly with ImageJ software (NIH, Bethesda, MD). Aver-
age-density profiles were recorded along rectangular selections with ImageJ. The
width of selection rectangles is specified in the figure legends.
RESULTS
Aspect of vitreous sections. A typical section of S. gordonii
cells vitrified in 20% dextran–PBS is shown in Fig. 1. It is devoid
of crevasses, chatter, and cracks, which are the most severe arti-
facts induced by cryosectioning and which complicate image in-
FIG. 1. Low-magnification view of a cryosection of S. gordonii. Ar-
rows, knife marks; asterisks, ice contamination; arrowhead, lysed cell.
Bar, 1 m.
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terpretation because they are not homogenous in space. Only
homogenous deformation, namely, compression along the cutting
direction and knife marks, cannot be avoided. A low level of ice
contaminations lies on the surface of the section.
Granular layer in the periplasmic space. The structures of
the envelopes of three representative species of gram-positive
bacteria (S. gordonii, B. subtilis, and E. gallinarum) are shown
in Fig. 2. Images are two-dimensional projections of three-
dimensional sections, and for geometrical reasons, the enve-
lope is clearly visible, and membranes look sharp only when
they are aligned with the electron beam (see reference 46 for
a schematic explanation). Therefore, an apparent discontinuity
of a membrane (e.g., bottom of Fig. 2A) is most likely due to
a change in the orientation of the plasma membrane. This
statement is supported by stereo-pair images (data not shown).
As described previously by Matias and Beveridge, who used
CEMOVIS, the envelope consists of a plasma membrane, a
low-density IWZ identified as a periplasmic space, and a high-
density OWZ corresponding to the network of cell wall poly-
mers (23, 24). In addition, a previously unreported dense GL in
the IWZ is visible in most of our images and in each of the
investigated species. It is more contrasted and therefore denser
in S. gordonii (Fig. 2A and B) and B. subtilis (strains W23 [Fig.
2C] and 168 [data not shown]) than in E. gallinarum (Fig. 2D
and E). Images were recorded with defocus values ranging
from 1.5 m to 5.7 m, which corresponds to the first
minima of the contrast transfer function in the range from 2.3
nm to 4.7 nm. A GL is visible over this whole range, indicating
that it is not an optical artifact. The GL is 3 to 4 nm thick and
is 8 to 9 nm distant from the plasma membrane. Measurements
of thickness and the positions of the envelope structures are
summarized in Table 1. In S. gordonii cultures, a small propor-
tion of lysed cells are present (Fig. 1, arrowhead). Similarly to
observations in osmotically lysed cells described previously by
FIG. 2. Structure of the cell envelope of three gram-positive species. (A) S. gordonii. (B) Higher magnification of the square in A. (C) B. subtilis
W23. (D and E) E. gallinarum. (F) S. gordonii lysed cell. (G) S. gordonii cell grown and vitrified in the presence of 10% glycerol. (H to J) Density
profiles acquired perpendicularly to the cutting direction through the cell envelope of S. gordonii (H), B. subtilis W23 (I), and E. gallinarum (J).
They were not acquired on the images shown in A to E. GL, granular layer; IWZ, inner wall zone; OWZ, outer wall zone; PM, plasma membrane.
Arrowheads, which are perpendicular to the cutting direction, show the regions where dimensions of the uncompressed layers of the cell envelope
can be accurately measured. B, D, E, F, and G were denoised by Gaussian filtering (radius, 1 pixel). Density profiles in H, I, and J have been
obtained from images denoised by Gaussian filtering (radius, 1.5 pixels) and have been averaged over a width of 60 pixels (H), 33 pixels (I), and
69 pixels (J). Bars, 50 nm (A to G) and 20 nm (H to J).
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Matias and Beveridge, the IWZ thickness is larger and highly
variable in every single lysed cell, suggesting that the plasma
membrane and OWZ are not bound anymore (Fig. 2F) (23,
24). Also, in agreement with the observations reported previ-
ously by those authors, the OWZ is thicker in lysed cells than
in normal cells (Table 1). This increase is consistent with lysis-
induced release of osmotic pressure acting on the OWZ, al-
lowing the relaxation of cell wall polymers (23, 24). In some of
the lysed cells, a GL is parallel to the plasma membrane (Fig.
2F). The GL is slightly closer to the plasma membrane in lysed
cells than in normal cells, but its thickness and granular aspect
are identical in both kinds of cell (Table 1).
Dextran does not induce the granular layer. Dextran was
used as a cryoprotectant because it produces a minimal os-
motic effect due to its high molecular weight, and it provides
good cryosectioning properties (2). In order to rule out the
possibility that the previously undescribed GL is an artifact due
to the sudden addition of dextran to the extracellular fluid, S.
gordonii cells were grown in medium containing 10% glycerol
as described previously (23, 24) and high-pressure frozen in a
buffered solution containing the same amount of this cryopro-
tectant. S. gordonii cells grew similarly with or without glycerol.
The only difference was a slight decrease in the growth rate
(doubling time, 37 min without glycerol; doubling time, 48 min
with glycerol). Cryosections of good quality were rarely ob-
tained when glycerol was used instead of dextran. However, in
the regions devoid of the severe artifacts that we could occa-
sionally obtain, the cell envelope is the same as that in S.
gordonii cells cryoprotected with 20% dextran (Fig. 2G).
Structure of the outer wall zone. B. subtilis 168 IWZ and
OWZ thicknesses are similar to previously published values
(Table 1) (23). The density of the OWZ fades from the inner
face to the outer face in B. subtilis (168 and W23) (Fig. 2I) and,
less steeply, in S. gordonii (Fig. 2H). The structure of the E.
gallinarum OWZ is different: it is subdivided into three layers
of different densities (Fig. 2J). This feature is best visible in
Fig. 2E. The first layer (OWZ1) is close to the inner face, the
second layer (OWZ2) corresponds to the central portion, and
the third layer (OWZ3) is close to the outer face of the OWZ.
The central portion is less dense than the first and the third
portions. The thickness of OWZ1 is smaller and more constant
among individuals than the thicknesses of OWZ2 and OWZ3
(Table 1).
Structure of the E. gallinarum septum. Is the structure of the
cell envelope different in cellular domains involved in pepti-
doglycan cross-linking? In E. gallinarum, peptidoglycan precur-
sors are translocated at the septum (T. Ribeiro, M. Ruivo, and
F. Lopes, unpublished data). A cell with septa at two different
steps of formation is shown in Fig. 3A. High-magnification
views of septa of this cell and other cells are shown in the rest
of Fig. 3. The OWZ enters the septum already at the initial
step of its formation (Fig. 3B) and develops during constriction
of the septum (Fig. 3C, D, and E). The GL and IWZ also enter
the septum (best seen in Fig. 3D and E). The OWZ is in
contact with the plasma membrane at the constriction ring, and
no space remains in between for the IWZ and GL (Fig. 3,
arrowheads). In some septa, OWZ density is uniform (Fig.
3D); in others, the central layer of the OWZ is less dense than
the layers closer to the surfaces (Fig. 3A and E). The septal
IWZ is thinner than the regular IWZ by 9.5% (P  0.01). In
contrast, the septal OWZ is thicker than the regular OWZ by
25.1% (P  0.01).
Structure of the S. gordonii septum. In Streptococcus pneu-
moniae, PBPs responsible for the cross-linking of peptidogly-
can are concentrated at the equatorial ring and at the septum
(26, 27). We investigated their structure in S. gordonii, a close
nonpathogenic relative of S. pneumoniae (18). S. pneumoniae
and S. gordonii are ovoid (43). The equatorial ring is identified
by an increased curvature of the plasma membrane and is
approximately halfway between the septum and the cell pole
(6, 43). The GL, IWZ, and OWZ are not different at the
equatorial ring (Fig. 4A). Contrary to the situation in E. galli-
narum and similarly to S. pneumoniae, the cell envelope is not
deeply invaginated at the level of the S. gordonii septum (Fig.
4) (38, 43). Accordingly, the septal OWZ is most probably split
in two simultaneously with the addition of new components on
its inner surface. The GL does not penetrate the septum but is
slightly concave (Fig. 4B and C). The OWZ is also slightly





Mean thickness (nm)  SD (no. of measurements)b
GL IWZ OWZ Cell envelopec OWZ1 OWZ2 OWZ3
S. gordonii
Normal cells 8.3  0.5 (10) 4.1  0.9 (9) 16.0  1.0 (10) 26.4  3.6 (10) 42.3  3.4 (10) NA NA NA
Lysed cellsd 7.7  0.7 (8)* 3.7  0.4 (8)# NA 31.8  4.4 (19)** NA NA NA NA
B. subtilis
Strain W23 9.1  0.8 (27) 3.8  0.6 (11) 19.8  1.7 (29) 33.0  5.4 (29) 52.7  5.7 (29) NA NA NA




9.0  1.2 (17) 3.4  0.8 (15) 18.4  1.9 (20) 18.7  2.8 (20) 37.1  3.4 (20) 4.3  0.6 (17) 6.6  2.7 (17) 8.0  3.0 (17)
Septal cell
envelopee
9.8  0.5 (6)# 3.5  0.6 (6)# 16.8  1.4 (14)** 23.4  2.0 (7)** 56.9  2.6 (7) NA NA NA
a Measured from the center of mass of the plasma membrane to the center of mass of the GL.
b Values in nm are presented as mean values  standard deviations (with numbers of measurements in parentheses). They have been measured using images with
a pixel size of 0.63 nm. NA, not applicable.
c In the septum, cell envelope thickness corresponds to the distance between the two plasma membranes.
d t test was performed between corresponding structures of normal and lysed cells. #, no statistical difference; *, P  0.05; **, P  0.01.
e t test was performed, between the normal cell envelope and the septal envelope.
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concave, but it does not cross the GL and is excluded from the
septum. Only the IWZ penetrates the septum, where its den-
sity is higher.
Cytoplasmic structures at the constriction ring of E. galli-
narum. At the level of the constriction ring of the E. gallinarum
septum, dense elements are found below the plasma mem-
brane. In some cases, they have the aspect of concentrated
dots, without higher-order organization (Fig. 5A). In others,
the dots are assembled in one or two layers parallel to the
plasma membrane (Fig. 5B, C, and D, arrowheads). The den-
sity profile of such a structure is shown in Fig. 5G. The dots are
3 to 5 nm in diameter. The distance between the plasma mem-
brane and the first cytoplasmic layer as well as the distance
between the first and the second cytoplasmic layers is between
7 and 12 nm. Inside the layers, the distance between the center
of mass of the dots lies between 5 and 7 nm. Finally, in some
images, weakly contrasted cytoplasmic filaments are situated
between the two edges of the septum (Fig. 5E and F). Figure
5G shows a density profile recorded across four filaments of
Fig. 5E. These are 3 to 6 nm in diameter, i.e., similar to the
diameter of the dots.
DISCUSSION
In every species investigated in the present study, the previ-
ously reported IWZ and OWZ were observed. This confirms
the new model of the structure of the gram-positive bacterial
cell envelope (23). Besides differences in IWZ and OWZ thick-
nesses, subtle differences in mass distribution within the OWZ
exist between species. In B. subtilis, the density of the OWZ
decreases from the inner to the outer face, which is consistent
with a centrifuge turnover of the cell wall (4, 20). According to
this model, nascent polymers are inserted on the inner face of
the cell wall, where they are not stretched. Due to a continuous
addition of new material, they are gradually displaced towards
the exterior of the wall. During the first step of this displace-
ment, the polymers become stretched. Consequently, they pro-
vide resistance against osmotic pressure but also become more
prone to cleavage by autolysins. This leads to reduced cross-
linking and eventually to the release of peptidoglycan frag-
ments in the extracellular medium. This mechanism, in com-
bination with the fact that the cell wall is inert (i.e., not
synthesized or degraded) at cell poles, is thought to be at the
origin of the rod shape (19, 20). In S. gordonii, the OWZ also
fades but in a less pronounced manner, reflecting the prob-
ably reduced centrifuge turnover due to the incorporation of
wall polymers in very restricted sites. A similar difference
between B. subtilis and S. aureus was previously noticed and
interpreted likewise by Matias and Beveridge (23). Indeed,
in S. aureus, the cell wall is polymerized exclusively at the
septum (31). In E. gallinarum, whose peptidoglycan poly-
mers are also mostly assembled at the septum (Ribeiro et
al., unpublished), the center of the OWZ is less dense than
its surfaces, suggesting yet another mode for the regulation
of wall polymer degradation.
We report a dense GL located in the IWZ, which was not
seen previously. The GL is observed over a wide range of
defocus values, including close to focus (Fig. 2C). This dem-
onstrates that the GL is not an optical artifact of phase con-
trast. To confirm that the GL was not induced by osmotic
shock due to the sudden change in dextran concentrations, we
adapted the protocol used previously by Matias and Beveridge
(23, 24): S. gordonii cells were grown in 10% glycerol–BHI and
FIG. 3. E. gallinarum septum. (A) Dividing coccus. Arrow, newly forming septum. (B to D) Progressive formation of septum. Arrowhead,
constriction ring. (E) Higher magnification of the rectangular area in A. Asterisks, ice contamination. See the legend to Fig. 2 for definitions of
abbreviations. OWZs, layer closer to the surface of the OWZ; OWZc, central layer of the OWZ. A model of the E. gallinarum septum is shown
in Fig. 6. Every image has been denoised by Gaussian filtering (radius, 1 pixel). Bars, 50 nm.
6656 ZUBER ET AL. J. BACTERIOL.
vitrified in 10% glycerol–HEPES. The GL is also visible under
these conditions, indicating that the GL is certainly a native
feature of the cell envelope. The reason why the GL was not
discovered by Matias and Beveridge (23, 24) is perhaps related
to the use of glycerol, which prevents the routine production of
crevasse-free sections. Lysed cells of S. gordonii reveal that the
GL is retained by the plasma membrane, suggesting that GL
components are anchored in the plasma membrane (Fig. 2F).
The only exception is found at the septum of (nonlysed) S.
gordonii, where the GL is aligned not with the plasma mem-
brane but with the OWZ (Fig. 4B and C and 6B). A possible
interpretation is that under normal conditions, the GL bridges
the plasma membrane to the mature peptidoglycan; under
special conditions, one of the connections can be broken.
In order to better understand how nascent polymers are
incorporated into the OWZ, we investigated areas of cell wall
assembly. In B. subtilis, these areas have been identified as the
septum and in a helical structure along the rod (7, 36). With
CEMOVIS, it was not possible to routinely observe B. subtilis
assembly sites because on the one hand, rod cells align longi-
tudinally along the long axis of the freezing tube when they are
introduced into the tube (23). Consequently, only cross-sec-
tions of the cells and almost no longitudinal sections are ob-
tained, making the observation of septa in rod cells virtually
impossible. On the other hand, the helical pattern of assembly
is not well defined morphologically.
Nevertheless, CEMOVIS revealed the close-to-native struc-
ture of peptidoglycan assembly sites of E. gallinarum in the
stationary state (septum) and of S. gordonii in the exponential
state (septum and equatorial ring), whose shape is closer to a
sphere, allowing the random orientation of cells in the freezing
tube. The structure of the cell envelope at the S. gordonii
equatorial ring is not different than that in the rest of the cell.
The structures of the E. gallinarum and S. gordonii septa are
modeled in Fig. 6 according to the observations shown in Fig.
3 and 4. It is unlikely that these two cartoons represent two
successive steps of one septum maturation process, since we
have never observed the typical wide OWZ-containing septum
of E. gallinarum in S. gordonii or the characteristic narrow
OWZ-free septum of S. gordonii in E. gallinarum. The struc-
tures of the three peptidoglycan assembly sites studied are not
identical but can be interpreted with a common mechanism. In
the three cases, the OWZ does not cross the GL. The OWZ is
therefore always exposed to the outer face of the GL. More-
over, the GL is always in the vicinity of the OWZ. Together,
these data suggest that after translocation through the plasma
membrane in the periplasmic space (IWZ), peptidoglycan pre-
cursors could diffuse relatively freely without polymerizing un-
til they interact with the interface between the GL and the
OWZ. Precursors could then polymerize with the OWZ. In the
case of the S. gordonii septum, the high density of the septal
IWZ situated below the GL might represent a high concentra-
tion of unpolymerized precursors (Fig. 4B and C). In the E.
gallinarum septum, the OWZ reaches the plasma membrane in
the constriction ring (Fig. 6A). At this site, peptidoglycan pre-
cursors are exposed to the outer face of the GL immediately
after translocation. On the basis of these considerations, the
GL could contain PBPs, the enzymes responsible for pepti-
doglycan cross-linking. The X-ray structure indicates that PBPs
protrude 9 to 13 nm into the periplasmic space, which is con-
FIG. 4. S. gordonii equatorial ring and septum. (A) Dividing coccus. A well-defined equatorial ring is shown between arrows. (B and C) Septa
of other cocci. See the legend to Fig. 2 and the text for definitions of the abbreviations. A model of the S. gordonii septum is shown in Fig. 6. Bars,
50 nm.
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sistent with the distance between the centers of mass of the GL
and of the plasma membrane (21, 29). PBPs are not distributed
homogenously over the plasma membrane; different members
of the PBP family are concentrated in specific areas (8, 26, 27,
32). The GL is, however, homogenously distributed over the
whole cell (except in the situations described above). It is
therefore most probable that the GL is not only composed of
the various PBPs. Other molecules interacting with the plasma
membrane, such as lipoproteins and lipoteichoic acids, could
compose the GL. It may also contain molecules that are not
bound to the plasma membrane, as suggested by the structure
of the GL at the S. gordonii septum (Fig. 6B). Interestingly,
electron microscopy experiments using labeled penicillin in S.
aureus cells indicated that a fraction of the PBPs may not be
bound to the plasma membrane (30). Since vitreous sections
cannot be immunolabeled, targeted gene deletions or selective
FIG. 5. E. gallinarum cytoplasmic structures associated with the constriction ring. (A to D) Arrows indicate concentrated dots without
higher-order organization; white arrowheads indicate dots assembled in parallel layers. (E and F) Black and white arrowheads show some of the
weakly contrasted lines. (G) Density profile of the area comprised between black arrowheads in B. PM, plasma membrane. (H) Density profile
of the area comprised between black arrowheads in E. The left extremity of the profile corresponds to the upper arrowhead. (I) Schematic
representation of the bacterial septal plane. X corresponds to the center of the septal ring. The OWZ is represented in gray; the plasma membrane
in the constriction ring is shown in black. The cytoplasmic filament ring is in red. A section of thickness, t, across the middle of the septal ring,
corresponding to A to D, is drawn in yellow. A section of the same thickness cut tangentially to the septal ring, corresponding to E and F, is
represented in blue. Images have been denoised by Gaussian filtering with a radius of 1 pixel in A to D and F and a radius of 2.5 pixels in E. Density
profiles have been recorded on Gaussian-filtered images with a radius of 1 pixel in G and 1.5 pixels in H. They have been averaged over a width
of 11 pixels in I and 21 pixels in H. Bars, 50 nm (A to F) and 10 nm (G and H).
FIG. 6. Model septa of (A) E. gallinarum and (B) S. gordonii. The position of peptidoglycan precursors is hypothetic and based on consider-
ations explained in the Discussion. C, cytoplasm. For definitions of other abbreviations, see the legend to Fig. 2 and the text.
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chemical extractions might contribute to the characterization
of the molecular composition of the GL.
The layered structure of the gram-positive envelope raises
questions. It is well accepted that the plasma membrane is the
diffusion barrier between the cell interior and the outer world.
It is subjected to the effect of the osmotic pressure, but it does
not have the mechanical strength to hold it. The peptidoglycan
layer of the cell wall (OWZ) probably confers the mechanical
resistance (39). However, the low-density zone of the IWZ, in
which we propose that envelope precursors can diffuse, sepa-
rates the plasma membrane from the OWZ. How is the force
that is generated at the plasma membrane reported to the
OWZ through the IWZ? One possibility, proposed previously
by Matias and Beveridge, is that rigid molecules keep the
OWZ distant from the plasma membrane by forming a scaffold
in between (24). Alternatively, pressure could be transferred
from the plasma membrane to the base of the OWZ by a gel
composed of osmotically active polymers freely floating in the
IWZ. Their osmotic effect would preclude that the IWZ vol-
ume decreases beyond a threshold value reached when the
periplasmic osmotic pressure equals the cytoplasmic osmotic
pressure. The osmotically active polymers should be large
enough not to diffuse through the plasma membrane or
through the OWZ, and they should be flexible enough (short
persistence length) to be osmotically active at relatively low
concentrations, which would be consistent with the low density
of the IWZ (9). Regarding this hypothesis, it is noteworthy that
the cytoplasm and periplasm of gram-negative bacteria are
isosmotic (42). Obviously, the cell envelope still has many
facets to reveal until its structure and functions are fully un-
derstood.
CEMOVIS revealed cytoplasmic structures at the constric-
tion ring of the E. gallinarum septum. They are strongly con-
trasted dots (Fig. 5A to D) or weakly contrasted lines (E and
F) of 3 to 6 nm in diameter. The signal is far above the noise
level, as is demonstrated by two successive images recorded in
the same area (data not shown). Dots of similar sizes are found
everywhere in the cell but not at this high concentration nor
with this layered organization. Weak lines were not found
anywhere other than in the septal area. These structures are
thus specific for the septum. In S. gordonii, the occurrence of
such structures was rarely observed.
The contrasted dots are present in images where the plasma
membrane in the constriction ring (i.e., the bottom of the
septum) is sharp or relatively sharp, indicating that these sec-
tions cross the center of the septum (shown in yellow in Fig.
5I). The weak lines are found in images where the plasma
membrane is not defined in the constriction ring, implying that
these sections are cut tangentially to the constriction ring
(shown in blue in Fig. 5I). Note that membranes and cell wall
layers that are close to parallel to the section plane are ex-
pected to slightly darken the corresponding area of the image
but are not expected to produce any sharp structure (46). The
blurred aspect of the lateral invaginated membranes indicates
that they are slightly tilted, but this tilt cannot account for the
blurred aspect of the membrane in the constriction ring. To-
gether, these data are consistent with a ring of cytoplasmic
filaments localized near the plasma membrane (red ring in Fig.
5I). Filaments are indeed seen with CEMOVIS as contrasted
dots in top views and as weak lines in longitudinal views (12,
35). From this assumption, we speculate that the observed
structure may represent polymerized FtsZ proteins. FtsZ is a
prokaryotic cytoskeletal protein that is homologous to eukary-
otic tubulin and is thought to be organized as a cytoplasmic
ring of filaments beneath the plasma membrane (5). It is es-
sential for septation and serves as a scaffold for proteins in-
volved in the division process (22, 37). Although immunoelec-
tron microscopy and fluorescence microscopy studies have
proven its septal localization and suggested a ring organization,
FtsZ filaments have never been observed in thin sections of
fixed and dehydrated bacteria (45). Most probably, FtsZ col-
lapses during dehydration steps and becomes indiscernible
from the plasma membrane. In spite of that, an electron mi-
croscopy study of isolated FtsZ has revealed that it can poly-
merize in vitro as (i) straight single protofilaments, (ii) two-
dimensional sheets of protofilaments, or (iii) curved
protofilaments (13). The cytoplasmic dots concentrated near
the constriction ring observed with CEMOVIS (Fig. 5A, ar-
rows) can be interpreted as cross-sectioned protofilaments; the
layers of dots parallel to the plasma membrane may represent
cross-sectioned two-dimensional sheets of protofilaments (Fig.
5B, C, and D). Supporting this hypothesis is the agreement of
the 5.3-nm distance between protofilaments in vitro and the 5-
to 7-nm distance between dots within a single layer in close-
to-native cells (13). A three-dimensional representation of the
cytoplasmic structures is necessary to confirm our interpreta-
tion (by determining the curvature of the filaments and their
relationship with the plasma membrane, for example), and the
developing technique of cryo-electron tomography of vitreous
sections should make it possible to solve the structures in the
next few years (16, 17, 28). Obtaining tomograms of vitreous
sections at 3-nm resolution will certainly require the thinnest
possible sections. Therefore, the probability of having a com-
plete septal ring in a section will be very low. Moreover, it
might be very difficult to detect such a configuration, because
sections must be screened at a low magnification to minimize
the electron dose. Such a cell slice might lack highly contrasted
characteristic features visible at low magnifications. However,
tomograms of sections containing an important part of septal
ring, as shown in Fig. 5E and F, should be sufficient to measure
the curvature of the filaments and their relationship with the
plasma membrane. If this prediction comes true, it will be
possible to gain structural insights into the cell division mac-
romolecular machinery at work, and this will most likely help
to solve its mechanism.
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Abstract
A total of 109 enterococcal isolates from dairy food products and from human and dog infections, isolated in Portugal, and 26 type and
reference strains of the genus Enterococcus were screened for vancomycin resistance. MIC values, both for vancomycin and teicoplanin, were
determined. The genetic relatedness of isolates carrying either vanA and/or vanB was determined using Pulsed Field Gel Electrophoresis. For
vanA carrying isolates, transposon Tn1546 was partially mapped using PCR. None of the 59 dairy isolates was resistant to vancomycin.
Among the 50 clinical isolates, only one, carrying vanB, behaved as resistant, with a MIC value of 256 μg/mL. The type and reference strains used
were susceptible both to vancomycin and teicoplanin. vanAwas found in 37% of the dairy isolates and 40% of the clinical isolates. vanB was only
detected in 18% of the clinical, both human and dog, isolates. PCR partial mapping of Tn1546 revealed 23 different patterns among 42 isolates.
Some patterns were shared between dairy and clinical isolates. Using Pulsed Field Gel Electrophoresis six groups of isolates were found to be
genetically undistinguishable and grouping was found to be geographically and location specific/related. No genetic relatedness was found
between isolates from dairy, human and veterinary sources. These results show that an incomplete and/or unfunctional Tn1546 element may
explain the absence of resistant behaviour in the studied isolates, even when vanA gene is present. Moreover, the work reported shows that both
clinical (human and animal) and dairy isolates have been in contact with VanA genotype of resistance and suggest that dissemination of vanA gene
has been through transposable elements, like Tn1546, and not by clonal dissemination of a resistant strain. Therefore, a national strategy should be
implemented to survey both vancomycin resistance and its genetic dissemination.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Enterococci constitute part of the natural gut microflora in
mammals (Devriese et al., 1992). They are also found in a
variety of food products, namely milk and cheese produced in
the south of Europe (Flahaut et al., 1997; Barros, 1998; Lopes
et al., 1999). In some of these cheeses enterococci play a key
role in the maturation and final organoleptic characteristics of
the food product and constitute the main microbial population
in the final product (Franz et al., 1999). For many years
enterococci have been considered harmless to man. However,
in the last decade, they have become the second most
frequently reported cause of surgical wound infections and
nosocomial urinary tract infections and the third most
frequently reported cause of bactereamia (Klein et al., 1998).
Moreover, treatment of these infections has become more and
more difficult due to the increasing number of antibiotic
resistant enterococci.
The optimal therapy for endocarditis, one of the most
serious enterococcal infections, involves a combination of a
cell-wall active agent and an aminoglycoside, usually genta-
micin (Malani et al., 2002). With the appearance of high-level
gentamicin resistance the only antibiotic available for a
successful treatment of enterococcal infections is vancomycin,
a glycopeptide. However, over the past decade, there has been a
rapid increase in vancomycin resistant enterococci (VRE).
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Colonization and infection by VRE have been reported in
hospitalized patients and in the community, and has also been
associated with environmental sources and meat products.
Glycopeptide resistance in enterococci is generally acquired
and is encoded in genetic mobile elements, like transposons.
This is the case of VanA, VanB, VanD, VanE and VanG
phenotypes. It can also be encoded in a non-transferable
chromosomal determinant, as in VanC phenotype (Tendolkar et
al., 2003). VanA and VanB are the most globally widespread
and prevalent phenotypes. The prototype vanA element is
Tn1546, a 10.8-kb transposon that carries a cluster of nine
genes, encoding nine different proteins, which mediates high-
level inducible resistance to both vancomycin and teicoplanin.
The nine polypeptides can be divided in four functional groups:
transposition (ORF 1 and 2), regulation (VanR and VanS),
resistance to glycopeptides (VanH, VanA and VanX) and
synthesis of peptidoglycan (VanY and VanZ). The VanB cluster
encodes inducible resistance to vancomycin, but not to
teicoplanin and is disseminated by large transposons such as
Tn1547 and Tn5382 (Tendolkar et al., 2003). Tn1547 is
homologous to Tn1546 and most of the VanB genes share a
large percentage of homology to the VanA cluster genes. In
Europe, VanA has been found in VRE isolated in the
community, from sewage, animal faeces and raw meat, which
suggests that these environments can act as reservoirs of these
microorganisms (Simjee et al., 2002). In fact, the emergence of
VRE has been related to the use of antimicrobial agents both in
human and veterinary medicine and as growth promoters in
animal feed. Although enterococci isolated from traditional
Portuguese cheeses have not been subjected to the selective
pressure of the use of glycopeptides, it would be of the utmost
importance to ascertain the dissemination of vancomycin
resistance in this environment. Therefore, the aim of this
study was to survey vancomycin resistance among a group of
dairy and clinical isolates and to ascertain the possible
relatedness of the VRE isolates. vanA and vanB genes were
chosen since they are the most widely found among VRE. Type
and reference strains of the genus Enterococcus were included
in this study since they are the representatives of the genus, but
are never included in published works on this subject.
2. Materials and methods
2.1. Microorganisms
A total of 135 (109 wild types plus 26 control and reference)
enterococci were used in this study. Fifty-nine strains were
isolated from Portuguese dairy products (ewe's cheese and
milk) collected from four different Registered Designation of
Origin (RDO) designated as A, B, C and D, as described by
Lopes et al. (1999). Thirty-nine isolates were obtained from
human infections in several Portuguese hospitals. Eleven dog-
infecting isolates were obtained from Lisbon Veterinary Faculty.
The dairy isolates were identified by phenotypic and molecular
methods as 25 Enterococcus faecalis, 6 E. faecium, 24 E. durans,
1 E. raffinosus, 6 E. hirae, 1 E. dispar and 33 Enterococcus
spp. (Alves et al., 2004). The same methods applied to the
clinical isolates identified 31 as E. faecalis, 8 as E. faecium,
1 as E. solitarius, 1 as E. durans and 9 as Enterococcus spp.
Twenty-six type and reference strains of the genus Entero-
coccuswere also studied and are described in Table 3. The more
recently described species E. pallens, E. gilvus (Tyrrell et al.,
2002), E. phoeniculicola (Law-Brown and Meyers, 2003),
E. italicus (Grazia Fortina et al., 2004) and E. hermaniensis
(Koort et al., 2004) were not included in this study. E. faecalis
ATCC 29212 was used as a control strain in the E-test, for MIC
determination. Vancomycin MIC values for this control strain
coincided always with the expected ones. E. faecium BM 4147
and E. faecalis DSMZ 12956 were used as positive control
strains for vanA and vanB PCR reactions, respectively.
2.2. MIC determination
Minimum inhibitory concentrations for vancomycin and
teicoplanin were determined using the E-test (Biodisk, Solna,
Sweden), according to manufacturer's instructions. Each plate
was inoculated with a suspension of the microorganism
equivalent to 2 in the MacFarland turbidity standard. Vanco-
mycin and teicoplanin were purchased from Sigma (Steinheim,
Germany). E. faecalis ATCC 29212 was used as a control
strain. Strains were classified as resistant (MIC≥32 μg/mL),
intermediate (MIC≥8 μg/mL and MIC≤16 μg/mL) and
susceptible (MIC≤4 μg/mL).
2.3. Preparation of DNA
Total DNAwas extracted from cells according to the method
of Pitcher et al. (1989).
Table 1
Sequence of each primer (forward, f and reverse, r) used to amplify the nine
genes/intergenic regions (IR) searched for using PCR and respective expected
amplicon sizes
Gene / IR Sequence a Size of amplicon
vanA f 5′-GGGAAAACGACAATTGC-3′ 732 bp
r 5′-GTACAATGCGGCCGTTA-3′
vanB f 5′-ATGGGAAGCCGATAGTC-3′ 635 bp
r 5′-GATTTCGTTCCTCGACC-3′
vanR f 5′-AGCGATAAAATACTTATTGTGGA-3′ 533 bp
r 5′-TCGGAGCTAACCACATTC-3′
vanS f 5′-AACGACTATTCCAAACTAGAAC-3′ 1049 bp
r 5′-GCTGGAAGCTCTACCCTAAA-3′
SH f 5′-ACGTTTAGGGTAGAGCTTCC-3′ 313 bp
r 5′-CTCATCCTGCTCACATCCATAAACA-3′
vanH f 5′-ATCGGCATTACTGTTTATGGAT-3′ 1016 bp
r 5′-TTACGTCATGCTCCTCTGAG-3′
vanX f 5′-ACTTGGGATAATTTCACCGG-3′ 404 bp
r 5′-TGCGATTTTGCGCTTCATTG-3′
XY f 5′-GCATATAGCCTCGAATGG-3′ 594 bp
r 5′-TCCTGGAAAACAGTGCTTCATTAA-3′
vanY f 5′-ACTTAGGTTATGACTACGTTAAT-3′ 486 bp
r 5′-TCGTCAAGCTTGATCCTA-3′
YZ f 5′-GTTTCCCGGATCAACACATACTA-3′ 336 bp
r 5′-CCCAGTAGCAGTAAATGGAGTCA-3′
a Sequences published by Miele, Bandera and Goldstein (1995) except for
vanX (Manson et al., 2003).
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2.4. PCR and sequencing
Except for the type and reference strains, all dairy and
clinical isolates were searched for the presence of the genes
vanA and vanB using PCR. Primers used were as presented
in Table 1. For the isolates for which vanA was detected by
PCR eight primer pairs (Table 1) were used to partially map
the Tn1546 transposon. PCR was performed with T-personal
Combi thermocycler (Biometra, Goettingen, Germany). Each
50 μl PCR reaction mixture contained 250 ng of DNA,
0.5 μM of each primer, 1.5 mM MgCl2, 0.2 mM deoxynucleo-
side triphosphates (dATP, dCTP, dGTP and dTTP), 1× PCR
buffer, 0.005% W1 and 2.5 U of Taq DNA polymerase. All
reagents were purchased from GibcoBRL (Life Technologies,
Paisley, UK), except the primers that were purchased from
MWG-Biotech (Ebersberg, Germany). The thermocycler was
programmed with the following conditions: 5 min at 95 °C;
30 s at 94 °C, 30 s at 47 °C and 30 s at 72 °C for 30 cycles;
10 min at 72 °C; and 4 °C until analysis. Visualisation of
amplicons was done with ethidium bromide (Sigma, Stein-
heim, Germany) under UV irradiation, after electrophoresis on
2% agarose (GibcoBRL, Life Technologies, Paisley, UK) gels.
Image analysis was performed with Kodak Digital Science™
(Stuttgart, Germany). Amplification of the above mentioned
genes was confirmed with sequencing of the PCR products,
after their purification either with Concert™ Rapid PCR
Purification System or with Concert™ Matrix Gel Extraction
System, both purchased from GibcoBRL (Life Technologies,
Paisley, UK). Sequencing was performed by MWG (Ebers-
berg, Germany).
2.5. PFGE
PFGE was performed with dairy and clinical isolates
carrying either the gene vanA or the gene vanB. Genomic
DNA agarose discs and DNA digestion with SmaI were
performed according to the method of Chung et al. (2000),
except for lysis solution, which contained only RNase A and
lysozyme. Agarose discs were electrophoresed on a 1% Seakem
GTG agarose gel (FMC Bioproducts, Maine, USA) in 0.5× TBE
buffer low EDTA (50 mM Tris, 50 mM boric acid, 0.2 mM
EDTA, pH 8.0) in a CHEF apparatus (BioRad, Hertfordshire,
UK) at 8 °C for 18 h at 220 V with pulse times of 5 s rising to
35 s during the electrophoresis period. Gels were stained by
immersion in ethidium bromide (1 μg/mL) for 30 min and
photographed with a UV light source.
3. Results
In this work 109 enterococcal isolates from two different
environments, dairy products and clinical settings (both human
and pets), and identified as different species, and 26 type and
reference strains of the genus Enterococcus, were firstly
investigated on their resistance to vancomycin using the E-test
for MIC determination. Teicoplanin MICs were also determined
and the study was completed with a survey of the presence of
vanA and vanB genes using PCR. vanA positive isolates were
subjected to PFGE to ascertain their relatedness and other
regions of the Tn1546 transposon were also searched in these
isolates, using eight primer pairs.
3.1. MIC determination
According to results shown in Table 2, no resistant isolates
were found among dairy isolates, although 12% (7 isolates) had
MIC values of 6 μg/mL and can be considered intermediate. In
contrast, among the clinical isolates, 72% behaved as
susceptible, 22% were intermediate and 6% were found to be
resistant. All type and reference strains behaved as vancomycin
susceptible, as they showed MIC values below 4 μg/mL, and
70% of these strains had MIC values below 1 μg/mL (Table 3).
Overall, reference strains had lower MIC values than those of
the other isolates studied. The clinical isolates showed higher
MIC values than dairy isolates, with 28% of the clinical isolates
presenting MIC values between 6 and 256 μg/mL, against only
12% of the dairy isolates with MIC values of 6 μg/mL
All MIC values for teicoplanin fell under the susceptible
classification, for all the isolates and reference strains studied
(results not shown).
3.2. Search for the genes vanA and vanB
vanA gene was found in 37% of the dairy isolates and in 40%
of the clinical isolates. vanB gene was not found in any dairy
isolate, but was found in 18% (seven human isolates and two dog
isolates) of the clinical enterococci studied. In four of the vanB
positive clinical enterococci (two from humans and two from
dogs), vanAwas also detected. Among the dairy isolates, vanA
was detected in four different species (E. faecalis, E. faecium,
E. durans and E. hirae), both in milk and cheese isolates. In
clinical enterococci, vanA was detected in E. faecalis and
E. faecium, and in E. solitarius. The four isolates that showed
both vanA and vanB were identified as E. solitarius, E. faecium
and two as Enterococcus spp.
Table 2
Distribution of dairy and clinical isolates, carrying vanA/B genes of resistance,
and of type and reference strains, between different MIC values for vancomycin
Strains a MIC (μg/mL)
0.38 0.5 0.75 1 1.5 2 3 4 6 8 12 256
Dairy vanA+ 1 0 0 3 0 0 7 7 4 0 0 0
vanA− 1 0 1 3 9 7 11 2 3 0 0 0
vanB+ 0 0 0 0 0 0 0 0 0 0 0 0
vanAB+ 0 0 0 0 0 0 0 0 0 0 0 0
Total 2 0 1 6 9 7 18 9 7 0 0 0
Clinical vanA+ 0 0 0 0 0 3 3 6 4 0 0 0
vanA− 0 0 0 0 2 3 11 5 3 0 0 0
vanB+ 0 0 0 0 0 1 0 1 1 1 0 1
vanAB+ 0 0 0 0 0 1 0 0 2 0 1 0
Total 0 0 0 0 2 8 14 12 10 1 1 1
Reference
Strains
Total 1 3 5 9 1 0 7 0 0 0 0 0
a Total number of isolates/strains in each column are in bold; vanA+/−,
presence/absence of vanA gene only; vanB+, presence of vanB gene only;
vanAB+, presence of both vanA and vanB genes.
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No correlation was evident between the presence of vanA
gene and higher MIC values for vancomycin (Table 2) or
teicoplanin. In fact, both dairy and clinical isolates that were
positive for vanA had MIC values under 6 μg/mL. Only two
clinical isolates had MIC values of 8 and 12 μg/mL and in both
of them vanB gene was also detected. In fact, the presence of
vanB gene seems to increase MIC values for vancomycin
since six, among nine isolates positive for vanB, had MIC
values between 6 and 256 μg/mL. In the E. faecium isolate with
a MIC value of 256 μg/mL, only vanB gene was detected.
3.3. PCR Tn1546-like patterns
Strains carrying vanA, both clinical and dairy, were
surveyed for the presence of other elements of Tn1546, the
prototype mobile element carrying the vanA operon. Eight
primer pairs were used in this screen assay. Two of these primer
pairs were directed to two intergenic regions, XY and YZ, and
the other six pairs of primers were directed to more conserved
regions of this transposon, namely genes vanR, vanS, vanH,
vanX and vanY. Among 42 isolates, 23 different PCR patterns
were found (Table 4). All the genes and intergenic regions were
detected, at least in one isolate, and with the exact size as
predicted from the Tn1546 sequence. The absence of vanX was
the only common feature among all the 42 isolates. The only
two isolates for which all (except vanX ) the searched elements
were detected (pattern B), come from the clinical environment,
but from different hospitals and with collection dates 10 years
apart. They were both identified as E. faecalis and their MIC
values for vancomycin were 4 and 6 μg/mL. PCR pattern A,
corresponding to absence of all the fragments, was found in
four isolates, one from dairy origin (E. durans, with a MIC
value for vancomycin of 4 μg/mL) and three from clinical
environment (two E. faecalis and one Enterococcus spp., with
MIC values for vancomycin of 4 and 3 μg/mL), and none of
these strains was highly susceptible. A higher variability in
PCR patterns was found among dairy isolates. In fact, seven
patterns (from B to H) were only found in clinical enterococci
(13 isolates), and 12 different patterns (from L to X) were
found in dairy isolates (16 enterococci). Four patterns were
common to both environments (A, I, J and K). The only
common feature among these four patterns was the absence of
the X and S fragment. The S fragment, corresponding to vanS
gene, was only found in six isolates and is the second most
absent after the vanX gene. Region H, corresponding to vanH
gene, was present in 43% of the isolates and the intergenic
region XY in 16 isolates (38%). The intergenic region YZ was
found in 55% of the isolates and is, overall, the most conserved
region of the transposon. Despite the variability of PCR
Table 4
Distribution of vanA carrying isolates in the different PCR patterns of the
Tn1546 element found in this work. Patterns are represented as + (presence of
the amplicon with the expected size) and − (absence of an amplicon) signs for
each of the seven regions searched: genes vanR, vanS, vanH, vanX and vanY
and intergenic regions SH, XY and YZ
Pattern Region of Tn1546 Origin
vanR vanS SH vanH vanX XY vanY YZ Dairy Clinical
A − − − − − − − − 1 3
B + + + + − + + + 0 2
C + − + + − − − − 0 2
D + + + + − − − − 0 1
E + + − − − + − + 0 1
F − − + + − − − + 0 2 a
G − − + − − − − + 0 2 a
H − − − − − − − + 0 3 b
I + − − − − − − − 2 1 c
J − − + + − + + + 1 1 c
K + − − + − − − + 2 2
L − − − − − + + + 2 0
M + + − − − + + + 1 0
N − − − + − + − + 2 0
O + − − − − − − + 1 0
P − − + − − + − − 1 0
Q − − − − − + + − 1 0
R − − − + − + − − 1 0
S − − − − − − + − 1 0
T − − − + − − − − 2 0
U − + − − − + + + 1 0
V + − − − − − + − 1 0
X − − − − − + − − 2 0
SUMd 16 6 12 18 0 16 11 23 22 20
a One of the isolates is from a dog infection.
b Two of the isolates come from dog infections.
c It is an enterococcus isolated from a dog infection.
d Sum of isolates from each column.
Table 3
Vancomycin and teicoplanin MIC values for the type and reference strains of the
genus Enterococcus
Strains a Taxon MIC (μg/ml)
Vancomycin Teicoplanin
DSMZ 11492T E. asini 0.5 0.25
DSMZ 20679T E. avium 0.75 0.75
DSMZ 20680T E. casselif lavus 0.5 0.094
DSMZ 20682T E. cecorum 3 0.75
DSMZ 7374T E. columbae 0.5 0.5
DSMZ 6630T E. dispar 3 0.5
DSMZ 20633T E. durans 1 0.094
DSMZ 20478T E. faecalis 0.75 0.75
CECT 187 E. faecalis 3 0.25
CECT 184 E. faecalis 3 0.25
DSMZ 20477T E. faecium 1 0.75
DSMZ 7370T E. f lavescens 0.75 0.094
DSMZ 20628T E. gallinarum 0.75 0.75
LMG 19487 E. haemoperoxidus 1 0.38
DSMZ 20160T E. hirae 1 0.75
DSMZ 20681T E. malodoratus 1 0.38
LMG 19486 E. moraviensis 1 0.25
DSMZ 4838T E. mundtii 1 0.38
ATCC 700913 E. porcinus 3 0.38
DSMZ 5632T E. pseudoavium 0.38 0.032
DSMZ 5633T E. raff inosus 3 0.38
ATCC 700914 E. ratti 1 0.25
DSMZ 20726T E. saccharolyticus 1 1
DSMZ 5634T E. solitarius 1.5 0.38
DSMZ 6905T E. sulfureus 0.75 0.38
LMG 12287 E. villorum 3 0.38
a DSMZ, Deutsch Sammlung von Mikroorganismen and Zellkulturen
(Braunschweig, Germany); CECT, Colección Española de Cultivos Tipo
(Valencia, Spain); LMG, Laboratorium voor Microbiologie (Gent, Belgium);
ATCC, American Type Culture Collection (Rockville, USA).
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patterns found in these 42 enterococcal isolates, results from
Table 4 suggest a higher presence of fragments XY, Y and YZ
in dairy isolates and of fragments R, S, SH and H in clinical
isolates. In fact, among the total of fragments detected in dairy
isolates, 60% were XY, Y and YZ, and in clinical isolates 62%
included the R, S, SH and H fragments. No correlation was
found between the different PCR patterns and MIC values for
vancomycin. The six veterinary isolates carrying vanA gene
had PCR patterns similar to both human and dairy isolates
(Table 4). No association was found between species and PCR
pattern. E. faecalis, which was the most common species in
both samples, were found in 11 of the 23 PCR patterns and
shared patterns with either E. faecium or E. durans.
Among patterns where dairy isolates were assigned, M and U
are the most similar, sharing four fragments S, XY, Y and YZ.
Isolates assigned to these two patterns are both from cheeses
from RDO A. With three fragments in common, namely frag-
ment XY, Yand YZ, are patterns J, L, M and U. Isolates assigned
to these patterns come from RDO A cheese (three isolates) and
RDO Bmilk. Although distant geographically, enterococci from
these two regions are phenotypically related. Among the nine
patterns with only one or two fragments (patterns I and O to X),
patterns I, O and V, that share vanR, were found only in cheese
and milk isolates from RDO B. Fragment S was only detected in
RDO A. Fragment SH was not detected in RDO C. However
vanH was mainly detected in this RDO. These observations
point to a possible geographic correlation with the genetic events
that led to the observed differences in Tn1546.
3.4. Genetic relatedness of isolates
Dairy and clinical isolates for which either vanA or vanB
were detected by PCR were subjected to PFGE and genetic
relatedness was determined using criteria defined by Tenover
et al. (1995). No relatedness was found between dairy, human
clinical and animal clinical enterococcal isolates. Among the
22 dairy isolates with vanA gene, only eight were found to be
related, in pairs (Table 5). These four pairs were from the three
RDOs where vanAwas detected (RDO A, B and C). Each pair
of isolates came from the same cheese manufacturing place,
from the same product (milk or cheese) and belongs to the
same species, but MIC values were different and so were the
Tn1546 patterns.
Among the 20 clinical isolates carrying vanA, only two
PFGE groups were found (Table 5). The three isolates in
group 5 were isolated in the same Hospital, were identified as
E. faecalis and presented the same MIC value for vancomycin.
Two of them had the same PCR pattern C, and the other had
pattern B. Group 6 isolates both came from dog infections, in
two consequent years. They both had the same MIC value for
vancomycin and their PCR patterns, H and G, although dif-
ferent, are related.
Among vanB carriers no genetic relatedness was found.
4. Discussion
As mentioned before, vancomycin is still at the moment an
antibiotic that can be used to treat infections caused by
multiresistant enterococci. It is important to have a correct idea
of the dissemination of the genes responsible for vancomycin
resistance in other environments than the clinical settings,
namely in food enterococci since these are microorganisms that
contact both with human commensal microorganisms and with
those in soil, water, different solid interfaces and animals.
The present work has demonstrated that vanA is equally
disseminated in dairy enterococci, as it is in clinical (human and
pets) environments. However, its presence does not correspond
to a resistant behaviour. In order to understand the reason for
this discrepancy between the susceptible behaviour and the
presence of vanA gene, some elements of the Tn1546 trans-
poson were searched for in vanA carrying isolates. Among 42
isolates, 23 different patterns were found, showing either a high
variability and heterogeneity in this element, as also reported by
other works (van den Braak, 2001; Woodford et al., 1998), or
that we are in the presence of remnant forms of Tn1546. In fact,
if this transposable element had been present in these isolates, it
had to suffer some independent deletions or insertions that
would prevent the primers used from annealing with DNA. This
is a very likely possibility in the light of some reports on the
instability of enterococci genomes. For example, the strain
V586, vancomycin resistant and appearing to have identical
pulsed field gel electrophoretic banding patterns to the vanco-
mycin resistant V583 strain, has been shown to derive from this
strain as a result of high-frequency spontaneous excisions by an
as yet unknown mechanism (Tendolkar et al., 2003). This
genetic instability of the Tn1546 transposon is also evident even
in genetically undistinguishable isolates. The lack of complete
and functional Tn1546 may therefore account for the lack of
resistance found both in dairy and clinical enterococci studied.
In the particular case of pattern B, the fact that no full resistance
Table 5
Relevant characteristics of isolates that were grouped according to their genetic
relatedness, as determined by their PFGE banding patterns





QA10 Cheese RDO A Enterococcus spp. 6 M
QA41b Cheese RDO A Enterococcus spp. 4 A
2:
LN37 Milk RDO B Enterococcus spp. 0,38 T
LN60 Milk RDO B E. hirae 1 I
3:
QN1 Cheese RDO B E. durans 3 O
QN8 Cheese RDO B E. durans 6 I
4:
QCB1 Cheese RDO C E. faecalis 4 X
QCB4 Cheese RDO C E. faecalis 3 R
5:
HSM 3221 Hospital A Enterococcus spp. 6 C
HSM 3720 Hospital A E. faecalis 6 C
HSM 4182 Hospital A E. faecalis 6 B
6:
Vet 85r Dog, otite ext, 2000 E. faecalis 2 H
344 Dog, urinary infection,
1999
E. faecalis 2 G
a See Table 4.
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was observed can be ascribed to the absence of vanX, that
code for a dipeptidase essential for the vancomycin resistance
phenotype. Although presenting only vanA gene, strains with
pattern A were not fully susceptible. This fact suggests that the
absence of vanX cannot, per se, explain the absence of resistant
phenotype in the strains carrying pattern B. If the presence of
vanA alone can account for the absence of full susceptibility
in strains with pattern A remains to be established.
No genetic association was found between dairy and clinical
(human or animal) isolates, despite the equal presence of vanA
in both environments. This excludes the hypothesis of clonal
dissemination of the VanA resistance. This is in accordance
with previous reports stating that in Europe there is a high
degree of heterogeneity among VRE isolates (van den Braak,
2001). However, the fact that dairy and clinical isolates share
some Tn1546 PCR patterns is indicative of a possible genetic
trading and share of a resistance genetic pool between these
two environments. Despite these differences in PCR patterns,
reasonable explanations based on deletion/insertions events can
be hypothesised. Pair no. 1 presents patterns A, characterized by
the absence of all the fragments searched for, and M, that
present all the genes, except vanH and the intergenic region SH.
One molecular event, like a deletion and/or an insertion in
the region upstream from vanH and downstream from vanS
would have been sufficient to prevent one of the primers of
either primer pair to anneal to DNA. Pair no. 2 isolates present
patterns T, with only vanH, and pattern I, with only vanR.
Although apparently not related, both these patterns are
probably the result of multiple insertion/deletion events. Pair
no. 3 isolates present patterns O and I, which are, as mentioned
above, similar. Pair no. 4 isolates present patterns X and R,
which are also related.
The scenario is different with vanB genes. It seems that
dairy enterococci have not been brought into contact with any
VanB resistant isolate. This is in agreement with other reports
showing that vanA resistance is more disseminated in the
environment than vanB resistance. On the other hand, vanB
carrier isolates, both human and animal, were found not to be
genetically related, demonstrating that dissemination of vanB
resistance is not clonal.
VRE are often identified as E. faecalis, E. faecium,
E. gallinarum and E. casseliflavus. The present work reports
detection of vanA gene in VSE also from other species, like
E. durans and E. hirae and E. solitarius, not often associated
with infectious processes in clinical settings, and therefore ne-
glected. This again shows that species is not a barrier for trading
antibiotic resistance genes among the genus Enterococcus.
In conclusion, this work demonstrated that, although
vancomycin resistant enterococci are not relevant in clinical
and food environment in Portugal, resistance genes, like vanA
and vanB, are disseminated in both environments, in the case
of vanA, and only in the clinical settings, in the case of vanB.
Although the presence of vanA genes is generalized, it does not
imply a resistance phenotype, which is probably due to lack of
a complete and functional Tn1546 element. The heterogeneity
of vanA carrying element in the isolates studied, even in
genetically undistinguishable isolates, is once again described.
But, as opposite to the generally published works, it describes a
genetically variable unfunctional Tn1546. This is probably due
to the lack of selective pressure of the studied isolates. Both the
antibiotic and the resistance genes are needed to produce a
clinical resistance problem (Levy, 2002). Low use of
vancomycin in Portugal, and in Europe in general, has so far
protected people from vancomycin resistance in hospitals.
However, from what has been shown with our work, the
resistance gene is, or has been, present in both dairy food and in
clinical environments. Therefore, if vancomycin use increases
in Portuguese hospitals, the resistance gene will become more
prevalent and the resistance problem will rise. This work also
shows that MIC determinations together with the search for
vanA or vanB genes is not enough to categorize and predict
the isolate behaviour to vancomycin.
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SHORT REPORT
Enterococcus hirae causing wound infections in a hospital
Ta^nia C Ribeiro，Vera Pinto，Frèdèric Gaspar，Maria F S Lopes
［Abstract］　Ｒｅｐｏｒｔｓ ｏｆ ｎｏｓｏｃｏｍｉａｌ ｉｎｆｅｃｔｉｏｎｓ ｃａｕｓｅｄ ｂｙ Enterococcus hirae（E．hirae） ａｒｅ ｒａｒｅ．Ｔｏ ｏｕｒ ｋｎｏｗｌｅｄｇｅ
ｔｈｉｓ ｉｓ ｔｈｅ ｆｉｒｓｔ ｄｅｓｃｒｉｐｔｉｏｎ ｏｆ E．hirae ａｓｓｏｃｉａｔｅｄ ｗｉｔｈ ｗｏｕｎｄ ｉｎｆｅｃｔｉｏｎｓ ｉｎ ｈｕｍａｎｓ．Ｔｗｏ E．hirae ｓｔｒａｉｎｓ ｗｅｒｅ ｉｓｏｌａｔｅｄ
ｆｒｏｍ ｗｏｕｎｄ ｉｎｆｅｃｔｉｏｎｓ ｉｎ ｄｉｆｆｅｒｅｎｔ ｐａｔｉｅｎｔｓ．Ｔｈｅｙ ｗｅｒｅ ｂｏｔｈ ｒｅｓｉｓｔａｎｔ ｔｏ ｍｅｔｈｉｃｉｌｌｉｎ，ｋａｎａｍｙｃｉｎ，ｎｅｔｉｌｍｙｃｉｎ，ｃｌｉｎｄａｍｙ唱
ｃｉｎ，ｌｉｎｃｏｍｙｃｉｎ，ｃｏｌｉｓｔｉｎ ａｎｄ ｐｏｌｙｍｙｘｉｎ Ｂ，ｄｅｓｃｒｉｂｅｄ ａｓ ａｓｓｏｃｉａｔｅｄ ｔｏ ｔｈｅ ｇｅｎｕｓ Ｅｎｔｅｒｏｃｏｃｃｕｓ．Ｔｈｅ ｓｃｒｅｅｎｉｎｇ ｏｆ ｖｉｒｕ唱
ｌｅｎｃｅ ｆａｃｔｏｒｓ ａｓｓｏｃｉａｔｅｄ ｗｉｔｈ ｅｎｔｅｒｏｃｏｃｃａｌ ｉｎｆｅｃｔｉｏｕｓ ａｂｉｌｉｔｙ ｒｅｖｅａｌｅｄ ｔｈａｔ ｂｏｔｈ E．hirae ｓｔｒａｉｎｓ ｃａｒｒｉｅｄ ｔｈｅ ｃｙｌ，ｆｓｒ ａｎｄ
ｇｅｌＥ唱ｓｐｒＥ ｏｐｅｒｏｎｓ，ａｌｌ ａｓｃｒｉｂｅｄ ａ ｒｏｌｅ ｉｎ ｖｉｒｕｌｅｎｃｅ ｉｎ E．faecalis．Ａｌｔｈｏｕｇｈ ｎｏｔ ｃｌｏｎｅｓ ｔｈｅ ｔｗｏ ｓｔｒａｉｎｓ ｗｅｒｅ ｒｅｌａｔｅｄ，ａｓ
ｒｅｖｅａｌｅｄ ｂｙ ＰＦＧＥ ａｎａｌｙｓｉｓ．Ｏｖｅｒａｌｌ，ｏｕｒ ｒｅｓｕｌｔｓ ｄｅｍｏｎｓｔｒａｔｅ ｔｈｅ ｐｏｔｅｎｔｉａｌ ｏｆ E．hirae ｓｔｒａｉｎｓ ｂｏｔｈ ｔｏ ｃａｕｓｅ ｈｏｓｐｉｔａｌ
ｏｕｔｂｒｅａｋｓ ａｎｄ ａｓ ｖｉｒｕｌｅｎｃｅ ｔｒａｉｔ ｃａｒｒｉｅｒｓ．
［Key words］　Enterococcus hirae；ｗｏｕｎｄ ｉｎｆｅｃｔｉｏｎｓ；ａｎｔｉｂｉｏｔｉｃ ｒｅｓｉｓｔａｎｃｅ；ｃｙｌ；ｆｓｒ；ｇｅｌＥ
INTRODUCTION
Ｅｎｔｅｒｏｃｏｃｃｉ ａｒｅ ｗｉｄｅｓｐｒｅａｄ ｉｎ ｎａｔｕｒｅ ａｎｄ ａｒｅ ｐａｒｔ ｏｆ
ｔｈｅ ｃｏｍｍｅｎｓａｌ ｆｌｏｒａ ｏｆ ｈｕｍａｎ ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌ ａｎｄ ｇｅｎｉ唱
ｔｏｕｒｉｎａｒｙ ｔｒａｃｔｓ．Ｅｎｔｅｒｏｃｏｃｃｉ ａｒｅ ｏｆｔｅｎ ｉｍｐｌｉｃａｔｅｄ ｉｎ ｉｎ唱
ｆｅｃｔｉｏｎｓ ｏｆ ｔｈｅ ｕｒｉｎａｒｙ ｔｒａｃｔ ａｎｄ ａｂｄｏｍｅｎ ｏｒ ｏｆ ｓｕｐｅｒｆｉ唱
ｃｉａｌ ｗｏｕｎｄｓ ｉｎ ｈｏｓｐｉｔａｌｉｚｅｄ ｐａｔｉｅｎｔｓ，ｂｕｔ ｃａｎ ａｌｓｏ ｃａｕｓｅ
ｓｅｖｅｒｅ ｉｎｆｅｃｔｉｏｎｓ ｓｕｃｈ ａｓ ｂａｃｔｅｒａｅｍｉａ，ｅｎｄｏｃａｒｄｉｔｉｓ ａｎｄ
ｏｃｃａｓｉｏｎａｌｌｙ ｍｅｎｉｎｇｉｔｉｓ ｏｒ ｐｎｅｕｍｏｎｉａ．Ａｓ ｏｐｐｏｒｔｕｎｉｓｔｉｃ
ｐａｔｈｏｇｅｎｓ ｔｈｅｙ ａｒｅ ｅｍｅｒｇｉｎｇ ａｓ ａｎ ｉｍｐｏｒｔａｎｔ ｃａｕｓｅ ｏｆ
ｈｏｓｐｉｔａｌ唱ａｃｑｕｉｒｅｄ ｉｎｆｅｃｔｉｏｎｓ．Ｎｏｓｏｃｏｍｉａｌ ｉｎｆｅｃｔｉｏｎｓ ｂｙ
ｅｎｔｅｒｏｃｏｃｃｉ ａｒｅ ｍａｉｎｌｙ ｄｕｅ ｔｏ ｔｗｏ ｓｐｅｃｉｅｓ，E．faecalis
ａｎｄ E．faecium．Ｆｒｅｑｕｅｎｔｌｙ ｏｔｈｅｒ ｓｐｅｃｉｅｓ ａｒｅ ｎｅｇｌｅｃｔｅｄ
ｂｅｃａｕｓｅ ｔｈｅｙ ａｒｅ ｒａｒｅｌｙ ａｓｓｏｃｉａｔｅｄ ｗｉｔｈ ｓｅｖｅｒｅ ｉｎｆｅｃ唱
ｔｉｏｎｓ ｉｎ ｈｕｍａｎｓ．Ｈｏｗｅｖｅｒ，ｔｈｅｒｅ ａｒｅ ｓｏｍｅ ｒｅｐｏｒｔｓ ｏｆ ｉｎ唱
ｆｅｃｔｉｏｎｓ ｄｕｅ ｔｏ E．gallinarum，E．casseliflavus［１，２］ ，E．
raffinosus［３］ ａｎｄ E．hirae［４，５］．Ｔｈｅ E．hirae ｓｐｅｃｉｅｓ ｉｓ
ｗｉｄｅｌｙ ｋｎｏｗｎ ｔｏ ｃａｕｓｅ ｉｎｆｅｃｔｉｏｎｓ ｉｎ ａｎｉｍａｌｓ［６，７］ ，ｂｕｔ ｉｓ
ｒａｒｅｌｙ ａｓｓｏｃｉａｔｅｄ ｗｉｔｈ ｈｕｍａｎ ｉｎｆｅｃｔｉｏｎｓ．Ｓｅｖｅｒａｌ ａｕｔｈｏｒｓ
ｈａｖｅ ｒｅｐｏｒｔｅｄ ｔｈｅ ｉｓｏｌａｔｉｏｎ ｏｆ E．hirae ｆｒｏｍ ｃｌｉｎｉｃａｌ
ｓｐｅｃｉｍｅｎｓ ｆｒｏｍ ｖａｒｉｏｕｓ ｓｏｕｒｃｅｓ［８，９］．Ｉｎ ａｌｌ ｓｔｕｄｉｅｓ ｐｕｂ唱
ｌｉｓｈｅｄ ｔｈｅ ｉｓｏｌａｔｉｏｎ ｏｆ E．hirae ｃｏｒｒｅｓｐｏｎｄｓ，ｏｎ ａｖｅｒａｇｅ，
ｔｏ １％ ｏｆ ａｌｌ ｔｈｅ ｅｎｔｅｒｏｃｏｃｃｉ ｉｓｏｌａｔｅｓ ｉｄｅｎｔｉｆｉｅｄ．Ｓｉｎｃｅ
ｔｈｉｓ ｉｓ ｓｕｃｈ ａ ｒａｒｅ ｓｐｅｃｉｅｓ ｉｎ ｃｌｉｎｉｃａｌ ｅｎｖｉｒｏｎｍｅｎｔ ｉｔ ｉｓ
ｃｏｍｐｒｅｈｅｎｓｉｂｌｅ ｔｈａｔ ｉｔ ｉｓ ｉｎｆｒｅｑｕｅｎｔｌｙ ａｓｓｏｃｉａｔｅｄ ｗｉｔｈ
ｉｎｆｅｃｔｉｏｎｓ ｉｎ ｈｕｍａｎｓ．
MATERIALS AND METHODS
Ｆｒｏｍ Ｎｏｖｅｍｂｅｒ ２００４ ｔｏ Ｊａｎｕａｒｙ ２００６，１０９ Ｅｎｔｅｒｏｃｏｃ唱
ｃｕｓ ｓｐｐ．ｉｓｏｌａｔｅｓ ｗｅｒｅ ｒｅｃｏｖｅｒｅｄ ｆｒｏｍ ｐａｔｉｅｎｔｓ ｉｎ ａ Ｐｏｒ唱
ｔｕｇｕｅｓｅ Ｈｏｓｐｉｔａｌ．Ｔｈｅ ｉｓｏｌａｔｅｓ ｗｅｒｅ ｉｄｅｎｔｉｆｉｅｄ ｂｙ
ＶＩＴＥＫ １２０ ｓｙｓｔｅｍ （ ＢｉｏＭéｒｉｅｕｘ， Ｍａｒｃｙ唱ｌ摧Ｅｔｏｉｌｅ，
Ｆｒａｎｃｅ） ａｓ E．faecalis（８１／１０９），E．faecium（２６／１０９）
ａｎｄ E．hirae （２／１０９），４８ ｃｏｒｒｅｓｐｏｎｄｉｎｇ ｔｏ ７４畅３％，
２３畅９％ ａｎｄ １．８％，ｒｅｓｐｅｃｔｉｖｅｌｙ．Ｔｈｅｓｅ ｃｌｉｎｉｃａｌ ｉｓｏｌａｔｅｓ
ｗｅｒｅ ｒｅｃｏｖｅｒｅｄ ｆｒｏｍ ｗｏｕｎｄ ｉｎｆｅｃｔｉｏｎｓ（５４畅１％），ｂｌｏｏｄ
（２５畅７％），ｃａｔｈｅｔｅｒｓ（１０畅１％），ｕｒｉｎｅ（５畅５％） ａｎｄ ｔｈｅ
ｒｅｍａｉｎｉｎｇ ４畅６％ ｗｅｒｅ ｒｅｃｏｖｅｒｅｄ ｆｒｏｍ ｏｔｈｅｒ ｂｉｏｌｏｇｉｃａｌ
ｐｒｏｄｕｃｔｓ ａｎｄ ｄｅｖｉｃｅｓ （ ｕｎｐｕｂｌｉｓｈｅｄ ｒｅｓｕｌｔｓ）．Ｔｈｅ ｔｗｏ
E．hirae ｉｓｏｌａｔｅｓ，ｎａｍｅｄ ＳＡＶＥ Ｈ１ ａｎｄ ＳＡＶＥ Ｈ２，ｗｅｒｅ
ｂｏｔｈ ｒｅｓｐｏｎｓｉｂｌｅ ｆｏｒ ｗｏｕｎｄ ｉｎｆｅｃｔｉｏｎｓ ｉｎ ｔｗｏ ｄｉｆｆｅｒｅｎｔ
ｐａｔｉｅｎｔｓ ａｎｄ ｗｅｒｅ ｉｓｏｌａｔｅｄ ｗｉｔｈｉｎ ｏｎｅ ｗｅｅｋ．Ｔｈｅｓｅ ｔｗｏ
E．hirae ｉｓｏｌａｔｅｓ ｗｅｒｅ ｔｅｓｔｅｄ ｆｏｒ ｔｈｅｉｒ ｓｕｓｃｅｐｔｉｂｉｌｉｔｙ ｔｏ唱
ｗａｒｄｓ ３０ ａｎｔｉｂｉｏｔｉｃｓ ａｓ ｐｒｅｖｉｏｕｓｌｙ ｄｅｓｃｒｉｂｅｄ ｂｙ Ｌｏｐｅｓ，
et al ．［１０］ ＰＦＧＥ ｏｆ ＳｍａＩ ｄｉｇｅｓｔｅｄ ｔｏｔａｌ ＤＮＡ ｏｆ ｂｏｔｈ
Ｉｎｓｔｉｔｕｔｏ ｄｅ Ｂｉｏｌｏｇｉａ Ｅｘｐｅｒｉｍｅｎｔａｌ ｅ Ｔｅｃｎｏｌóｇｉｃａ（ ＩＢＥＴ） ／Ｉｎｓｔｉｔｕｔｏ ｄｅ Ｔｅｃｎｏｌｏｇｉａ Ｑｕíｍｉｃａ ｅ Ｂｉｏｌóｇｉｃａ（ ＩＴＱＢ），Ｕｎｉｖｅｒｓｉｄａｄｅ Ｎｏｖａ ｄｅ Ｌｉｓｂｏａ，Ａｐａｒｔａｄｏ １２，
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